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COORDINATING STEM CELL BEHAVIOR IN THE HAIR FOLLICLE 
 
Chiung-Ying Chang, Ph.D. 
The Rockefeller University 2014 
 
Tissue stem cells perform important functions throughout an organism’s life. 
They generate new cells to replenish cells that are lost during normal wear and tear or in 
response to acute injury. Remarkably, hair follicles naturally undergo repetitive cycles of 
regeneration and degeneration, a process that is accomplished with the support of stem 
cells within the hair follicles. It is this feature that makes this miniorgan an attractive 
model system to study stem cell biology.  
Interestingly, hair follicle is home to two distinct stem cell populations: epithelial 
hair follicle stem cells (HFSCs), which contribute to the formation of hair shafts, and 
melanocyte stem cells (McSCs), which contribute to hair pigmentation. During the hair 
cycle, HFSCs and McSCs work in harmony to generate a pigmented hair. However, little 
is known about the inter-stem-cell crosstalk governing this intricate coordination.  
To identify candidate transcription factors that specify HFSCs in mouse, the gene 
expression profiles of the HFSCs residing in the bulge of hair follicles versus the 
epithelial basal cells outside the bulge were compared. One of the “molecular signature” 
genes being upregulated in the HFSCs is nuclear factor I/B (Nfib). Embryonic ablation of 
Nfib revealed that Nfib is required for the hair follicle morphogenesis and hair follicle-
mediated re-epithelization during wound repair.  
Meanwhile, to address the function of Nfib in established HFSCs, I conditionally 
induced Nfib ablation in the adult HFSCs. Interestingly, I found that the ablation of Nfib 
in the adult HFSCs did not perturb the HFSC maintenance, as the growth of hair follicles 
and the hair cycle proceeded relatively normally. Instead, and even more unexpected, 
NFIB loss in the HFSCs promoted the proliferation and precocious differentiation of their 
nearby McSCs. These findings provide new insights into how McSC and HFSC 
behaviors maintain reliance upon cooperative factors within the hair follicle and how this 
might be uncoupled in injury, stress and disease states.   
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Stem cells perform important functions for living organisms throughout their 
lives. They are distinguished from other cell types by their self-renewing ability to retain 
stem cell identity, and capability to differentiate into tissue specific types of cells. 
Throughout an organisms’ life, tissue stem cells can generate new cells to replenish cells 
that are lost during injury or normal wear and tear. Given their unique regenerative 
capacity, understanding the molecular basis of stem cell specification and maintenance 
offers new potentials for improving the treatment for diseases and wounds.  
Hair is one of the defining characteristics of mammals. Hair is not only important 
for thermal regulation in animals, but also aids in sensing the environment, and with 
specific color patterns, can facilitate social interactions. Remarkably, the hair follicle, a 
structure cyclically generating a hair shaft, naturally undergoes repetitive regeneration 
and degeneration, a process that is accomplished with the support of stem cells within 
hair follicles. It is this feature and the synchrony of hair follicles in young mice that make 
this miniorgan a favorable model system to study stem cell biology. Interestingly, there 
are two populations of stem cells sharing a residence in hair follicles:  hair follicle stem 
cells (HFSCs), which produce the progeny that form the follicular structure and hair 
shaft; and melanocyte stem cells (McSCs), which are responsible for generating the 
mature melanocytes that transfer pigment to hair shaft cells. They coordinate their 
activities during each hair cycle to grow pigmented hair.  
In this chapter, I summarize recent studies of individual stem cell populations 
within hair follicles and discuss the importance of coordinating stem cell behaviors for 
tissue regeneration. Beginning with a description of the epithelium and hair follicle 
development, I focus on a historical summary of HFSC identification and the regulation 
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of HFSC characteristics. Then, I turn the focus to the melanocyte lineage, describing the 
origin of melanocytes, molecular basis of melanocyte development and recent studies of 
McSC regulation. Finally, I discuss how two stem cell populations synchronize their 
behaviors during the hair cycle.  
 
Development of the epidermis and hair follicles 
The outermost part of skin is called the epidermis, a stratified squamous 
epithelium, which provides a protective barrier against dehydration, scratches and 
environmental attacks such as pathogen infection. Underlying the epidermis is connective 
tissue dermis, which is separated from the epidermis by a basement membrane; 
underlying the dermis is the subcutis, which is composed of adipocytes for fat storage 
(Fig. 1-1a). Growing downward into the dermis and even the subcutis, specific areas of 
mammal epidermis also give rise to several appendages including sweat glands, hair 
follicles and their associated sebaceous glands (Fig. 1-1a). Notably, in contrast to human 
skin covered with very abundant sweat glands for thermoregulation, mouse and non-
primate mammal skin have limited sweat glands and are dominated instead by the 
presence of hair follicles.  
Developmentally, the epidermis is derived from ectoderm, which is formed during 
gastrulation. Further, the ectoderm is divided into three domains as a consequence of 
neural induction occurring around embryonic (E) 8.5 (Fig. 1-2a).  During neurulation, 
central ectodermal tissue is thickened and becomes neural plate, which gives rise to brain 
and spinal cord of an organism. Lying next to the neural plate is neural plate border, 
which becomes neural crest, and non-neural ectoderm, which develops into the epidermis 
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(Chapter 3 in (Gilbert, 2010)). 
The epidermis appears first as a single layer structure by E9.5. From E14.5, its 
thickness is expanded to become a four-layered stratified squamous epithelium, which is 
completed around E17.5 (Fig. 1-2b) (reviewed in (Blanpain and Fuchs, 2006)). As 
development proceeds, proliferative basal cells gradually weaken their adhesion to the 
basement membrane, exiting their residence and moving upward to further differentiate  
 
 
Figure 1-1. Architecture of mouse skin. a, Cross-section views of mouse dorsal skin. 
Mammalian skin consists of three major layers: the epidermis, the dermis and the 
subcutis. The epidermis gives rise to several appendages including hair follicles and their 
associated sebaceous glands. Melanins, present only in hair follicles of mouse dorsal 
skin, were detected by Fontana-Masson silver staining followed by Nuclear Fast Red. 
Scale bars: 25μm. b, Epidermal stratification. During skin development, the epidermis 
appears first as a single layer (basal layer), which resides on the basement membrane and 
cells in which divide symmetrically to support the expansion of skin surface.  During 
epidermal stratification, about 70% of proliferative basal cells undergo asymmetric 
division to establish differentiated cell layers sequentially including the spinous layer, 
granular layer and cornified layer. Individual layer can be identified by the presence of 
specific proteins. After stratification, basal cells still constantly proliferate and supply 
new cells into differentiated layers to support long-term skin renewal and wound healing.  
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into suprabasal spinous cells and later granular cells. Interestingly, the stratification can 
also be achieved through asymmetric division, by which basal cells orient their mitotic 
plane of cell cleavage perpendicularly to the basement membrane and place one daughter 
cell in the upper layer (Lechler and Fuchs, 2005).  
Along the path, epidermal cells (keratinocytes) switch their gene expression 
profiles to fulfill differentiation. Basal layer keratinocytes express two markers keratin 5 
(Krt5; K5) and keratin 14 (K14), and as they exit, they downregulate these keratins and 
express genes encoding keratin 1 (K1) and keratin 10 (K10).  When this spinous layer 
 
 
Figure 1-2. Illustration of neurulation. a, The ectoderm is divided into three domains 
during neurulation including neural plate (purple), neural plate border (green) and non-
neural ectoderm (blue). b-c,  Two sides of the neural plate borders (green) elevate and 
fuse with each other (neural fold), causing the neural plate to roll into a neural tube 
separated from non-neural ectoderm. d, Soon after, neural crest cells derived from neural 
plate borders delaminate from the neural tube, migrating either dorsal-laterally to become 
melanocytes or ventrally to differentiate into neurons, Schwann cells and many other cell 
types. Neural tube further gives rise to brain and spinal cord, and non-neural ectoderm 
further becomes the epidermis. Figures are modified from Gammill and Bronner-Fraser, 
2003. 
5
differentiates further, loricrin (Lor) and filaggrin (Flg) are induced as the granular layer 
forms (Fig. 1-2b). When granular cells terminally differentiate, transcriptional and 
metabolic activities cease, organelles are lost and cells die when they reach the cornified 
layer (or called stratum corneum).  These dead squames are sacs of crosslinked proteins 
that are sealed by lipids at the skin surface to constitute a protective barrier. Throughout 
life, the dead keratinocytes in the cornified layer are constantly shed and replaced by new 
cells generated by basal cells from the bottom layer, which are epidermal stem cells. 
They stay undifferentiated during epidermal stratification and maintain their stemness in 
adult to accomplish the renewal of the skin surface.  
Besides epidermis, embryonic epidermal cells also give rise to hair follicles and 
their associated sebaceous glands (Fig. 1-1a and 1-3a) (reviewed in (Paus et al., 1999)). 
The mouse hair coat consists of four different pelage hair types named guard, awl, 
auchene, and zigzag hairs, which are formed in consecutive waves during embryogenesis 
and completed by early postnatal life (Schlake, 2007). The hair follicles of primary or 
guard hairs appear first at E14.5, followed by secondary awl and auchene follicle 
induction at E16.5, and finally zigzag hair follicles at ~E18.5 (reviewed in (Schmidt-
Ullrich and Paus, 2005)). Hair follicle induction depends on a series of reciprocal 
communications between the epithelium and underlying mesenchyme. At the beginning 
of the follicle formation, signals from dermal cells are thought to initiate epidermal 





Figure 1-3. Hair follicle morphogenesis and hair cycle.  a, Hair follicle 
morphogenesis. Hair follicles are formed during embryonic stage. The reciprocal 
interactions between epidermal and dermal cells drive epidermal invagination to form a 
placode concomitant with the aggregation of dermal cells, called dermal condensate. 
Cells in the placode proliferate and the placode elongates to become a hair germ and 
subsequently a hair peg, which warps the dermal papilla (DP). Melanoblasts in the 
epidermis migrate into hair follicles. The DP acts as a signal center to induce the 
differentiation of melanoblast to become differentiated melanocytes (red) as well as the 
differentiation of transit-amplifying matrix cells to form differentiated hair layers 
including hair shaft, inner root sheath (IRS) and companion layer surrounded by outer 
root sheath (ORS). Keratinocytes in the upper region of hair germ/peg are SOX9+ and 
stay undifferentiated as HFSC precursors, and melanoblasts there become melanocyte 
stem cells (McSCs; green). Around one week after birth, the formation of hair follicles is 
completed and hair shafts start coming out of skin surface. By P16, it enters the 
destructive phase (catagen), in which the lower portion of hair follicles is degenerated 
and the DP is dragged upward to stay attached to the base of degenerating hair follicles. 
b, Hair cycle. After catagen, hair follicles, which have two major regions including the 
bulge and the secondary hair germ (HG), go into the resting phase (telogen). When 
activated by signals from the DP in early anagen, CD34+ bulge HFSCs and and HG cells 
proliferate to generate a new hair follicle. The old hair shaft in the bulge, called the club 
hair, might stay there or sometimes detach from the new hair follicle, the process called 






Soon thereafter, further signal interactions between the hair placode and a local 
aggregation of fibroblasts (dermal condensate) directly below guide the elongation of 
placode forming the hair germ. Regional variations in proliferation rate appear in the hair 
germ as it grows. Low-proliferative cells in the upper region of follicles become SOX9 
positive and are specified as the precursors of hair follicle stem cells (HFSCs) (Nowak et 
al., 2008) (Fig. 1-3a). Conversely, cells in the high-proliferative region in the leading 
edge give rise to the hair matrix, which gradually wraps around the dermal condensate 
and then forms a mature dermal papilla (DP). The DP acts as a signal center to instruct 
nearby matrix cells to proliferate and further differentiate into a three-layered central hair 
shaft (cuticle, cortex, medulla), a three-layered inner root sheath (IRS; Henle, Huxley, 
cuticle) and a companion layer (Fig. 1-3a) (Hardy, 1992). The outer layer is called outer 
root sheath (ORS), which is contiguous with the basal layer of the epidermis and is 
surrounded externally by the basement membrane. Postnatally, hair follicles keep 
growing and reach maturation with maximal length around one week after birth, the time 
when the hair shaft starts extruding out of skin surface.  
 
Hair cycle 
Following morphogenesis, hair follicles undergo cyclic degeneration and 
regeneration throughout the life of the animal. There are four major phases in the hair 
cycle: the growth phase (anagen), the destructive phase (catagen), the resting phase 
(telogen) and the shedding phase (exogen) (reviewed in (Müller-Röver et al., 2001)) (Fig. 
1-3b). As morphogenesis is completed, matrix cells remain proliferative to fuel the 
growth of hair shaft for another 7-9 days until ~postnatal (P) 16, when hair follicles enter 
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the destructive catagen phase. In catagen, the lower two-third or cycling portion of hair 
follicle rapidly degenerates in 2-3 days owing to the cells there undergoing apoptosis. At 
the same time, the DP is unwrapped from the matrix, dragged upward to keep attached 
with the surviving region of the hair follicle. Thus, the upper, permanent region of hair 
follicle survives through catagen and subsequently enters the dormant telogen phase, in 
which follicle cells remain mitotically quiescent until the beginning of next hair growth. 
In the following anagen, a new hair follicle is formed next to the original hair follicle, in 
which the old hair shaft (named club hair) sits in a silo-like structure separated from the 
anagen portion.  Quite frequently, when the new hair follicle grows, club hairs shed off 
and the process is called exogen (Milner et al., 2002). 
In mice, hair follicles rest in telogen for one to two days in the first hair cycle, 
while with additional hair cycles, they stay in telogen progressively longer, from weeks 
to months accompanied with more asynchronous activation pattern of hair follicles. 
Conversely, the duration of anagen is relatively consistent, which lasts 2-3 weeks 
resulting in the growth of 1cm-long hair in mouse. Thus, the periodic cycling of hair 
regeneration renews the mouse hair coat, implicating the existence of stem cells to fuel 
the regenerative process. 
 
Hair follicle stem cells  
Hair follicle stem cells (HFSCs) reside within a discrete microenvironment, which 
is the permanent, bulge structure of the hair follicle that remains after degeneration in 
catagen (Fig. 1-3b) (Cotsarelis et al., 1990; Tumbar et al., 2004). Specified during 
morphogenesis, the cells located in the upper ORS stay undifferentiated during hair 
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growth, and they escape from apoptosis in catagen, becoming HFSCs in adults (Nowak et 
al., 2008) (Fig. 1-3a). Throughout most of the resting phase of the hair cycle, they stay 
quiescence; while in response to activating signals released from the DP at the onset of 
anagen, HFSCs become proliferative to support hair growth. Notably, only in a rather 
short period of early anagen do they enter the cell cycle and perform a limited number of 
divisions (average ~3 times); nevertheless, they produce and supply sufficient number of 
new cells to the matrix, in which transit-amplifying or progenitor cells proliferate 
intensively throughout anagen to generate hair shaft and other differentiated layers within 
the follicles (Sotiropoulou et al., 2008; Waghmare et al., 2008; Zhang et al., 2009). 
Besides contributing to hair growth, HFSCs are multipotent and engaging in multiple 
lineages including sebaceous gland (Horsley et al., 2006; Oshima et al., 2001) and 
surface epidermis (Ito et al., 2005; Taylor et al., 2000a; Tumbar et al., 2004) when 
recruited to help in wound repair.   
Given their slow cycling nature, HFSCs were first identified by nucleotide pulse-
chase experiments. When radioactive thymidines were given to the mice (pulse), they 
were incorporated into DNA during cell division. Once labeled, cells in the bulge that 
cycle slowly retained the markers over an extended period of time (chase) and were 
identified as label-retaining cells (LRCs), which are distinguished from other rapidly-
proliferating cells that constantly dilute out the label during cell division (Cotsarelis et al., 
1990). Evidence from subsequent experiments using a second pulse of nucleotide 
analogue to trace bulge LRC fate revealed their ability to proliferate and contribute to 
follicle regeneration, a feature of stem cells (Taylor et al., 2000b). The hypothesis was 
further strengthened when new markers and methods were developed for the purification 
11
and characterization of this population. Those included an in vivo pulse chase system 
coupled with doxycycline-inducible GFP-tagged histone labeling (Tet-Off-H2B-GFP) 
(Tumbar et al., 2004), K15 promoter-mediated fluorescent protein expression in the bulge 
(Morris et al., 2004), and identification of antibodies recognizing bulge cell surface 
markers CD34 and α6-Integrin (Blanpain et al., 2004; Trempus et al., 2003). All these 
methods were compatible with fluorescence-activated cell sorting (FACS) for isolating 
bulge cells, making it possible to study the molecular basis specifying their unique 
features. In addition, the Tet-Off-H2B-GFP mouse carrying strong labeling signals 
permitted monitoring of the LRC behaviors. Besides forming new hair follicles, bulge 
LRCs also contribute to repairing the epidermis in response to wounding (Tumbar et al., 
2004).  
  
Bulge hair follicle stem cells vs. hair germ cells 
There is a group of cells lying at the base of resting (telogen) hair follicle between 
the bulge and the signal center DP, The region is called the hair germ (HG), sometimes 
called secondary HG to distinguish from primary HG formed during morphogenesis (Fig. 
1-3b). Monitoring the relationship of bulge HFSCs and HG cells reveals that HG cells, 
staying in closee proximity to the DP, act as the first responders to DP signals to fuel the 
initiating stage of hair growth, which is then further maintained by the activation of bulge 
stem cells as a second step of this process (Greco et al., 2009; Panteleyev et al., 2001). 
Like bulge stem cells, HG cells are quiescent throughout most of the resting phase of the 
hair cycle; during the transition from telogen to anagen, HG cells become proliferative 
while the timing of their activation is earlier than bulge HFSCs. In vitro, HG cells also 
proliferate sooner but surprisingly display a shorter-lived potential than bulge stem cells. 
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Molecularly, bulge HFSCs and HG cells can be separated by cell surface marker CD34, 
which is expressed in the bulge but not HG, while they also share the expression of genes 
that are essential for bulge HFSC function including Lhx2, Sox9 and Tcf3 
{Greco:2009ik}.   
 Thus, it is tempting to speculate that the cells in the HG, a transient structure of 
the hair follicle, act as progenitors contributing quickly and largely to the transit 
amplifying pool of matrix cells that maintain contact with the DP in the mature hair 
follicle and that fuel the production of the hair shaft and its channel (IRS). By contrast, 
bulge HFSCs, which are activated later and are used more sparingly to extend the ORS, 
are thought to serve as long-term HFSCs (Rompolas et al., 2013), which not only sustains 
hair growth but also renew themselves to generate a new bulge and HG during each hair 
cycle (Hsu et al., 2011a).  
 
Molecular regulation of hair follicle stem cell behavior 
Stem cell activation relies on a series of activating signals counterbalancing 
inhibitory cues from the niche. In the long period of rest in telogen, high levels of bone 
morphogenetic protein (BMP) signals are critical for maintaining HFSCs in a quiescent 
state. When activated upon ligand binding, BMP receptors induce phosphorylation of 
mediators SMAD1, 5 and 8 (pSMAD1/5/8), which are recognized as the sign of BMP 
activation. Further, pSMAD1/5/8 forms a complex with their partner SMAD4 and 
translocate to the nucleus, where they act as transcription factors to modulate gene 
expression (reviewed in (Shi and Massagué, 2003)). During telogen, bulge and HG cells 
display nuclear pSMAD1/5/8 signals (Andl et al., 2004; Zhang et al., 2006), which is 
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accompanied by the upregulation of their targets inhibitor of DNA binding (Id) genes 
revealed in HFSC transcriptional profiles (Morris et al., 2004; Tumbar et al., 2004). 
Consistent with the notion that BMP activation promotes quiescence, BMP receptor-
deficient hair follicles fail to stay in telogen because mutant HFSCs lose dormancy and 
begin to proliferate rapidly (Kobielak et al., 2007; Zhang et al., 2006). Complicating the 
phenotype, these abnormally activated stem cells, however, cannot generate a proper 
follicular structure. They are further blocked in terminal differentiation stages, suggesting 
that BMP signaling has additional roles in hair shaft differentiation of the normal hair 
matrix (Andl et al., 2004; Kobielak et al., 2003; Kulessa et al., 2000).  
By the transition of telogen to anagen, while there are still abundant BMP ligands 
coming from numerous sources within the bulge and also exterior dermal environment 
(Blanpain et al., 2004; Hsu et al., 2011a; Plikus et al., 2008; Zhang et al., 2006), the DP 
lying beneath the HG augments the secretion of antagonist noggin (NOG), which 
overrides BMP’s ability of inhibiting HFSC activation to induce hair growth. 
(Botchkarev et al., 2001; Kulessa et al., 2000; Zhang et al., 2006). In concert with BMP 
inhibition at the onset of anagen, upregulated within the DP are several other activating 
cues including FGF7 (Greco et al., 2009) and TGF-β factors (Oshimori and Fuchs, 2012), 
accompanied with the activation of Wnt signaling in the HG (Celso et al., 2004; Greco et 
al., 2009; Lowry et al., 2005; Rendl et al., 2005; Van Mater et al., 2003).  
Following a two-step model for HFSC activation, the first responders to receive 
and react to those positive regulators are HG cells, which drive the initiation of hair 
growth. Soon after, bulge stem cells are activated to further sustain the hair growth 
(Greco et al., 2009). This raises an interesting question: what signals activate bulge 
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HFSCs that stay one-step away from the DP? It is still an open question in regard to the 
direct activating signals acting on the bulge stem cells. Possibly, bulge stem cells also 
respond to the DP signals yet in a rather distant manner than HG cells. It has also been 
proposed that in a paracrine fashion, DP-activated HG cells further pass down secondary 
activating cues back to the bulge as factors such as sonic hedgehog (Shh) appear when 
the HG is active and enlarged to become the matrix (Jaks et al., 2008; Panteleyev et al., 
2001; Xiong et al., 2013). It is also possible that besides the DP, HFSC activation relies 
on other uncharacterized niche components surrounding hair follicles such as the dermis 
and subcutis (Festa et al., 2011; Plikus et al., 2008).  
Within the nucleus, several transcription factors have also been found to be 
involved in bulge regulation. For instance, NFATc1, which is enriched in telogen bulge, 
is required for maintaining HFSC quiescence (Horsley et al., 2008). Following BMP 
inhibition, Nfatc1 is down regulated during the onset of anagen, suggesting its inhibitory 
role in HFSC activation. Loss of function studies supported the notion, since hair follicles 
losing Nfatc1 are not able to stay in telogen, owing to the ectopic expression of positive 
cell cycle regulator Cdk4. Meanwhile, Lhx2-deficient hair follicles also lose quiescence 
and constantly re-enter the hair cycle (Folgueras et al., 2013; Rhee et al., 2006). 
Surprisingly however, and in contrast to Nfatc1 loss, Lhx2 loss results in HFSCs 
differentiating to become sebocytes. Additionally, although many HFSC transcription 
factors and other signature genes have been identified through the development of new 
purification methods and high-throughput sequencing techniques (Lien et al., 2011), the 
functions of most of these genes are still uncharacterized, and the links between 
extracellular signals and intrinsic factors also await to be uncovered.   
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Skin pigmentation 
Animal skins also display diverse color patterns and the coloration plays an 
essential role in the basic pursuits of life including survival and reproduction. For 
instance, some animals use cryptic colors and patterns to escape predators by blending 
into particular natural background (camouflage), while some animals defend themselves 
by displaying very bright coloration as warning signals. On the other hand, some animals 
use coloration to increase mating success by exhibiting attractive patterns to gain 
potential mates’ attentions. For humans, pigments not only contribute to skin coloration, 
but also provide protection against UV-induced DNA damage. As skin is directly 
exposed to high levels of sunlight, melanin can absorb UV or neutralize UV-induced 
reactive oxygen species (ROS), preventing the accumulation of DNA mutations in skin 
cells and reducing the incidence of skin cancers.   
Interestingly, different cell types are involved in generating pigments in different 
species. In Drosophila melanogaster, epithelial cells are responsible for producing 
pigments and creating pigmented cuticles in a cell-autonomous manner. In vertebrates, 
more specialized cells are used to produce pigments. In cold-blooded animals such as fish 
and amphibians, chromatophores can generate colorful pigments and they can further 
change body patterns rapidly by aggregating or dispersing pigments within them.  
Mammalian skins have chromatophore-like cells called melanocytes. Notably, 
different from cold-blooded animals, pigmentation in mammals is determined in a rather 
non-cell-autonomous way, in which melanocytes tightly interact with epidermal cells. In 
human, melanocytes reside in the basal layer of epidermis and intermingle with 
keratinocytes, where they produce pigments and transfer them to nearby keratinocytes to 
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impart color to the epidermis (Fig. 1-1b). In both human and mouse, melanocytes also 
reside in the bulb of mature hair follicles and work in harmony with matrix cells to 
transfer pigment to the differentiating hair cells (Fig. 1-1a). Interestingly, the number of 
melanocytes in human skin types is relatively constant in such a way that one melanocyte 
interacts with approximately 36 keratinocytes to form an epidermal-melanin unit 
(Fitzpatrick and Breathnach, 1963). Thus, color heterogeneity between different ethnic 
groups or even between different regions of skin from the same individual largely 
originates from varied pigment-producing activities of individual melanocytes (reviewed 
in Costin and Hearing, 2007). In response to stimuli such as UV, melanocytes increase 
pigment production, which is mediated by the activation of α-melanocyte-stimulating 
hormone (α-MSH)-induced cAMP/CREB pathway in melanocytes (Cui et al., 2007; 
D'Orazio et al., 2006).   
Surprisingly, melanocyte distributions are distinct in different parts of the skin. 
For instance, in the dorsal skin or most of the hairy regions of the mouse, melanocytes are 
present in hair follicles and are absent in surface epidermis. By contrast, melanocytes are 
in both compartments of non-hairy skin of ear and tail. Also, their territory is not limited 
to only one organ but they are also present in the eye, some internal organs and the inner 
ear (Colombo et al., 2011). Notably, eye pigmentation does not simply rely on 
melanocytes in uvea (pigmented layer of the eye). Retinal pigment epithelium (RPE) 
cells, which are specialized epithelial cells providing visual acuity, can also synthesize 
melanin to provide for photoprotection against UV-induced damage to the most bared 




Melanins, the basic unit of pigmentation, are the polymerized derivatives of the 
amino acid tyrosine after a series of oxidation reactions (Hearing and Tsukamoto, 1991; 
Hearing, 2011). Classified by their structures, there are two major types of melanins 
including black/brown eumelanins and pheomelanins with yellow or red color. In 
general, most of hairs contain a mixture of melanins while the proportion of the two 
different melanins determine a wide spectrum of hair/skin colors.    
In both melanocytes and eye RPE cells, melanins are synthesized in a specialized 
structure called melanosomes, which is a type of lysosome-related organelle with its 
contents derived from early endosomes (reviewed in Raposo and Marks, 2007). The 
process of melanosome formation and maturation can be divided into four stages 
according to their morphology and pigment density (Fig. 1-4). Melanosomes at the first 
two stages lack pigments but the structural component---premelanosome protein (PMEL), 
which is sorted into immature melanosomes to form scaffold fibrils completed by stage 2. 
Once the fibrous scaffolds are fully formed, melanin-synthesizing enzymes such as 
tyrosinase (TYR), tyrosinase-related protein1 (TYRP1) and dopachrome tautomerase 
(DCT or called TYRP2) are targeted to melanosomes, in which they convert tyrosine to 
melanin. Synthesized melanins are deposited onto the fibrils resulting in fibril thickening 
and darkening at stage 3; then, the fibrils become completely covered by melanins when 
melanosomes are mature at stage 4. In epidermal and hair follicle melanocytes, mature 
melanosomes are then delivered along microtubules to dendritic dips where they are 
transferred to surrounding keratinocytes, while RPE cells keep the melanosomes for 
themselves. The process of how melanocytes transfer melanosomes to keratinocytes is 
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unclear. Some hypotheses have been proposed that melanosome transfer could be 
mediated by exocytosis, cytophagocytosis, fusion and membrane vesicle transport 
(Yamaguchi and Hearing, 2009).  
Besides ubiquitous components from late endosomes or lysosomes, melanosomes 
harbor numerous melanocyte-specific genes for enzymes and structural components, 
which when mutated cause albinism in humans or coat-color defect in animals (reviewed 
in Hirobe, 2011).  For instance, albino mice have white hair coats owing to the mutations 
in Tyr, which encodes the most essential enzyme during pigment production; Tyrp1 and 
Dct mutations result in brown and diluted hair coats. Meanwhile, color switches between 




Figure 1-4. Melanosome maturation. Melanosomes (grey color) are derived from early 
endosomes accumulated with melanocyte-specific protein, PMEL. PMEL is a 
transmembrane protein, which is further cleaved by proprotein convertase in 
melanosomes (stage 1). As a result, the luminal fragment of PMEL dissociates from the 
membrane and forms melanosomal fibrils, completed in stage 2. As melanin-synthesizing 
enzymes such as tyrosinase and tyrosinase-related proteins are targeted to maturing 
melanosomes (stage 3), melanins are deposited onto the fibrils promoting the maturation 
of melanosomes (stage 4).  
 
19
displayed on melanocyte cell surface (Burchill et al., 1989; Robbins et al., 1993; 
Valverde et al., 1995). Inducing cAMP/CREB pathway, α-MSH signals increase 
tyrosinase activity and its level to promote dark eumelanin production (Bertolotto et al., 
1998; 1996; Price et al., 1998b). Notably, melanocytes with pigment-producing defects 
retain relatively normal morphology and are still present in skin and hair follicles, 
suggesting that melanin content is not essential for melanocyte development and 
maintenance.       
 
The origin of melanocytes  
Melanocytes are derivatives of neural crest cells, a population of multipotent cells 
that develop from ectoderm but are unique to the vertebrate embryo (Rawles, 1947) (Fig. 
1-2d). A single neural crest cell can differentiate into any of several cell types, and the 
cell fate choice is dependent on its location in the embryo. The cranial neural crest 
gives rise to the majority of the bone and cartilage of the head and face, as well as to 
nerve ganglia, smooth muscle, connective tissue and melanocytes. The cardiac neural 
crest contributes to heart development by forming the aorticopulmonary septum and 
conotruncal cushions. The vagal and sacral neural crest becomes mainly enteric ganglia 
of the gut. The trunk neural crest cells give rise to neurons and glia of the peripheral 
nervous system, to secretory cells of adrenal medulla and to most of the melanocytes in 
skin. 
In 1868, embryologist Wilhelm His first described the neural crest as a 
“Zwischenstrang,” a band of particular material lying between the epidermis and the 
neural tube (Hörstadius, 1950) (Fig. 1-2d). In the early phase of neural development, the 
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ectoderm is specified by inductive signals and divided into three regions: non-neural 
ectoderm, which becomes the epidermis; neural plate, which forms the neural tube and 
further gives rise to central nervous system; and two border regions between non-neural 
ectoderm and neural plate, which are called the neural plate borders and are the origin of 
neural crest (Fig. 1-2a). In harmony with the folding of the neural plate during 
neurulation, the neural plate borders arise to form the neural folds, which further fuse 
with each other to become neural crest as part of the dorsal region of the neural tube lying 
beneath non-neural ectoderm (Fig.1-2b-d).  
Complex signaling pathways and transcriptional networks are involved in the 
induction of the neural crest (Gammill and Bronner-Fraser, 2003; Knecht and Bronner-
Fraser, 2002). Studies done in Xenopus laevis have revealed a model: the diffusion of 
BMPs (bone morphogenetic proteins) and their antagonists create a gradient of BMP 
activity across ectoderm, so that high BMP activity specifies non-neural ectoderm; low 
activity specifies neural plate; and intermediate signals specifies neural plate borders 
(Wilson and Hemmati-Brivanlou, 1997).  However, BMPs alone are not sufficient to 
induce neural crest formation and segregate it from the neural and non-neural ectoderm. 
It requires further inputs as secondary signals from adjacent non-neural ectoderm or 
underlying mesoderm, including WNTs (García-Castro et al., 2002; Mayor et al., 1997), 
and FGFs (Fibroblast growth factors) (LaBonne and Bronner-Fraser, 1998; Mayor et al., 
1997; Monsoro-Burq et al., 2003). Driving the neural crest induction, these extracellular 
signals further lead to transcription cascades within neural crest cells to upregulate 
specific transcription factors (Meulemans and Bronner-Fraser, 2004). Those factors 
include Slug/Snail (Nieto et al., 1994), FoxD3 (Dottori et al., 2001; Kos et al., 2001; 
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Sasai et al., 2001), Sox10 (Dutton et al., 2001), and Sox9 (Spokony et al., 2002), which 
specify neural crest cells and segregate them from the neural tube cells.  
The neural crest is a transient structure. The cells in the neural crest have the 
potential to migrate and enter new locations to become tissue-specific cell types. Soon 
after the structure forms or even before the neural tube is closed fully by E8.5, neural 
crest cells detach from the neural tube through undergoing epithelial-mesenchymal 
transformation, the process that allows them to detach from neuroepithelium and migrate 
into the cell-free space between the surface ectoderm, neural tube and somite (Fig. 1-2d) 
(Erickson and Weston, 1983; Serbedzija et al., 1990; Sternberg and Kimber, 1986b; 
1986a). On the migration trajectory, neural crest cells are exposed to a variety of 
instructive signals that guide them to adopt specific cell fates. For instance, migratory 
neural crest cells in the trunk region either enter a dorsal-lateral migration pathway to 
become melanocytes, or migrate ventrally to become neurons, glial Schwann cells and 
other cell types.  
In addition to inducing neural crest formation, the transcription factor FOXD3 
was found to play a critical role in migration of neural crest cells (Kos et al., 2001). 
Expressed in undifferentiated early migratory neural crest cells as a neural crest specifier, 
FoxD3 is later down regulated in melanocyte precursors (melanoblasts) as they go into 
the dorsal-lateral pathway, while its level remains high in cells entering the ventral 
pathway. Loss- and gain-of-function studies have further revealed its function in lineage 
specification: down-regulation of FoxD3 in nascent neural crest cells promotes the 
expansion of melanocyte lineage at the expense of neural/glial lineages; conversely, 
neural crest cells with ectopic FoxD3 lose the freedom and only follow the ventral 
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pathway. Probing deeper into the mechanism, further studies have showed that FOXD3 
represses the melanocyte lineage at least partly through inhibiting the expression of Mitf, 
which encodes a master transcription factor in melanogenesis (Thomas and Erickson, 
2009).  
The final destination for most of dorsal-lateral migrating melanoblasts is skin. 
Entering the skin dermis from E11.5, melanoblasts further migrate upward to cross the 
basement membrane and penetrate into epidermis by E12.5 (Fig. 1-3a). As the epidermis 
starts invaginating to form hair follicles around E15.5, melanoblasts in the epidermis 
gradually migrate toward the hair follicles where they complete maturation to become 
pigment-producing melanocytes. While most of melanoblasts still linger in the epidermis 
of mouse at birth, the number of epidermal melanoblasts significantly decreases 
postnatally by P4 (Hirobe, 1984). In adult mice, melanocytes are rarely seen in the 
epidermis and are only seen in hair follicles of dorsal/hairy skin. However, it is still not 
clear what the signals are that attract melanoblasts to migrate from the epidermis into the 
hair follicles. The existence of attractive signals from developing hair follicles has been 
proposed since 1947 and is evident by transplantation experiments (Rawles, 1947). When 
a part of mouse neural crest was transplanted into chick peritoneum, melanocytes 
scattered randomly if the hair follicles were absent in the graft. Comparatively, 
melanocytes can find their way to hair follicles and were observed chiefly in follicles 
when they were simultaneously developing in the graft, although the development of 
melanocyte and hair follicle seems to go on separately and independently. 
Although it has been widely accepted that melanocytes are derived from the 
neural crest cells migrating in the dorsal-lateral pathway during development, recent 
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studies have showed unexpectedly that Schwann cells associated with the nerves are 
another source of melanocytes (Adameyko et al., 2009). As some neural crest cells in the 
ventral pathway become Schwann cell precursors during development, Schwann cell 
precursors can differentiate not only into mature Schwann cells but also into 
melanocytes. Lineage-tracing experiments showed that Schwann cell precursors migrate 
along the extending nerves, at the end of the nerves that project toward the skin.  Some of 
the Schwann cells detach from the nerves, populate the cutaneous area, and contribute to 
a substantial number of melanocytes in hair follicles.  
Interestingly, myelinating Schwann cells in adult skin still maintain the potential 
to differentiate into melanocytes when they lose contact with the nerves (Adameyko et 
al., 2009), although the mechanism is unclear if mature Schwann cells directly trans-
differentiate into melanocytes or undergo de-differentiation process back to neural crest 
cell-like state. Also, it is not clear how the fate choices in Schwann cells are controlled. 
Although nerve-derived neuregulin 1 can promote Schwann cell precursor adopting glial 
fate and IGF1/PDGF produced by Schwann cells act in opposing manner to favor 
melanocyte differentiation (Adameyko et al., 2009), it is unknown if similar mechanisms 
occur in adult after nerve damage.  In addition, it is also not clear if the melanocytes from 
two different sources contribute equally to skin pigmentation, although some evidence 
points to melanoblasts in the dorsal-lateral pathway contributing little to adult skin 
melanocytes (around 5-10%) since their number decreases shortly after migration is 
initiated (Adameyko et al., 2009). Further elucidation about the relationship between 
melanocytes and glial cells is important and it might provide insights into the mechanism 
of abnormal pigmentation happening in conjunction with neurological disorders such as 
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neurofibromatosis and nerve sheath tumor.  
 
Molecular basis of melanocyte development 
Before genomics and the gene-targeting era, we learned the function of individual 
loci through analyzing the phenotypes of spontaneous or mutagen-induced mutants. As 
organisms lacking melanocytes are in general viable, mutations affecting pigmentation or 
hair coat color are easily noticed and isolated. So far in mouse, more than 350 loci have 
been associated with coloration (http://www.espcr.org/micemut/#cloned). Approximately 
half of the loci are cloned and analyzed at the molecular level, and a plethora of 
pigmentation enzymes, transcription factors and signaling pathways required for 
melanogenesis have been identified and mostly their functions are conserved between 
human and mouse.  
 
A central mediator in melanocyte development: MITF 
MITF is a master transcription factor in melanocytes that controls their 
development and pigment production (Levy et al., 2006). MITF is a basic-helix-loop-
helix leucine zipper (bHLH-Zip) transcription factor belonging to Myc supergene family 
(Hodgkinson et al., 1993; Hughes et al., 1993). During melanocyte development, MITF is 
the earliest marker appearing in committed melanoblasts when they are on the migratory 
trajectory toward the skin around E10-11 (Nakayama et al., 1998; Opdecamp et al., 
1997). In Mitf-null embryos, neural crest cells are not able to differentiate into 
melanoblasts judged by the absence of DCT+ or KIT+ cells, which instead appear 
subsequent to MITF appearance in WT embryos (Steel et al., 1992). Thus, loss of Mitf 
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results in white hair coat phenotype in conjunction with complete lack of melanocytes in 
mutant mice (Nakayama et al., 1998; Opdecamp et al., 1997). The importance of Mitf in 
melanocyte development was further highlighted by the study showing that ectopic 
expression of Mitf is sufficient to convert embryonic fibroblasts (NIH3T3 cells) into cells 
with characteristics of melanocytes (Tachibana et al., 1996), suggesting that MITF is a 
master transcription factor to specify melanocyte cell fate.  
Many MITF target genes have been identified, revealing its function in 
controlling many aspects of melanocyte behaviors including differentiation, proliferation 
and survival (Fig. 1-5). Through binding to specific E-box elements (CACGTG or 
CATGTG) in their promoters, MITF controls melanin production by regulating the 
expression of three major melanin biosynthesis-required enzymes including TYR, 
TYRP1 and DCT (Hemesath et al., 1994; Lowings et al., 1992). Other melanosomal 
proteins such as PMEL17, MLANA (Du et al., 2003), OA1/GRP143 (Vetrini et al., 2004) 
are also shown to be transcriptionally regulated by MITF as well as differentiation-
involved signaling proteins including MC1R (Adachi et al., 2000) and ENDRB (Sato-Jin 
et al., 2008). Therefore, the involvement of MITF in promoting melanosome formation 
places MITF as an important factor not only during development to facilitate pigment-
free precursors to become fully functional pigment-producing melanocytes, but also in 
adult to increase melanocyte activity during sun-tanning (Cui et al., 2007; D'Orazio et al., 
2006; Price et al., 1998b). Upon UV exposure, Mitf is upregulated in skin melanocytes 
leading to increased melanin production and skin hyperpigmentation.  
Given that failure in upregulating differentiation genes cannot account for the 
complete lack of pigment cells in MITF-deficient mutants (Nakayama et al., 1998),  
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Figure 1-5. Molecular basis involved in melanocyte development. MITF is a master 
transcription factor of melanocyte development. It promotes melanocyte proliferation, 
differentiation and survival by modulating the expression of its target genes. Mutations in 
Mitf are associated with Waardenburg syndrome (WS) type II.  The expression of Mitf is 
regulated by transcription factors SOX10 and PAX3, mutations in which cause WS type 
IV and I/III respectively. The promoter of Mitf also contains TCF/LEF1 binding sites, 
which are bound by LEF1/β-catenin complex when Wnt signaling is activated. In 
addition, Edn and Kit signaling can modulate the expression of Mitf by inducing the 
phosphorylation of transcription factor CREB-binding protein (CBP), which binds to 
CRE binding elements. The binding of endothelins (EDN) to endothelin receptor type B 
(EDNRB) activates protein kinase C (PKC), which activates CBP through cAMP-PKA 
pathway. Mutations in Edn ligands and receptors are associated with WS type IV. The 
binding of Kit ligands (KITL) to its receptor KIT induces MAPK pathway, which can not 
only modulate Mitf level transcriptionally through phosphorylating CBP but also regulate 
MITF protein function by directly phosphorylating MITF.  
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further studies had proposed its other functions in controlling melanocyte viability and 
cell-cycle progression. Other hints came from that fact that Mitf is an oncogene amplified 
in 10-20% cases of human melanoma (Garraway et al., 2005). Indeed, those MITF targets 
found to be regulating proliferation and survival of melanocytes are also regulating that 
of melanoma cells, which include genes encoding several cell-cycle regulators such as 
TBX2 (Carreira et al., 2000; Vance et al., 2005), CDK2 (Du et al., 2004), P21  (Carreira 
et al., 2005) and P16 (Loercher et al., 2005) and also survival regulators such as 
MET/HGFR (McGill et al., 2006), anti-apoptotic proteins ML-IAP (Dynek et al., 2008) 
and BCL2 (McGill et al., 2002). BCL2 is particularly interesting since Bcl2-null mice are 
born with normal hair color. Remarkably, one month later or during first hair molting, 
hair-graying phenotype appears due to progressive loss of melanocytes in hair follicles 
(Kamada et al., 1995; Mak et al., 2006; Nishimura, 2005). Thus, Bcl2 is critical for the 
survival of postnatal melanocytes in the follicles especially the establishment of adult 
melanocyte stem cells, by which melanocytes are prevented from being depleted with 
age; nevertheless, the existence of other or redundant anti-apoptosis mechanisms during 
embryonic development are still unclear.  
In human, MITF mutation causes Waardenburg syndrome (WS), specifically WS 
type IIA (Online Mendelian Inheritance in Man (OMIM) #193510). WS was described in 
1951 by ophthalmologist Petrus Johannes Waardenburg when he noticed the coincidence 
of deafness and hypopigmentation abnormalities in many of his patients (Waardenburg, 
1951). Thus far, four related syndromes displaying the core phenotypes including 
deafness and hypopigmentation of skin, hair and iris, have been classified and named WS 
type I-IV, and three of four subtypes cause the same defects as WS type II but also 
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accompanied with additional abnormalities in other tissues (Price and Fisher, 2001). 
Notably, similar defects are also seen in mice bearing mutations at mi locus (Hertwig, 
1942; Moore, 1995). Thus, it had long been suggested that at least some forms of variants 
in human patients occur in the homologue of mouse mi (Asher and Friedman, 1990). 
Indeed, shortly after mouse Mitf gene was mapped in mi locus in 1993 (Hodgkinson et 
al., 1993; Hughes et al., 1993), mutations in human Mitf homologue was also found to be 
the cause in 20% of Waardenburg syndrome type II patients while genetic heterogeneity 
of the disorder has also been noticed (Tassabehji et al., 1994).  
The identification of genetic variants in other subtypes of WS and the epistatic 
relationship between genes involved and Mitf have revealed a clear view of the regulatory 
network for melanocyte development and function. Mutations in Pax3, encoding a 
paired-homeobox-containing transcription factor, result in WS type I and III (Baldwin et 
al., 1994; Tassabehji et al., 1992; 1993); WS type IV is associated with mutation in SRY-
box containing transcription factor Sox10 (Pingault et al., 1998), endothelin receptor type 
B (Ednrb) (Attié et al., 1995; Puffenberger et al., 1994) or its ligand endothelin 3 (Edn3) 
(Edery et al., 1996).  
Surprisingly, these genes all converge on Mitf (Fig. 1-5). Pax3 and Sox10, which 
are also expressed in migratory neural-crest derivatives, bind directly to Mitf promoter 
and act in concert to activate Mitf expression in melanocytes (Bondurand et al., 2000; Lee 
et al., 2000; Potterf et al., 2000; Verastegui et al., 2000; Watanabe et al., 1998). 
Endothelin signals, which will be discussed in more detail in the following sections, can 
stabilize MITF protein through inducing its phosphorylation as well as control its level of 
transcription (Sato-Jin et al., 2008). Therefore, these connections could possibly account 
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for the phenotypic overlap seen in all subtypes of WS. Similarly, the dependence of Mitf 
activity on these genes are also observed in mouse genetics:  mutations in any of these 
genes cause melanocyte development defects (Baynash et al., 1994; Epstein et al., 1991; 
Hosoda et al., 1994; Southard-Smith et al., 1998). Therefore, lying at the heart of 
regulatory network, Mitf is a center mediator that integrates extracellular signals into 
changes of gene expression required for melanocyte development and also their activity 
postnatally (Fig. 1-5).  
 
Wnt signaling 
During melanocyte development, canonical Wnt signaling plays an instructive 
role to direct neural crest cells to adopt a melanocyte cell fate. Triggered by receipt of 
Wnt ligands by transmembrane receptor Frizzleds, the activation of Wnt signaling 
inhibits its negative regulator GSK3 and stabilizes cytoplasmic β-catenin, which 
translocates into the nucleus to form a complex with LEF/TCF DNA-binding proteins 
leading to upregulation of Wnt target genes; whereas without Wnt stimulation, 
transcription factor TCF alone acts as a repressor inhibiting those targets (Logan and 
Nusse, 2004) (Fig. 1-5). Loss of β-catenin or two ligands Wnt1 and Wnt3a have a broad 
effect in reducing the number of neural crest derivatives in multiple lineages, suggesting 
that Wnt signaling is required for expansion of the neural crest cell population before a 
final fate specification occurs (Hari et al., 2002; Ikeya et al., 1997).  
Apart from its function at the early stage of neural crest development, Wnt 
signaling, interestingly, in the following stages governs the choice of whether to become 
melanocytes or other neural crest cell derivatives. In zebrafish, manipulation of Wnt 
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activity in individual neural crest cells can switch their fates: carrying ectopic positive 
regulator β-catenin, neural crest cells with higher Wnt activity tend to become 
melanocytes; whereas Wnt-low cells with additional negative regulator TCF tend to 
become neurons or glia (Dorsky et al., 1998).  
However, the story in the mouse system is more complicated and its preference 
regarding fate specification depends on timing.  Before migration occurs, elevated 
Wnt/β-catenin signals in neural crest cells promotes the formation of neurons at the 
expense of other derivatives; during migration, in contrast, Wnt/β-catenin signaling later 
has opposite effect, inducing migratory neural crest cells to become melanocytes (Hari et 
al., 2012; Lee et al., 2004). Interestingly, the mechanism behind Wnt-promoted 
melanocyte cell fate converges on Mitf, whose promoter contains LEF/TCF binding sites 
essential for Mitf expression and its level depends on Wnt activity (Dorsky et al., 2000; 
Takeda et al., 2000) (Fig. 1-5). Therefore, Wnt signaling promotes melanocyte 
development at least partly through upregulating Mitf level, while its effect upon the fate 




Once fate specification is determined, the survival and differentiation of 
melanocyte precursors or (melanoblasts) in the later stage of development requires Kit 
signaling. Activated by cytokine kit ligand (KITL), KIT is a transmembrane tyrosine 
kinase receptor, which transduces extracellular signals into the nucleus through inducing 
a phosphorylation cascade and ultimately altering the activity of transcription factors and 
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gene expression (Fig. 1-5). Mice carrying spontaneous mutations in Kitl (steel locus, sl) 
(Copeland et al., 1990) or its receptor Kit (white spotting locus, w) (Chabot et al., 1988; 
Geissler et al., 1988) have a white hair coat phenotype due to lack of melanocytes 
(Russell, 1979).  Mutations in human Kit showed similar pigmentation defects, causing 
Piebaldism characterized by patches of white skin and hairs (Giebel and Spritz, 1991).  
Digging into the mechanism of melanocyte loss upon Kit-signal deficiency, 
studies have found that it is essential for melanoblast survival but not required for lineage 
commitment, while the dependence oscillates in accordance with their proliferative 
activity. In Kitl or Kit mutants, the specification of melanocyte fate is unperturbed as 
migratory neural crest cells can become Dct+ melanoblasts when leaving neural crest 
around E10.5; however, the number of Dct+ melanoblasts greatly decreases in a very 
short time since their appearance (Cable et al., 1995; Mackenzie et al., 1997; Steel et al., 
1992; Wehrle-Haller and Weston, 1995).  By injecting KIT blocking antibodies to inhibit 
Kit signaling at different embryonic stages, Yoshida et al. found that KIT functions as a 
survival signal for proliferating melanoblasts, whereas dormant melanoblasts do not rely 
on Kit signals for survival (Yoshida et al., 1996). Thus, Kit signals are required for the 
melanoblast expansion that occurs before they enter the dermis and upon their arrival in 
the epidermis, while melanoblasts can be maintained in the environment without Kit 
signals once they migrate into the hair follicles or turn less proliferative.   
Because early disappearance of melanoblasts in Kit mutant embryos makes it 
difficult to address its function in detail, gain-of-function and in vitro culture studies have 
provided more insights on Kit’s role in melanocyte development. K14-driven 
overexpression of Kitl in epidermis induces hyperpigmentation in concert with largely 
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increased melanocyte number, more profoundly after E16.5 in the epidermis and also hair 
follicle (Kunisada et al., 1998a; 1998b). It suggests that Kit signals are sufficient to drive 
melanocyte proliferation and differentiation, and possibly also migration as ectopic 
melanocytes extend their territory into other areas such as mouth and paw skin. 
Consistently, addition of KITL into culture increases melanoblast number and facilitates 
their differentiation (Reid et al., 1995). Postnatally, Kit signaling also has similar 
functions in controlling melanocyte behavior to support them going through cyclical 
activation and inactivation during each hair cycle (Botchkareva et al., 2001; Nishikawa et 
al., 1991).  
Behind the scene, Kit signals have been linked to MITF to induce its 
phosphorylation, which can have both positive and negative effects on MITF function 
depending on the duration of stimulation. KIT-mediated phosphorylation via MAPK 
pathway enhances a short-lived MITF transactivation as well as a net degradation of 
MITF protein mediated by proteasomes (Hemesath et al., 1998; Price et al., 1998a; Wu et 
al., 2000; Xu et al., 2000), while mRNA level of MITF has also been showed to increase 
upon KIT stimulus (Sato-Jin et al., 2008). Upon KITL binding, KIT receptors dimerize 
and can activate multiple downstream signal transduction cascades such as MAPK and 
PI3K. But melanocytes seem to favor the MAPK pathway, supported by the notion that 
blocking of Kit-mediated PI3K activation causes no effect on mouse pigmentation but on 
spermatogenesis (Blume-Jensen et al., 2000; Kissel et al., 2000). Since most of the 
studies were done in cultured melanocytes, it remains to be learned when and where 
MITF phosphorylations occur in vivo and whether they are mediated by the Kit-MAPK 
pathway.  
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Although the signaling connection is obscure, the genetic interactions between Kit 
signaling and MITF are evident (Hou et al., 2000). Given that in the condition without 
Kit signals MITF is not sufficient to drive the expression of tyrosinase, and double 
heterozygous mutants show much greater pigmentation defects than in either 
heterozygous alone, MITF and Kit signals are individually indispensible for melanocyte 




Endothelins (EDNs) are 21 amino-acid secreted peptides with three different 
isoforms including EDN1, EDN2 (containing two amino acids different from EDN1 
sequence) and EDN3 (containing six amino acids different from EDN1 sequence) 
(reviewed in Sakurai et al., 1992). They are produced as ~200 amino acid long precursors 
called prepro-endothelins and are further processed to become mature forms by two 
proteases: first furin-like proteases and then endothelin-converting enzymes (ECEs). Two 
subtypes of endothelin receptors belonging to G-protein coupled receptor family have 
been identified including EDNRA, which prefers to bind EDN1 and EDN2, and EDNRB, 
which has equal affinity for all three EDNs.  
After the isolation of the first endothelin or EDN1 from vascular endothelial cells 
as a vasopressor, endothelins later were found to exert a wide range of effects in many 
cell types including human melanocytes, in which endothelins especially EDN1 and 
EDN2 act as mitogens to stimulate their proliferation and pigment-producing activity 
(Yada et al., 1991). Physiologically, upon sun or UV exposure, epidermal keratinocytes 
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are the major source of secreted endothelins, which act on receptor EDNRB in 
neighboring melanocytes to induce skin hyperpigmentation (Imokawa et al., 1995; 1992). 
Genetically, Edn signals are required for melanocyte development. Mice carrying 
mutations in Edn3 (lethal spotting locus) or its receptor Ednrb (piebald lethal locus) 
results in melanocyte loss associated with megacolon caused by the absence of the enteric 
ganglia (Baynash et al., 1994; Hosoda et al., 1994), the phenotypes that are also seen in 
WS type 4 patients with mutations in EDNRB human homologs (Attié et al., 1995; Edery 
et al., 1996; Hofstra et al., 1996; Puffenberger et al., 1994).  
Similar to Kit pathway, Edn signaling is not required for melanocyte fate 
specification but for melanoblast proliferation, survival and differentiation. In Ednrb 
mutants, some if not all of DCT+ melanoblasts appear at the right time (between E10-
E11.5); however, their number becomes reduced greatly, and soon after, none of 
melanocytes can be detected in the epidermis or hair follicles of white patches after 
E14.5, suggesting that Edn signal-negative melanoblasts cannot be maintained during 
development (Lee et al., 2003; Pavan and Tilghman, 1994). Carefully manipulating Edn 
signals in the melanocyte lineage reveals that proper pigmentation requires the input of 
Edn signals between E10-12.5, the period when melanoblasts are proliferating and 
migrating into epidermis (Shin et al., 1999).  
In cultured melanocytes, Edn signals, mostly via protein kinase C (PKC), can 
regulate MITF both transcriptionally and post-translationally (Sato-Jin et al., 2008) (Fig. 
1-5). Not only does EDN-mediated PKC activation trigger a quick reaction inducing 
MITF transactivation through MAPK-dependent protein phosphorylation, but it also 
exerts long-term increases of MITF amount by enhancing its transcription. The Mitf 
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promoter contains CRE binding elements bound by active transcription factor CBP, 
whose phosphorylation depends on biphasic induction of MAPK-RSK and cAMP-PKA 
pathways, in which MAPK takes action first followed by PKA activation. Again, though 
the signaling mechanisms underlying the connection between Edn pathway and MITF are 
evident in vitro, it still awaits to be uncovered whether similar relationship occurs in vivo. 
As the phenotypes caused by loss of Edn pathway are similar to Kit mutants, the 
reminiscence of Kit function from Edn studies implies the potential interaction between 
them in melanocyte lineage. Indeed, studies in culture show that Edn and Kit pathways 
act synergistically to regulate melanoblast proliferation and differentiation (Aoki et al., 
2005; Reid et al., 1996a). Simultaneous addition of EDN3 and KITL into culture 
dramatically increases melanoblast number to the extent greater than the addition of 
individual factors (Reid et al., 1996a), though individual factors also has significant effect 
in promoting melanoblast proliferation (Lahav et al., 1996; Opdecamp et al., 1998; Reid 
et al., 1995). In addition, melanoblasts can fully differentiate into pigmented cells in the 
presence of both factors, whereas adding either one of the factors is not sufficient to 
induce pigment production (Reid et al., 1996a). Molecularly, Edn and KIT can act in 
concert to rapidly induce MAPK-mediated signal transduction (Imokawa et al., 2000).  
Notably, all isoforms of endothelins have a similar capability of facilitating 
melanoblast proliferation and differentiation in vitro by acting on receptor Ednrb 
(Opdecamp et al., 1998; Reid et al., 1996a). However, the requirement of Edn1 and 2 in 
vivo is unclear as no significant melanocyte-defects have been observed in individual 
mutants in contract to Edn3-null embryos (Chang et al., 2013; Kurihara et al., 1994; Reid 
et al., 1996b). It could be due to the presence of possible redundancy among endothelins 
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or non-essential roles of Edn1 and Edn2 in melanocyte development that is dominated by 
Edn3. In addition, because endothelin-deficient mutants die immediately (Edn1-null) or 
within one month (Edn3-null and Edn2-null) after birth, it’s also unclear whether they 
play roles in controlling melanocyte behavior postnatally or in the adult. 
Surprisingly, the functional similarity between Edn and KIT signals seen in a 
simplified in vitro system is not completely translated in vivo. Although both Edn3 and 
Kitl upregulation in epidermis are sufficient to induce hyperpigmentation (Garcia et al., 
2008), the areas with accumulated pigments in Edn3 transgenice mice are different from 
what are seen in Kitl upregulated mice, which contain ectopic pigments in hair follicles 
and epidermis (Kunisada et al., 1998a; 1998b). Instead, in K5-Edn3 transgenic mice, 
hyperpigmentation occurs mainly in the dermis surrounding hair follicles, while 
melanocyte numbers are increased in both epidermal and dermal compartments (Garcia et 
al., 2008).  Notably, early embryonic induction of Edn3 is required for initiating dermal 
pigmentation, as Edn3 upregulation in late embryonic stage or after E10.5 is surprisingly 
not sufficient to cause the phenotype. But it is still unknown whether Edn1 and 2 have 
similar potential to induce dermal hyperpigmentation, either during embryonic or adult 
stage.  In addition, given that ectopic pigments are restrictedly present in the areas that 
normally contain melanocytes but not in regularly melanocyte-free skin such as oral 
cavity and paw pad, EDN3, unlike KITL, induces in situ hyperpigmentation but it does 
not act as an attractive signal inducing melanocyte migration. Thus, in vivo, melanocytes 
in different compartments respond to extracellular signals differently in such a way that 
dermal melanocytes are more responsive to Edn stimulus and epidermal-hair follicle 
melanocytes are more sensitive to Kit signals (Aoki et al., 2009).  
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Melanocyte stem cells in hair follicles 
Coupled with hair growth and cycle in adults, melanogenesis in hair follicles also 
relies on cyclic activation and inactivation of stem cells called melanocyte stem cells 
(McSCs) (Nishimura et al., 2002). When epidermal melanoblasts migrate into the hair 
follicles during morphogenesis, some of them close to the dermal papilla (DP) undergo 
differentiation and become mature melanocytes, which upregulate MITF and the 
components of enzymatic machinery for melanosomes including TYR and TYRP1 to 
support melanin production and hair pigmentation; whereas, some of them colonizing 
next to the hair follicle stem cells (HFSCs) in the upper part of hair follicles, maintain an 
undifferentiated state and function as McCSs to support hair pigmentation long-term (Fig. 
1-3a).  
Thus, the hair follicle is home to two distinct stem cell populations: epithelial 
HFSCs, which contribute to hair growth, and McSCs, which contribute to hair 
pigmentation.  Interestingly, they behave in concert such that both of them survive the 
destructive catagen phase, when differentiated melanocytes and hair cells undergo 
apoptosis; and both of them stay in quiescence during telogen (Fig. 1-3b). When anagen 
ensues, these two stem cell populations are coordinately activated to become 
proliferative, supplying new cells in the lower differentiating region of hair follicles, in 
which differentiated melanocytes produce and transfer pigments to adjacent HFSC 
progeny in the matrix as they stop proliferating and begin to differentiate into hair (Fig. 
1-3b). Although no McCS-specific markers have been identified so far, they can be 
distinguished from mature melanocytes as being negative for differentiated markers 
including MITF, TYR and TYRP1 and positive for markers that are expressed in all 
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melanocytes such as KIT and DCT (Fig. 1-3b). 
Understanding the molecular basis of McSC behavior and maintenance is 
important as loss of McSCs has been considered as the cause of hair greying (Commo et 
al., 2004; Nishimura, 2005). Either with age or under stress conditions, McSCs in hair 
follicles progressively lose their ability to self-renewal and undergo ectopic 
differentiation, which results in the depletion of melanocytes/pigments in the follicles 
(Inomata et al., 2009; Nishimura, 2005). Discussed in the following contents will be how 
intrinsic mechanisms and extrinsic signals from the niche modulate McSC activity.  
 
Activation of melanocyte stem cells 
Interestingly, several signaling pathways that are known to control melanocyte 
development have also been found to play critical roles in regulating adult McSC activity. 
For instance, Wnt signaling is required and sufficient to drive McSC proliferation and 
differentiation (Rabbani et al., 2011).  At the start of a new hair cycle, McSCs next to the 
DP show signs of nuclear β -catenin, an indicator of activated canonical Wnt signaling; 
during follicle growth, Wnt-positive melanocytes move downward along with the matrix 
and become mature melanocytes. Manipulating Wnt signaling specifically in melanocytes 
by increasing or decreasing nuclear β-catenin level shows that Wnt-negative McSCs fail 
to proliferate and differentiate into mature melanocytes upon anagen initiation, whereas 
forced activation of Wnt signaling drives McSC differentiation ectopically within their 
residence (upper ORS), leading to hair greying due to progressive depletion of McSCs 
with time. In addition, Kit signals are also required for melanogenesis. Inhibition of the 
Kit pathway by injecting anti-KIT antibodies intradermally results in blockage of McSC 
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activation and differentiation, resulting in white hair coat phenotype (Botchkareva et al., 
2001). Notably, in conditions lacking either signaling input, McSCs are still maintained 
with relatively normal number within hair follicles, suggesting that McSC survival and 
maintenance is independent on Wnt and Kit pathways.  
While in vitro the MAPK cascade is thought to mediate Kit signal-induced 
melanocyte differentiation, in vivo they seem to have additional functions in regulating 
McSC self-renewal independent upon Kit. Melanocytes including both McSCs and 
mature melanocytes are normally formed during development in mice lacking Raf 
kinases (RAF), which are upstream activators of MAPK (Fig. 1-5); however, in 
agreement with the well-known implication of RAF-MAPK pathway in cell-cycle 
regulation, S-phase entry of Raf-deficient McSCs upon anagen start in adult mice is 
impaired, accompanied with a progressive decrease of McSC number and hair greying 
(Valluet et al., 2012). Owing to the fact that loss of RAFs does not have significant 
effects on McSC differentiation, in contrast to Kit deficiency, it is tempting to speculate 
that in vivo Kit-induce melanocyte differentiation is independent of MAPK cascade. 
Therefore, there are still several questions left to be answered: what are the 
environmental cues that activate the MAPK pathway within McSCs and drive McSC self-
renewal? Where are they from? What are, on the other hand, downstream mediators of 
Kit signals to control McSC differentiation? 
In addition to programmed inputs, McSCs also respond to accidental stimuli 
originating from the environment. For instance, upon wounding or UV irradiation, 
McSCs in hair follicles are activated, migrate upward and repopulate a new location: the 
epidermis (Chou et al., 2013; Walker et al., 2009; Zaidi et al., 2011). Therefore, the hair 
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follicle acts as a reservoir of McSCs not only supporting regular hair pigmentation but 
also supplying new melanocytes into epidermal surface. Understanding the mechanisms 
driving McSC repopulation is particularly important as it provides a protective design for 
skin against damage, and clinically it provides potential therapeutic methods for treating 
hypopigmentation diseases such as vitiligo by inducing recovery of the epidermal 
melanocyte population from the hair follicle reservoir (Cui et al., 1991; Falabella, 2009; 
Ortonne et al., 1979).  
  
Quiescence of melanocyte stem cells 
After a short window of proliferative time during early anagen, active McSCs 
return to quiescence, which is a non-cycling state that starts from the middle of anagen, 
specifically at anagen stage V, through catagen and telogen. Thus, they stay in dormancy 
most of the time except at the beginning of each hair cycle, when they respond to stimuli 
by entering the cell-cycle again (Nishimura et al., 2010). Interestingly, Nishimura et al. 
showed that transforming growth factor-β (TGF-β) signaling plays an important role in 
facilitating their active-state to quiescence transition. Acting on type I and type II 
receptors, TGF-β induces phosphorylation of regulatory R-SMADs including SMAD2 
and 3, which form a complex with a mediator co-SMAD named SMAD4 and further 
translocate into the nucleus where they act as a bipartite transcription factor to modulate 
the transcription of TGF-β target genes (Siegel and Massagué, 2003). At the right timing 
when active McSCs are about to enter quiescence from mid anagen, TGF-β ligands are 
upregulated in the nearby bulge HFSCs, which provide the cues to activate TGF-β 
signaling within McSCs to induce cell cycle arrest and maintain McSCs in 
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undifferentiated form within their residence (upper ORS). When lacking TGFβRII 
receptor, McSCs fail to enter quiescence and instead undergo differentiation ectopically, 
causing accelerated hair graying due to progressive McSC loss.  
Notably, in concordance with its function in regulating McSC activation 
negatively in follicles, TGF-β signaling has also been shown to inhibit the proliferation 
and differentiation of epidermal melanocytes against tanning response (Rodeck et al., 
1994; Yang et al., 2008). Thus, in the absence of stimuli, epidermal keratinocytes secrete 
TGF-β that suppresses melanocyte activity, whereas upon UV exposure a reduced 
amount of TGF-β in the skin results in the increases of melanocyte proliferation and 
pigment production. Taken together, the TGF-β pathway has a global effect in 
maintaining the quiescence of McSCs and epidermal melanocyte precursors, though the 
molecular basis behind the scene is unclear, and whether TGF-β modulates the activity of 
undifferentiated melanocytes within the two different compartments in similar or 
different ways.  
Interestingly, TGF-β seems to have an otherwise positive effect on HFSCs. At the 
onset of anagen, TGF-β secreted from the DP right under HFSCs can promote HFSC 
activation and hair cycle progression (Oshimori and Fuchs, 2012). Given that the known 
TGF-βs that modulate HFSC and McSC activity come from different sources and at 
different times, it remains unclear whether and how quiescent McSCs can respond to DP-
secreted, in addition to HFSC-released, TGF-βs during the growing phase. Along the 
line, it is also unknown if other quiescent signals known to act on HFSCs, such as BMP 
and FGF18, also play similar functional roles in maintaining McSC quiescence (Hsu et 
al., 2011a; Kobielak et al., 2007; Zhang et al., 2006).     
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Besides through releasing signaling molecules, it is tempting to speculate that 
HFSCs, which sit right next to McSCs, might also provide a physical support for McSC 
maintenance. Collagen XVII (Col17a1) is a structural component of hemidesmosomes 
that function in stable attachment between HFSCs and the dermis. Indeed, in mice 
lacking Col17a1, not only do HFSCs lose stemness leading to hair loss, but nearby 
McSCs also undergo ectopic differentiation and progressive depletion (Tanimura et al., 
2011). Interestingly, mice carrying mutations in other genes required for HFSC 
maintenance, such as Lhx2, Sox9 and Foxc1, also frequently display a hair-graying 
phenotype after the time when HFSCs show abnormal behavior (personal communication 
with Alicia R Folgueras, Meelis Kadaja, and Kenneth Lay). Thus, mutations affecting 
one population (HFSCs) typically can affect the other (McSCs) as well. Ionizing 
irradiation-induced hair greying studies also supports the notion. The primary victim of 
radiation, which induces hair greying in mouse, was thought to be McSCs (Inomata et al., 
2009), but HFSCs have also been aware to be comprised upon genotoxic stress (Aoki et 
al., 2013). Thus, careful characterization to distinguish between direct and secondary 
effects that are caused by HFSC abnormalities is especially essential in McSC studies.  
 
Survival of melanocyte stem cells 
Extrinsically, Notch signaling plays a critical role in maintaining the survival of 
melanoblasts and McSCs (Moriyama et al., 2006). Upon the binding of Delta ligand on 
the membrane of one cell to Notch receptor of the other cell, proteolytic cleavage of the 
Notch receptor occurs and triggers the release of the Notch intracellular domain (NICD), 
which enters the nucleus and forms a complex with the DNA-binding protein RBP-J to 
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control gene expression (Bray, 2006; Kopan and Weintraub, 1993). While mice carrying 
melanocyte-specific targeting of Rbp-j or Notch receptors still exhibit pigmented hairs 
extruding out of skin surface at 1-2 weeks after birth, melanoblasts or McSCs 
progressively diminish in number, which is evident from embryonic E16.5 followed by a 
complete disappearance of McSCs in adult mice and re-growth of a white hair coat after 
the first molting (Moriyama et al., 2006; Schouwey et al., 2006).  Digging into the 
mechanism, Moriyama et al. found that Notch-negative melanoblasts undergo 
unexpected apoptosis, implying the importance of the Notch pathway in maintaining 
survival of melanoblasts or McSCs.  Although multiple roles of Notch signaling in 
regulating melanoblast behavior have further been proposed (Aubin-Houzelstein et al., 
2008), whether they can be applied to adult McSCs is unclear. The use of temporally 
controlled Cre recombinase tools for loss-of-function studies could bypass the defects 
resulting from a developmental abnormality, which will be helpful for future studies of 
adult McSCs.  
Intrinsically, the anti-apoptotic gene Bcl2 provides a way out for McSCs against 
death signals. Similar to the phenotype seen in Notch-deficient mice, Bcl2-null mice 
progressively lose hair color from first hair molting, and grey hairs appear in conjunction 
with loss of McSCs in the follicles (Kamada et al., 1995; Mak et al., 2006; Nishimura, 
2005; Yamamura et al., 1996). It suggests that Bcl2 is critical for the survival of postnatal 
melanocytes in hair follicles, providing a mechanism to prevent them from being 
depleted with age. In contrast, mice with ablation of Pten, which is a tumor suppressor 
gene that inactivates several pathways involved in anti-apoptosis and cell proliferation, 
are resistant to hair greying induced by multiple rounds of hair depilation (Inoue-Narita et 
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al., 2008). Besides increased activation of AKT and MAPK pathways, Pten-deficient 
melanocytes contain upregulated Bcl-2, the alteration that might prevent McSCs from 
depletion after several rounds of regeneration.   
 
The coupling of epithelial-melanocyte stem cell behaviors  
During the hair cycle, McSCs and HFSCs work in harmony to generate 
pigmented hairs (Fig. 1-3b). Synchrony is achieved such that upon initiation of a new hair 
cycle, stem cells of each type activate lineage commitment (Nishimura et al., 2002; 
Tumbar et al., 2004). They remain quiescent within hair follicles for weeks in telogen. 
With each new hair cycle, these two stem cell populations are coordinately activated. 
HFSCs divide and fuel new cells into the differentiating region or matrix, the structure of 
which is enlarged and accompanied by the appearance of pigments and mature 
melanocytes (Fig. 1-6). Thus, during anagen, differentiated melanocytes at the base of the 
mature hair follicle (hair bulb) produce and transfer pigments to neighboring committed 
HFSC progeny as they differentiate into hair cells.  
Coupling of these two stem cell populations must be maintained during the hair 
cycle. Given that the pigments are only produced from mature melanocytes in the hair 
bulb but not from McSCs next to HFSCs, the coupling of stem cell behavior can result in 
pigments are produced at the right place (hair bulb) and transferred to the right cells, in 
this case differentiating hair cells. Speaking of the mechanism, recipient hair cells in the 
hair bulb express the transcription factor FOXN1, which controls the secretion of FGF2. 
Thus, through sending out FGF2 signals, hair cells can direct donor melanocytes to the 
correct location for depositing melanins (Weiner et al., 2007).  
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Figure 1-6. Pigmentation in hair follicles. Top row images: Fontana-Masson silver 
staining was conducted to detect melanins in hair follicles of mouse dorsal skin, followed 
by Nuclear Fast Red. Bottom row images: immunofluorescence with indicated 
antibodies. Telogen hair follicles with KIT+MITF- melanocyte stem cells (McSCs) are 
pigment-free. When hair follicles enter anagen, pigments appear in the enlarged region of 
hair follicles close to the DP, and KIT+ melanocytes upregulate MITF. In full anagen, 
melanocytes staying close to HFSCs in the upper ORS of hair follicles are KIT+MITF- 
McSCs, which don’t synthesize melanins. Conversely, melanocytes migrating into the 
hair bulb become differentiated melanocytes (KIT+MITF+), which generate and transfer 
melanins to nearby differentiating hair cells. Bu: bulge. Mx: matrix. Scale bars: 10μm. 
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Uncoupling McSC and epithelial stem cell behaviors feature prominently not only 
under transient conditions, i.e. in response to ultraviolet radiation, but also in a variety of 
disease states. Given the global impact of Wnts and other signals on HFSCs and McSCs 
and their lineages (Nishimura et al., 2010; Rabbani et al., 2011), it remains a mystery as 
to how uncoupling is achieved and conversely, whether and/or how intercellular 




Characterization of nuclear factor I/B’s function during skin development
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Introduction 
Normal homeostasis of tissues and their regeneration during wound repair require 
stem cells. Hair follicles provide a good model system to analyze this process, since it 
undergoes cyclical bouts of regeneration, degeneration and rest as part of its natural 
homeostasis. Hair follicle stem cells (HFSCs) are responsible for driving hair growth. 
While slow cycling, interestingly, they apply a cascade amplification strategy by which 
their descendants (transit-amplifying cells) enter cell cycle more quickly to supply a 
sufficient pool of uncommitted cells for generating multiple lineages. In hair follicles, the 
most quiescent stem cells reside in the upper region of the ORS, specifically called the 
bulge (Fig. 1-3b) (Cotsarelis et al., 1990; Tumbar et al., 2004). When they are activated 
in anagen, they proliferate briefly to generate progeny traveling along the ORS trail. The 
lower region the cells reach, the higher their proliferation frequency becomes (Hsu et al., 
2011a). When reaching the matrix, they become transit-amplifying (TA) cells, which 
have a fast-cycling nature but exit cell cycle suddenly to differentiate into IRS and hair 
shaft when reaching the top of the matrix.   
Interestingly, the specification of HFSCs begins as early as when epidermis 
invaginates to form a follicular structure during morphogenesis (Nowak et al., 2008) (Fig. 
1-3a). By E17.5, the cells within the upper region of the hair germ become SOX9-
positive.  SOX9 is required for the specification of HFSC precursors in the ORS, which 
proceed to become HFSCs by P21. During hair follicle morphogenesis, hair follicles 
without SOX9 face growth retardation and they degenerate prematurely with the 
concomitant lack of HFSC precursor population (Nowak et al., 2008; Vidal et al., 2005). 
Epidermal wound repair, meanwhile, is also compromised due to SOX9 loss.  Thus, the 
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establishment of HFSC precursors is important for forming proper hair follicle structure 
and also maintaining skin reconstitution ability upon wound healing.  
To identify candidate genes that modulate HFSC features, gene expression 
profiles of cells residing in the bulge/upper ORS were compared to epithelial basal cells 
outside the bulge region (Morris et al., 2004; Rendl et al., 2005; Tumbar et al., 2004). 
Seven out of 33 genes encoding nuclear or transcription factors were found enriched in 
HFSC population in more than one study. Interestingly, nuclear factor I/B (Nfib) was the 
only one factor that repeatedly surfaced on all three independent microarray analyses 
accompanying with three different strategies of HFSC isolation  (Table 2-1). Meanwhile, 
Nfib is also enriched in SOX9+ HFSC precursors of developing hair follicles 






Nfib belongs to nuclear factor I (Nfi) gene family, which encodes site specific 
DNA-binding proteins (Gronostajski et al., 1985; Hennighausen et al., 1985; Leegwater 
et al., 1985; Nowock et al., 1985; Roulet et al., 2000). Originally, NFI was isolated as a 
host protein required for adenovirus DNA replication (Nagata et al., 1982), and was later 
found to function in gene regulation, playing a duel role as transcriptional activator and 
repressor (Jones et al., 1987) (reviewed in (Gronostajski, 2000)). In vertebrates, the Nfi 
gene family consists of four members including Nfia, Nfib, Nfic and Nfix, all of which 
contain a highly conserved N-terminal DNA-binding and dimerization domain, and a C-
terminal transcription modulation domain with high variability due to extensive 
alternative splicing (Meisterernst et al., 1989; Mermod et al., 1989). Forming a homo- or 
hetero-dimer, NFI proteins recognize the palindromic consensus binding sequence 5’-
TGGCA-(N3-5)-TGCCA-3’, while they could also bind individual half sites with 
otherwise a lower affinity (Kruse and Sippel, 1994; Meisterernst et al., 1988).  
Nfi genes are widely expressed in mouse tissues. Gene ablation studies revealed 
that each member of NFI family has essential roles in different organ development, while 
they also converge on the same tissues, particularly on brain. Nfia-knockout mice die 
perinatally and show evident defects in brain formation (Neves et al., 1999); due to 
abnormal tooth formation. Nfic-null mice show eating difficulty, which further causes 
growth retardation and premature lethality (Steele-Perkins et al., 2003).  Loss of Nfix 
results in complex phenotypes including brain malformation, impaired bone ossification 
and developmental defects in skeletal muscle. Nfix mutants die within one month after 
birth possibly due to nutrient deprivation (Campbell et al., 2008; Driller et al., 2007; 
Messina et al., 2010). Loss of Nfib, which is the only member exhibiting preferential 
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expression in HFSCs, causes perinatal lethality owing to its essential role in lung and 
brain development (Gründer et al., 2002; Steele-Perkins et al., 2005). Interestingly, Nfib 
is often amplified and/or found at oncogenic chromosomal breakpoints in epithelial and 
gland cancers and thought to act as an oncogene (Dooley et al., 2011; Geurts et al., 1998; 
Ho et al., 2013). While the function of NFI proteins in stem cell is still unknown, the 
potential role in regulating developmental process makes it a candidate to study HFSC 
behavior.  
In this study, I assessed the functional significance of NFIB in skin development. 
Expressed in embryonic hair progenitors upon induction of hair morphogenesis, NFIB 
becomes enriched in the ORS including stem cell compartment as hair follicle 
development progressed. In Nfib-null embryos, epidermal differentiation is delayed and 
hair follicle number is reduced during embryonic development. During morphogenesis, 
SOX9 expression is reduced in HFSC precursors upon NFIB loss, accompanied with 
diminished population of transit-amplifying cells in matrix and precocious termination of 
hair follicle morphogenesis. NFIB-deficient hair follicle cells also fail to support skin 
regeneration in a wound response. By analyzing its expression in genetic mutant embryos 
defective in aspects of hair follicle formation, NFIB is positioned downstream of 
NOG/BMP signaling necessary for follicle induction.  
 
Results 
NFIB is enriched in the bulge and the ORS of hair follicles   
To validate microarray data and documented its expression pattern at different 
stages of skin development, I performed immunostaining with an anti-NFIB antibody. 
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NFIB first appeared in the epidermis at E14.5, concomitant with the beginning of 
stratification (Fig. 2-1a). As epidermal stratification progressed, NFIB was maintained in 
the basal epidermal progenitors but was down regulated in the differentiating suprabasal 
cells by E17.5 (Fig. 2-1b and c). At the onset of epidermal invagination from E15.5, the 
hair placode (Pc) upregulates P-cadherin (PCAD), but NFIB still persisted throughout the 
epidermal basal layer (Fig. 2-1b). Interestingly as the hair follicle elongated, NFIB 
became highly enriched in the hair germ (HG) specifically in the upper PCAD-low  
region of HG where HFSC precursors locate (lower panel of Fig. 2-1c, Nowak et al., 
2008), whereas it was less expressed in the PCAD-high leading edge cells, which are the 
early progenitors of the transit-amplifying (TA) matrix cells of mature hair follicles 
(lower panel of Fig. 2-1c).  
As the hair follicle become mature poatnatally, NFIB signals concentrated in the 
HFSC precursors within the upper ORS and also extended in a trail down along the ORS 
(Fig. 2-1d). During hair differentiation, NFIB signals are gradually diminished in the 
matrix, and eventually absent in differentiated progeny within the IRS and HS (Fig. 2-
1d). In telogen (P21), NFIB was enriched in the bulge and the hair germ (HG) (Fig. 2-1e). 
As the hair follicle is activated to enter a new hair cycle, NFIB signals remained strong in 
the CD34+ bulge throughout most of the hair cycle, while it is down regulated in the 
emerging TA population of committed progenitors (Fig. 2-1f and data not shown).  
Within the bulge where HFSCs reside, NFIB is also co-expressed with HFSC 
transcription factors such as NFATc1 (Horsley et al., 2008) and LHX2 (Folgueras et al., 
2013; Rhee et al., 2006), which are required for maintaining HFSC quiescence (Fig. 2-
2a); conversely its expression waned in proliferative differentiating cells marked by Ki67 
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in the matrix (Fig. 2-2b). Thus, HFSCs in the bulge/ORS upregulate the expression of 
NFIB and down-regulate it when they are undergoing differentiation program, the pattern 
that suggests an intrinsic regulatory role of NFIB in HFSCs.  
 
  
Figure 2-1. NFIB is enriched in the ORS and the bulge of hair follicles. a-f, 
Immunofluorescence with indicated antibodies. a, Nuclear NFIB appears in the basal 
layer of epidermis (Epi) as early as E14.5. b, Before or at the onset of epidermal 
invagination, NFIB is equally expressed in epidermal basal cells. PCAD marks placode 
(Pc) structure. c, As morphogenesis proceeds, NFIB is upregulated in the hair germ (HG), 
specifically in the area above PCAD+ leading edge where early HFSC precursors reside. 
d, Enrichment of NFIB in the ORS of developing HFs. Matrix (Mx). e, During telogen, 
NFIB is enriched in the bulge (Bu) and secondary hair germ (HG), expressed at lower 
level in sebaceous glands (SG) and epidermis (Epi), and absent in the dermal papilla 
(DP). f, At the onset of anagen, NFIB level remains high in CD34+ HFSCs but is down-
regulated in the emerging transit-amplifying population (TA) of committed progenitors 
close to the DP. ECAD: E-cadherin. PCAD: P-cadherin. Scale bars: 10μm.  
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Loss of NFIB delays epidermal development 
To address the physiological significance of NFIB in skin, I performed loss of 
function study in Nfib-null mice. When WT epidermal basal progenitors migrated 
upwards to differentiate into K10-positive cells in spinous layer and further into Loricrin 
(LOR)-labeled granular layer at E15.5, epidermis of Nfib KO mice still stayed in 
undifferentiated stage, in which Nfib KO epidermis was negative for differentiating layers 
until E16.5 (Figure 2-3a and b). The phenotype of epidermal stratification was manifested 
functionally in the delayed acquisition of the epidermal barrier, which cannot exclude X-
gal dye from penetrating into skin at E17.5 but one day later (E18.5) (Fig. 2-3c). 
Consistently, transcriptional profiling by quantitative RT-PCR in purified basal cells 
through fluorescence activated cell sorting (FACS) also revealed that the expression of 
differentiation markers including K1, K10 and epithelium secreted peptide complex     
 
             
Figure 2-2. Co-localization of NFIB with HFSC markers. Immunofluorescence with 
indicated antibodies. a, NFIB is expressed in NFATC1 and LHX2 positive HFSCs in the 
upper ORS. b, NFIB level is decreased in Ki67+ proliferative cells in the matrix (Mx). 
Scale bars: 10μm (a); 25μm (b).  
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(called SSC, including Dmkn, Krtdap, Sbsn) were reduced upon loss of NFIB at E15.5 
while progenitor marker K5 displayed normal level (Ezhkova et al., 2009); however, later 
at E17.5, their mRNA levels in KO cells reached the levels in WT cells (Fig. 2-3c).  
The delayed differentiation process upon NFIB loss in vivo was also recapitulated 
in vitro.  In culture, when undifferentiated keratinocytes isolated from the newborn skin 
were exposed to higher levels of calcium, they stopped proliferating and underwent 
terminal differentiation. Upregulated genes upon elevated calcium treatment were 
differentiation markers including K1, K10, Lor and Filaggrin (Flg) in both WT and KO 
cells, albeit KO cells showed the changes in a delayed fashion (Fig 2-3e). Notably, the 
differences in SSC expression in response to NFIB deficiency were not significant in 
vitro, suggesting that the in vivo changes might be due to secondary effects. Taken 
together, these data implied that disruption of NFIB resulted in delayed epidermal 
stratification. 
 
Loss of NFIB impedes hair follicle induction and morphogenesis 
Hair follicle induction is initiated around E15.5 and the hair follicle numbers are 
gradually increased along with the expansion of skin area. To monitor hair follicle 
formation, I used PCAD to label hair placodes to quantify their numbers. Starting from 
E15.5, Nfib-null embryos displayed an ~40-60% reduction in the overall density of 
PCAD-positive hair follicles (Fig 2-4a). In mouse skin, there are four types of hairs 
formed in a sequential fashion during embryonic stage, in which hair follicles of guard 
hairs were induced at E14.5, awl/auchene hairs from E16.5 and zigzag hairs from E18.5.  
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Figure 2-3. Epidermal stratification is delayed upon NFIB loss. a,b, Immunostaining 
shows that K10+ spinous layer and LOR-labeled granular layer were formed in WT 
embryos in E15.5 but were formed one day later (E16.5) in Nfib KO embryos. K5 labels 
basal layer. c, Dye exclusion assay to measure skin barrier showed that Nfib KO skin 
acquired protective barrier later than WT skin. Failure of forming a differentiated layer 
(cornified barrier) resulted in the diffusion of dye into the skin and skin color darkened 
when embryos were immersed in X-gal reaction mix.	   d, Quantitative PCR of FACS-
purified basal cells (α+β+) from control and KO skin. e, Quantitative PCR of control and 
KO cultured keratinocytes before (0h) and after calcium elevation (24h, 48h). Scale bars: 
10µm. Error bars indicate s.e.m. 
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To understand whether Nfib is generally required for hair formation or its function 
is hair-type specific, I quantitatively assessed the progression of the early steps of hair 
follicle morphogenesis in Nfib-null skin at E18.5, when first wave of hair follicle growth 
reached PEG stage while others had smaller structures. However, the percentage of hair 
follicles in each stage of morphogenesis showed no significant difference between WT 
and Nfib- KO mice. Thus, it implies that disruption of Nfib caused overall reduction of 
hair follicle density but the induction of individual hair types seems fine (Fig. 2-4b). 
Given that Nfib-null mice cannot survive after birth due to a severe lung structural defect, 
it is difficult to follow postnatal hair growth and cycle upon NFIB loss. To overcome this 
limitation, I grafted the skins from E18.5 KO and control embryos onto recipient nude 
mice, which provided a platform to extend the analysis of Nfib-KO skin development. 
Notably, when WT skin became hairy after 12-day grafting (D12), Nfib-KO grafts still 




Figure 2-4. Disruption of Nfib reduces hair follicle density during embryonic stage. 
a, Immunofluorescence with indicated antibodies. Quantifications of hair follicle number 
per microscope field reveal that loss of NFIB results in decreased hair follicle density 
starting from E15.5. b, The progression of hair follicle growth from placode (Pc) to Peg 
stage is normal in KO skin. HFs: hair follicles. PCAD: P-cadherin.  Scale bars: 20µm. 
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follicles showed growth retardation. At D8, WT hair follicles were reaching full length 
and forming hair shaft, while Nfib-KO hair were still in the early stage of morphogenesis 
with shorter appearance (Fig. 2-5b).  
Later, surprisingly, the growth of Nfib-KO hair follicles became asynchronous. 
By D12 when most of WT hair follicles are still in growing phase, some of Nfib-null hair 
follicles showed signs of degeneration, which was visualized by histological analysis 
(Fig. 2-5c). Also, KO hair follicles showed positive immunostaining with active-
caspase3+, indicating the presence of apoptotic cells (Fig. 2-5d). Meanwhile, some of KO 
hair follicles were still maintained, while their matrix marked by Ki67 was smaller than 
of control (Fig. 2-5e). One month later, both WT and KO hair follicle entered telogen by 
D45 with proper formation of bulge HFSC populations indicated by CD34 staining (Fig. 
2-5f and g). Taken together, these results suggested that NFIB loss impedes hair follicle 
induction and morphogenesis accompanied with immature formation of transit-
amplifying population in the matrix, while the establishment of bulge HFSCs seems not 
affected.  
To determine if NFIB regulates epidermal cell function in a cell-autonomous or 
non-autonomous manner, I generated mice with conditional knockout of Nfib specifically 
in epidermal cells by crossing Nfib (fl/fl) mice (Hsu et al., 2011b) to mice carrying cre 
recombinase (Cre) driven by K14 promoter (Vasioukhin et al., 1999). In K14Cre/Nfib 
(fl/fl)  (cKO) mice, ablation of Nfib was targeted in the basal layer of skin as early as 
E13.5, right before the timing of NFIB appearance. Heterozygous deletion of Nfib 
(K14Cre/Nfib (fl/+)) or expression of Cre only in skin had no obvious effect on 
development, and animals survived and showed normal coat formation. In contrast, most  
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Figure 2-5. Loss of NFIB impedes hair follicle morphogenesis. a, Skin grafting on 
nude mice reveals delayed hair shaft formation upon NFIB loss. b, H&E staining of 8-
day grafts show that the length of KO hair follicles is shorter than WT hair follicles. c, 
H&E staining of 12-day grafts reveal precocious degeneration of KO hair follicles. d, 
Apoptotic cells (active-casp3+) are present in degenerating hair follicles of KO grafts. e, 
Immunofluorescence shows that the matrix, marked by Ki67, of KO hair follicles is 
smaller than WT hair follicles. f, H&E staining shows that both WT and KO hair follicles 
enter telogen after 45-day grafting. g, The bulge of KO (lacking NFIB signals) hair 
follicles express CD34 normally. ECAD: E-cadherin. Scale bars: 50µm (b-f); 10µm (g).  
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of Nfib cKO mice died within 1-2 days after birth. Occasionally, some cKO mice 
survived for ~1-2 weeks with mosaic Nfib targeting. They displayed sparse hairs at P15 
when WT mice developed full hair coat (Fig. 2-6a).  In addition, the whiskers of cKO 
mice were in disarray  (Fig. 2-6b). In sum, epidermal Nfib is required for hair follicle 
development and proper establishment of hair structure.  
Next, I performed histological analysis to investigate the possible defect in hair 
follicle morphology upon Nfib ablation. At P0, no significant abnormalities in follicle 
structure and length were found in cKO mice (Fig. 2-7a). However, differences in HF 
length became evident by P3 when cKO follicles only had 40% the length of WT follicles 
and remained shortened by P6 (Fig. 2-7a and b). Despite defects in HF length, overall 
features of HF differentiation were relatively normal: IRS, hair shaft and sebaceous gland 
 
 
Figure 2-6. NFIB loss specifically in epidermal cells results in delayed hair coat 
formation. a, K14-Cre/Nfib(fl/fl)-cKO mice have spare hairs at P15 while WT mice have 
full hair coat. b, Whiskers of cKO mice are malformed.  
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were all present and properly organized (data not shown). Interesting and unexpectedly, 
by P13 cKO follicles were not only shorter than WT follicles, but they displayed signs of 
exiting the previous hair cycle precociously and going into next hair cycle. At P13, the 
upper region of follicles exhibited the previous (club) hair in its center, with a new hair 
follicle growing downward (Fig. 2-7a). In contrast, the WT follicles were still in the 
process of completing the first round of hair growth, which normally completes after P15.  
The phenotype of precocious exit from previous hair cycle in Nfib-cKO mice was  
  
 
Figure 2-7.  Hair follicle morphogenesis is retarded upon NFIB loss. a,  H&E-stained 
backskins. At P0, K14-Cre/Nfib(fl/fl) (cKO) hair follicles have normal morphology. By 
P6, cKO follicles are shorter than WT follicles. By P13, cKO preciously enter anagen of 
first hair cycle as WT follicle is still in morphogenesis stage. b, Quantification of hair 
follicle length at different stages. Scale bars: 50µm. *P < 0.001. Error bars indicate s.e.m. 
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consistent with straight KO results (Fig. 2-5c, b), though the outcome of grafting 
experiments was more complicated in that hair follicles of KO grafts behaved less 
synchronously than of cKO skin.  
Closer inspection revealed that the matrix size of Nfib cKO follicles was restricted 
(Fig. 2-8), which was also observed in engrafted straight KO skins  (Fig. 2-5e). The 
matrix structure of these cKO follicles were smaller than of WT follicles accompanied 
with smaller population of Ki67+ transit-amplifying cells, which had not reached AE13+ 
differentiated layers (Fig. 2-8). Taken together, I found that hair follicle morphogenesis is 
retarded and shortened in NFIB-deficient skin, while the determination of differentiated 
HF lineages is not affected.  
 
  
Figure 2-8. NFIB loss results in reduced transient-amplifying matrix population. 
Immunofluorescent tracking of Ki67-positive matrix cells over time. Quantification of 
the number of Ki67-positive and AE13-negative matrix cells per hair follicle cross 
section. Scale bars: 10µm. *P < 0.001. Error bars indicate s.e.m. 
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Hair follicle stem cell precursors cannot maintain SOX9 expression upon NFIB loss 
HFSC precursors, specified in the upper ORS during morphogenesis, are required 
for hair follicle formation. Because Nfib is expressed in HFSC precursors, I speculated 
that impeded formation of hair follicles in Nfib cKO skin might be due to the defects in 
HFSC precursors. To examine this hypothesis, I first performed immunostaining with 
antibodies against SOX9, which is a marker of HFSC precursors and required for their 
establishment (Nowak et al., 2008). At P0, SOX9 was expressed in the upper ORS of 
cKO follicles (Fig. 2-9a). However, by P6, SOX9 signals were dramatically decreased in 
the upper ORS of cKO follicles compared to WT follicles, and only scattered cells in 
cKO follicles were SOX9 positive (2-9b). Quantitatively, the number of SOX9-positive 
cells in the upper ORS was significantly decreased in the absence of Nfib (Fig. 2-9c).  
However, other two markers LHX2 (Folgueras et al., 2013; Rhee et al., 2006) and 
NFATc1 (Horsley et al., 2008), required for maintaining HFSCs in quiescence, were still 
expressed in the upper ORS (Fig. 2-9d). Taken together, in light of the findings that cKO 
follicles cannot grow normally accompanied with undersized matrix and the expression 
of HFSC precursor marker SOX9 is declined in the ORS, it is possible that Nfib might be 
required for forming HFSC precursors. As a consequence, there may not be sufficient 
HFSC precursors established and/or with sufficient function to be able to provide a 
sufficient input of cells toward the matrix, whose residents have low capacity for self-
renewal and rely on constant influx of cells from upstream stem cells for expanding its 
population over time.  
If NFIB is required for establishing proper HFSC precursors, Nfib deficiency 
might impair their ability of regenerating tissue in wounds. To further gain insight into  
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Figure 2-9. Expression of HFSC markers in Nfib cKO hair follicles. a, 
Immunofluorescence shows SOX9 is normally expressed in the ORS of cKO follicles at 
P0. b, By P6, the number of SOX9+ cells is dramatically decreased in the upper ORS of 
cKO follicles. c, Quantifications of percentage of SOX9+ cells in the top 30 ORS cells 
below sebaceous gland. d, Immunofluorescence shows LHX2 and NFATc1 are expressed 
in cKO follicles. ECAD: E-cadherin. Scale bars: 10µm. *P < 0.001. Error bars indicate 
s.e.m. 
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their functionality in vivo, I conducted engraftment experiments on Nude mice recipient 
with split dermis tissue (Nowak et al., 2008). After removing the epidermal layer, split 
dermis from donor mice, which contained hair follicles with HFSC precursors, were 
grafted above a wound on Nude mice recipient. To trace the behaviors of targeted cells, I 
crossed cKO and control mice to Rosa26floxed/stop/floxed/YFP (RosaYFP) Cre-reporter mice, in 
which Cre-targeted cells and its progeny can be followed by YFP signals. Surprisingly, 
when control grafts were fully covered by hairs 2 weeks after grafting, cKO grafts still 
lacked hairs (Fig.2-10a).  Examining YFP signals, I observed that YFP+ hair follicle cells 
from control split graft emigrated upwards to regenerate epidermal tissue; meanwhile, 
they were also able to split their effort to support hair follicle growth downward (Fig.2-
10b and c). However, in NFIB-deficient grafts, though epidermal wounds seemed to be 
repaired, most of them were YFP negative, suggesting that they were not generated from 
NFIB-targeted cells but WT cells possibly due to mosaic activity of K14-Cre in the grafts 
and the invasion of surrounding recipient epidermal cells (Fig.2-10b). More dramatically, 
most hair follicles were degenerated and disappeared quickly within one week in NFIB-
deficient grafts left with few sporadic untargeted WT hair follicles. It suggests that NFIB 
loss impairs hair follicle-mediated re-epithelization (Fig.2-10c).    
 
NFIB acts downstream of NOG/BMP signaling 
Multiple signaling pathways converge to regulate hair follicle morphogenesis. To 
elucidate their relations with NFIB, I examined NFIB’s expression in various genetic 
backgrounds carrying mutations in key signaling pathways responsible for hair follicle 
induction and growth. In Wnt signaling-deficient embryos with Lef1, Tcf3/4, or β-catenin 
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(βcat) knocked out, NFIB was still present in skin (Fig. 2-11a). NFIB was also expressed 
normally in the absence of sonic hedgehog (Shh), which is required for follicle down-
growth (Fig. 2-11b). Only upon the ablation of Noggin (Nog) was NFIB level decreased 
in the hair germ accompanied with reduced formation of hair follicles, the phenotype that 
was also observed in Nfib-KO embryos (Fig. 2-11c). Given that NOG is an antagonist of 
BMP ligands and acts by sequestering BMPs from their receptors, I tested if NOG 
modulates NFIB expression through inhibiting BMP pathway in vitro. After 24-hour 
addition of BMP4 into the culture, mRNA level of Nfib in WT keratinocytes was 
 
 
Figure 2-10. NFIB is required for hair follicle-mediated re-epithelization upon 
wounding. a, Split thickness (dermis with HFs) skins from E18.5 WT and cKO embryos 
were grafted onto Nude recipients. Hairs grew on WT grafts 30 days after grafting while 
cKO grafts were hairless. b, Control and cKO mice were crossed to Rosa26floxed/stop/floxed/YFP 
(RosaYFP) reporter mice to follow the behavior of targeted (YFP+) cells in split-thickness 
grafting experiments. New epidermis formed on top of control split thickness grafts are 
YFP+, but cKO grafts have very few YFP+ cells in the epidermis. c, Degeneration of cKO 
hair follicles in split thickness grafts. Scale bars: 10µm (b); 50µm (c). 
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Figure 2-11. NFIB level is regulated by NOG/BMP signaling. a-c, 
Immunofluorescence with indicated antibodies. a, NFIB levels in hair follicles are 
unchanged in Wnt-deficient embryos.  b, NFIB is expressed in Shh KO embryos. c, 
Nuclear NFIB signals are decreased in Nog-mutant hair follicles. d, Quantitative PCR 
indicates that Nfib mRNA level is decreased after 24h BMP4 addition in keratinocyte 
culture. The inhibition is reversed by the addition of BMP inhibitor noggin (NOG) and is 
not seen in BMP receptor (Bmpr1a)-KO keratinocytes. ECAD: E-cadherin. PCAD: P-
cadherin. Scale bars: 5µm (a); 10µm (b,c). Error bars indicate s.e.m. 
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decreased by 2-fold and the inhibition was blocked by the presence of antagonist NOG 
(Fig. 2-11d). Conversely, BMP receptor Bmpr1a KO keratinocytes showed 2-fold 
increases in Nfib mRNA level, which is not responsive to exogenous BMP or NOG 
treatment (Fig. 2-11d). Taken together, these findings suggested that NFIB acts 
downstream of BMP/NOG pathway. Noggin, secreted from mesenchymal cells nearby 
placode forming region during morphogenesis, might upregulate Nfib expression in the 
follicle possibly through inhibiting BMP signals. 
 
Discussion 
Through analysis of transcriptional profiles, a novel transcriptional factor NFIB in 
HFSCs was identified. It is upregulated at first in the undifferentiated epidermal stem 
cells and further become enriched in HFSCs when the follicles appear. Conversely, NFIB 
is down regulated in both epidermal and hair cells when they undergo differentiation 
program. Although further loss-of-function studies indicated that NFIB is not required for 
differentiation of epidermal stem cells to form stratified epithelium, the timing is 
disrupted. During development, the establishment of skin barrier was delayed in Nfib-null 
mice, accompanied with delayed upregulation of differentiation markers. However, the 
molecular basis behind the scene is still not clear and merits further investigation. Are the 
defects caused by unbalanced control of epidermal stem cell proliferation and 
differentiation or due to ectopic apoptosis in skin? Do NFIB-deficient epidermal stem 
cells enter the cell cycle properly? Could NFIB-deficient epidermal stem cells perform 
asymmetric cell division, in which their mitotic spindle orients perpendicularly to the 
basement membrane to drive the generation of committed suprabasal cells? Waiting to be 
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addressed are also questions concerning the long-term effect of NFIB loss, such as if 
delayed stratification process of epidermis still remains unsolved in adult, the defect that 
further slows down regular skin turnover as well as regeneration process in wound 
healing.  
Furthermore, I also found that hair follicle numbers were reduced in Nfib-null 
embyros. The induction process of follicles relies on reciprocal interactions between 
epidermal and underlying mesenchymal cells, in which extracellular signal exchanges 
take place to mediate the crosstalk. By examining if NFIB acts as an intracellular 
responder upon extracellular signal stimulation required for placode formation, I found 
that NFIB levels are regulated by NOG/BMP pathway. In Nog-KO embryos, hair follicle 
induction is retarded (Botchkarev et al., 1999), the phenotype reminiscent of Nfib mutants 
and concomitant with reduced level of NFIB in hair follicles. I also showed that NOG 
modulates NFIB expression by its canonical role of inhibiting BMP pathways. Digging 
into the mechanism, studies have indicated LEF1/Wnt signals are also diminished in 
Nog-KO hair follicles. Notably, however, forced expression of Lef1 in Nog mutant cannot 
fully rescue hair follicle defect (Jamora et al., 2003), raising the possibility that other 
LEF1/Wnt-independent mechanisms might act downstream of NOG/BMP pathway to 
regulate hair follicle morphogenesis. Thus, knowing whether NFIB is the missing factor 
needs further study. Meanwhile, it also has not been examined if NFIB acts rather 
upstream of other well known signaling pathways. Testing the sensitivity of Nfib-KO 
keratinocytes in response to extracellular stimuli will be helpful to solve this issue. 
Interestingly, protein sequence analysis to search for conserved secondary structure 
revealed that DNA binding region of NFI family contains a N-terminal Mad Homology 1 
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(MH1) domain (NCBI: NP_001106680.1), which is shared by most of SMAD proteins 
involved in TGF-β/BMP signaling (Shi et al., 1998). However, the similarity seems not 
assist them to target the same genomic sites as SMAD and NFI proteins recognize 
specific but different DNA-binding elements (Shi et al., 1998). However, MH1 domain of 
SMAD proteins can negatively regulate the modulation domain (MH2) by interacting 
with MH2, which creates a close structure to prevent the association of several SMAD 
proteins becoming a functional unit in the absence of inputs (Hata et al., 1997). Thus, it is 
tempting to examine if MH1 domain of NFI proteins also have inhibitory effect to itself 
and/or to other factors such as SMADs, and what stimuli can open the structure.  
As whole embryo targeting of Nfib results in perinatal lethality due to lung 
development defects, I generated conditional Nfib-knockout (cKO) mice with K14-Cre, 
in which Nfib was targeted in the epidermis and hair follicles of skin. During hair follicle 
morphogenesis, the growth of cKO hair follicles was retarded concomitant with a 
diminished population of transit-amplifying matrix cells. Premature transition from 
morphogenesis to next anagen in Nfib-cKO hair follicles reflects the possibility that 
diminished hair bulb, which precociously exhausts its supply of transit-amplifying matrix 
cells, might fail to last long. But the overall features of differentiated layers in hair 
follicles and sebaceous glands were relatively normal, suggesting that NFIB is not 
required for lineage commitment and differentiation. While the possible causes of a 
reduced matrix population might be due to a defect in the matrix itself with decreased 
proliferation, or increased differentiation or apoptosis, retarded hair follicle growth and 
matrix production could also be due to impaired establishment of functioning HFSC 
precursors, which are needed to proliferate to support the elongation of follicular 
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structure and fuel the production of matrix cells. 
Examining the characteristics of HFSC precursors, I found that SOX9 expression 
was gradually decreased after birth upon NFIB loss. It suggested that HFSC precursors 
might be specified during embryonic stage but they either fail to mature or their 
characters are not maintained during hair follicle morphogenesis. Meanwhile, in a wound 
response created by the split-thickness grafting assay, NFIB-deficient hair follicles 
completely degenerate with reduced epithelial reconstitution efficiency, implying that the 
regenerative capacity of hair follicle cells including HFSC precursors is limited in the 
absence of NFIB.  
Making HFSCs versus utilizing them could be two distinct processes. Since the 
hair follcile forms from the epidermis, defects in the epidermis and/or hair follicle 
specification could be at the root of the hair follicle defects that I see. In addition, 
establishing proper HFSCs could be dependent upon proper communication of HFSC 
precursors with developing niche components, which must occur in synchrony with the 
HFSC precursors during morphogenesis. Since K14-Cre targets the skin epithelium from 
early development, and encompasses both epidermal and hair follicle cells, it is not 
possible to know whether once developed the HFSCs and their niche would be able to 
function properly. Inducible targeting methods to knockout Nfib postnatally will be 
helpful for further studies to address this issue, and to detail the defects and the 
underlying mechanisms.  
 In sum, these results revealed that NFIB is involved in multiple processes of skin 
development. During embryonic stage, loss of NFIB delays the formation of skin barrier 
and inhibits hair follicle induction. In addition, during morphogenesis, NFIB is required 
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for hair follicle growth and establishing functional HFSC precursors. However, whether 
NFIB functions in adult HFSCs is unknown. Further exploration of this issue and 
characterization of NFIB’s target genes and its affect on their action will shed light into 
the mechanisms by which this important somatic stem cell niche is established and 
regulated during development. Beyond morphogenesis stage, whether NFIB plays a role 
in regulating the homeostasis of hair follicles and in regulating adult HFSC behavior will 
be discussed in the following chapter (Chapter 3). 
 
Materials and Methods 
Mice, barrier assay and engraftment experiments. 
Nfib(fl/fl) and Nfib(-/-) mice have been described (Hsu et al., 2011b; Steele-
Perkins et al., 2005), as have transgenic K14-Cre (Vasioukhin et al., 1999) and 
ROSA26flox/STOP/flox/YFP (RosaYFP) (Srinivas et al., 2001) mice. Dye exclusion assays were 
performed as described (Hardman et al., 1998). Full thickness grafts from E18.5 embryos 
were performed as described (Rhee et al., 2006) and split thickness grafts were performed 
as described (Nowak et al., 2008).  
All animals were maintained in an AAALAC-approved Comparative Bioscience 
Center (CBC) at The Rockefeller University and procedures were performed using 
IACUC-approved protocols that adhere to the standards of the National Institutes of 
Health.  
 
Histology and immunofluorescence. 
Embryos (<E16.5) or backskins were embedded in OCT (Tissue Tek), frozen on 
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dry ice and stored at -80°C. Only in the case of RosaYFP reporter mice, tissues were 
prefixed in 4% paraformaldehyde (PFA) for 30 min at room temperature (r.t.) before 
embedding in OCT in order to preserve the fluorescence signals. Un-prefixed frozen 
sections (10-20 µm) were fixed in 4% PFA for 10 min at (r.t.). For histological analysis, 
sections were stained with hematoxylin and eosin. For immunofluorescence, sections 
were permeabilized in 0.3% Triton X-100 in PBS for 20 min and blocked for 1 hr at r.t. 
in blocking buffer including 2.5% normal donkey serum, 2.5% normal goat serum (or 5% 
normal donkey serum alone when goat primary antibodies were used), 0.5% BSA and 
0.1% Triton X-100 in PBS. MOM Basic kit (Vector Laboratories) was used for blocking 
when primary antibodies were generated from mouse. Primary antibodies were diluted in 
blocking buffer and sections were incubated overnight at 4°C. After washing with PBS 
for 30 min at r.t., sections were incubated for 1–2 hr at r.t. with secondary antibodies 
conjugated to Alexa-488, Alexa-546, Alexa-647 (Molecular Probes), or RRX (Jackson 
Laboratories). Nuclei were stained using 4’6’-diamidino-2-phenylindole (DAPI). 
Imaging was performed on a Zeiss Axioplan 2, Zeiss Apotome, Zeiss Inverted LSM 510 
laser scanning confocal microscope, or Zeiss Inverted LSM 780 laser scanning confocal 
microscope.  
The following antibodies and dilutions were used: NFIB (rabbit, 1:1,000, Active 
Motif; mouse, 1:500, Abcam); P-cadherin (goat, 1:100, R&D); E-cadherin (rat, 1:500, 
Fuchs lab); K5 (guinea pig, 1:500, Fuchs lab); CD34 (rat, 1:100, BD Pharmingen); Ki67 
(rabbit, 1:300, Novocastra); cleaved-Caspases3 (rabbit, 1:300, R&D); GFP (chicken, 
1:2,000, Abcam); LHX2 (rabbit, 1:500, Fuchs lab); NFATc1 (mouse, 1:100, Santa Cruz); 
SOX9 (rabbit, 1:1000, Fuchs lab); K10 (rabbit, 1:500, Covance); LOR (rabbit, 1:400, 
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Fuchs lab); AE13 (mouse, 1:500, Abcam).  
 
Isolation of epidermal basal cells and FACS.  
Back skins from one litter of E15.5 and E17.5 embryos were dissected using the 
shoulders and hips as landmarks, and incubated in 4ml 0.25% Collagenase (Sigma) in 
HBSS (GIBCO) at 37°C for 15 min to digest the dermis. 11ml cold PBS was added and 
dermal tissues were separated from the epidermis by repetitive pipetting. Additional 25 
ml cold PBS was added before centrifugation (300g, 15min). 25ml cold PBS was added 
to resuspend cells, and centrifugation with 40g for 6 min was conducted to enrich 
epidermal cells leaving dermal cells in supernatant. The epidermal fraction was treated 
with 2ml 25% trypsin (GIBCO) at 37°C for 20 min. Single cells were washed once and 
resuspended in 10ml staining buffer (PBS with 5% fetal bovine serum treated with 
BioRad Chelex to remove calcium) to inactivate Trypsin, and cells were collected by 
centrifugation for 5 min at 300g. Cell suspensions were incubated with the appropriate 
antibodies diluted in staining buffer for 30 min at 4°C. The following antibodies were 
used: α6-PE (1:500, eBioscience); β1-FITC (1:500, eBioscience). DAPI (100 ng/ ml) 
was used for death cell exclusion. Cell isolations were performed on BD FACSAria II 
sorters equipped with BD FACSDiva software. For RNA extraction, cells were sorted 
directly into TRIzol LS Reagent (Life Technologies).  
 
RNA extraction and quantitative PCR (qPCR).  
RNA was extracted using Direct-zol RNA MiniPrep (Zymo Research) with 
DNase treatment to remove residual genomic DNA. cDNA was synthesized from isolated 
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RNA using SuperScript III First-Strand Synthesis System with oligo-dT primers 
(Invitrogen). cDNAs were mixed with indicated primers and Power SYBR Green PCR 
Master Mix (Applied Biosystems), and quantitative PCR (qPCR) was performed on a 
Applied Biosystems 7900HT Fast Real-Time PCR system for 40 cycles. Specificity was 
confirmed by subsequent melting curve analysis or gel electrophoresis. Levels of PCR 
product were expressed as a function of peptidylprolyl isomerase B (Ppib). Primers were 
designed through Primer 3 and amplified products encompassed exon/intron boundaries. 
The following primer sequences were used:  
Nfib forward 5’-ATGACCCATCCAGTCCTCAA-3’,  
reverse 5’-TTGAAGGAAAGGCTCTCCAA-3’; 
K5 forward 5’-GGCTCTCAAAGATGCCAGAA-3’,  
reverse 5’-TGACTGGTCCAACTCCTTCC-3’; 
K14 forward 5’-CGCCGCCCCTGGTGTGG-3’,  
reverse 5’-ATCTGGCGGTTGGTGGAGGTCA-3’; 
K1 forward 5’-GACACCACAACCCGGACCCAAAACTTAG-3’,  
reverse 5’-ATACTGGGCCTTGACTTCCGAGATGATG-3’; 
K10 forward 5’-GGAGGGTAAAATCAAGGAGTGGTA-3’,  
reverse 5’-TCAATCTGCAGCAGCACGTT-3’; 
Lor forward 5’-TCACTCATCTTCCCTGGTGCTT-3’,  
reverse 5’- GTCTTTCCACAACCCACAGGA-3’; 
Flg forward 5’-GGAGGCATGGTGGAACTGA-3’,  
reverse 5’-TGTTTATCTTTTCCCTCACTTCTACATC-3’; 
Dmkn forward 5’-AGACCACTGCCAAGGCGGGA-3’,  
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reverse 5’-CCCCAGGCGAGATGACAGGC-3’; 
Krtdap forward 5’-GCAGCCCAAACCGGACACCA-3’,  
reverse 5’-AGGCCCTCTGTTGCGGTAGGG-3’; 
Sbsn forward 5’-GCCAGGCCGAGAAGGAAGCG-3’,  
reverse 5’-CCTCCGTGCTGGCCTCCGTA-3’; 
 
Cell Culture.  
Enzymatic separation of epidermis from skins and primary keratinocyte culturing 
were conducted as described (Blanpain et al., 2004). Primary Nfib-null (KO) 
keratinocytes were isolated from epidermis of E18.5 Nfib knockout embryos (Nfib-/-) and 
control keratinocytes were from heterozygous Nfib (+/-) embryos. Keratinocytes were 
maintained in E-media supplemented with 15% serum and a final concentration of 0.05 
mM Ca2. Experiments were performed using primary cells with less than 15 passages. To 
induce keratinocyte differentiation, calcium concentration was raised from 0.05 to 1.5 
mM. BMP4 (300ng/ml, R&D Systems) and noggin (300ng/ml, R&D Systems) 
recombinant proteins were reconstituted according to manufacture’s manual.   
  
Statistics. 
To determine significance between two groups indicated in figures, comparisons 
were performed in Prism 5 software with unpaired two-tailed student’s t-test.  
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Chapter 3: 
The role of nuclear	  factor	  I/B in coordinating epithelial-melanocyte stem cell 
behavior in the hair follicle 
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Introduction 
Adult stem cells reside in specialized niches where they receive environmental 
cues to maintain tissue homeostasis. In mammals, the hair follicle is home to two distinct 
stem cell populations including epithelial hair follicle stem cells (HFSCs) and melanocyte 
stem cells (McSCs), which behave cooperatively to sustain cyclical bouts of hair 
regeneration and pigmentation (Cotsarelis et al., 1990; Morris et al., 2004; Nishimura et 
al., 2002; Tumbar et al., 2004). When hair follicles are in the dormant phase (telogen), 
HFSCs and McSCs reside in the bulge and HG, and remain quiescent for many weeks 
(Fig. 1-3b). When follicle regeneration (anagen) initiates, these two stem cell populations 
are coordinately activated at the hair-follicle base (hair germ; HG) in response to 
activating cues that are secreted from specialized underlying mesenchymal cells, the 
dermal papilla (DP) (Blanpain and Fuchs, 2006; Greco et al., 2009; Nishimura et al., 
2002; Rendl et al., 2005). Thus, at the onset of anagen, a subset of stem cells of each type 
enter the cell cycle and produce progeny. In the mature hair follicle, transit-amplifying 
HFSC progeny (matrix cells) in the hair bulb have enveloped the dermal papilla. They 
divide rapidly, but only briefly, progressing to differentiate to form the new hair.  Just 
before they do so, differentiated melanocytes produce and transfer pigment to adjacent 
HFSC progeny in the upper matrix as they stop proliferating and begin to differentiate to 
form a hair shaft (Tobin et al., 1999).  
For both melanocyte and hair lineages, stem cells remain in the bulge and the 
upper ORS of mature hair follicles. When differentiated melanocytes and matrix cells 
simultaneously undergo apoptosis during the destructive phase (catagen), HFSCs and 
McSCs in the upper hair follicles survive and stay in quiescence during telogen until the 
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beginning of next hair cycle (Sharov et al., 2005). 
The molecular mechanisms of how HFSCs and McSCs coordinate their behaviors 
during hair cycle are still unclear. Given the global impact of environmental signals from 
the DP cells or other adjacent cell types on HFSCs and McSCs (discussed in Chapter 1), 
it remains a mystery as to whether and/or how intercellular communication between 
HFSCs and McSCs might contribute to the coordination of stem cell activity.  
To study the function of Nfib in adult HFSC maintenance, I generated inducible 
Nfib conditional knockout mice, in which Cre recombinase activities were induced after 
hair follicle morphogenesis was completed. Surprisingly I found that ablation of Nfib in 
adult HFSCs did not perturb HFSC maintenance, as hair follicle growth and hair cycle 
proceeded relatively normally. Instead, and even more unexpected, NFIB loss in the 
HFSCs promoted proliferation and precocious differentiation of nearby McSCs. My 
findings provide new insights into how McSC and HFSC behaviors maintain reliance 
upon cooperative factors within hair follicles and how this might be uncoupled in injury, 
stress and disease states.   
 
Results 
NFIB is expressed in hair follicle stem cells but not in melanocytes 
The venture into this study was inspired by the finding that relative to their 
progeny, HFSCs display elevated expression of transcription factor NFIB (see Chapter 
2). To know within the hair follicle if NFIB is specifically expressed in HFSCs or present 
in both stem cell populations, I conducted co-immunostaining with antibodies 
recognizing NFIB and of tyrosine kinase receptor KIT, which is a marker of melanocytes. 
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I found that NFIB was not detected in KIT+ McSCs, which were mostly located in the 
hair germ (HG) of telogen follicles and intermingled with NFIB+ HFSCs (Fig. 3-1a).  
Although in telogen KIT is only expressed in the cells of melanocyte lineage, 
during hair growth KIT becomes upregulated in transit-amplifying matrix cells derived 
from HFSCs and is not a suitable markers to label differentiated melanocytes in the hair 
bulb (Botchkareva et al., 2001). To circumvent this problem and identify melanocytes 
specifically, I used Dct-EGFP BAC transgenic mice, in which EGFP expression is under 
the control of the promoter of melanocyte-specific gene dopachrome tautomerase (Dct) 
(Fig. 3-1b). The co-localization of KIT and EGFP signals confirmed the reliability of 
using Dct-EGFP mice as a tool for labeling melanocytes (Fig. 3-1c). To examine the 
differential expression of Nfib at the RNA-level, I isolated EGFP+ melanocytes as well as 
α6+CD34+ bulge HFSCs by fluorescence-activated cell sorting (FACS) for quantitative 
PCR (qPCR) analysis (Fig. 3-1d). The results of qPCR showed that Nfib accompanied 
with Sox9 were enriched in bulge HFSCs; conversely, melanocyte-specific genes such as 
endothelin receptor type B (Ednrb) and Dct were predominantly expressed in EGFP+ 
melanocytes (Fig. 3-1e). At protein level, within the bulge and along the upper ORS, 
NFIB was not detected in EGFP+ McSCs (Fig. 3-1f). NFIB was also not found in EGFP+ 
differentiated melanocytes, which were confined to the hair bulb where they transfer 
pigment to differentiating hair cells. Thus, both inside and outside their residence, HFSCs 
and McSCs displayed synchronized behaviors but distinct expression patterns.  
 
Postnatal ablation of Nfib does not perturb hair cycle or follicle architecture 
In K14-Cre Nfib cKO mice, perturbed hair follicle morphogenesis implied that  
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Figure 3-1. NFIB is not expressed in melanocytes. a, Immunofluorescence reveals the 
absence of NFIB in KIT+ McSCs of telogen (P59) hair follicles. b, Whole-mount green 
fluorescent imaging of dorsal skin from P53 Dct-EGFP BAC transgenic mouse. c. 
Immunofluorescence shows co-staining of KIT and EGFP in telogen (P100) hair follicles 
of Dct-EGFP mice. d, FACS isolation. Melanocytes (Mc) were EGFPhigh; bulge HFSCs 
(Bulge) were isolated with markers EGFPneg Sca1neg α6high CD34+. e, Quantitative PCR on 
FACS-isolated populations confirm the enrichment of Nfib and Sox9 in bulge cells and of 
melanocyte markers including Ednrb and Dct in Mc population. f, NFIB signals in 
anagen HFs of P32 Dct-EGFP transgenic mice. Note NFIB is not seen in EGFP+ McSCs 
in the ORS and also not seen in EGFP+ differentiated melanocytes close to the matrix 
(Mx). upORS: upper ORS. Bu: Bulge. HG: Hair germ. DP: Dermal papilla. Scale bars: 
10 μm (a, c); 100 μm (b); 25 μm (f). 
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Nfib might play a role in HFSC establishment (see Chapter 2). However, Nfib disruption 
during the embryonic stage by K14-Cre also caused premature lethality of mice, which 
impeded studies to address Nfib’s function in mature hair follicles and adult HFSC 
maintenance.   
To overcome these issues, I generated two inducible Nfib conditional knockout 
mice (cKO mice), one carrying Sox9-CreER (Soeda et al., 2010) and the other with K15-
CrePGR (Morris et al., 2004) (Fig. 3-2a). The activities of both types of Cre 
recombinases can be temporally controlled and are dependent on chemical application, 
while two lines exhibit different advantages for gene targeting. The Sox9 promoter 
displays higher efficiency than K15 to drive Cre expression; however, Cre is not 
restricted solely to HFSCs, but extends upward to the so-called junctional zone of resting-
phase hair follicles. On the other hand, the K15 promoter can be used to conduct gene 
ablation prominently in HFSCs of bulge and HG but with relatively lower efficiency, 
which causes mosaic-targeting pattern (Fig. 3-2a). Notably, postnatally, the Cre activities 
from both lines are restricted to keratinocytes and not in melanocytes.  As shown 
previously by transcriptional profiling analysis (Rendl et al., 2005), K15 (or called Krt1-
15) and Sox9 mRNAs were enriched in ORS/bulge, down in matrix and absent in 
melanocytes and DP (Fig. 3-2b); furthermore, Rosa26floxed/stop/floxed/YFP (RosaYFP) Cre-
reporters marked only HFSCs and not KIT+ melanocytes or dermal cell types (Fig 3-2c 
and d). As will be shown below, both gave similar results.  
To target Nfib in adult follicles, I treated Sox9-CreER cKO, K15-CrePGR cKO 
and their control mice with inducing chemicals (tamoxifen for CreER and RU486 for 
CrePGR) from first telogen and followed hair growth and cycle in response to NFIB loss 
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(Fig. 3-3a). Anti-NFIB immunofluorescence showed that Nfib was efficiently ablated in 
HFSCs of both lines (Fig. 3-3a and b). Despite efficient targeting in telogen phase 
HFSCs, the hair coat of Nfib-cKO mice appeared unaffected, and no significant 
abnormalities were detected in HF morphology or cycling (Fig. 3-3c). Since Sox9-CreER 
displays higher gene targeting efficiency than K15-CrePGR (Fig. 3-3a and b) and both 
lines gave similar results, Sox9-CreER cKO mice were used for most of the phenotype 
 
 
Figure 3-2. Two inducible-Cre lines used in this study to ablate Nfib in hair follicles. 
a, Schematic. RosaYFP/Cre reporters show Sox9-CreER is active in most of regions in hair 
follicle and K15-CrePGR activity is more specific to the bulge and HG HFSCs after 
induction. Both are not active in McSCs. b, Transcriptional profiling of multiple 
populations in P4 skin by microarray shows Sox9 and K15 (Krt1-15) are expressed in 
ORS but absent in Mc, DP and DF. Array data are from Rendl et al., 2005.  c, d, 
Immunofluorescence of Sox9-CreER/RosaYFP and K15-CrePGR/RosaYFP reporters with 
anti-YFP and KIT antibodies. Note YFP signals are absence in KIT+ melanocytes. Bu: 




Figure 3-3. Conditional Nfib targeting in HFSCs does not perturb hair growth and 
cycle. a, Immunofluorescence showed Nfib targeting in the bulge and HG cells and not in 
sebaceous gland (SG) by Sox9-CreER 4 days after tamoxifen treatment. b, 
Immunofluorescence showed NFIB loss in the CD34+ bulge HFSCs and HF cells in K15-
CrePGR cKO mice 5 days after RU486 treatment. c, H&E-stained dorsal skin sections 
reveal normal hair cycle and follicle architecture upon NFIB loss. Bu: Bulge. HG: Hair 
germ. Scale bars: 10µm (b); 50 µm (P32, P38 in c); 25 µm (P74 in c). 
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characterization in the following context while some key results were shown from both 
lines.    
 
NFIB loss disrupts the stem cell synchrony within the hair follicle  
Equally surprising to the absence of HFSC-lineage defects was the presence of 
melanocyte-lineage abnormalities. Fontana-Masson staining gave the first indication, 
unveiling atypical pigmentation at the base of both Sox9-CreER cKO and K15-CrePGR 
cKO hair follicles but not in control telogen hair follicles (Fig. 3-4a and b). Additional 
abnormalities in the Nfib-null stem cell-residing region  were exposed by immunostaining 
and quantifications, which revealed an increase in KIT+ and DCT+ melanocytes 
throughout both HG and bulge (Fig. 3-4c and d), and that some of the KIT+ melanocytes, 
mostly within the HG, were differentiated melanocytes carrying pigment-producing 
proteins including MITF, TYRP1, and TYR (Fig. 3-4e-g). To further test for melanocyte 
activity, I mated Sox9-CreER cKO and control to Dct-EGFP mice and isolated EGFP+ 
cells from telogen-phase follicles.  Melanocyte differentiation markers, e.g. Mitf, Tyrp1, 
Tyr, Sox10 and Kit, were all upregulated in EGFP+ cells from cKO follicles, while genes 
expressed by both McSCs and differentiated melanocytes showed no change upon NFIB 
loss (Fig. 3-4h). 
A priori, ectopic differentiated melanocytes in Nfib-ablated HGs could have 
arisen from precocious differentiation of nearby McSCs. Alternatively, differentiated 
melanocytes could have somehow escaped apoptosis during catagen-phase, and therefore 
derive from the hair bulb. To distinguish between these possibilities, I analyzed 
melanocyte behavior at each hair cycle stage (Fig 3-5 and 6). 
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Figure 3-4. NFIB loss enhances McSC self-renewal and perturbs McSC activity. 
Analyses shown were from second telogen hair follicles. a, b, Ectopic pigmentation in 
telogen cKO HG of Sox9-CreER and K15-CrePGR lines as detected by Fontana-Masson 
melanin staining. Quantifications show the percentage of melanin+ hair follicles in skin 
cross-sections (>40 hair follicles per mouse sample, n=3 mice per experiment). c-g, 
Immunofluorescence and quantifications (Sox9-CreER cKO and control mice). 
Quantifications were conducted on skin cross sections (>30 hair follicles per mouse 
sample, 2-3 mice per experiment). c, d, Increased melanocyte numbers in telogen cKO 
hair follicles. KIT and DCT mark both McSCs and differentiated melanocytes. e-g, 
Ectopic presence of differentiated melanocytes in telogen cKO HFs. MITF, TYRP1 and 
TYR are differentiated melanocyte markers. Quantifications of the percentage of double 
positive melanocytes (KIT+ together with MITF+, TYRP1+ or TYR+) among KIT-only 
cells in the bulge and HG per hair follicle cross section. h, Quantitative PCR on FACS-
isolated melanocytes. Dct-EGFP/Sox9-CreER cKO and Dct-EGFP control mice were 
used to fluorescently tag melanocytes for purification. Bu: Bulge. HG: Hair germ. DP: 
Dermal papilla. Ctrl: control. Scale bars: 10µm. Error bars indicate s.e.m. 
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During anagen, TYRP1+ EGFP+ melanocyte numbers were as wild-type levels in 
the Sox9-CreER cKO bulge/upper ORS, and were restricted to their customary location in 
HF bulb (more specifically upper matrix), where pigment transfer to the differentiating 
recipient hair cells occurred normally (Fig. 3-5a and f-g). In contrast to differentiated 
melanocytes, TYRP1- EGFP+ McSCs sustained their higher levels, where they remained 
largely in the Sox9-CreER cKO bulge/upper ORS but also spread to lower ORS 
ectopically (Fig. 3-5a and g). At catagen, TYRP1+ or TYR+ melanocytes (EGFP+ and 
KIT+) underwent apoptosis and were eliminated by mid-catagen in both control and Sox9-
CreER cKO hair bulbs (Fig. 3-5b-c and g). However, as the DP returned and were close 
to stem cell-residing region during late catagen to telogen, TYRP1+ or TYR+ melanocyte 
numbers again soared, persisting until the next anagen (Fig. 3-5d-e and f-g). On the other 
hand, it is the time at which McSCs dropped transiently in the Sox9-CreER cKO 
bulge/HG, when McSCs near DP precociously differentiated (Fig. 3-5g). 
Taken together, these results pinpointed McSC increase and differentiation 
defects in the Nfib-ablated hair follicles; furthermore, the DP proximity seemed to affect 
primarily the uncoupling and premature differentiation of McSCs rather than self-renewal 
(Fig. 3-6). In addition, McSCs in anagen stem-cell-residing region were still negative for 
TYRP1 even in one-year-old Sox9-CreER cKO hair follicles (Fig. 3-5f), indicating that 
ectopic differentiated melanocytes from telogen do not accumulate within the stem cell 
residing region over hair cycles.   
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Figure 3-5. Ectopic differentiation of McSCs induced by NFIB loss occurs from late 
catagen. a-e, Immunofluorescence with indicated antibodies (Sox9-CreER cKO and 
control mice). a, In both cKO and control HFs, lineage committed melanocytes (TYRP1+ 
Dct-EGFP+) are only present in the upper matrix (Mx) of hair bulb (HB) but not in the 
stem cell-residing resgion including the bulge (Bu) and upper ORS (upORS). Note the 
number of McSCs is increased in cKO HFs and undifferentiated melanocytes also 
propagate to lower ORS in anagen. b-c, Differentiated melanocytes (TYRP1+/ or 
TYR+/KIT+) disappear from both cKO and control HFs during mid catagen when the hair 
bulb, which encases the DP, is degenerated. The DP is spared and draws upward to the 
stem cell-residing region at the end of catagen. d-e, During late catagen, melanocytes 
close to DP precociously express differentiating markers including TYRP1 and TYR in 
Nfib cKO hair follicles. f, Percentage of differentiated melanocytes (TYRP1+ with Dct-
EGFP+ in anagen hair follicles and with KIT+ in catagen/telogen hair follicles) among 
total melanocytes (EGFP+ of anagen hair follicles and KIT+ of catagen/telogen hair 
follicles) in the stem cell (SC)-residing region at different hair follicle stages 
(anagen/catagen: upper ORS; telogen: bulge and HG) in skin cross sections. g, 
Quantifications of the number of melanocytes (MCs) in hair follicles at different hair 
follicle stages in skin cross sections. Co-staining of TYRP1 with Dct-EGFP+ in anagen 
hair follicles and with KIT+ in catagen/telogen hair follicles. The regions examined in 
telogen hair follicles included the bulge and HG. Ana: anagen. Cata: catagen. Telo: 
telogen. Bulb: hair bulb. Ctrl: control. Scale bars: 25 μm (a-b); 10 μm (c-e). *P<0.001. 
Error bars indicate s.e.m. 
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Finally, if McSCs more distant from DP were still fully functional in cKO 
animals, then the hair coat should escape graying, customarily featured in McSC 
differentiation mutants (Inomata et al., 2009; Nishimura et al., 2010; Rabbani et al., 2011; 
Tanimura et al., 2011). Indeed, hair coats of aged Sox9-CreER cKO mice were fully 
pigmented and McSC levels were sustained (Fig. 3-5g and 3-7a). Interestingly in older 
Sox9-CreER cKO mice, black-pigmented dermal cells swarmed HFs and were even 
visible from the skin surface (Fig. 3-7a and b). Although dermal melanoblasts exist in 
certain skin regions such as ear, and have been reported to differentiate in backskin under 
certain aberrant conditions (Aoki et al., 2009), very few TYRP1+ melanocytes were found 
in the dermis of Sox9-CreER cKO mice (Fig. 3-7c). Rather, a number of cells 
encompassing this pigment were Mac1-positive with features of macrophages (Fig. 3-7d). 
Irrespective of whether the pigment-laden vacuoles within the dermal cells reflected  
 
 
Figure 3-6. Schematic summary of melanocyte behavior upon NFIB loss. In anagen, 
Nfib ablation in HFSCs increases McSC numbers, whereas hair pigmentation is 
unaffected concomitant with normal differentiated melanocyte (Mc) numbers in cKO hair 
bulb. Upon follicle degeneration, however, the proximity of DP to the stem cells at the 
end of catagen induces precocious McSC differentiation in Nfib-ablated hair follicles.  
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indirect uptake of dying, pigmented cells, or direct uptake of pigment from McSCs, these 
defects made the normalcy of the hair coat of aged Sox9-CreER cKO mice all the more 
remarkable. Taken together, these data provided compelling evidence that NFIB loss in 
HFSCs affects the timing of melanocyte differentiation without compromising McSC 
biology and/or function. In this regard, the Nfib-cKO mutant phenotype differed from 
most melanocyte-differentiation mutants, which exhibit hair graying reflective of global 
McSC malfunction (Inomata et al., 2009; Nishimura et al., 2010; Rabbani et al., 2011; 
Tanimura et al., 2011). 
   
Premature transfer of pigment promotes apoptotic cell death of hair follicle stem 
cells in the NFIB-deficient hair follicles 
Ultrastructural analysis unveiled new defects of the stem cells in hair follicles. In 
the NFIB-deficient hair follilces, melanocytes (pseudocolored-red) closest to the DP 
(pseudocolored-blue) indeed displayed features of differentiated melanocytes, including 
pigment granules and immature melanosomes (Fig. 3-8a and b). Surprisingly however, 
adjacent HFSCs (pseudocolored-green) in the HG also displayed pigment granules (Fig. 
3-8a). Their epithelial identity was evidenced by keratin filament bundles, desmosomes 
and hemidesmosomes. Although poorly understood, hair cell uptake of pigment from 
differentiated melanocytes is thought to be dependent upon Foxn1 (Weiner et al., 2007), 
expressed by differentiating matrix cells but not by HFSCs (Lien et al., 2011).  
Inappropriate accumulation of pigment seemed calamitous for quiescent telogen-
phase HFSCs in the HG: it elicited their apoptotic death, as reflected by condensed 
93
chromatin, mitochondrial destruction, and cleaved Caspase-3-immunolabeling (Fig. 3-8a, 
3-9a and d).  In addition, unaffected neighboring K5-positive HG cells proliferated, as 
judged by Ki67 and incorporation of nucleotide analogue EdU (Figs. 3-9b-d). Although 
HG proliferation is a normal sign of telogen to anagen transition (Greco et al., 2009), 





Figure 3-7. Hyperpigmentation in the dermis of aged Sox9-CreER/Nfib cKO skin. a, 
Black pigmented spots on the skin surface of control and cKO mice. b, Melanin is 
detected by Fontana-Masson staining. Note hyperpigmentation in the dermis of Nfib-
cKO animals become more severe with age. c, TYRP1+KIT-  dermal melanocytes in Nfib 
cKO skin. Given that TYRP1+KIT-  dermal melanocytes are not frequently seen in the 
pigmented area, they could not account for the majority of pigmented cells in the dermis. 
d, Pigmented macrophages marked by Mac-1 and identified by ultrastructural analysis 
were prevalent in the dermis of old Nfib-cKO skin. EM image is courtesy of H. Amalia 





Figure 3-8. Ultrastructure of Nfib cKO hair follicles. a, K15-CrePGR cKO and control 
hair follicles.  Pseudo-coloring highlights distinct cell types in the hair follicles: green-
HFSC; red-melanocyte; blue-DP. Arrowheads mark cells shown at higher magnification. 
Note the presence of differentiated melanocytes in cKO hair follicles, judged by that their 
cytoplasm contains immature (open arrow) and mature (solid arrow) melanosomes, the 
structure used for synthesizing pigments and absent in McSCs. Note pigment-laden 
apoptotic HFSC whose boxed regions at higher magnification reveal condensed 
chromatin, degenerating mitochondrion, keratin filaments (Kf), desmosomes (De) and 
melanosomes. b, Undifferentiated (without melanosomes) and differentiated (containing 
melanosomes) melanocytes (M) were observed in Sox9-CreER cKO hair follicles. Kc: 
keratinocyte. DP: dermal papilla. Scale bars: 10 μm (low magnifications in a); 2 μm 
(apoptotic HFSC in a); 0.5 μm (cytoplasmic segments and melanocyte in a and b). 
Courtesy of H. Amalia Pasolli.  
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Figure 3-9. Apoptosis and proliferation of Nfib cKO HFSCs. Immunofluorescence 
with indicated antibodies (Sox9-CreER cKO and control mice). a, Activated caspase3 
(Casp3) antibody marks K5+ apoptotic cKO HFSCs, seen in telogen but not anagen. 
Quantifications of the percentage of hair follicles with Casp3+ K5+ cells in the bulge and 
HG in skin cross sections. b-c, Increased HFSC proliferation in telogen but not anagen 
Nfib-cKO HFs. Assessment was by EdU incorporation (administered twice, 24h before 
analysis) and Ki67 immunostaining. Quantifications of the percentage of hair follicles 
with Ki67+ K5+ cells in the bulge and HG in skin cross sections. d, Apoptotic (Casp3+) 
and proliferative (EdU+ or Ki67+) cells in cKO HFs are not KIT+ melanocytes. Bu: Bulge. 
HG: Hair germ. DP: Dermal papilla. Ctrl: control. Telo: telogen. Ana: anagen. Scale bars: 
10µm. Error bars indicate s.e.m. 
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 Apoptotic and proliferative defects of HFSCs disappeared in anagen (Fig. 3-9a 
and c), concomitant with the movement of differentiated melanocytes from the 
bulge/upper ORS to the hair bulb (Fig. 3-5a and 3-6). These results imply that apoptosis 
and hyperproliferation of Nfib-null HFSCs depend upon precocious differentiation of 
neighboring McSCs. They also suggest that when precociously differentiated 
melanocytes inappropriately bequeath pigment to HFSCs rather than their customary  
differentiated progeny (hair cells), pigment-laden HFSCs are unable to cope, while 
healthy HFSC neighbors proliferate to restock the stem cell population.   
 
RNA-seq and ChIP-seq analyses identify endothelin 2 (Edn2) as a direct NFIB-
regulated gene 
To identify factors mediating the molecular miscommunication between HFSCs 
and McSCs in hair follicles, I used high throughput RNA-seq to transcriptionally profile 
bulge and HG HFSCs. Fluorescence activated cell sorting (FACS) of skins of K15-
CrePGR/RosaYFP/Nfibfl/fl (cKO) and Nfibfl/+ (control) mice were used for purifying HFSCs. 
Restricted YFP expression pattern in K15-CrePGR/RosaYFP mice provided an advantage 
to enrich bulge (YFP+Sca1-α6highCD200+CD34+) and HG (YFP+Sca1-CD200+CD34-)  
HFSCs during FACS (Fig. 3-2a and 3-10a). RNA-seq results confirmed the ablation of 
Nfib exon 2, encoding the DNA-binding domain, in K15-CrePGR cKO cells (Fig. 3-10b).  
Of 800-1000 mRNAs that were changed by ≥2X in NFIB-deficient HFSCs 
relative to control, 145 were upregulated and 99 were downregulated in both bulge and 
HG (Fig. 3-10c and Table 1). I selected ten of these genes and validated their differences 
by qPCR in independently purified samples (Fig. 3-10d). Notably absent among the 244  
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Figure 3-10. Isolation of bulge and HG HFSCs from K15-CrePGR/Nfib cKO skins 
for RNA-seq analysis. a, FACS isolation. Bulge HFSCs were isolated with markers 
YFP+ Sca1- α6high CD34+ CD200+; HG HFSCs with the markers YFP+ Sca1- CD34- 
CD200+. b, Visualization of RNA-seq profiles in Nfib. Note the ablation of Nfib exon 2 in 
cKO cells. c, Venn diagrams representing gene expression changes in cKO bulge/HG 
cells compared to control by RNA-seq analysis (≥ 2-fold). d, Quantitative PCR confirms 
the results from RNA-seq analysis. *P < 0.05. **P < 0.001.  Error bars indicate s.e.m. 
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changes were Foxn1, Fgf2, Nog, Egfr, F2rl1 and derivatives of Pomc1, all of which were 
previously implicated in melanocyte differentiation and/or pigment-transfer in skin 
(D'Orazio et al., 2006; Fitch et al., 2003; Weiner et al., 2007). Also absent were genes 
involved in TGFβ/BMP signaling, known to function in maintaining quiescence of 
HFSCs. Similarly, NFIB loss did not seem to affect canonical Wnt signaling, a key 
stimulus for both SC activity and fate commitment: the Wnt-sensitive target gene Axin2 
was unchanged in NFIB-deficient HFSCs, and upregulated Wnt pathway genes included 
negative and positive Wnt regulators (indicated by arrows in Fig. 3-11).  
These results were in good agreement with the normal hair cycle displayed by 
Nfib-cKO skin (Fig. 3-3c), and with the prediction that had there been major 
perturbations in any of these signaling pathways, both stem cell populations—not just 
McSCs—should have been affected.  Conversely, hair follicles from mice genetically 
defective for Wnt, BMP and TGFβ signaling still displayed NFIB protein in the bulge 
HFSCs, and Nfib mRNA levels did not appear to be dramatically changed in these 
mutants (Fig. 3-12a and b).  Thus at least within HFSCs, these signaling pathways 
appeared to be refractory to loss of NFIB, and NFIB appeared to be refractory to these 
signaling pathways.  
To identify direct NFIB target genes in HFSCs that might act to stimulate McSCs, 
I performed chromatin immunoprecipitation with deep sequencing (ChIP-seq) analysis. I 
collaborated with Olivier Elemento and his postdoc Jenny Giannopoulou at at Weill 
Cornell Medical College for bioinformatics analyses. At first, I tested the performance of 
NFIB antibody for immunoprecipitation (IP) in enriched hair follicle cells from newborn 
skins (Fig. 3-13). NFIB antibody raisedfrom rabbits were used for IP followed by 
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Figure 3-11. Pathway analysis of RNA-seq results. The heatmap shows the enriched 
biological processes (Gene Ontology) for the up- or down-regulated genes in K15-
CrePGR cKO bulge and HG HFSCs relative to control in RNA-seq results, compared to 
the rest of the known genes in RefSeq annotation database. The categories indicate genes 
over/under expressed in cKO bulge (Bulge Up/Bulge Down), and over/under expressed 
in HG HFSCs (HG Up/HG Down). Note: for this analysis, we excluded the small subset 
of pigment mRNAs, which might appear to arise from ectopic melanosome uptake by 
HFSCs nearest the DP. Courtesy of Eugenia Giannopoulou.  
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Western blotting with the same antibody as well as the antibody raised from different 
species (mouse), which can avoid antibody heavy-chain and light-chain background on 
the blot.  NFIB proteins were immuneprecipitated by NFIB antibody accompanied with 
decreased NFIB proteins in the fraction after binding (flow through) (Fig. 3-13).  
 
 
Figure 3-12. NFIB expression in mutants lacking major signaling pathways. a,c, 
Immunofluorescence with indicated antibodies. Frozen skin sections were from the 
following genetic backgrounds and where relevant, induced for Cre expression: K15-
CrePGR X Bmpr1a fl/fl, K14-Cre X TGFβRII (TβRII) fl/fl, K15-CrePGR X Sonic 
Hedgehog (Shh) fl/fl, K15-CrePGR X β-catenin (βcat) fl/fl, K15-CrePGR X Tcf3(fl/fl) X 
Tcf4-null, Lef1-null, K14-ΔNβcat, P63-null.  b, Relative Nfib RNA levels in HFSCs 
FACS-purified from these different backgrounds (CD34+α6+) followed by transcriptional 
profiling analyses (full array databases to be reported elsewhere). The HFs (Pcad+α6+) 
were isolated from E17.5 Lef1 KO and control embryos. Bu: bulge. HG: Hair germ. Scale 
bars: 10 μm. Error bars indicate s.e.m. 
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Two independent NFIB ChIP-seq experiments were conducted. For each 
experiment, 10-15 X 106 WT bulge HFSCs (α6+β1+CD34+) from 15-20 mice were 
isolated by FACS (Fig. 3-14a). Applying immunoprecipitation-grade NFIB antibody to 
chromatin, I identified 1,449 genes that were directly and reproducibly bound by NFIB 
(Table 2). NFIB-bound genes included Krt5 (K5) (Fig. 3-14b). Intriguingly, like K5 and 
its regulators of the transcription factor-AP2 (TCFAP2) family, NFIB was lost in most 
areas of p63-null skin (Fig 3-12c). Additionally, Nfib is bound by p63 (McDade et al., 
2012)  and harbors binding motifs for TCFAP2 (data not shown), suggesting a possible 
link to early epithelial stem cell markers. NFIB peaks were particularly enriched in ±2kb 
(12%) and upstream 2-50kb (29%) sequences proximal to gene transcription initiation 
sites compared to genomic representation of each compartment (Fig. 3-14c and d).  A de 
novo motif search identified five sequences within these peaks (Fig. 3-14e). Most 
 
 
Figure 3-13. Immunoprecipitation with NFIB antibody.  Hair follicle cells from 
newborn skins were used for immunoprecipitation (IP) with NFIB antibody (raised from 
rabbits) and control IgG produced from rabbits. NFIB proteins were detected by Western 
blot (Blot) with the same rabbit anti-NFIB antibody and also mouse NFIB antibody to 
avoid background from antibody heavy chain and light chain. Flow through: the lysate 
after IP.  
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Figure 3-14. Genomic distributions of NFIB ChIP-seq peaks and motif analysis. a, 
FACS strategy for isolating bulge HFSCs (β1+α6+ CD34+) for NFIB ChIP-seq. b, 
Visualization of NFIB ChIP-seq profiles of Krt5 promoter. c, Genomic distribution of 
NFIB ChIP-seq peaks relative to RefSeq transcripts. Promoter: within ±2kB of 
transcription start site. Downstream: within ±2kB of transcription end site. Gene 
proximal: within upstream 2-50kB of transcription start site. Gene distal: beyond 
upstream 50kB of transcription start site. d, Comparison of the observed NFIB bound 
peak distribution to the predicted distribution based on the genomic representation of 
each compartment, using the Binomial test. e, The motifs discovered from de novo motifs 
analysis using FIRE program are shown. The percentage of NFIB bound peaks 
occurrences and the corresponding z-scores are indicated for each motif. f, The 
discovered motifs are grouped based on their similarity to reported first and second 
halves of the NFIB palindromic motif. c-e, courtesy of Eugenia Giannopoulou. 
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common were TGGCA/T and A/TGCCA, which when combined, comprised a palindromic 
motif (Fig. 3-14f).  Notably, NFIB protein self-dimerizes, and its preferred binding motif 
is a TTGGCANNNTGCCAA palindrome (Roulet et al., 2000).  
I next examined how NFIB target genes in HFSCs change in response to NFIB 
loss.  201 (~14%) NFIB target genes were differentially expressed in K15-CrePGR cKO 
versus control HFSCs (Fig. 3-15).  Of these, 44% were upregulated while 56% were 
downregulated in NFIB-deficient HFSCs.  By these criteria, there did not seem to be a 
strong bias for whether NFIB functions in activation or repression. In contrast, based 
upon studies from cultured fibroblasts, NFIC has been regarded as an activator (Pjanic et 
al., 2011).  
Searching for possible genes whose altered expression might enhance McSC 
proliferation and differentiation, I focused on the 33 NFIB-binding genes whose 
expression was ≥2-fold up- or down-regulated in HFSCs of both bulge and HG upon 
Nfib-ablation (Fig. 3-15). Among them the most attractive of these candidates was the 
gene Edn2 encoding endothelin-2. Within the Edn2 promoter was an NFI-binding 
palindrome sequence containing an optimal spacer, and in both ChIP-seq replicates, 
NFIB bound to this site (Fig. 3-16a). 
Endothelins are secreted factors with the ability to mediate intercellular crosstalk. 
All three endothelins stimulate the proliferation and differentiation of cultured 
melanocytes (Opdecamp et al., 1998; Reid et al., 1996a). Additionally, endothelin-3 is 
required for neural crest migration and melanocyte specification during embryogenesis 
(Pla and Larue, 2003), and Edn1 was recently implicated in Wnt-mediated melanocyte 
proliferation (Rabbani et al., 2011). Neither Edn3 nor Edn1 surfaced on the list of HFSC 
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Figure 3-15. Identification of direct NFIB target genes in HFSCs. The Venn diagram 
on the left shows the comparison between 1449 NFIB direct target genes from ChIP-seq 
analysis and genes up or down-regulated in K15-CrePGR cKO bulge/HG HFSCs from 
RNA-seq. Genes that are bound by and regulated by NFIB are listed. Unique in Bulge or 
HG means their expression levels are only changed in each population. Common between 
Bulge and HG indicates genes that are changed in both populations. Genes with NFIB 
bound peak in their promoter (± 2kb from TSS), and with both halves of NFIB 
palindromic motif are explicitly marked. Courtesy of Eugenia Giannopoulou. 
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genes bound by NFIB.  Moreover, by RNA-seq and qPCR, Edn3 was not expressed in 
HFSCs, and Edn1 showed very low expression and little change upon NFIB loss (Fig. 3-
16b; Table 1). Interestingly, in wild-type follicles, Edn2 is the only family member that is 
repressed in telogen HFSCs, but transiently activated in early anagen HFSCs (Lien et al., 
2011), and Edn2 was upregulated >2X-fold in purified Nfib-ablated HFSCs relative to 
controls (Fig. 3-16b; Table 1). Pan anti-endothelin immunolabeling was markedly 
stronger in Nfib-null HFSCs relative to control HFs (Fig. 3-16c). Immunolabeling 
showed no endothelin expression in McSCs or DP. Finally, since HFSCs express  
 
 
Figure 3-16. RNA-seq and ChIP-seq analyses identify Edn2 as a direct NFIB-
regulated gene. a, NFIB ChIP-seq profiles of Edn2 promoter. NFIB palindromic-
binding-sequence exists within the peak. b, Quantitative PCR on FACS-isolated 
populations confirm RNA-seq results (normalizations to Het). c, Immunofluorescence 
shows ectopic endothelins in Sox9-CreER cKO and K15-CrePGR cKO hair follicles. d, 
Regulation of Edn2 expression by NFIB in vitro. Quantitative PCR from Nfib het or KO 
keratinocyte cultures transfected with EGFP or EGFP-NFIB3 transgenes. Bu: Bulge. 
HG: Hair germ. DP: Dermal papilla. ND: not determined. Scale bars: 10µm. Error bars 
indicate s.e.m.  
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endothelial converting enzyme (ECE1) necessary to process/activate endothelin-2, these 
data increasingly supported Edn2 as the prime NFIB target gene for explaining the Nfib-
cKO phenotype (Lien et al., 2011).    
The changes I observed in Edn2 expression were cell-autonomous, since Edn2 
mRNA was also upregulated in cultured Nfib-null keratinocytes (Fig. 3-16d). Moreover, 
this difference was dependent upon NFIB, as it was rescued by transfecting an expression 
vector encoding the main keratinocyte isoform, NFIB3 (red bars). In contrast, even 
though Kit-ligand (Kitl) mRNA appeared to be modestly induced in Nfib-null HFSCs 
(Table 1), the levels were not influenced by NFIB3-rescued Nfib-null keratinocytes (Fig. 
3-16d), nor did I observe NFIB binding to the Kitl promoter/enhancer in ChIP-seq 
analyses. Interestingly however, while KITL was not detected in HFSCs, it was seen in 
the DP (Botchkareva et al., 2001) (Fig. 3-17a).  
Together, these results suggest a model whereby endothelin-2 induction by Nfib-
null HFSCs enhances proliferation of neighboring McSCs and sensitizes them to 
precociously differentiate when they encounter KITL and possibly additional signals 
from DP. If true, then blocking KIT signaling should ameliorate precocious McSC 
differentiation in Nfib-cKO follicles, while elevating endothelin-2 levels in wild-type 
HFSCs should recapitulate the phenotypic features of Nfib-cKO HFs. I first tested this 
hypothesis by injecting a KIT-receptor blocking antibody into skins of Sox9-CreER cKO 
mice beginning in late catagen (assessed by transition of skin color from dark to pink). 
By telogen, marked reductions were seen in TYRP1+ melanocytes and in activated-
Casp3+ HFSCs (Fig. 3-17b). Importantly and in agreement with previous findings 
(Botchkareva et al., 2001; Nishikawa et al., 1991), KIT-inhibition in anagen-phase hair 
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follicles only affected lineage-committed proliferation and differentiation; thus, 
undifferentiated McSCs remained elevated in the Nfib-cKO hair follicles (Fig. 3-17c).  
 
 
Figure 3-17. Inhibition of Kit signaling reduces ectopic McSC differentiation upon 
NFIB loss. a,  Immunofluorescence reveals KITL in DP of Sox9-CreER cKO and control 
skins. b, Reductions in TYRP1+ melanocytes and apoptosis (judged by activated Casp3  
staining) in Sox9-CreER cKO hair follicles after injecting anti-KIT blocking antibody 
(αKIT) during catagen/telogen transition. IgG: control IgG. Quantifications indicated the 
percentage of TYPR1+ KIT+ cells among KIT+-only cells per hair follicle cross section, 
and the percentage of hair follicle with Casp3+ signals in the bulge and HG in skin cross 
sections. c, Immunofluorescence of anagen hair follicles with indicated antibodies after 
anti-KIT blocking antibody or control IgG treatment in Sox9-CreER cKO skin. Note the 
disappearance of TYRP1+KIT+ mature melanocytes in the hair bulb after αKIT antibodies 
treatment during anagen. McSCs (TYRP1-KIT+) in the bulge/ORS were not affected. 
Quantifications of the number of TYRP1-KIT+ melanocytes in the bulge (Bu)/ORS and 
TYRP1+KIT+ differentiated melanocytes in the hair bulb (bulb) per hair follicle cross 
section. Bu: Bulge. HG: Hair germ. DP: Dermal papilla. NS: not significant. Scale bars: 
10 μm. Error bars indicate s.e.m. 
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Upregulation of Edn2 in skin induces hyperpigmentation 
 I next induced Edn2 in wild-type adult skin by co-transducing E9.5 mouse 
embryos in utero with high-titer lentiviruses harboring: a) tetracycline-regulatable 
transactivator (rtTA) coupled in a bicistronic transcript to EGFP and b) H2BmRFP1 and a 
tetracycline-inducible promoter driving either Edn2 (TRE-Edn2) or empty control (TRE-
only) (Fig. 3-18a). This lentiviral-delivery method confers efficient and sustained 
epithelial-specific expression to adult skin (Beronja et al., 2010), which I confirmed by 
immunofluorescence (Fig. 3-18b). Notably, KIT+ melanocytes were not be targeted by 
lentiviruses since the timing when injection was conducted is earlier than their arrival 
time at epidermis from neural crest. 
Transduced mice were fed with doxycycline-containing chow beginning at P21 to 
induce Edn2 expression. Quantitative PCR from FACS-isolated cells confirmed that 
Edn2 was only upregulated in double infected cells (Fig. 3-18c). Interestingly, mice with 
ectopic Edn2 showed apparent hyperpigmentation in the epidermis of ear skin where 
melanocytes are normally distributed (Fig. 3-18d). In hair follicles, Edn2-transduced hair 
follicles displayed increased numbers of KIT+ McSCs (Fig. 3-18e). Quantification of 
Fontana-Masson-stained sections showed that melanin production had been induced in 
HGs of rtTA/TRE-Edn2-transduced skin but not rtTA/TRE-only skin (Fig. 3-18f). 
Notably, de novo melanogenesis was not detected in doubly-transduced epidermis of 
hairy backskin, suggesting that the effects of endothelin-2 were confined to locations 
where preexisting McSCs reside.  
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Figure 3-18. Up-regulation of Edn2 induces hyperpigmentation in skin. a, Schematic 
of lentiviral constructs used to upregulate Edn2 expression in skin. b, 
Immunofluorescence with KIT and GFP antibodies. As judged by H2BmRFP1/GFP 
expression, transduction is confined to skin epithelial cells and not seen in KIT+ McSCs. 
c, Upregulation of Edn2 in doubly transduced cells examined by qPCR on FACS-isolated 
populations after 10 or 30 days of feeding on Doxcycline-containing chow. Values are 
normalized to no-color control. d, Edn2 upregulation in epithelial cells induce 
hyperpigmentation in mouse ear epidermis and dermis. Fontana-Masson melanin staining 
was conduced on ear sections. Edn2: mice infected with lentiviruses carrying rtTA/TRE 
driven Edn2 constructs. Ctrl: mice infected with lentiviruses carrying rtTA/TRE-empty 
constructs. e, Quantifications reveal increased KIT+ melanocyte number upon EDN2 
induction. Edn2: doubly transduced hair follicles. Control (Ctrl): singly-transduced and 
uninfected hair follicles. Quantifications indicated the number of cells per hair follicle 
cross section. f, Quantifications of percentage of melanin+ hair follicles in Edn2 (infected 
with lentiviruses carrying rtTA/TRE driven Edn2) skin and Ctrl (infected with lentiviruses 
carrying rtTA/TRE-empty constructs) skin cross section. Bu: Bulge. HG: Hair germ. 
Scale bars: 10µm (b); 25µm (d). Error bars indicate s.e.m. 
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To determine whether premature McSC differentiation in the Nfib-cKO hair 
follicles appears to depend upon EDN2, I performed a rescue assay. Chemical BQ788, 
which inhibits endothelin-receptor type B (EDNRB), was injected intradermally into 
Sox9-creER cKO skin at mid-catagen (assessed by transition of skin color from dark to 
pink). After 5-days application, hair follicles showed marked reductions in the number of 
TYRP1+ melanocytes and in activated-Casp3+ HFSCs (Fig. 3-19a and b).   
 
                           
Figure 3-19. Inhibition of Edn signaling reduces precocious melanocyte 
differentiation in Nfib cKO hair follicles. a, Quantification of percentage of TYRP1+ 
KIT+ melanocytes in Sox9-CreER cKO hair follicles after injection of endothelin receptor 
(EDNRB) inhibitor BQ788 during catagen/telogen transition. b, Quantification of 
percentage of activated Casp3+ hair follicles in cKO skin upon BQ788 treatment. Error 
bars indicate s.e.m. 
 
Discussion 
In summary, my findings expose an unexpected gatekeeper, NFIB, which governs 
the coordination of stem cell behavior in the hair follicle.  While NFIB-deficiency 
resulted in many changes in HFSC gene expression, upregulation of NFIB target, Edn2, 
was sufficient to disrupt the intricate synchronization of McSC and HFSC proliferation 
and differentiation that normally accompanies hair growth and maintenance. In contrast 
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to all known genetic pathways perturbing McSC function within hair follicles, precocious 
melanocyte differentiation and ensuing chaos was cyclical and did not compromise stem 
cell pools, hair pigmentation or growth, even in aged animals. The mechanism underlying 
this unprecedented phenotype lends new insights to the importance of the two-tiered 
structure of the HFSC-residing region coupled with the existence of DP/Kit-ligand-
independent and dependent steps in unleashing Edn2’s effect. Thus, through Nfib 
ablation, upregulated Edn2 promoted self-renewal of McSCs, whose numbers remained 
elevated throughout aging but were still checked by the quiescent microenvironment. 
Edn2 also primed McSCs to trigger differentiation, but since the second differentiation 
signal comes from DP and is cyclic, only McSCs in the HG and not bulge were affected. 
Similarly, even though aberrant pigment uptake by quiescent HFSCs resulted in their 
death, only some HG cells were affected, and all bulge HFSCs were spared.  
 The ability of Edn2 to uncouple the normal timing of melanogenesis was at first 
surprising given that Edn2 has not been implicated hitherto in normal cutaneous 
melanocyte physiology, and that Edn3 showed only non-cutaneous effects on 
melanogenesis in neonatal transgenic mice expressing Edn3 under the control of the 
keratin 14 promoter (Aoki et al., 2009; Garcia et al., 2008). Based upon this and 
seemingly normal melanogenesis in Edn1 and Edn2 knockout mice (Chang et al., 2013; 
Kurihara et al., 1994; Reid et al., 1996a), researchers have posited that endothelins 
function primarily in embryogenesis and not postnatally (Garcia et al., 2008). Like Edn3, 
elevating Edn2 in epidermis did not promote melanogenesis; however, by unearthing 
Edn2’s impact on adult McSCs, this findings show that when provided with the proper 
microenvironment, endothelins can influence adult McSCs and their differentiation.  
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Recently NFIB was linked oncogenically to lung cancer, and it has an established 
role in lung development (Dooley et al., 2011; Gründer et al., 2002; Steele-Perkins et al., 
2005). In this regard, NFIB’s high level in HFSCs is intriguing, since long-term stemness 
is required of both normal and cancerous tissues. While beyond the scope of the present 
study, testing this possible function merits future investigation with methods that 
challenge regenerative capacity and remove possible NFI redundancy. 
Overall, this work reveals how McSC and HFSC behaviors maintain reliance 
upon cooperative factors within the hair follicles and how this might be uncoupled in 
injury and disease states. Notably, Edn2 is upregulated upon UV irradiation and a variety 
of other stress conditions that are associated with increased pigmentation (Adur et al., 
2007; Klipper et al., 2010). In the future, it will be interesting to see the extent to which 
Nfib downregulation will function in tipping the balance from a coupled to uncoupled 
state; my studies here emphasize the importance of endothelins as important messengers 
to achieve McSC-HFSC asynchrony.  
 
Materials and Methods 
Mice. 
P52-60 CD1 mice from Charles River laboratories were used for NFIB ChIP-seq 
experiments. Nfib(fl/fl) and Nfib(-/-) mice have been described (Hsu et al., 2011b; Steele-
Perkins et al., 2005), as have transgenic K15-CrePGR (Morris et al., 2004), knock-in 
Sox9-CreERT2 (Soeda et al., 2010) and ROSA26flox/STOP/flox/YFP (RosaYFP) (Srinivas et al., 
2001) mice. DCT-EGFP animals were generated by GENSAT project (Heintz, 2004).  
CreER was activated by intraperitoneal (IP) injection of P20-21 mice with 20 mg/ml 
114
Tamoxifen (Sigma) in corn oil (Sigma) (1mg/10g body weight per day). Cre-PGR was 
induced by RU486 treatment: 5-day IP injection of 10 mg/ml RU486 (VWR) in sesame 
oil (sigma) (0.75mg/10g body weight per day), together with 2-week topical application 
with 4% RU486 in Ethanol.  
All animals were maintained in an AAALAC-approved Comparative Bioscience 
Center (CBC) at The Rockefeller University and procedures were performed using 
IACUC-approved protocols that adhere to the standards of the National Institutes of 
Health.  
 
Histology and immunofluorescence. 
Embryos (<E16.5) or backskins were embedded in OCT (Tissue Tek), frozen on 
dry ice and stored at -80°C. Only in the case of RosaYFP reporter or lentiviral transduced 
mice, tissues were prefixed in 4% paraformaldehyde (PFA) for 30 min at room 
temperature (r.t.) before embedding in OCT in order to preserve the fluorescence signals. 
Un-prefixed frozen sections (10-20 µm) were fixed in 4% PFA for 10 min at (r.t.). For 
histological analysis, sections were stained with hematoxylin and eosin. Melanin staining 
was performed using a Fontana-Masson Stain Kit (MarketLab Inc.) according to the 
manufacturer’s directions. For immunofluorescence, sections were permeabilized in 0.3% 
Triton X-100 in PBS for 20 min and blocked for 1 hr at r.t. in blocking buffer including 
2.5% normal donkey serum, 2.5% normal goat serum (or 5% normal donkey serum alone 
when goat primary antibodies were used), 0.5% BSA and 0.1% Triton X-100 in PBS. For 
melanocyte markers, including DCT, TYRP1, and TYR, sections were permeabilized 
with 0.3% H2O2 in cold methanol for 30 min at-20°C (Govender et al., 2006). MOM 
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Basic kit (Vector Laboratories) was used for blocking when primary antibodies were 
generated from mouse. Primary antibodies were diluted in blocking buffer and sections 
were incubated overnight at 4°C. After washing with PBS for 30 min at r.t., sections were 
incubated for 1–2 hr at r.t. with secondary antibodies conjugated to Alexa-488, Alexa-
546, Alexa-647 (Molecular Probes), or RRX (Jackson Laboratories). EdU staining was 
performed using Click-iT EdU Alexa Fluor 594 Imaging Kit (Life Technologies) and 
following manufacturer’s directions. Nuclei were stained using 4’6’-diamidino-2-
phenylindole (DAPI). Imaging was performed on a Zeiss Axioplan 2, Zeiss Apotome, 
Zeiss Inverted LSM 510 laser scanning confocal microscope, or Zeiss Inverted LSM 780 
laser scanning confocal microscope.  
For quantifications, the images from individual hair follicles with clear bulge and 
HG structures on sections were acquired by microscopes first and then counted on 
computer.   
The following antibodies and dilutions were used: NFIB (rabbit, 1:1,000, Active 
Motif); KIT (rat, 1:1,000, BD Pharmingen); P-cadherin (goat, 1:100, R&D); E-cadherin 
(rat, 1:500, Fuchs lab); K5 (guinea pig, 1:500, Fuchs lab); CD34 (rat, 1:100, BD 
Pharmingen); Ki67 (rabbit, 1:300, Novocastra); cleaved-Caspases3 (rabbit, 1:300, R&D); 
GFP (chicken, 1:2,000, Abcam); EDN 1/2/3 (rabbit, 1:100, Santa Cruz); KITL (rat, 
1:300, R&D); Mac-1 (rat, 1:100, eBioscience) MITF (mouse,1:100, Abcam); DCT 
(rabbit, 1:500, gift of Dr. V.J. Hearing, National Cancer Institute, National Institutes of 
Health, Bethesda, MD); TYRP1 (rabbit, 1:1,000, gift of Dr. V.J. Hearing); TYR (rabbit, 




Electron Microscopy (EM) was conducted by H. Amalia Pasolli. Backskins were 
fixed in 2% glutaraldehyde, 4% PFA, and 2 mM CaCl2 in 0.05 M sodium cacodylate 
buffer, pH 7.2, at r.t. for > 1 hr, postfixed in 1% osmium tetroxide, and processed for 
Epon embedding. Ultrathin sections (60–70 nm) were counterstained with uranyl acetate 
and lead citrate. Images were taken with a transmission electron microscope (Tecnai G2-
12; FEI) equipped with a digital camera (model XR60; Advanced Microscopy 
Techniques, Corp.). 
 
Isolation of HFSCs and FACS.  
Subcutaneous fat was removed from skins with a scalpel. To isolate bulge HFSCs 
for NFIB ChIP-seq experiment, skins were placed on 0.25% Trypsin (GIBCO) at 37°C 
for 30 min with dermis side down. For isolation of bulge and HG HFSCs, skins were first 
incubated in 0.25% Collagenase (Sigma) in HBSS (GIBCO) at 37°C for 1 h to remove 
dermis. After gentle PBS washing, skins were treated with Trypsin as described above.  
Single cell suspensions were obtained by scrapping the skin gently and filtering through 
70 µm strainers, followed by 40 µm strainers. Staining buffer (PBS with 5% FBS treated 
with BioRad Chelex to remove calcium) was added to inactivate Trypsin, and cells were 
collected by centrifugation for 5 min at 300g. Cell suspensions were incubated with the 
appropriate antibodies diluted in staining buffer for 30 min at 4°C. The following 
antibodies were used: CD34-Alexa 660 (1:200, eBioscience); α6-PE (1:500, 
eBioscience); β1 -PE-Cy7 (1:500, eBioscience); Sca1-Alexa 700 (1:200, eBioscience); 
CD200-biotin (1:200, AbD Serotec); Streptavidin-PE-Cy7 (1:200, eBioscience). DAPI 
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(100 ng/ ml) was used for death cell exclusion. Cell isolations were performed on BD 
FACSAria II sorters equipped with BD FACSDiva software. For RNA extraction, cells 
were sorted directly into TRIzol LS Reagent (Life Technologies).  
 
RNA extraction and RNA-seq analysis. 
Cells were isolated from Nfib(fl/+)/K15-CrePGR/RosaYFP (het) and Nfibfl/fl/K15-
CrePGR/RosaYFP (cKO) mice. Nfib ablation was induced from second telogen (P50-60) 
with RU486 treatment, and mice were taken during third telogen (P120-130). The 
protocol of cell sorting was described above with antibodies: CD34-Alexa 660, CD200-
biotin, α6-PE, Sca1-Alexa 700 and Streptavidin-PE-Cy7. Cells were lysed with TRIzol 
LS Reagent (Life Technologies) and RNA was extracted using Direct-zol RNA MiniPrep 
(Zymo Research) with DNase treatment to remove residual genomic DNA. Isolated RNA 
samples were provided to the Genomics Resources Core Facility at Weill Cornell 
Medical College for quality control, library preparation, clustering and sequencing. RNA-
seq reads were aligned to the mouse genome (mm9, NCBI Build 37) using TopHat 
(Trapnell et al., 2009)  (http://tophat.cbcb.umd.edu/). Cufflinks (Trapnell et al., 2010) 
(http://cufflinks.cbcb.umd.edu/) was subsequently used to assemble the aligned reads into 
transcripts and then estimate the transcript abundances. Pathway analysis was performed 
using iPAGE algorithm (Goodarzi et al., 2009), included in the ChIPseeqer framework 





Quantitative PCR (qPCR).  
RNA isolation was described above. cDNA was synthesized from isolated RNA 
using SuperScript III First-Strand Synthesis System with oligo-dT primers (Invitrogen). 
cDNAs were mixed with indicated primers and Power SYBR Green PCR Master Mix 
(Applied Biosystems), and quantitative PCR (qPCR) was performed on a Applied 
Biosystems 7900HT Fast Real-Time PCR system for 40 cycles. Specificity was 
confirmed by subsequent melting curve analysis or gel electrophoresis. Levels of PCR 
product were expressed as a function of peptidylprolyl isomerase B (Ppib). Primers were 
designed through Primer 3 and amplified products encompassed exon/intron boundaries. 
The following primer sequences were used:  
Nfib forward 5’-ATGACCCATCCAGTCCTCAA-3’,  
reverse 5’-TTGAAGGAAAGGCTCTCCAA-3’ 
Sox9 forward 5’-CCACGGAACAGACTCACATC-3’,  
reverse 5’-CCCTCTCGCTTCAGATCAAC-3’ 
Ednrb forward 5’-CTCTGTTGGCTTCCCCTTC-3’,  
reverse 5’-CGATTGGATTGATGCAGGA-3’ 
Dct forward 5’-AGAGAAACAACCCTTCCACAGA-3’,  
reverse 5’-CCAATGACCACTGAGAGAGTTG-3’ 
Kit forward 5’-GGGCTAGCCAGAGACATCAG -3’,  
reverse 5’-AGGAGAAGAGCTCCCAGAGG -3’ 
Mitf forward 5’-TTGAAAACCGACAGAAGAAGC -3’,  
reverse 5’-TGGATGGGATAAGGGAAAGTC -3’ 
Tyrp1 forward 5’-GCCTCCAGTTACCAACACAGA -3’,  
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reverse 5’-AACGGATCAGACAAGAAGCAA-3’ 
Tyr forward 5’-CCAGAAGCCAATGCACCTAT-3’,  
reverse 5’-ATAACAGCTCCCACCAGTGC -3’ 
Sox10 forward 5’-GACCAGTACCCTCACCTCCA-3’,  
reverse 5’-AGCCTCTCAGCCTCCTCAAT -3’ 
Pax3 forward 5’-GCGAGAAAAAGGCTAAACACA-3’,  
reverse 5’-CGGAGCCTTCATCTGACTG-3’ 
S100a1 forward 5’-CAAGGAAGGGGACAAATATAAGC-3’,  
reverse 5’-CGTTTTCATCCAGTTCCTTCA-3’ 
Edn1 forward 5’-TACTTCTGCCACCTGGACATC-3’,  
reverse 5’-CCCTGAGTTCTTTTCCTGCTT-3’ 
Edn2 forward 5’-TTCTGCCATCGAAGACACTG-3’,  
reverse 5’-TGGCCTTTCTTGTCACCTCT-3’ 
Edn3 forward 5’-TGGGAAACAAGAGGACAAGG-3’,  
reverse 5’-CTGGGAGCTTTCTGGAACTG-3’ 
Axin2 forward 5’-ACTGACCGACGATTCCATGT-3’,  
reverse 5’-CTGCGATGCATCTCTCTCTG-3’ 
Gpnmb forward 5’-TGCCTGCTGTCTGTGAGAAG-3’,  
reverse 5’-GGCAGTTTCCTATTGGCTTG-3’ 
Kitl forward 5’-CAAGTCTTACAAGGGCAGTTGA-3’,  
reverse 5’-ACAAGGTCACGGGTAGCAAG-3’ 
Chd3 forward 5’-ACTTTGATGAGCGTCCTGAAG-3’,  
reverse 5’-GGCTTGTCCTTCTCATTTCG-3’ 
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Whrn forward 5’-TGGCTTATAGACCTGATGGAGAA-3’,  
reverse 5’-CTTCTGAGGGGGATTTGACAT-3’ 
Acsbg1 forward 5’-AAGTTCCTGTCCATGCTGCT-3’,  
reverse 5’-TGGAGAAGTCACGTTGGAGA-3’ 
Adamtsl4 forward 5’-GGCAACCAGACTCTCAGCTC-3’,  
reverse 5’-CGGCAGCAGGTAGTTGTGTA-3’ 
Cyp4b1 forward 5’-GCCTGATCTCTCTGCACATCTA-3’,  
reverse 5’-CACCTTCATCTCGTTCATAGCA-3’ 
Gfra1 forward 5’-TGCTGGCCCTCTAGATCCATAAC-3’,  
reverse 5’-ACAGCGCTTCTGGCAGTTGATA-3’ 
Myoc forward 5’-TCGGCTTTAGAGGAAGAGAAGA-3’,  
reverse 5’-CATACTTGCCAGCGATTGTTT-3’ 
Nt5e forward 5’-ATGAACATCCTGGGCTACGA-3’,  
reverse 5’-GTCCTTCCACACCGTTATCAA-3’ 
Steap4 forward 5’-TGATTCCTATCCGTTACTATGTTCG-3’,  
reverse 5’-ATGGGCTGTCTTTATTAGTTAGGG-3’ 
Tns1 forward 5’-TCTTACCATTGCCCTCAATCC-3’,  
reverse 5’-CCACGGACTCCACATAGCTC-3’ 






NFIB ChIP-seq analysis. 
At first, the quality of NFIB antibody for immunoprecipitation was examined in 
hair follicle cells of newborn skins. Back skins from nine CD-1 newborns were dissected 
using the shoulders and hips as landmarks and treated with dispase (Gibco, 0.4mg/mL) at 
4°C overnight. Separated from the epidermis, the dermis were incubated in 8ml 0.25% 
collagenase solution, which was made by adding 0.1ml 20% collagenase (Sigma, solved 
in PBS) into 7.9ml Hanks’ balanced salt solution (Gibco), for 45 minutes at 37°C. PBS 
was added to bring the volume up to 40 ml, followed by repetitive pipetting to dissociate 
dermal cells from hair follicles and centrifugation at 300g for 10 minutes at 4°C. The 
pellet was resuspended in 30ml PBS, followed by low-speed centrifugation (40g, 6 
minutes, 4°C) to enrich hair follicles. Hair follicles were treated with 10ml 0.25% trypsin 
with EDTA (Gibco, 0.25%) for 10 minutes at 37°C. Trypsin was inactivated by the 
addition of 20ml PBS with 5% fetal bovine serum (5% FBS), followed by centrifugation 
at 300g for 10 minutes at 4°C. Single cells were washed once by 20ml PBS. 0.55ml RIPA 
buffer (Cell signaling) with protease inhibitors (Roche) was added to lyse cells with 10-
minute incubation on ice. After centrifugation at 13k rpm for 10 minutes at 4°C, 20μl 
supernatant were collected as input control (5ul were loaded in Western blot), and 250ul 
cell lysate were incubated with 6μg NFIB antibody (Active Motif, rabbit) conjugated 
with Dynabeads (Life technologies) accompanied with 250ul cell lysate with IgG control 
at 4°C overnight. RIPA buffer was used to wash beads and proteins (IP) were 
reconstituted in 50ul SDS-PAGE sample buffer, 20% of which were used for Western 
blot. For Western blotting, anti-NFIB antibodies (Active Motif, rabbit, 1:1000; Abcam, 
mouse, 1:100) were used.  
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All materials and methods for ChIP-seq experiments have been described (Lien et 
al., 2011). For each independent NFIB ChIP experiment, 10-15 X 106 bulge HFSCs were 
isolated by FACS from 15-20 CD-1 mice, and then used to isolate chromatin and 
incubate with 5μg anti-NFIB antibody (Active Motif) for ChIP-seq analysis. ChIP-Seq 
reads were aligned to the mouse genome (mm9, build 37) with the Bowtie program 
(Langmead et al., 2009) and the Illumina Analyzer Pipeline. ChIP-seq peak calling, 
genomic annotation of NFIB peaks, and comparison between NFIB targets and gene 
expression signature genes were performed using ChIPseeqer (Giannopoulou and 
Elemento, 2011). Motif analysis was performed using FIRE algorithm (Elemento et al., 
2007), included in the ChIPseeqer framework. 
 
Plasmid DNA Constructions. 
Plasmids encoding full-length Nfib1 cDNA were obtained from ATCC (clone: 
MGC-13959).  Since NFIB3 is the major isoform present in epidermal keratinocytes, 
Nfib3 cDNA was used in this study. Nfib3 DNA fragment was amplified from Nfib1 
cDNA clone by PCR with primers: forward 5’-
GTTGCGAGCTCTCATGATGTATTCTC-3’; reverse 5’-
GTCAACCCGGGCTAGCCCAGGTACCAGGACTGGCTCGTTTGAGGA-3’. For 
expression of EGFP-NFIB3, Nfib3 DNA fragment was then inserted into pEGFP-C1 
between SacI and XmaI.  
All lentiviral vectors (LV) were present in the pLKO lentiviral backbone (pLKO-
no-stuffer-PGK-MCS, Addgene 10879). For construction of LV-rtTA-IRES-EGFP, DNA 
fragment of rtTA-IRES-EGFP was excised from pMSCV-rtTA2S-M2-IRES-EGFP with 
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BglII and SalI restriction enzymes (RE) and cloned between BamHI and SalI sites of 
pLKO backbone. rtTA2S-M2 (Tet-On Advanced) was cloned from pUHD-rtTA2S-M2. 
This was excised by digesting with BamHI and SacII, and blunting with Klenow. The 
blunted fragment was subcloned into pMSCV-IRES-EGFP digested with HpaI, and 
dephosphorylated with SAP. For construction of LV-TRE-PGK-H2BmRFP1, TRE 
promoter was first inserted into ClaI and AgeI sites of pLKO vector to replace U6 
promoter (pLKO-TRE-PGK). The TRE promoter from Clontech's pTRE2 was amplified 
by PCR using primers flanked with ClaI and AgeI sites: forward 5’-
CGTATATCGATGCCCTTTCGTCTCGA-3’, reverse 5’-
GAATTACCGGTCGCGGAGGCTGGAT-3’. H2BmRFP1 DNA fragment was obtained 
from pCR-H2BmRFP1 by BglII and NsiI RE digestion (Beronja et al., 2010), which was 
then inserted between BamHI and NsiI sites of pLKO-TRE-PGK.  Edn2 cDNA were 
amplified from keratinocyte cDNA library with primers flanked with EcoRI site: forward 
5’-CGCCAGAATTCATGGTCTCCGCCTGGT-3’; reverse 5’-
CGCCAGAATTCGGTGTTATCTCTTCCTCCATC -3’. Afterwards, DNA fragment 
was inserted into EcoRI site of LV-H2BmRFP1-TRE vector. All insertions were verified 
by DNA sequencing.  
 
Cell Culture and in vitro Nfib overexpression. 
Primary Nfib-null (KO) keratinocytes were isolated from epidermis of E18.5 Nfib 
knockout embryos (Nfib-/-) and control keratinocytes were from heterozygous Nfib (+/-) 
embryos. Keratinocytes were maintained in E-media supplemented with 15% serum and 
a final concentration of 0.05 mM Ca2. Experiments were performed using primary cells 
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with less than 15 passages. Plasmids expressing EGFP or EGFP-NFIB3 were introduced 
into control and KO keratinocytes with Fugene 6 Transfection Reagent (Roche). After 24 
h transfection, GFP-positive cells were isolated by FACS for qPCR analysis.  
 
Intradermal injection of EDNRB receptor inhibitor BQ788 and anti-KIT blocking 
antibody. 
To inhibit EDNRB receptor from late catagen, 100µl BQ788 dissolved in PBS 
(1mg/ml, Tocris Bioscience) or PBS alone was injected intradermally into backskin of 
mice on first catagen when skin color turned from black to pink6. To inhibit KIT 
signaling, 100µl anti-KIT antibody (BD Pharmingen, 1.0 mg/ml, clone: ACK45 NA/LE) 
or control Rat IgG was used (Botchkareva et al., 2001). Injections were conducted every 
other day for 3 days (day 0, 2, 4), and mice were taken and analyzed on day 5. For 
inhibition of KIT signaling during anagen, 100µl anti-KIT antibody or control IgG was 
injected intradermally into backskin one day after depilation. Injections were conducted 
every other day for 5 days (day 0, 2, 4, 6, 8) and mice were taken and analyzed on day10. 
 
Statistics. 
To determine significance between two groups indicated in figures, comparisons 
were performed in Prism 5 software with unpaired two-tailed student’s t-test.  
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Chapter4: 
Summary and future directions
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In the hair follicle “miniorgan”, hair follicle stem cells (HFSCs) support their 
long-term repetitive regeneration. To investigate the molecular basis in modulating 
follicle formation, HFSCs and basal epidermal keratinocytes were selectively isolated 
from adult mouse skin using genetic methods and cell surface markers. Comparing the 
gene expression profiles of these isolated cell populations revealed several 
uncharacterized transcription factors with a HFSC-specific expression pattern, among 
which was NFIB.   
With cell-type-restricted expression patterns, lineage-specifying transcription 
factors have been recognized as key components in orchestrating tissue development. 
Surprisingly, these factors are not only required for the specification of cell fates during 
development, but, in many cases, they are also sufficient to direct the formation of 
specific cell types from other differentiated cell types. As early as 1987, the phenomenon 
was observed from the studies of transcription factor MyoD, which, when ectopically 
introduced into fibroblasts, can convert them to become myoblasts (Davis et al., 1987). 
Other examples include MITF, which can reprograms fibroblasts to become melanocyte-
like cells (Tachibana et al., 1996); C/EBPβ, which can trans-differentiate pancreatic cells 
into hepatocytes (Shen et al., 2000); and PAX6, which can induce ectopic eye formation 
on the fly body outside its head (Halder et al., 1995). Recently, an additional example of 
cellular reprogramming was the finding that several coordinated transcription factors 
(Oct4, Sox2, Klf4, and c-Myc) are able to convert somatic cells to pluripotent stem cells 
(Takahashi and Yamanaka, 2006). Therefore, because of their fascinating ability to direct 
cell fate determination, transcription factors have attracted a lot of attention from 
researchers when they are looking for the secret ingredients of organogenesis.  
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The importance of stem cells in tissue regeneration 
To understand the functional significance of NFIB in HFSCs, I followed the 
morphogenesis and cycling of hair follicles in the absence of NFIB. At first, I generated 
Nfib cKO mice with K14-Cre, in which Nfib was targeted during the embryonic stage. 
Upon NFIB loss, the morphogenesis of hair follicles was slowed and hair follicles 
degenerated precociously. Further, I found that in the absence of NFIB, the expression of 
SOX9, which is required for the specification of HFSC identity, was gradually 
diminished in hair follicles. However, there were differences between the phenotypes in 
loss of SOX9 and NFIB mutants. Sox9-ablated hair follicles lost HFSC markers including 
LHX2 and NFATc1 due to the failure of forming HFSC precursors; conversely, these 
markers were still present in Nfib-deficient hair follicles. It implies that HFSC precursors 
might be specified but they fail to maintain a high level of SOX9 expression upon NFIB 
loss and do not appear to be functional in their ability to fuel tissue growth, either in hair 
follicle formation or wound-repair. To identify the role of NFIB in hair follicle 
morphogenesis, more studies are required to further quantify the number and qualify the 
functionality of HFSC precursors in Nfib-deficient hair follicles. Meanwhile, it would be 
interesting to examine the relationship between NFIB and SOX9 (i.e. is the level of NFIB 
decreased upon SOX9 loss? Is Sox9 a direct target of NFIB during morphogenesis?).  
Preliminary results imply the importance of NFIB in hair follicle-mediated wound 
repair; however, more functional studies are required to confirm this notion. First, lineage 
tracing of NFIB-deficient hair follicle cells can provide insights into the questions of how 
they are lost during epithelial reconstitution and whether they show defects in 
proliferation or migration during this process. Meanwhile, it would be interesting to 
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identify if, after hair follicle maturation, NFIB also regulates the adult HFSC’s capacity 
for wound healing. It could be examined by following HFSC behavior after scratching 
the skin surface of adult mice, which remove the epidermal layer. Do NFIB-deficient 
HFSCs migrate out of the bulge upon wounding? Do they give rise to new epithelial cells? 
Do they contribute to re-epithelization at the expense of the HFSC population? 
Elucidating the molecular details by which NFIB acquires and maintains stem cell 
character will also further our understanding into the specification and development of 
HFSCs. Identifying genes directly regulated by Nfib will be important in this regard. 
Although retarded hair follicle morphogenesis upon NFIB loss is evident, NFIB 
seems not to be required for hair growth after HFSCs are established. Surprisingly, 
quantitative ablation of Nfib in adult hair follicle stem cells by using inducible Cre 
recombinases including Sox9-CreER and K15-CrePGR didn’t cause significant hair 
growth or hair cycle defects. Genome-wide RNA-seq analysis also confirmed this notion. 
NFIB-deficient HFSCs expressed comparable levels of most HFSC genes (such as CD34, 
Sox9, Lhx2, Nfatc1, Tcf3/4) when compared to control HFSCs. Most importantly, they 
not only expressed these genes but also appeared to be fully functional in performing 
their duties in driving the hair cycle. This suggests that NFIB is not essential for HFSC 
maintenance and its function in HFSCs can be replaced by other factors.  
It is possible that in adult hair follicles, the established interaction between 
HFSCs and other surrounding cell types compensates for NFIB’s function in HFSCs. In 
the mature stem cell niche of hair follicles, involved in maintaining HFSCs are multiple 
cell types surrounding them including the inner layer of the bulge (Hsu et al., 2011a), the 
DP (Greco et al., 2009), the dermis and adipocytes in the subcutis (Festa et al., 2011; 
129
Plikus et al., 2008). Nerve endings, arrector pili muscles and melanocytes are also close 
to HFSCs. Thus, it will be interesting to examine if the cross talk between developing 
hair follicles and nearby cells is disrupted upon NFIB loss. 
Intrinsically, factors expressed in mature HFSCs might take over the role of NFIB. 
The potential redundancy from other members of the NFI family, particularly if this 
changes developmentally, needs to be taken into consideration. Nfic has been shown to 
regulate hair cycling (Plasari et al., 2010). In Nfic-null skin, the overall morphology of 
hair follicles is intact, but the transition of hair follicles from resting telogen to the growth 
phase anagen is delayed both during hair cycle and in response to hair growth-stimuli 
after depilation. However, the underlying mechanism of Nfic-regulated hair growth 
induction is unclear. Since Nfic mutants used in the study are straight knockout mice, it is 
unclear whether the defects are caused by loss of Nfic in HFSCs or whether Nfic 
modulates hair cycle in a indirect way, for instance, through regulating the function of 
dermal papilla or other cells that surround HFSCs. From transcriptional profiling analysis, 
Nfic RNA is detected in adult HFSCs (Fig. 4-1a), implying that the hair cycle defects in 
Nfic KO mice might be due to impaired HFSCs.  
But, notably, Nfic levels in HFSCs are much lower than Nfib and the other family 
member Nfix (Fig. 4-1a). Immunostaining with an anti-NFIX antibody revealed that 
NFIX displays similar a expression patter to NFIB. The antibody is specific for NFIX 
judged by the disappearance of immunofluorescent signals in Nfix KO skin (Fig. 4-1b). In 
mature hair follicles of P10 skin, both NFIB and NFIX are enriched in the ORS of hair 
follicles, and their levels are diminished in the matrix when hair cells are differentiating 
and absent in the differentiated follicular layers (Fig. 4-1c). The differences are in the 
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epidermis. NFIB’s level is lower in the epidermis compared to in hair follicles whereas 
NFIX displays comparable level in both compartments. Meanwhile, in hair follicles of 
adult mice, NFIX is only present in CD34+ bulge HFSCs but not KIT+ McSCS similar to 
the expression pattern seen for NFIB (Fig. 4-1d). While Nfix is involved in maintaining 
the quiescence of neural stem cells (Martynoga et al., 2013), it will be interesting in the 
future to examine if Nfix is involved in the biology of skin, and if Nfix also plays a role in 
stem cells of the skin, modulating hair follicle regeneration or wound repair.   
 
 
Figure 4-1. NFIX expression pattern in hair follicles. a, Expression levels of all Nfi 
family members from RNA-seq analysis of bulge HFSCs (Bulge) and epidermal cells 
(Epi), conducted by Brice Keyes. Cells were isolated from telogen (P50-60) hair follicles 
by FACS with antibodies conjugated with fluorochromes (bulge: Sca1- CD34+ α6+; Epi: 
Sca1+ CD34- α6+). FPKM: Fragments Per Kilobase of transcript per Million mapped 
reads. b-d, immunofluorescence with indicated antibodies. Note NFIX is expressed in the 
ORS and the bulge of hair follicles but not in KIT+ melanocytes. Nfix KO tissues were 
from Dr. Gronostajski. Scale bars: 50µm (b,c); 10µm (d). 
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Stem cell quiescence 
Quiescence is a state of cessation. Cells in quiescence are not proliferative but 
able to respond to extracellular stimuli that originate from their niche environment by 
activating and entering the cell cycle.  For tissue stem cells, the ability to stay in 
quiescence is crucial so that they can withstand metabolic stress and preserve genomic 
integrity over an organism’s lifetime. Thus, balancing between quiescence and activation 
allows tissue stem cells to properly maintain the architecture of the tissue during 
homoeostasis, and meanwhile fulfill the immediate demands for tissue regeneration 
following damage without compromising long-term stem cell maintenance. 
Dysregulation and loss of quiescence in tissue stem cells often results in their short-term 
expansion but ultimately leads to stem cell depletion due to their limitation in 
proliferative capacity (Orford and Scadden, 2008).   
The hair follicle is special as it is home to two distinct stem cell populations, 
McSCs and HFSCs. Synchrony is achieved such that they stay in quiescence together 
during telogen, a break period in the hair cycle that can last for weeks.  Several 
mechanisms have been found to regulate the quiescence of individual types of stem cells 
independently. For instance, the absence of transcription factors such as LHX2 
(Folgueras et al., 2013; Rhee et al., 2006), NFATc1 (Horsley et al., 2008), and FOXP1 
(Leishman et al., 2013) specifically in HFSC lineage leads to the shortening of telogen 
due to HFSC activation precociously. Extrinsically, BMP signals coming from the 
microenvironment maintain HFSC quiescence during telogen (Kobielak et al., 2007). 
While the intrinsic mechanism is still not identified, maintaining the quiescence of 
McSCs requires TGF-β signaling (Nishimura et al., 2010). Given the closeness of HFSCs 
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and McSCs in space and their synchronized behaviors in time, it was tempting to 
speculate the involvement of direct communication between them for achieving this 
coupling.  
Unexpectedly, I came upon a factor NFIB, which is responsible for mediating this 
crosstalk. In the absence of the HFSC-specific transcription factor NFIB, the quiescence 
of McSCs is perturbed: their population is expanded and some undergo ectopic 
differentiation in telogen when HFSCs are still dormant. Thus, the uncoupling happens 
when HFSCs lack NFIB. They can no longer repress the expression of Edn2, which 
encodes a secreted ligand acting on EDNRB receptor present on the surface of McSCs, 
whereby McSCs precociously undergo differentiation. It reveals an interesting notion that 
factors within HFSCs not only can regulate the quiescence of themselves, but they also 
play an important role in modulating their neighbor’s activity through signal exchanges.  
Given that in the NFIB-deficient hair follicles, only McSCs close to the dermal 
papilla (DP) are affected but McSCs away from the DP are relatively unperturbed, it led 
the study one step further showing that the DP signal KITL is required for EDN2-induced 
melanocyte differentiation in the absence of NFIB. The DP is a specialized mesenchymal 
structure lying under the stem cell niche and thought to act as a major signal center by 
secreting regulatory factors to modulate stem cell activity and the hair cycle. Thus, the 
DP releases inhibitory cues during telogen to maintain stem cells in quiescence; 
conversely, it upregulates the secretion of activating signals to counterbalance the 
inhibitory environment present during the transition from telogen to anagen.  
Surprisingly, noticeable levels of activating signals such as KITL can be detected 
in telogen DP, while its presence in telogen is not sufficient to drive McSC activation 
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until anagen ensues. It could result from that the environmental inhibitory signals are so 
strong to override its activating effect, and it is also possible that there are not enough 
activating stimuli in the telogen niche to push McSCs to take action in response to KITL. 
In vitro melanocyte culture experiments provide some hints. While the addition of KITL 
alone into melanoblast culture is not sufficient to induce pigment production, in the 
presence of both factors EDN and KITL melanoblasts can fully differentiate into 
pigmented cells (Reid et al., 1996a). Meanwhile, simultaneous addition of EDN and 
KITL into culture dramatically increases melanoblast number to an extent greater than 
the addition of each individual factor (Reid et al., 1996a), although each factor has 
significant effect in promoting melanoblast proliferation (Lahav et al., 1996; Opdecamp 
et al., 1998; Reid et al., 1995). Thus, EDN and KITL act synergistically to promote the 
proliferation and differentiation of melanocytes, a finding that can explain at least partly 
why Kit signals are not able to induce McSC activation in telogen but in anagen when 
EDN is present. Thus, through repressing the level of EDN2, NFIB in HFSCs acts as a 
gatekeeper to maintain McSCs in quiescence. It makes the bulge/HG favorable for 
McSCs without being agitated by the stimuli in the environment.    
How are HFSCs involved in McSC activation in the normal hair cycle? To 
explore the dynamics of HFSC gene expression changes during the hair cycle, 
transcriptional profiling and chromatin mapping have been conducted in HFSCs when 
they are quiescent, being activated, and when their progeny are differentiating (Lien et 
al., 2011).  Interestingly, Edn2 has been shown to be upregulated naturally in activated 
HFSCs. Thus, it is tempting to speculate that EDN2 released from neighboring HFSCs 
during hair growth might act as an important factor to promote the self-renewal of 
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McSCs within the hair follicles. Later, as melanocytes reach the follicle base, EDN 
factors from differentiated hair cells (Rabbani et al., 2011) could not only promote their 
proliferation but also differentiation with the help from the DP signals including Kit 
(Botchkareva et al., 2001).  While Edn2-null mice exhibit normal coat color, the 
premature lethality of the mutants makes it hard to study the potential function of Edn2 in 
adult McSC maintenance.  Conditional ablation of Edn2 in adult HFSCs would be helpful 
to address this question and to investigate the long-term influence of Edn2 loss in hair 
pigmentation. Meanwhile, also awaiting further investigation is what are the upstream 
positive regulators of Edn2 in activated HFSCs and how they outcompete the repressive 
regulator NFIB to activate Edn2 expression.  
Beyond the NFIB-EDN2 axis, it would be also interesting to identify other 
possible mechanisms in mediating the crosstalk between HFSCs and McSCs within hair 
follicles. At first, transcriptional profiling of the melanocyte lineage might reveal some 
clues about the mechanisms modulating McSC activation. By crossing Lef1-RFP 
transgenic mice (Rendl et al., 2005) to Dct-EGFP mice, it should be possible to separate 
McSCs (EGFP+ only) from differentiated melanocytes (EGFP+ RFP+) in the follicles 
during FACS isolation for RNA-seq analyses. Further, through combining the profiles 
from HFSCs and McSCs, we might be able to identify signal exchanges between them, 
either the signals from HFSCs to McSC or vice versa. Predicted components and 
relationships in this network could then be tested quickly by in utero lentiviral-mediated 
overexpression or loss of function experiments with hair coat color changes as one 
rapidly scored phenotypic readout. Furthermore, recent studies have shown that both 
HFSCs and McSCs react to tissue damage, migrating out of their residence to the 
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wounded region for skin regeneration (Chou et al., 2013; Ito et al., 2005; Tumbar et al., 
2004), implying that not only do they coordinate their behaviors during hair cycle but 
also during wound healing process. Thus, dissecting the crosstalk between HFSCs and 
McSCs would provide new insights in stem cell-mediated tissue regeneration, revealing 
the potential for developing therapies for skin disorders or injury impairing.   
Surprisingly, besides within hair follicles, adult targeting of Nfib also induces 
hyperpigmentation in dermis, specifically the dermal region nearby hair follicles, and the 
phenotype becomes more severe with age. However, it is unclear where dermal pigments 
are from. In dorsal skin of WT mice, dermal melanocytes are rarely seen. Thus, it is 
possible that NFIB loss in hair follicles induces proliferation and differentiation of in situ 
dermal melanocytes. It is also possible that melanocytes within mutant hair follicles 
invade the dermis, although I didn’t observe signs of abnormal melanocyte migration 
even inside hair follicles upon NFIB loss.  
 The phenotype is reminiscent of other factors such as HGF and EDN3, which, 
when upregulated in epidermal cells by K14 promoter from embryonic stage, results in 
dermal pigmentation concomitant with increased dermal melanocytes (Garcia et al., 
2008; Kunisada et al., 2000). Thus, it has been proposed that in transgenic HGF or EDN3 
mice, melanoblasts are not able to invade the epidermis and accumulate in the dermis 
when migrating toward skin during development. But this cannot explain the induced 
appearance of dermal pigments in adult K15-CrePGR X Nfib-conditional knockout mice 
since this targeting happens postnatally, that is to say, after most of melanocytes enter the 
epidermis/hair follicles.  
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Another possibility is trans-differentiation of Schwann cells into pigmented cells. 
Besides retaining heat, hair follicles also work like a sensory organ with nerve fibers 
attached to the region above the bulge (Li et al., 2011). This network of neurons in skin 
allows animals to sense the touch or stimuli in the surroundings. Interestingly, these 
sensory nerves and associated glial Schwann cells are derived from the same origin 
(neural crest) with melanocytes, and Adameko et al., reported that Schwann cells are 
competent to differentiate into pigmented cells when in a challenged microenvironment, 
such as when losing contact with nerves (Adameyko et al., 2009). Thus, it would be 
interesting to examine if pigmented cells that are ectopically present in the dermis nearby 
NFIB-deficient hair follicles, are derived from Schwann cells, and what signals induce 
the trans-differentiation. Meanwhile, it is also unknown if a perturbation of Schwann cell 
homeostasis would comprise neuron function and animal sensation.  
 
Implications beyond the hair follicle 
During development, NFIB is also required for lung formation. Like in skin, 
NFIB is expressed in the mesenchymal and epithelial cells in lung (Gründer et al., 2002; 
Hsu et al., 2011b; Steele-Perkins et al., 2005). Loss of NFIB causes a delay in lung 
development accompanied with reduced formation of multiple differentiated cell types 
and branching structure; as a consequence, mutant mice have breathing difficulty and die 
shortly after birth. The importance of Nfib in lung tissue has been emphasized recently. 
Hinsz et al. proposed that NFIB might be one of the master transcription factors that 
control lung development (Hnisz et al., 2013). In lung, Nfib is strongly associated with 
137
super-enhancers, which are large clusters of transcriptional enhancers that drive 
expression of genes that define cell identity.  
Interestingly, by using tissue specific K14 promoter to drive Nfib ablation in the 
epithelium, I found that the mutants, although they exhibit a functional skin barrier, were 
still not able to survive after labor, implying the possible cause of lethality from the 
epithelial defect is in the respiratory system (see Chapter 2). It supports this notion that 
besides in skin, K14 promoter is also active in the airway epithelium, specifically in their 
basal cells that are thought to be multipotent stem cells capable of regenerating the 
epithelium upon injury (Hong et al., 2004a; 2004b; Rock et al., 2009). Thus, it would be 
interesting to further investigate if mice with K14-Cre driven Nfib loss suffer from 
respiratory failure during development and whether they exhibit abnormal airway 
structure. Given that transcription factor P63 is required for the formation of basal cells in 
the airway (Daniely et al., 2004) and P63 is an upstream regulator of Nfib in skin 
epithelium (McDade et al., 2012), it also would be interesting to test if Nfib is involved in 
P63-dependent basal cell development in lung. Beyond the embryonic stage, it is also 
unknown if Nfib plays a role in regulating the function and maintenance of adult K14+ 
basal stem cells in lung during homeostasis and in the wound response. The idea can be 
examined by using an inducible K14-CreER line to temporarily control Nfib targeting in 
adult mice. The results from lineage tracing of Nfib-deficient basal cells during lung 
regeneration might provide new insights into pathological airway remodeling. 
Meanwhile, the identification of Nfib targets in skin might provide some hints in 
the understanding of lung development. Interestingly, knockout mice of Edn2, one of 
Nfib targets I identified in this study, also display abnormalities in lung structure 
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including enlarged air space and reduced alveologenesis, suggesting its importance in 
lung maintenance (Chang et al., 2013). Thus, the implication of our findings in the link 
between Nfib and Edn2 or other potential targets might be extended into the studies 
outside the skin and also provide insights into why mutations in Nfib are frequently seen 
in lung cancer cells (Dooley et al., 2011) as well as salivary gland cancer cells (Geurts et 
al., 1998; Ho et al., 2013).  
In sum, future studies on the molecular basis regulating tissue stem cells, 
regardless of within hair follicles or other tissues, will provide new insights in the biology 
of organ development, homeostasis and aging. Given the importance of transcription 
factors in regulating lineage specification, perhaps further understandings of the 
molecular basis behind their regulation will reveal the mechanisms of tissue construction 




GENE Description WT Bulge KO Bulge WT HG KO HG Log2 KO Bulge/WT Bulge Log2 KO HG/WT HG
Mir23b 0 101.69 0 0 6.682151888 0
Snord47 0 98.06 0 184.98 6.630230716 7.539003674
Snord100 0 92.27 86.05 80.26 6.543341212 -0.099298933
Mir24-1 0 90.59 0 0 6.517118185 0
Mir5117 0 73.77 42.16 67.79 6.224387628 0.672503991
Snord2 0 63.97 0 0 6.0217018 0
Slc15a2 solute carrier family 15 member 2 isoform 2 0 53.71 0 65.66 5.773732651 6.058749412
Mir3058 0 53.23 0 0 5.761019265 0
Mir5133 0 44.93 0 0 5.521364878 0
Snora75 0 39.71 15.14 0 5.347311316 -4.012568674
Snora3 0 35.51 28.45 53.48 5.190219764 0.887459069
Snord22 0 35.37 26.81 59.57 5.184677021 1.122999667
Snora68 0 33.21 37.66 51.34 5.096346199 0.437072287
Mir675 0 32.93 0 32.47 5.084489525 5.064796646
Snora30 0 29.96 0 0 4.952333566 0
Snora7a 0 29.45 0 0 4.928370323 0
Snora44 0 25.97 16.53 28.7 4.753283616 0.760636935
H19 1.26 41.51 1.04 68.06 4.233407581 5.081209277
Ccl20 C-C motif chemokine 20 isoform 2 0 12.8 18.46 39.31 3.786596362 1.050626073
Snora24 0 12.48 16.41 0 3.752748591 -4.121844298
Ugt1a10 UDP glycosyltransferase 1 family, polypeptide 0.12 13.69 0 0 3.713263758 0
Rmrp 0 11.42 0 0 3.634593268 0
Insl3 insulin-like 3 precursor 0.23 13.65 0.16 5.31 3.574170444 2.4435152
Mir678 2.56 41.05 0 0 3.562156654 0
Prr9 proline-rich protein 9 0 10.27 1.42 12.3 3.49441561 2.458347293
Itga8 integrin alpha-8 precursor 2.28 34.84 1.03 9.41 3.449802917 2.358418436
Hist2h2bb histone H2B type 2-B 0 9.84 2.49 8.22 3.438292852 1.401539714
Atp12a potassium-transporting ATPase alpha chain 2 3.34 45.42 32.8 60.65 3.418979575 0.867077648
Gap43 neuromodulin 0 9.49 0 0 3.390942773 0
Kcnn3 small conductance calcium-activated potassium 3.86 45.31 0.36 2.22 3.252295538 1.243454037
Kcnip2 Kv channel-interacting protein 2 isoform b 0 8.51 9.79 38.71 3.249445341 1.879807496
Slc18a3 vesicular acetylcholine transporter 2.67 33.85 0 3.76 3.247306688 2.250961574
C2cd4b family with sequence similarity 148, member B 4.21 46.26 7.52 22.76 3.181264352 1.479609501
Hba-a2 hemoglobin alpha, adult chain 2 1.98 25.27 2.98 4.62 3.140031965 0.4978017
Car2 carbonic anhydrase 2 0 7.52 1.38 8.39 3.09085343 1.980163584
Sphkap A-kinase anchor protein SPHKAP 19.75 174.31 0.36 6.42 3.078725051 2.447812535
Fam71a hypothetical protein LOC619288 4.05 40.2 2.22 14.87 3.028289044 2.301169535
Crygn gamma-crystallin N 0 7.05 4.47 2.79 3.008988783 -0.529342985
Rpph1 0 7 0 0 3 0
Hmga2 high mobility group protein HMGI-C 2.88 28.84 0.39 3.66 2.943118978 1.745245072
Mpp4 MAGUK p55 subfamily member 4 isoform 1 0.28 8.41 0.22 0.26 2.878050913 0.046542586
Ptgds prostaglandin-H2 D-isomerase 1.5 16.67 9.06 11.58 2.82130204 0.322501617
Chst9 carbohydrate sulfotransferase 9 0 5.56 0 0 2.713695815 0
C2 complement C2 precursor 15.85 104.06 5.32 16.24 2.640392993 1.447763311
Nts neurotensin/neuromedin N 0 5.22 0 1.49 2.63691458 1.316145742
Nppc C-type natriuretic peptide preproprotein 180.97 1130.03 71.35 315.96 2.635864668 2.131235863
Pcp4 Purkinje cell protein 4 2.06 17.68 2.62 11.06 2.609890897 1.736168305
Glrb glycine receptor subunit beta precursor 25.67 155.33 9.57 34.39 2.551304931 1.743366385
Hbb-b2 hemoglobin subunit beta-2 1.68 14.68 8.31 11.46 2.548620654 0.420450995
Plekha6 pleckstrin homology domain-containing family A 3.08 22.26 13.46 20.29 2.51121004 0.558108398
Sync syncoilin 0.9 9.68 0.71 1.32 2.490840323 0.44012848
Sprr1b cornifin-B 0 4.45 2.62 5.74 2.44625623 0.896758894
Nuf2 kinetochore protein Nuf2 2.65 18.77 35.81 22.58 2.437344502 -0.642534031
Wnt16 protein Wnt-16 precursor 2.86 19.78 18.63 30.86 2.428522902 0.698686094
Gpihbp1 glycosylphosphatidylinositol-anchored high 0 4.34 0 0 2.416839742 0
Klk14 kallikrein-14 preproprotein 0 4.3 0 0 2.40599236 0
Cpa6 carboxypeptidase A6 precursor 0 4.26 0 3.36 2.3950628 2.124328135
As3mt arsenite methyltransferase 0.82 8.53 2.55 3.79 2.388537764 0.432206631
Asphd2 aspartate beta-hydroxylase domain-containing 0 4.22 0 2.13 2.384049807 1.646162657
Pcdh20 protocadherin-20 precursor 20.9 113.02 7.95 29.84 2.380284132 1.784843178
Lst1 leukocyte-specific transcript 1 protein 0 4.19 0 0 2.375734539 0
Nxf7 nuclear RNA export factor 7 isoform 2 0 4.17 0.91 13.78 2.370164281 2.952001726
1700125H03Rik 0 4.16 5.12 12.61 2.367371066 1.153063509
Tas1r2 taste receptor type 1 member 2 precursor 0 4.13 0 0 2.358958826 0
Serpinb6e serine (or cysteine) peptidase inhibitor, clade 4.01 24.57 3.66 19.05 2.351569652 2.105200377
Birc5 baculoviral IAP repeat-containing protein 5 5.78 33.07 69.33 46.56 2.329144769 -0.564391502
Ifitm5 interferon-induced transmembrane protein 5 0 4.02 3.71 0 2.327687364 -2.23572706
Fhod3 FH1/FH2 domain-containing protein 3 1.23 10.09 7.66 30.59 2.31414375 1.867029007
Hmmr hyaluronan mediated motility receptor 2.32 15.29 33.6 20.41 2.294731457 -0.692487242
Kcnq3 potassium voltage-gated channel subfamily KQT 0.77 7.67 0 0 2.292282633 0
Ccnb2 G2/mitotic-specific cyclin-B2 4.59 26.36 57.53 41.29 2.291148042 -0.468859718
Kirrel3 kin of IRRE-like protein 3 isoform D precursor 0 3.88 3.15 2.98 2.286881148 -0.060342906
Cdk1 cyclin-dependent kinase 1 6.08 33.47 69.51 42.86 2.283520033 -0.684922069
Shcbp1 SHC SH2 domain-binding protein 1 1.65 11.9 36.07 19.55 2.283306801 -0.851113721
Ntm neurotrimin precursor 2.7 16.57 0 0 2.247517015 0
Ephb1 ephrin type-B receptor 1 isoform 1 4.53 25.25 3.38 4.72 2.246966037 0.385084277
Icam2 intercellular adhesion molecule 2 precursor 0 3.73 0 1.9 2.241840184 1.5360529
Pthlh parathyroid hormone-related protein 74.71 355.93 679.17 418.8 2.237085392 -0.696193208
Klrd1 natural killer cells antigen CD94 0 3.71 0 0 2.23572706 0
Nlgn1 neuroligin-1 isoform 2 2.25 14.28 0.82 2.33 2.23313292 0.871583727
Anxa9 annexin A9 5.33 28.6 23.26 12.86 2.225319771 -0.807652293
Iqgap3 IQ motif containing GTPase activating protein 3 2.97 17.56 36.56 20.87 2.224985798 -0.780243843
Mki67 antigen KI-67 8.13 41.51 114.46 72.14 2.219115494 -0.658660599
Tpx2 TPX2, microtubule-associated protein homolog 3.69 20.6 42.7 29.93 2.203371485 -0.498626446
Pdgfc platelet-derived growth factor C 18.44 88.47 29.41 49.65 2.202375797 0.736016453
Fmod fibromodulin precursor 43.76 204.85 5 26.21 2.201311507 2.181102551
C1qtnf5 complement C1q tumor necrosis factor-related 0.17 4.37 0.02 0.03 2.198413558 0.014075185
Table 3-1. Gene list from RNA-seq analysis of bulge/HG HFSCs from K15-CrePGR/Nfib cKO
and heterozygous (WT) skins. Fold change is estimated as log2 ratio between cKO and WT.
140
Adamtsl1 ADAMTS-like protein 1 1.22 9.17 3.42 10.49 2.195688098 1.378260523
Lmo3 LIM domain only protein 3 0 3.55 0 0.88 2.185866545 0.910732662
1500015A07Rik 7.16 36.08 13.82 40.7 2.184000187 1.492501936
Cenpf centromere protein F 1.76 11.54 26.72 16.58 2.183797176 -0.656992187
Mlana melanoma antigen recognized by T-cells 1 0 3.53 0 6 2.17951105 2.807354922
Top2a DNA topoisomerase 2-alpha 17.01 79.85 215.36 130.29 2.166449592 -0.720676768
Pbk lymphokine-activated killer T-cell-originated 7.16 35.49 63.7 49.15 2.160860094 -0.367516011
Pitpnm3 membrane-associated phosphatidylinositol 1.05 8.15 3.84 13.43 2.158147834 1.575992347
A330040F15Rik 0 3.46 0 0 2.15704371 0
Kif22 kinesin-like protein KIF22 3.78 20.29 47.06 27.98 2.155093426 -0.729779054
D4Bwg0951e hypothetical protein LOC52829 4.23 22.29 68.71 120.22 2.154827788 0.798190215
Lce6a late cornified envelope 6A 0 3.44 6.2 12.73 2.150559677 0.931262814
Nme3 nucleoside diphosphate kinase 3 26.43 119.59 60.33 63.47 2.136283749 0.072035033
1190002F15Rik 5.72 28.44 45.91 29.85 2.131244533 -0.604625011
B930003M22Rik 0 3.37 1.42 1.68 2.12763328 0.147225953
Timp3 metalloproteinase inhibitor 3 precursor 63.68 279.68 460.54 686.08 2.117534684 0.574022402
Bub1 mitotic checkpoint serine/threonine-protein 1.37 9.27 20.34 15.2 2.115477217 -0.397566363
Nek2 serine/threonine-protein kinase Nek2 2.41 13.75 27.3 17.88 2.11287131 -0.583943288
Gpnmb transmembrane glycoprotein NMB precursor 55.7 243.45 16.13 44.41 2.108118765 1.406484885
Rpl39l ribosomal protein L39-like protein 0 3.31 0 0 2.107687869 0
Loxl2 lysyl oxidase homolog 2 precursor 9.21 42.79 2.27 21.7 2.100618584 2.795329757
Lmcd1 LIM and cysteine-rich domains protein 1 47.45 206.43 46.98 74.42 2.098055991 0.652513993
Ifi27l2a interferon, alpha-inducible protein 27 like 2A 22.79 100.78 24.15 47.38 2.09702692 0.943852369
Gm14005 0 3.25 3.2 0 2.087462841 -2.070389328
St3gal5 lactosylceramide alpha-2,3-sialyltransferase 1.76 10.68 1.63 5.21 2.081300102 1.239530469
Wfdc2 WAP four-disulfide core domain protein 2 0 3.23 0 0 2.080657663 0
Ube2c ubiquitin-conjugating enzyme E2 C 9.52 43.49 93.58 62.16 2.080346394 -0.582523971
Ttr transthyretin 0 3.19 0 0 2.066950244 0
Ltc4s leukotriene C4 synthase 0 3.17 0 0 2.060047384 0
Fxyd4 FXYD domain-containing ion transport regulator 4 0 3.15 0 3.89 2.053111336 2.289834465
E130306D19Rik vav-like protein C9orf100 homolog 1.61 9.8 11.94 9.49 2.0489096 -0.302822939
Prc1 protein regulator of cytokinesis 1 12.11 53.04 93.92 62.41 2.043359989 -0.582001724
Fam64a family with sequence similarity 64, member A 2.47 13.29 29.25 19.58 2.041998349 -0.55569216
Tmem95 transmembrane protein 95 0 3.11 0 3.25 2.039138394 2.087462841
Slc16a1 monocarboxylate transporter 1 21.3 90.05 119.29 172.13 2.029615307 0.525339024
Eya1 eyes absent homolog 1 2.76 14.25 2.6 9.74 2.020004676 1.576925182
Slc20a1 sodium-dependent phosphate transporter 1 isoform 33.31 136.72 59.44 144.45 2.005037055 1.266947731
Adcy7 adenylate cyclase type 7 6.46 28.87 37.86 68.23 2.001449702 0.833111447
Neil3 endonuclease 8-like 3 1.56 9.24 24.07 12.48 2 -0.8951415
Kif20a kinesin-like protein KIF20A 5.41 24.42 49.6 45.69 1.987567768 -0.116023796
Depdc1a DEP domain-containing protein 1A isoform 2 0.86 6.36 14.1 9.31 1.984403145 -0.550504217
Itga1 integrin alpha-1 precursor 9.54 40.69 4.71 23.77 1.983826505 2.117031218
Ccna2 cyclin-A2 10.15 42.68 101.36 60.21 1.969929146 -0.741812779
Col4a4 collagen alpha-4(IV) chain precursor 3.44 16.36 22.19 15.67 1.967135366 -0.476248716
Kif23 kinesin family member 23 5.18 23.12 52.37 34.21 1.964551164 -0.600043784
Vit vitrin isoform 2 54.79 215.96 5.92 6.7 1.959350627 0.154086408
Bst1 ADP-ribosyl cyclase 2 5.75 25.16 6.53 12.41 1.954403134 0.832587467
Spc24 kinetochore protein Spc24 3.55 16.62 41.66 27.45 1.953275474 -0.584455313
Fam84a family with sequence similarity 84, member A 141.94 552.53 681.87 936.24 1.953251816 0.456807573
Fgf21 fibroblast growth factor 21 precursor 0 2.87 0 3.58 1.952333566 2.195347598
Anln actin-binding protein anillin 21.37 85.35 130.24 75.94 1.948630921 -0.770401764
Ckap2 cytoskeleton-associated protein 2 7.47 31.51 59.59 32.08 1.940449681 -0.873120471
Aurkb serine/threonine-protein kinase 12 4.06 18.37 35.63 21.72 1.936614664 -0.689062866
Kcnmb4 calcium-activated potassium channel subunit 2.45 12.2 3.27 4.69 1.935869663 0.414192583
Nusap1 nucleolar and spindle-associated protein 1 6.44 27.42 66.17 39.19 1.933532028 -0.740980452
Pglyrp1 peptidoglycan recognition protein 1 precursor 2.62 12.81 0 0 1.931651717 0
Wnt6 protein Wnt-6 precursor 4.81 21.15 48.38 88.69 1.93069663 0.861020304
Tyrp1 5,6-dihydroxyindole-2-carboxylic acid oxidase 5.47 23.58 11.16 35.15 1.925647298 1.571852418
Il17rb interleukin-17 receptor B precursor 17.45 69.03 16.74 32.25 1.924352271 0.906348331
Amtn amelotin precursor 0 2.79 0 24.97 1.922197848 4.698774109
Cdca5 sororin 2.44 12.02 24.87 13.4 1.920248978 -0.845211242
C1s complement C1s-A subcomponent 106.07 402.95 9.14 84.23 1.915622423 3.07130368
S100a9 protein S100-A9 0 2.74 0 4.59 1.90303827 2.482848283
9430076C15Rik 3.77 16.76 1.69 6.28 1.89657041 1.436332278
Dlgap5 disks large-associated protein 5 isoform 1 2.29 11.19 26.44 16.24 1.889538637 -0.670520707
BC002163 5.16 21.8 12.72 7.35 1.888031568 -0.716432379
2810417H13Rik PCNA-associated factor 4.08 17.75 71.63 32.1 1.883990193 -1.133734363
Spag5 sperm-associated antigen 5 1.93 9.8 23.1 16.41 1.882058743 -0.469116943
AI662270 0 2.68 0.91 0 1.879705766 -0.933572638
Melk maternal embryonic leucine zipper kinase 2.65 12.38 33.35 19.92 1.874109747 -0.715427247
Rbpjl recombining binding protein suppressor of 1.07 6.58 0 2.03 1.872567081 1.599317794
Wif1 wnt inhibitory factor 1 precursor 136.91 502.54 154.15 384.03 1.868379315 1.311307162
Xlr3b X-linked lymphocyte-regulated protein 3B 1.07 6.54 0.53 6.05 1.864933756 2.204091605
Batf3 basic leucine zipper transcriptional factor 0 2.64 0 0 1.86393845 0
2810408I11Rik 0 2.63 5.6 2.95 1.859969548 -0.740613371
Kifc1 kinesin-like protein KIFC1 3.79 16.25 34.09 21.31 1.848498801 -0.653369434
Gja1 gap junction alpha-1 protein 731.73 2620.21 564.38 2167.39 1.838879351 1.939331504
Cdc25c M-phase inducer phosphatase 3 2.04 9.85 22.18 12.08 1.835551814 -0.825518026
Racgap1 rac GTPase-activating protein 1 7.16 27.97 63.84 46.42 1.827918627 -0.451388428
Tubb6 tubulin beta-6 chain 17.12 63.24 34.14 73.24 1.825888937 1.079082519
Spc25 kinetochore protein Spc25 isoform 1 6.8 26.64 45.54 31.4 1.825211587 -0.522477398
Thy1 thy-1 membrane glycoprotein preproprotein 84.33 301.04 27.86 74.08 1.823614669 1.37935735
Kif11 kinesin-like protein KIF11 5.76 22.83 60.69 37.37 1.8176838 -0.685057881
Cep55 centrosomal protein of 55 kDa isoform 1 2.61 11.68 27.67 17.26 1.812484003 -0.650855139
Scrg1 scrapie-responsive protein 1 precursor 103.44 363.68 2.13 50.76 1.803956718 4.047603055
Ccnb1 G2/mitotic-specific cyclin-B1 4.43 17.71 45.95 24.89 1.784785455 -0.858730193
Edn2 endothelin-2 precursor 11.99 43.53 35.72 81.25 1.777376181 1.16344962
Foxm1 forkhead box protein M1 4.26 17.02 32.94 24.26 1.776464307 -0.426131926
F630043A04Rik spindle and kinetochore-associated protein 3 1.42 7.29 16.51 12.13 1.776365054 -0.415312168
Agrp agouti-related protein precursor 0 2.42 0 0 1.773996325 0
Casc5 protein CASC5 1.47 7.42 17.47 11.64 1.769309191 -0.547187403
Crct1 cysteine-rich C-terminal 1 27.56 96.31 104.44 117.85 1.768592091 0.172719628
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Gm5506 hypothetical protein LOC433182 12.4 44.28 24.53 54.2 1.756640957 1.112474729
Gm4532 0 2.36 2.07 1.75 1.748461233 -0.158807037
Bhlhe40 class E basic helix-loop-helix protein 40 110.53 372.58 1033.25 1092.58 1.743985394 0.080473806
Cnksr2 connector enhancer of kinase suppressor of ras 3.05 12.51 0.45 2.62 1.738033862 1.319936797
Cks2 cyclin-dependent kinases regulatory subunit 2 8.98 32.21 73.71 51.89 1.734506002 -0.498306387
Cdca3 cell division cycle-associated protein 3 11.14 39.26 92.43 55.19 1.729578751 -0.733572468
Hist3h2ba histone H2B type 3-A 0 2.3 4.15 6.18 1.722466024 0.479411412
Diap3 protein diaphanous homolog 3 3.9 15.11 43.54 21.57 1.71710284 -0.98069514
Cdc20 cell division cycle protein 20 homolog 10.2 35.76 78.29 45.53 1.714638034 -0.768977739
Akr1cl aldo-keto reductase family 1, member C-like 0 2.27 1.89 5.09 1.709290636 1.075372735
Gm16386 0 2.27 4.65 2.83 1.709290636 -0.560906475
Kntc1 kinetochore-associated protein 1 1.32 6.56 17.19 12.84 1.704261429 -0.3943016
Abcc8 ATP-binding cassette, sub-family C (CFTR/MRP), 0 2.23 0 0.3 1.691534165 0.378511623
Calml4 calmodulin-like protein 4 isoform b 0 2.23 0 0 1.691534165 0
Tspan12 tetraspanin-12 0 2.23 0 0 1.691534165 0
Tnfsf13 tumor necrosis factor ligand superfamily member 3.09 12.19 6.63 5.41 1.689271816 -0.2513587
Kif4 chromosome-associated kinesin KIF4 1.87 8.2 21.58 12.86 1.680583124 -0.704118229
Mis18bp1 mis18-binding protein 1 1.98 8.53 19.02 11.32 1.677163883 -0.700439718
Ccnb1ip1 E3 ubiquitin-protein ligase CCNB1IP1 0 2.18 0 5.1 1.669026766 2.608809243
D630032N06Rik 0 2.18 0 0 1.669026766 0
Klk6 kallikrein related-peptidase 6 precursor 0 2.17 16.83 6.2 1.66448284 -1.308237891
Asf1b histone chaperone ASF1B 5.78 20.49 43.72 26.83 1.664308304 -0.68427928
Gpr64 G-protein coupled receptor 64 isoform 2 4.07 15.04 5.49 8.27 1.661616489 0.514350861
Gm12166 0.53 3.83 5.36 7.98 1.658491536 0.497688679
Airn 17.56 57.51 3.71 21.18 1.656486508 2.235460401
Gm13124 hypothetical protein LOC627085 0 2.15 0 0 1.655351829 0
Vpreb2 immunoglobulin omega chain precursor 0 2.15 0 0 1.655351829 0
Pkp2 plakophilin-2 1.44 6.6 7.3 5.34 1.639118271 -0.388628496
Cdca8 borealin 9.68 32.14 68.58 43.31 1.633661956 -0.651040352
Serpinb11 serpin B11 452.94 1405.65 587.66 541.76 1.631689879 -0.117120197
Aspm abnormal spindle-like microcephaly-associated 1.66 7.23 21.33 12.1 1.629466185 -0.769416439
Tgif2 homeobox protein TGIF2 5.84 20.16 12.98 32.98 1.629271397 1.281321492
Bub1b mitotic checkpoint serine/threonine-protein 5.84 20.15 51 34.77 1.628589433 -0.539761505
Ngb neuroglobin 0 2.09 0 0 1.627606838 0
Hs6st2 heparan-sulfate 6-O-sulfotransferase 2 isoform 1.18 5.73 4.27 11 1.62627837 1.187159539
Mest mesoderm-specific transcript protein 18.81 60.13 12.51 18.18 1.625651687 0.505575046
Cdca2 cell division cycle-associated protein 2 1.27 5.99 15.25 10.51 1.622600158 -0.497551885
Rpl26 60S ribosomal protein L26 7.39 24.81 39.84 21.8 1.621187426 -0.840949042
Rbp7 retinoid-binding protein 7 0 2.07 0 0 1.618238656 0
4833422C13Rik 0.01 2.1 2.08 3.58 1.617912923 0.572417247
4930474M22Rik 0 2.06 9.43 8.81 1.613531653 -0.088414116
Adamts20 A disintegrin and metalloproteinase with 0 2.06 0.23 1.87 1.613531653 1.222392421
Cenpe centromere-associated protein E 1.51 6.68 17.68 10.94 1.613418947 -0.645691618
Esco2 N-acetyltransferase ESCO2 3.31 12.18 35.63 19.2 1.612590596 -0.858670408
Cd36 platelet glycoprotein 4 7.82 25.97 17.44 26.24 1.612504961 0.562888048
Gm14403 8.52 28.07 4.6 22.21 1.610497593 2.05124779
1700086O06Rik 10.52 34.08 6.46 30.39 1.606508031 2.073057493
Gfra3 GDNF family receptor alpha-3 preproprotein 2.84 10.68 4.25 3.32 1.604862058 -0.28128611
Gm889 hypothetical protein LOC380755 0 2.04 0 1.23 1.604071324 1.15704371
Kif2c kinesin-like protein KIF2C 1.75 7.36 23.65 14.86 1.604071324 -0.636194876
Synpo2 synaptopodin-2 16.25 51.41 25.2 119.15 1.603245747 2.197197932
Gm106 RPE-spondin precursor 6.2 20.86 4.22 12.55 1.602224589 1.37617114
Sprr2d small proline-rich protein 2D 0 2.02 0 0 1.59454855 0
Kif15 kinesin-like protein KIF15 2.63 9.87 25.38 16.22 1.582310487 -0.615359422
Kif20b kinesin-like protein KIF20B 3.23 11.66 20.06 12.63 1.581547836 -0.627719874
Gm13363 2.22 8.62 29.53 14.22 1.578976206 -1.004259231
Gm5077 complement C1s-B subcomponent precursor 21.24 65.43 2.53 15.12 1.578678126 2.191111655
Snhg11 small nucleolar RNA host gene 11 (non-protein 2.14 8.37 0.86 2.25 1.577284489 0.805137097
Matn4 matrilin-4 precursor 0 1.98 0 0 1.575312331 0
Lonrf3 LON peptidase N-terminal domain and RING finger 1.23 5.62 3.87 3.94 1.569787507 0.02058927
Arhgap11a rho GTPase-activating protein 11A 3.84 13.3 25.78 15.5 1.562936194 -0.698689936
Iyd iodotyrosine dehalogenase 1 precursor 1.02 4.94 0 4.22 1.556107638 2.384049807
Ly6g5b lymphocyte antigen 6 complex locus protein G5b 0 1.94 1.83 0 1.555816155 -1.500802053
Nhedc2 mitochondrial sodium/hydrogen exchanger NHA2 2.28 8.62 3.58 7.69 1.552341079 0.924008579
Fabp4 fatty acid-binding protein, adipocyte 45.4 134.71 24.43 43.67 1.548330321 0.812774793
Gm1564 hypothetical protein LOC268491 0.59 3.64 0 0.48 1.54509804 0.565597176
Fanca Fanconi anemia group A protein homolog 0.73 4.04 7.25 7.12 1.542651696 -0.022914392
Lzts1 leucine zipper putative tumor suppressor 1 1.58 6.48 4.72 12.83 1.535667204 1.273714104
Col4a3 collagen alpha-3(IV) chain precursor 2.9 10.29 21.07 16.71 1.533499457 -0.317522418
Ly6k lymphocyte antigen 6K precursor 0 1.89 5.37 10.88 1.531069493 0.899169559
Lrrc23 leucine-rich repeat-containing protein 23 0 1.88 0 0 1.526068812 0
Cxcl3 C-X-C motif chemokine 3 precursor 0 1.86 0 0 1.516015147 0
Slc1a3 excitatory amino acid transporter 1 1.3 5.57 16.82 10.1 1.514259509 -0.68293766
Gpx2-ps1 11.47 34.6 27.41 36.51 1.513415776 0.400876431
Hoxc12 homeobox protein Hox-C12 0 1.85 0 2.68 1.510961919 1.879705766
Mir17hg 18.26 53.84 24.85 44.07 1.509620868 0.80200317
Bgn biglycan precursor 175.19 499.83 87.56 254.79 1.507188939 1.530232737
Plk1 serine/threonine-protein kinase PLK1 3.53 11.87 29.07 18.32 1.506429098 -0.638229774
Mxd3 max dimerization protein 3 7.59 23.38 37.06 23.29 1.504968089 -0.647913072
Galnt14 polypeptide N-acetylgalactosaminyltransferase 22.72 66.18 15.33 49.23 1.501927786 1.621024484
Tnni2 troponin I, fast skeletal muscle 0 1.83 0 0 1.500802053 0
Dact1 dapper homolog 1 isoform 1 11.15 33.34 3.57 7.76 1.498933726 0.938736705
Sgol1 shugoshin-like 1 1.34 5.61 14.73 7.62 1.498141742 -0.867758896
Cry1 cryptochrome-1 23.44 67.9 35.45 59.45 1.495259698 0.729823525
Ect2 protein ECT2 isoform 2 10.46 31.28 53.66 35.29 1.494033535 -0.590913403
Gm5577 0 1.81 3.25 1.24 1.49057013 -0.923964109
Car9 carbonic anhydrase 9 precursor 0.76 3.93 1.75 2.27 1.486012218 0.249859017
Frat2 GSK-3-binding protein FRAT2 6.6 20.26 16.87 31.47 1.484070273 0.86156775
Eid3 EP300-interacting inhibitor of differentiation 2.32 8.24 5.22 11.01 1.47670961 0.949249666
Clspn claspin 0.96 4.45 16.64 6.95 1.475402576 -1.149823795
Dct L-dopachrome tautomerase precursor 20.76 59.2 37.62 85.03 1.46808493 1.155491673
Tacc3 transforming acidic coiled-coil-containing 8.17 24.35 56.22 37.56 1.466992108 -0.569414446
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Klhl34 kelch-like protein 34 1.08 4.75 0 1.74 1.466978428 1.454175893
5730405O15Rik 0 1.76 0 0 1.464668267 0
Ebi3 interleukin-27 subunit beta precursor 0 1.76 0 0 1.464668267 0
Rem1 GTP-binding protein REM 1 0 1.76 0 0 1.464668267 0
Cdk18 cyclin-dependent kinase 18 4.68 14.67 3.85 13.6 1.464042345 1.589911717
Stmn1 stathmin 61.59 171.61 457.59 408.28 1.463511967 -0.164116727
Tsc22d1 TSC22 domain family protein 1 isoform 3 177.46 489.86 394.68 1417.4 1.459710862 1.841858391
Zfp618 zinc finger protein 618 0 1.75 0 2.97 1.459431619 1.989139007
Pitpnc1 cytoplasmic phosphatidylinositol transfer 4.06 12.87 3.77 10.31 1.454758498 1.245537758
Dnajb13 dnaJ homolog subfamily B member 13 0 1.74 1.18 3.43 1.454175893 1.022978564
Ear2 eosinophil cationic protein 2 precursor 0 1.73 27.83 3.09 1.448900951 -2.817398089
Xlr3c X-linked lymphocyte-regulated protein 3C 0.79 3.88 0.3 3.36 1.44692156 1.745816512
Tmem88b transmembrane protein 88B 1.87 6.82 1.61 5.21 1.446117871 1.250543462
Reep1 receptor expression-enhancing protein 1 4.73 14.56 8.46 11.95 1.441235016 0.453040009
Cenpi centromere protein I 2.23 7.73 15.31 10.43 1.434447489 -0.512931378
Tmem37 voltage-dependent calcium channel gamma-like 0 1.7 0 0 1.432959407 0
Kif18b kinesin-like protein KIF18B 1.51 5.76 19.21 12.05 1.429335882 -0.631019515
Bves blood vessel epicardial substance 5.42 16.23 0 1.33 1.424277499 1.220329955
C1rl complement C1r subcomponent-like protein 3.21 10.29 0 0.68 1.423153348 0.748461233
Fgf13 fibroblast growth factor 13 4.39 13.42 6.18 6.04 1.419713986 -0.028408415
Hlf hepatic leukemia factor 8.01 23.09 7.99 19.14 1.418835382 1.163670662
Wnt11 protein Wnt-11 precursor 8.81 25.21 14.99 10.58 1.417792312 -0.465534685
Beta-s hemoglobin subunit beta-1-like 21.23 58.25 16.81 25.97 1.414307206 0.598668005
Malat1 279.88 746.53 496.29 681.06 1.412177578 0.455811237
Troap tastin 1.21 4.87 13.38 7.11 1.409314134 -0.826289856
Kif14 kinesin-like protein KIF14 0.7 3.51 8.21 6 1.407592687 -0.395846234
Rgag1 retrotransposon gag domain-containing protein 1 0 1.65 0 0 1.40599236 0
Zglp1 GATA-type zinc finger protein 1 0 1.65 1.37 0 1.40599236 -1.244887059
D630041G03Rik 2.11 7.22 9.7 9.54 1.402223814 -0.02173593
Ptprcap protein tyrosine phosphatase receptor type 1.37 5.26 2.59 0 1.401275598 -1.843983844
Tmem176a transmembrane protein 176A 29.26 78.72 53.86 57.3 1.397529723 0.087741261
Gngt2 guanine nucleotide-binding protein 2.28 7.64 4.32 0 1.397335498 -2.411426246
Prex2 phosphatidylinositol 1.87 6.56 1.49 9.61 1.397335498 2.091207009
Pmel melanocyte protein PMEL precursor 11.29 31.31 14.02 41.97 1.394495835 1.516444964
Ncapg non-SMC condensin I complex, subunit G 4.77 14.15 37.05 16.14 1.39267457 -1.150529344
Gpx2 glutathione peroxidase 2 41.43 110.09 93.38 116.08 1.388572372 0.310941574
Ncam1 neural cell adhesion molecule 1 isoform 2 1.22 4.79 2.48 13.66 1.383003672 2.074725892
Krt8 keratin, type II cytoskeletal 8 6.53 18.61 8.31 20.19 1.380867766 1.186530515
Slc17a9 solute carrier family 17 member 9 2.43 7.93 1.86 2.33 1.380451599 0.21950703
Ska1 spindle and kinetochore-associated protein 1 0.93 4.01 10.75 7.18 1.376209756 -0.522488009
Uhrf1 E3 ubiquitin-protein ligase UHRF1 isoform B 12.95 35.19 77.51 56.11 1.375325986 -0.459133041
Thsd4 thrombospondin type-1 domain-containing protein 3.08 9.58 22.71 32.38 1.37469857 0.493488292
Gzmm granzyme M 1.79 6.23 3 3.83 1.373730525 0.272023189
AI593442 hypothetical protein LOC330941 isoform 2 0 1.59 0.78 2.7 1.372952098 1.05564803
Tnmd tenomodulin 4.81 14.04 1.58 3.21 1.372194498 0.706449168
Tk1 thymidine kinase, cytosolic 10.02 27.51 62.8 44.27 1.371343815 -0.495001117
Morn3 MORN repeat-containing protein 3 0 1.58 0 0 1.367371066 0
Ndc80 kinetochore protein NDC80 homolog 2.68 8.49 25.6 12.95 1.366702321 -0.931161124
Gpx3 glutathione peroxidase 3 isoform 2 21.51 57 8.7 35.7 1.365486843 1.919723411
Gnal guanine nucleotide-binding protein G(olf) 4.85 14.04 6.53 10.38 1.362296037 0.595778788
Pi15 peptidase inhibitor 15 336.21 864.61 137.78 86.22 1.360069846 -0.670068776
E330013P04Rik 0 1.56 0 0 1.35614381 0
Htr2b 5-hydroxytryptamine receptor 2B 0 1.56 1.14 1.47 1.35614381 0.206900245
Ecscr endothelial cell-specific chemotaxis regulator 10.82 29.24 1.83 4.5 1.355228104 0.958629566
Dtl denticleless protein homolog 2.76 8.61 30.95 18.46 1.353803769 -0.715304221
Olr1 oxidized low-density lipoprotein receptor 1 0.62 3.14 4.45 4.33 1.353636955 -0.032120697
Gm6994 0.46 2.73 0 0.67 1.353207261 0.739848103
1700001K19Rik hypothetical protein LOC66323 0 1.55 1.96 1.63 1.350497247 -0.170534376
Kpna2 importin subunit alpha-2 6.85 19.01 30.36 25.02 1.349956608 -0.269304597
Apcdd1 protein APCDD1 precursor 40.88 105.48 457.74 518.03 1.346249129 0.17814122
Chi3l1 chitinase-3-like protein 1 0 1.54 16.23 15.45 1.344828497 -0.066835118
Gch1 GTP cyclohydrolase 1 precursor 5.05 14.31 28.26 19.86 1.339467235 -0.488190612
Gpr27 probable G-protein coupled receptor 27 0 1.53 2.49 1.63 1.339137385 -0.408164237
Ltb lymphotoxin-beta 0 1.53 0 0 1.339137385 0
Sgol2 shugoshin-like 2 isoform 2 3 9.12 20.74 11.56 1.339137385 -0.791515476
Mpdz multiple PDZ domain protein 35.67 91.76 34.78 58.15 1.338902554 0.725224781
2010015L04Rik hypothetical protein LOC544678 isoform 2 0 1.51 0 0.56 1.327687364 0.641546029
Shox2 short stature homeobox protein 2 0 1.51 0 0 1.327687364 0
Zdhhc12 probable palmitoyltransferase ZDHHC12 isoform b 13.56 35.39 30.89 11.81 1.321531696 -1.315833622
Tgm3 protein-glutamine gamma-glutamyltransferase E 4 11.49 1.1 3.42 1.320773477 1.073657042
Fstl1 follistatin-related protein 1 precursor 155.66 390.03 65.22 127.49 1.319642433 0.956317167
Col12a1 collagen alpha-1(XII) chain 111.27 279.2 8.04 54.72 1.319484483 2.62380058
Slc12a1 solute carrier family 12 member 1 isoform F 0.58 2.94 0.68 1.61 1.318271071 0.635588574
Btnl9 butyrophilin-like protein 9 0 1.49 0 0 1.316145742 0
Cpa2 carboxypeptidase A2 precursor 0 1.49 0 0 1.316145742 0
Lrrc46 leucine-rich repeat-containing protein 46 0 1.49 1.16 1.67 1.316145742 0.30580843
Ripply3 protein ripply3 0 1.49 9.09 8.02 1.316145742 -0.161726836
Camk1g calcium/calmodulin-dependent protein kinase type 0.45 2.61 1.28 0.86 1.315945937 -0.293731203
Aox1 aldehyde oxidase 3.47 10.12 4.67 7.03 1.314810052 0.502051253
Tmem173 transmembrane protein 173 11.06 28.96 11.52 46.93 1.312807717 1.936694378
Ankle1 ankyrin repeat and LEM domain containing 1 0.54 2.82 6.88 5.21 1.310642287 -0.343602361
1700040L02Rik hypothetical protein LOC73287 0 1.48 1.33 1.54 1.310340121 0.124498542
Fam178b hypothetical protein LOC381337 isoform A 0 1.48 2.51 4.41 1.310340121 0.624157564
Krt35 keratin, type I cuticular Ha5 0 1.48 13.98 20.64 1.310340121 0.530662875
Orm3 alpha-1-acid glycoprotein 3 precursor 0 1.48 1.05 0 1.310340121 -1.03562391
Tmem180 transmembrane protein 180 8.92 23.58 11.58 11.31 1.30907289 -0.03130116
Nnat neuronatin isoform beta 4.1 11.63 6.9 9.12 1.308285487 0.357284732
Stil SCL-interrupting locus protein homolog 1.09 4.17 9.41 7.66 1.306661338 -0.265531139
Syt4 synaptotagmin-4 0.59 2.93 1.37 3.36 1.305502547 0.879441076
Ngf beta-nerve growth factor isoform A 4.28 12.05 1.95 2.1 1.305439972 0.071553261
Hsd17b2 estradiol 17-beta-dehydrogenase 2 0 1.47 4.62 3.47 1.304511042 -0.330295299
Chst15 carbohydrate sulfotransferase 15 7.62 20.26 42.03 29.94 1.302381822 -0.475869643
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Apitd1 centromere protein S 6 16.23 24.98 18.83 1.299495874 -0.389716753
0610005C13Rik 0 1.46 0 0 1.298658316 0
Rep15 rab15 effector protein 0 1.46 1.86 0 1.298658316 -1.516015147
Gmnn geminin 5.15 14.08 40.49 26.11 1.293978113 -0.613938544
AI428936 nesprin-4 0 1.45 0 1.24 1.292781749 1.163498732
Cldn11 claudin-11 0 1.45 0 0 1.292781749 0
Gm10451 0 1.45 0 2.55 1.292781749 1.827819025
E2f8 transcription factor E2F8 1.72 5.65 14.16 8.54 1.289747689 -0.668208582
C8g complement component C8 gamma chain precursor 0 1.44 1.39 2.05 1.286881148 0.351798624
Trpm1 transient receptor potential cation channel 0 1.44 0.57 1.51 1.286881148 0.676922805
Slfn10-ps schlafen 10 4.04 11.28 5.73 8.16 1.284814922 0.444741093
Acsm3 acyl-coenzyme A synthetase ACSM3, mitochondrial 1.37 4.74 3.37 9.65 1.276163678 1.285148246
Gm436 hypothetical protein LOC230890 0 1.42 20.06 31.77 1.275007047 0.637870237
Hsf3 heat shock factor protein 3 0 1.42 0.79 0 1.275007047 -0.839959587
Cnih2 protein cornichon homolog 2 4.92 13.3 7.52 12.89 1.272346066 0.705121264
Ccdc3 coiled-coil domain-containing protein 3 690.23 1663.94 160.91 329.3 1.268232449 1.028584876
Wnt5a protein Wnt-5a precursor 4.4 11.97 3.69 13.4 1.264147167 1.618408984
Osgin1 oxidative stress-induced growth inhibitor 1 9.01 23.04 39.55 47.53 1.263994922 0.259174946
Nrp neural regeneration protein 0.75 3.2 2.41 4.72 1.263034406 0.746243408
Slc25a2 mutant ornithine transporter 2 0 1.4 0.89 2.06 1.263034406 0.695145418
Atp8b5 probable phospholipid-transporting ATPase FetA 0.55 2.71 0 0.45 1.259150971 0.5360529
Nsl1 kinetochore-associated protein NSL1 homolog 2.03 6.25 13.22 8 1.258663201 -0.659924558
Sit1 signaling threshold-regulating transmembrane 0 1.39 0 0 1.257010618 0
Tsc22d2 TSC22 domain family protein 2 64.87 156.42 60.66 99.11 1.25692539 0.699179298
Pdpn podoplanin precursor 6.1 15.95 4.65 12.12 1.255394344 1.215444947
Cdkn3 cyclin-dependent kinase inhibitor 3 2.6 7.59 29.72 15.9 1.254661225 -0.86215497
Brca1 breast cancer type 1 susceptibility protein 1.92 5.96 14.43 8.7 1.253118937 -0.669681409
Lag3 lymphocyte activation gene 3 protein precursor 5.79 15.18 9.04 13.42 1.252728128 0.522311895
Tm4sf1 transmembrane 4 L6 family member 1 24.16 58.93 449.12 206.75 1.252146452 -1.115461192
4930547N16Rik PARP1-binding protein 1.44 4.81 11.46 5.98 1.251657016 -0.836005127
Rpp25 ribonuclease P protein subunit p25 0 1.38 10.91 4.49 1.250961574 -1.117295359
Mcm10 protein MCM10 homolog 0.77 3.21 9 6.47 1.250070873 -0.420819852
Spon1 spondin-1 precursor 2.51 7.33 2.14 5.27 1.246845465 0.997700884
D2Ertd750e putative TRAF4-associated factor 1 5.33 14 27.54 20.25 1.244685096 -0.425522494
Smc2 structural maintenance of chromosomes protein 2 14.68 36.11 62.69 41.67 1.242882442 -0.577844761
Gimap4 GTPase IMAP family member 4 isoform b 1.21 4.22 0 0.99 1.240003437 0.992768431
2700099C18Rik 2.15 6.4 13.86 8.67 1.232173442 -0.619846321
Kifc5b kinesin family member C5B 3.73 10.11 19.98 12.52 1.231946728 -0.633919526
Trh prothyroliberin 4.56 12.02 1.13 6.19 1.22757266 1.75513834
Fam47e hypothetical protein LOC384198 isoform 3 0 1.34 0 0 1.22650853 0
Gm438 hypothetical protein LOC329993 0 1.34 0 1.8 1.22650853 1.485426827
Mir27a 245.88 576.44 117.62 226.8 1.225861081 0.94142047
Prelp prolargin precursor 18.16 43.8 6 8.5 1.225401171 0.440572591
Slfn9 schlafen 9 3.79 10.2 28.53 16.76 1.225401171 -0.733549775
Igfbp3 insulin-like growth factor-binding protein 3 841.05 1965.65 100.49 99.17 1.223762421 -0.018887084
2610021K21Rik EF-hand calcium-binding domain-containing 0.63 2.8 4.1 3.46 1.221127454 -0.193453537
Gm885 allergin-1 precursor 0 1.33 0 0 1.220329955 0
Cldn19 claudin-19 isoform 1 0.5 2.49 0.36 0.52 1.218264536 0.160464672
Epha4 ephrin type-A receptor 4 precursor 219.15 511.16 127.81 203.46 1.218107738 0.666574026
Rprm protein reprimo 0 1.32 0 0 1.214124805 0
Tac4 tachykinin-4 precursor 0 1.32 0 1.09 1.214124805 1.063502942
Rrad GTP-binding protein RAD 4.75 12.32 5.73 35.39 1.211960221 2.434863641
Fam70a family with sequence similarity 70, member A 5.08 13.08 2.34 13.32 1.211504105 2.100111485
Slc7a1 high affinity cationic amino acid transporter 1 9.13 22.45 22.48 40.31 1.210953749 0.815058652
Lgals3 galectin-3 1504.4 3479.72 1161.48 1568.52 1.209238887 0.433117517
Slc25a18 mitochondrial glutamate carrier 2 0 1.31 0.9 1.91 1.207892852 0.615019735
Dusp18 dual specificity protein phosphatase 18 8.43 20.76 11.89 13.25 1.206348881 0.144709656
Dgat2l6 diacylglycerol O-acyltransferase 2-like protein 1.22 4.12 0 1.3 1.205584134 1.201633861
Cyp2b19 cytochrome P450 2B19 5.6 14.21 38.01 51.02 1.204482223 0.415222401
Prkca protein kinase C alpha type 13.03 31.25 7.79 13.28 1.200784152 0.700060909
Chd3 chromodomain helicase DNA binding protein 3 52.75 122.2 53.86 159.55 1.196665596 1.549196138
4933433C11Rik hypothetical protein LOC74472 0 1.29 0 0 1.195347598 0
G530011O06Rik 1.15 3.92 1.68 4.62 1.194321656 1.06833713
Ces4a carboxylesterase 4A 2.13 6.15 1.28 3 1.191780585 0.810966176
Gsdma3 gasdermin-A3 9.59 23.17 172.3 88.35 1.190514884 -0.95573202
Ncf4 neutrophil cytosol factor 4 0 1.28 1.06 0 1.189033824 -1.042644337
F730043M19Rik 0 1.27 5.83 5.61 1.182692298 -0.047235307
Kir3dl1 killer cell immunoglobulin-like receptor 3DL1 0 1.27 0 0 1.182692298 0
2010317E24Rik protein C9orf140 homolog 1.2 3.99 10.63 5.97 1.181536292 -0.738620536
Peg10 retrotransposon-derived protein PEG10 isoform 2 1.25 4.1 0.27 0.88 1.180572246 0.565904165
Lrr1 peptidylprolyl isomerase-like 5 0.95 3.42 7.21 3.83 1.180572246 -0.765359033
1810011O10Rik thyroid cancer-1 40.43 92.9 390.27 531.37 1.180449338 0.444264777
Fam113b hypothetical protein LOC239647 1.91 5.58 4.37 4.46 1.177068431 0.023978863
4930512B01Rik 0 1.26 0.59 0.37 1.176322773 -0.214850872
Krt85 keratin, type II cuticular Hb5 0 1.26 0 5.52 1.176322773 2.704871964
Ybx2 Y-box-binding protein 2 3.12 8.31 4.45 5.08 1.17613683 0.157815094
Cnn1 calponin-1 6.78 16.57 4.59 4.98 1.175272131 0.097297201
Rad51ap1 RAD51-associated protein 1 2.58 7.07 19.31 11.41 1.172609086 -0.710687124
Gpr18 N-arachidonyl glycine receptor 0 1.25 0 0 1.169925001 0
Cenpn centromere protein N 3.35 8.77 22.08 17.51 1.167343161 -0.318338329
Mtap1b microtubule-associated protein 1B 12.39 29.04 25.53 55.87 1.165728852 1.100043129
Lck proto-oncogene tyrosine-protein kinase LCK 1.06 3.62 2.25 3.28 1.165248514 0.397171078
Sqle squalene monooxygenase 51.54 116.82 145.08 153.44 1.165096353 0.080287789
Apobec2 probable C->U-editing enzyme APOBEC-2 0 1.24 0 0 1.163498732 0
Mettl7b methyltransferase-like protein 7B precursor 0 1.24 10.77 23.4 1.163498732 1.051766827
Mylk myosin light chain kinase, smooth muscle 20.72 47.6 5.27 13.2 1.161932211 1.179353582
Grk5 G protein-coupled receptor kinase 5 12.64 29.48 9.16 9.65 1.160019258 0.067953028
Ehf ETS homologous factor 1.11 3.71 55.51 65.6 1.158484061 0.237015988
Dpysl2 dihydropyrimidinase-related protein 2 2.67 7.18 2.45 3.04 1.15632078 0.227758931
Ppifos 6.75 16.24 28.26 28.28 1.153491559 0.000985784
Mlf1ip centromere protein U 1.18 3.84 8.95 7.23 1.150678912 -0.273804095
Prdm11 PR domain containing 11 6.63 15.92 3.79 5.08 1.148974606 0.344045668
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Mthfd2 bifunctional methylenetetrahydrofolate 2.76 7.32 12.75 11.63 1.145850866 -0.12257698
2610203C20Rik 13.77 31.63 10.73 30.67 1.143529161 1.432913854
Pax3 paired box protein Pax-3 isoform a 0.93 3.26 1 2.78 1.142252583 0.918386234
Dio2 type II iodothyronine deiodinase 8.35 19.63 3.69 8.09 1.141705551 0.954692372
1190002H23Rik response gene to complement 32 protein 16.49 37.58 177.07 165.08 1.141322854 -0.100566133
Meis2 homeobox protein Meis2 isoform 6 3.24 8.35 3.5 15.71 1.1409021 1.892714827
Tnfsf12 tumor necrosis factor ligand superfamily member 1.74 5.04 2.13 2.11 1.140372656 -0.009248077
Nr1h5 nuclear receptor subfamily 1, group H, member 5 0 1.2 0 4.13 1.137503524 2.358958826
Gucy2g guanylate cyclase 2G precursor 1.39 4.25 4.91 4.72 1.135306805 -0.047142983
Pisd-ps1 82.57 182.47 13.64 66.33 1.13448714 2.201333911
Vegfa vascular endothelial growth factor A isoform 6 20.25 45.63 53.24 62.88 1.133795588 0.236007134
Rsph4a radial spoke head protein 4 homolog A 25.07 56.16 3.53 9.94 1.132615334 1.272029783
Plk3 serine/threonine-protein kinase PLK3 53.51 118.45 114.53 138.5 1.131814028 0.271997593
Asb2 ankyrin repeat and SOCS box protein 2 0 1.19 0 0 1.13093087 0
Pla2g2c group IIC secretory phospholipase A2 precursor 0 1.19 0.71 0 1.13093087 -0.773996325
Sap25 histone deacetylase complex subunit SAP25 4.42 10.86 5.84 7.32 1.129739253 0.282587203
Sulf2 extracellular sulfatase Sulf-2 precursor 60.75 134.12 33.03 36.98 1.129730191 0.158432754
Olfm1 noelin isoform c 152.27 334.13 83.1 148.62 1.128645497 0.83112533
Sdk1 protein sidekick-1 precursor 14.37 32.6 3.91 10.68 1.128344068 1.250245345
AI450353 1.34 4.11 3.32 4.24 1.126814761 0.278535499
Snai1 zinc finger protein SNAI1 2.58 6.8 3.44 4.51 1.123514536 0.311492642
Gm9790 HIG1 domain family, member 1A-like 19.55 43.75 52.28 57.13 1.122749288 0.125688826
Ccrn4l nocturnin 55.55 122.02 140.84 189.74 1.121293952 0.427342981
Ccl2 C-C motif chemokine 2 41.5 91.44 168.31 237.32 1.121054419 0.493232843
Chsy3 chondroitin sulfate synthase 3 28.32 62.73 10.59 18.6 1.120087557 0.757973088
Irf1 interferon regulatory factor 1 isoform a 74.9 163.6 201.33 238.12 1.116792545 0.241024554
Tgfb1i1 transforming growth factor beta-1-induced 34.72 76.36 25.02 29 1.114855714 0.205341539
Depdc1b DEP domain-containing protein 1B 1.07 3.48 8.24 3.58 1.113867965 -1.012545253
Emr4 EGF-like module-containing mucin-like hormone 0.59 2.44 0.66 0.76 1.113381799 0.084392187
Afap1l1 actin filament-associated protein 1-like 1 4.57 11.05 24.03 27.65 1.113283914 0.194876848
Ckap2l cytoskeleton-associated protein 2-like 12.41 27.97 67.09 42.39 1.111250447 -0.650080347
Zbtb10 zinc finger and BTB domain containing 10 20.91 46.29 27.75 25.86 1.109945657 -0.098102651
Tmc4 transmembrane channel-like protein 4 6.37 14.9 10.32 10.99 1.109290241 0.082957701
Whrn whirlin isoform 6 20.33 44.98 8.91 26.25 1.1081225 1.459299267
Mlf1 myeloid leukemia factor 1 isoform a 3.77 9.28 9.25 18.33 1.107779093 0.915217728
Pappa pappalysin-1 precursor 26.03 57.21 16.61 14.78 1.106705506 -0.158297704
Ccdc30 coiled-coil domain-containing protein 30 0.86 3 0.78 1.3 1.104697379 0.36975662
Ndp norrin precursor 0 1.15 3.16 3.19 1.10433666 0.010366716
Pnma5 paraneoplastic antigen-like protein 5 0 1.15 0 0 1.10433666 0
Hs3st6 heparan sulfate glucosamine 3-O-sulfotransferase 93.69 202.52 106.9 198.67 1.103886597 0.887922722
Prrt2 proline-rich transmembrane protein 2 14.56 32.38 6.08 13.04 1.101141894 0.98772167
Cyp2g1 cytochrome P450, family 2, subfamily g, 38.18 83 30.35 187.36 1.10027193 2.58695528
Ccne1 G1/S-specific cyclin-E1 1.6 4.57 6.5 7.11 1.099165704 0.112811319
Fbn2 fibrillin-2 precursor 1.21 3.73 2.82 8.93 1.097793814 1.378221079
A630001G21Rik hypothetical protein LOC319997 0 1.14 1.16 5 1.097610797 1.473931188
Gm5887 MANSC domain-containing protein ENSP00000370673 0 1.14 0 0 1.097610797 0
Ntn5 netrin-5 0 1.14 0 0 1.097610797 0
A430110N23Rik soluble scavenger receptor cysteine-rich 4.38 10.51 0.68 2.37 1.097209756 1.004287358
Glt1d1 glycosyltransferase 1 domain-containing protein 4.1 9.9 5.1 7.81 1.095758983 0.530332776
Hbegf proheparin-binding EGF-like growth factor 164.1 351.75 229.06 430.08 1.095305963 0.905945463
D130020L05Rik 4.64 11.05 5.94 5.25 1.095266079 -0.151079473
Creb5 cyclic AMP-responsive element-binding protein 5 100.41 215.57 34.01 96.51 1.094633487 1.477783118
Krt17 keratin, type I cytoskeletal 17 3364.52 7182.85 12026.7 12564.9 1.093927797 0.063153215
S100a7a protein S100-A15A 14.68 32.44 7.13 9.5 1.092649288 0.36906207
Rgs16 regulator of G-protein signaling 16 6.39 14.76 6.41 15.07 1.092621265 1.116824481
Ncaph condensin complex subunit 2 7.34 16.78 53.52 26.02 1.092136035 -1.012757887
Gkn1 gastrokine-1 0 1.13 0 0 1.09085343 0
Lepr leptin receptor isoform 2 3.26 8.06 2.3 3.84 1.08865762 0.552541023
Plekho1 pleckstrin homology domain-containing family O 4.22 10.1 6.12 7.43 1.088437965 0.24365539
Nrg1 pro-neuregulin-1, membrane-bound isoform 2.2 5.8 0 2.02 1.087462841 1.59454855
F2rl3 proteinase-activated receptor 4 precursor 0 1.12 0 0 1.084064265 0
Rimkla N-acetylaspartyl-glutamate synthetase A 0 1.12 0 0.58 1.084064265 0.659924558
Nr2f2 COUP transcription factor 2 isoform 1 1.14 3.53 2.03 1.85 1.081900254 -0.088355874
Fibin fin bud initiation factor homolog precursor 1.67 4.65 3.07 1.53 1.081411126 -0.68589141
Homer1 homer protein homolog 1 isoform S 36.49 78.22 55.24 69.96 1.079358876 0.335409415
Rsph1 radial spoke head 1 homolog 0 1.11 3.77 2.56 1.077242999 -0.422112025
Wdr86 WD repeat domain 86 0 1.11 0 1.81 1.077242999 1.49057013
6330403K07Rik hypothetical protein LOC103712 3.21 7.88 5.86 19.09 1.076739443 1.550197083
Akr1c19 aldo-keto reductase family 1, member C19 0.94 3.09 26.02 33.59 1.076044191 0.356327339
Psors1c2 psoriasis susceptibility 1 candidate gene 2 1.42 4.1 2.87 4.07 1.0754902 0.389652181
Igf2 insulin-like growth factor II isoform 2 0.96 3.13 0.49 1.84 1.075288127 0.930578599
E2f1 transcription factor E2F1 7.91 17.77 39.12 24.99 1.074931313 -0.626364972
Bard1 BRCA1-associated RING domain protein 1 2.28 5.9 10.79 8.31 1.072900547 -0.340710645
Egfl6 epidermal growth factor-like protein 6 329.68 694.3 96.8 166.47 1.072199798 0.775996309
Nkain2 sodium/potassium-transporting ATPase subunit 0 1.1 0 0.64 1.070389328 0.713695815
Tmem200a transmembrane protein 200A 1.08 3.36 0 2.25 1.067744607 1.700439718
Pcdhb11 protocadherin beta 11 2.47 6.27 1.37 4.55 1.067019701 1.227600712
Rasd2 GTP-binding protein Rhes precursor 2 5.28 1.84 7.43 1.065802058 1.569641701
Thpo thrombopoietin precursor 0 1.09 0.45 9.61 1.063502942 2.871299851
H2-T24 histocompatibility 2, T region locus 24 2.96 7.25 8.84 10.21 1.058893689 0.188056057
Cnrip1 CB1 cannabinoid receptor-interacting protein 1 1.19 3.56 1.35 1.67 1.058102955 0.184178985
Zwilch protein zwilch homolog 5.58 12.69 25.3 19.42 1.056962958 -0.365079933
Ctsl cathepsin L1 preproprotein 404.4 842.31 252.81 752.53 1.056716973 1.569916039
Rad51 DNA repair protein RAD51 homolog 1 9.8 21.44 43.21 28.28 1.055041364 -0.594457181
Rerg ras-related and estrogen-regulated growth 18.41 39.29 30.46 102.1 1.053621687 1.712453757
Ttk dual specificity protein kinase TTK isoform 1 6.57 14.71 28.31 17.56 1.053317975 -0.659196258
Gm13308 C-C motif chemokine 27-like 2.58 6.42 1.84 0.99 1.051459599 -0.513122499
Fam54a DUF729 domain containing 1 0.84 2.81 8.11 3.56 1.050085231 -0.99841723
2310046A06Rik hypothetical protein LOC69642 0 1.07 0 0 1.049630768 0
Cd40 tumor necrosis factor receptor superfamily 0 1.07 0 0 1.049630768 0
G6b 0 1.07 2.8 3.45 1.049630768 0.227805918
Slc47a2 multidrug and toxin extrusion protein 2 0 1.07 0.6 0 1.049630768 -0.678071905
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Ifit2 interferon-induced protein with 2.01 5.23 1.73 2.37 1.049468676 0.30384764
A3galt2 alpha-1,3-galactosyltransferase 2 precursor 2.16 5.54 1.75 2.72 1.049366077 0.435871003
Pif1 ATP-dependent DNA helicase PIF1 0.59 2.29 5.99 4.27 1.049060818 -0.407489494
Chek1 serine/threonine-protein kinase Chk1 3.56 8.43 20.24 14.81 1.048223947 -0.425946398
9530077C05Rik hypothetical protein LOC68283 4.51 10.39 1.64 3.43 1.047643523 0.746768769
Trps1 zinc finger transcription factor Trps1 34.69 72.75 26.57 58.28 1.047123148 1.10444618
Slc16a4 monocarboxylate transporter 5 1.01 3.15 2.11 2.95 1.045915835 0.344938073
Gm129 hypothetical protein LOC229599 1.03 3.19 2.48 3.05 1.045470517 0.218834602
Adamts1 A disintegrin and metalloproteinase with 211.81 437.88 702.48 734.9 1.044260582 0.065000327
Pdgfd platelet-derived growth factor D 3.82 8.94 0 1.01 1.044212705 1.007195501
Gas5 115.77 239.71 178.96 284.23 1.043626407 0.664449458
Apln apelin precursor 3.11 7.47 17.79 17.38 1.043223576 -0.0318283
2510049J12Rik hypothetical protein LOC70291 0 1.06 0.82 0.58 1.042644337 -0.204013892
Galnt12 polypeptide N-acetylgalactosaminyltransferase 0 1.06 0 0 1.042644337 0
Hsd17b13 17-beta-hydroxysteroid dehydrogenase 13 isoform 0 1.06 61.86 21.22 1.042644337 -1.500283455
Tagln transgelin 24.79 52.12 18.77 63.36 1.042443374 1.702851455
Tmem117 transmembrane protein 117 1.19 3.51 0 0.85 1.042196564 0.887525271
Gm13177 arylacetamide deacetylase-like 4 8.37 18.29 6.92 8.68 1.04173219 0.289506617
Incenp inner centromere protein 15.2 32.35 54.19 40.62 1.041692948 -0.40712992
Rasa4 ras GTPase-activating protein 4 isoform 1 2.61 6.43 1.73 2.93 1.041363374 0.525628361
Grrp1 glycine/arginine-rich protein 1 2.99 7.2 2.92 2.26 1.039235163 -0.26598169
Bcl3 B-cell lymphoma 3 protein homolog 7.72 16.92 25.08 38.41 1.039170597 0.59561788
Hbb-b1 hemoglobin subunit beta-1 11.9 25.49 4.33 6.51 1.038076778 0.494677375
Cd44 CD44 antigen isoform f precursor 410.92 844.48 666.41 873.38 1.037406453 0.389687099
Snora28 81.89 169.13 83.39 112.85 1.037367594 0.431990333
Degs2 sphingolipid delta(4)-desaturase/C4-hydroxylase 1.88 4.91 7.4 6.09 1.037089319 -0.2446037
Procr endothelial protein C receptor 9.55 20.64 6.2 17.05 1.0364575 1.325930025
Sema3b semaphorin-3B 9.5 20.53 2.08 7.26 1.035958992 1.423211431
Gimap1 GTPase IMAP family member 1 0 1.05 0 0 1.03562391 0
ORF63 TAK1-like protein 0 1.05 0 0 1.03562391 0
Slc5a3 sodium/myo-inositol cotransporter 9.48 20.47 12.79 19.49 1.034683474 0.571297527
Igfbp7 insulin-like growth factor-binding protein 7 913.81 1871.86 139.17 255.99 1.033699018 0.874534614
Ogn mimecan precursor 9.49 20.43 3.15 5.63 1.030617172 0.675897534
Cd72 B-cell differentiation antigen CD72 isoform 4 16.28 34.26 22.16 3.44 1.028929257 -2.383003672
Fgf17 fibroblast growth factor 17 precursor 0 1.04 0 0 1.028569152 0
Hes1 transcription factor HES-1 125.53 257.06 209.55 215.84 1.028227052 0.042468037
Ager advanced glycosylation end product-specific 1.28 3.65 0.83 2.94 1.028196892 1.106351981
Kcnk10 potassium channel subfamily K member 10 18.68 39.12 1.4 2.06 1.027591385 0.350497247
Car3 carbonic anhydrase 3 0 1.03 0 0 1.021479727 0
Foxj1 forkhead box protein J1 0 1.03 0 1.1 1.021479727 1.070389328
Gm5151 hypothetical protein LOC381582 0 1.03 0 0 1.021479727 0
Cd3g T-cell surface glycoprotein CD3 gamma chain 9.45 20.2 7.85 5.37 1.020561322 -0.474384083
Dusp10 dual specificity protein phosphatase 10 19.85 41.29 50.91 59.11 1.020269177 0.211592532
Mybl2 myb-related protein B 1.54 4.15 8.29 6.49 1.019743935 -0.310712878
Dbf4 protein DBF4 homolog A isoform 1 6.51 14.2 29.3 23.71 1.017186511 -0.294222783
Gm4925 ribosomal protein S12-like 0 1.02 0 0 1.014355293 0
Pvr poliovirus receptor 37.91 77.56 16.28 29.17 1.013653949 0.804011479
Cit citron Rho-interacting kinase 0.61 2.25 5.68 3.97 1.01337903 -0.426602251
Kif26b kinesin-like protein KIF26B 1.7 4.45 7.48 22.95 1.013296823 1.497889486
Armc2 armadillo repeat-containing protein 2 1.52 4.08 0.89 1.16 1.011404763 0.192645078
Slfn8 schlafen 8 isoform 2 1.92 4.88 2.27 3.02 1.009847786 0.297904866
Mir24-2 161.61 326.39 108.93 154.05 1.009594275 0.496148373
Ednrb endothelin B receptor isoform 1 1.61 4.25 1.85 2.56 1.008267616 0.320915322
4933432I09Rik 0 1.01 0 0 1.007195501 0
Ppm1n probable protein phosphatase 1N 0 1.01 0 0 1.007195501 0
Soat2 sterol O-acyltransferase 2 0 1.01 0 0 1.007195501 0
Arl5c ADP-ribosylation factor-like protein 5C 2.93 6.89 1.57 1.26 1.005495988 -0.185445587
Cd97 CD97 antigen isoform 4 15.09 31.29 46.99 35.57 1.004923115 -0.392073186
Lrrk2 leucine-rich repeat serine/threonine-protein 2.75 6.52 2.92 6.61 1.003842066 0.957042799
Gm11428 activated macrophage/microglia WAP domain 3.22 7.46 0 0 1.003414664 0
Kcnj13 inward rectifier potassium channel 13 2.08 5.17 3.21 3.07 1.002340138 -0.048791439
Robo4 roundabout homolog 4 0.81 2.62 0.61 0.62 1 0.008933125
Tgtp1 T-cell specific GTPase 0.6 2.2 1.2 0.75 1 -0.330148602
BB283400 0 1 0 0 1 0
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HG Up
GENE Description WT Bulge KO Bulge WT HG KO HG Log2 KO Bulge/WT Bulge Log2 KO HG/WT HG
Snord69 0 0 0 232.99 0 7.870303065
Snord47 0 98.06 0 184.98 6.630230716 7.539003674
Mir3109 0 0 0 83.95 0 6.408542042
Mir705 69 71.9 0 81.65 0.058563892 6.368942914
Mir5114 70.08 0 0 79.43 -6.151371776 6.329661815
Mir5121 0 0 0 78.95 0 6.321026129
Slc15a2 solute carrier family 15 member 2 isoform 2 0 53.71 0 65.66 5.773732651 6.058749412
Snord16a 0 0 0 63.42 0 6.009436756
Mirlet7d 31.52 34.93 0 39.43 0.143861678 5.337354298
H19 1.26 41.51 1.04 68.06 4.233407581 5.081209277
Mir675 0 32.93 0 32.47 5.084489525 5.064796646
Snord89 0 0 0 30.79 0 4.990501111
Mir5122 34.36 0 0 28.32 -5.14404637 4.873813198
Amtn amelotin precursor 0 2.79 0 24.97 1.922197848 4.698774109
Scrg1 scrapie-responsive protein 1 precursor 103.44 363.68 2.13 50.76 1.803956718 4.047603055
Snora43 0 0 0 15.33 0 4.029452886
Bex1 protein BEX1 1.54 2.97 4.83 77.62 0.64431051 3.753328575
Krtap8-1 keratin-associated protein 8-1 0 0 0 10.32 0 3.500802053
C1s complement C1s-A subcomponent 106.07 402.95 9.14 84.23 1.915622423 3.07130368
Nxf7 nuclear RNA export factor 7 isoform 2 0 4.17 0.91 13.78 2.370164281 2.952001726
Thpo thrombopoietin precursor 0 1.09 0.45 9.61 1.063502942 2.871299851
Mlana melanoma antigen recognized by T-cells 1 0 3.53 0 6 2.17951105 2.807354922
Krt73 keratin, type II cytoskeletal 73 2.32 1.08 0.79 11.44 -0.674599713 2.796954993
Loxl2 lysyl oxidase homolog 2 precursor 9.21 42.79 2.27 21.7 2.100618584 2.795329757
1700084E18Rik 0 0 0 5.67 0 2.737686761
Lrrc4 leucine-rich repeat-containing protein 4 39.86 76.33 7.89 57.39 0.920339009 2.715465987
Krt85 keratin, type II cuticular Hb5 0 1.26 0 5.52 1.176322773 2.704871964
A830018L16Rik hypothetical protein LOC320492 isoform 1 0.22 0.9 0.71 9.95 0.639118271 2.67886264
Krtap7-1 keratin-associated protein 7-1 0 0 0 5.29 0 2.653060017
Sstr2 somatostatin receptor type 2 isoform A 0 0 0 5.17 0 2.625270489
Col12a1 collagen alpha-1(XII) chain 111.27 279.2 8.04 54.72 1.319484483 2.62380058
Krtap11-1 keratin associated protein 11-1 0 0 0 5.14 0 2.618238656
Ccnb1ip1 E3 ubiquitin-protein ligase CCNB1IP1 0 2.18 0 5.1 1.669026766 2.608809243
Cyp2g1 cytochrome P450, family 2, subfamily g, 38.18 83 30.35 187.36 1.10027193 2.58695528
Gm1673 neuropeptide-like protein C4orf48 homolog 0 0 0 4.86 0 2.550900665
Fmo2 dimethylaniline monooxygenase [N-oxide-forming] 2.01 2.04 5.61 37.63 0.014307837 2.546999501
S100a9 protein S100-A9 0 2.74 0 4.59 1.90303827 2.482848283
Pamr1 inactive serine protease PAMR1 precursor 2.83 4.4 1.14 10.86 0.495615015 2.470421308
Prr9 proline-rich protein 9 0 10.27 1.42 12.3 3.49441561 2.458347293
Sphkap A-kinase anchor protein SPHKAP 19.75 174.31 0.36 6.42 3.078725051 2.447812535
Insl3 insulin-like 3 precursor 0.23 13.65 0.16 5.31 3.574170444 2.4435152
Ifnk interferon kappa precursor 0 0 0 4.43 0 2.440952198
Rrad GTP-binding protein RAD 4.75 12.32 5.73 35.39 1.211960221 2.434863641
Iyd iodotyrosine dehalogenase 1 precursor 1.02 4.94 0 4.22 1.556107638 2.384049807
Tmem178 transmembrane protein 178 precursor 0 0 0 4.15 0 2.364572432
Nr1h5 nuclear receptor subfamily 1, group H, member 5 0 1.2 0 4.13 1.137503524 2.358958826
Itga8 integrin alpha-8 precursor 2.28 34.84 1.03 9.41 3.449802917 2.358418436
Mkx homeobox protein Mohawk 11.15 18.13 2.18 15.01 0.65488056 2.331874637
Fam71a hypothetical protein LOC619288 4.05 40.2 2.22 14.87 3.028289044 2.301169535
Tnc tenascin 487.81 801.82 48.02 238.72 0.715802758 2.28990789
Fxyd4 FXYD domain-containing ion transport regulator 4 0 3.15 0 3.89 2.053111336 2.289834465
AW112010 hypothetical protein LOC107350 4.49 8.82 0 3.88 0.838916875 2.286881148
Ugt1a9 UDP-glucuronosyltransferase 1-9 precursor 0.03 0 2.59 16.4 -0.042644337 2.277031557
Relt tumor necrosis factor receptor superfamily 0.66 1.36 0.81 7.71 0.507603618 2.266683022
Prtn3 myeloblastin precursor 2.96 3.61 0 3.81 0.21926632 2.266036894
Slc18a3 vesicular acetylcholine transporter 2.67 33.85 0 3.76 3.247306688 2.250961574
Airn 17.56 57.51 3.71 21.18 1.656486508 2.235460401
Dbn1 drebrin isoform 2 37.14 50.23 12 60.17 0.425684048 2.234312653
Stfa1 stefin-1 1.72 0 0 3.69 -1.443606651 2.229587923
Xlr3b X-linked lymphocyte-regulated protein 3B 1.07 6.54 0.53 6.05 1.864933756 2.204091605
Pisd-ps1 82.57 182.47 13.64 66.33 1.13448714 2.201333911
Synpo2 synaptopodin-2 16.25 51.41 25.2 119.15 1.603245747 2.197197932
Fgf21 fibroblast growth factor 21 precursor 0 2.87 0 3.58 1.952333566 2.195347598
Gm5077 complement C1s-B subcomponent precursor 21.24 65.43 2.53 15.12 1.578678126 2.191111655
Fmod fibromodulin precursor 43.76 204.85 5 26.21 2.201311507 2.181102551
Mcoln3 mucolipin-3 3.07 5.88 2.11 12.78 0.75737977 2.147589403
Gm1045 hypothetical protein LOC381651 precursor 11.63 17.21 4.14 21.76 0.527876283 2.146660293
Nppc C-type natriuretic peptide preproprotein 180.97 1130.03 71.35 315.96 2.635864668 2.131235863
Cpa6 carboxypeptidase A6 precursor 0 4.26 0 3.36 2.3950628 2.124328135
Itga1 integrin alpha-1 precursor 9.54 40.69 4.71 23.77 1.983826505 2.117031218
Col14a1 collagen alpha-1(XIV) chain 3.38 4.12 6.78 32.62 0.22521294 2.111477664
Fam198b protein ENED 18.59 34.68 4.53 22.84 0.864998218 2.10803285
Serpinb6e serine (or cysteine) peptidase inhibitor, clade 4.01 24.57 3.66 19.05 2.351569652 2.105200377
Fam70a family with sequence similarity 70, member A 5.08 13.08 2.34 13.32 1.211504105 2.100111485
Prex2 phosphatidylinositol 1.87 6.56 1.49 9.61 1.397335498 2.091207009
Cpt1b carnitine O-palmitoyltransferase 1, muscle 0 0 0 3.25 0 2.087462841
Tmem95 transmembrane protein 95 0 3.11 0 3.25 2.039138394 2.087462841
Ncam1 neural cell adhesion molecule 1 isoform 2 1.22 4.79 2.48 13.66 1.383003672 2.074725892
1700086O06Rik 10.52 34.08 6.46 30.39 1.606508031 2.073057493
Gm14403 8.52 28.07 4.6 22.21 1.610497593 2.05124779
2810429I04Rik 0 0 0 3.11 0 2.039138394
Krtap17-1 keratin-associated protein 17-1 245.56 365.04 37.99 158.56 0.570062545 2.032922969
Islr immunoglobulin superfamily containing 2.82 4.26 0 2.97 0.461490161 1.989139007
Zfp618 zinc finger protein 618 0 1.75 0 2.97 1.459431619 1.989139007
Car2 carbonic anhydrase 2 0 7.52 1.38 8.39 3.09085343 1.980163584
5430421N21Rik type II hair keratin 0.53 0 0 2.9 -0.613531653 1.963474124
Cmah cytidine monophosphate-N-acetylneuraminic acid 1.47 3.29 1 6.77 0.796466606 1.957914599
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Camk2n2 calcium/calmodulin-dependent protein kinase II 3.35 2.33 0 2.88 -0.385493224 1.956056652
Krt25 keratin, type I cytoskeletal 25 32.89 48.23 10.23 42.51 0.538678103 1.953989089
Tmem151b transmembrane protein 151B 0 0 1.11 7.16 0 1.951326153
Fam71f2 hypothetical protein LOC245884 1.26 1.52 0 2.84 0.157100961 1.941106311
Gja1 gap junction alpha-1 protein 731.73 2620.21 564.38 2167.39 1.838879351 1.939331504
Tmem173 transmembrane protein 173 11.06 28.96 11.52 46.93 1.312807717 1.936694378
Gm684 hypothetical protein LOC270157 0 0 0 2.81 0 1.929790998
Sfrp1 secreted frizzled-related protein 1 precursor 1557.95 1076.39 35.57 138.21 -0.533034078 1.928530318
Gpx3 glutathione peroxidase 3 isoform 2 21.51 57 8.7 35.7 1.365486843 1.919723411
Foxe1 forkhead box protein E1 0 0 0 2.77 0 1.914564523
Rab42-ps RIKEN cDNA 9530096D07 3.76 4.09 0 2.74 0.096704083 1.90303827
Ica1l islet cell autoantigen 1-like protein 0.67 0.59 2.4 11.69 -0.070821337 1.900085418
Ppp1r3b protein phosphatase 1 regulatory subunit 3B 37.08 49.83 4.07 17.85 0.416646752 1.894506871
Meis2 homeobox protein Meis2 isoform 6 3.24 8.35 3.5 15.71 1.1409021 1.892714827
Nanos3 nanos homolog 3 0 0 0 2.71 0 1.891419187
Expi extracellular peptidase inhibitor precursor 0 0 5.25 22.15 0 1.889084099
Ly6g6d lymphocyte antigen 6 complex locus protein G6d 0 0 0 2.7 0 1.887525271
Scube3 signal peptide, CUB and EGF-like 0.8 1.89 9.67 38.36 0.683072586 1.883170045
Kcnip2 Kv channel-interacting protein 2 isoform b 0 8.51 9.79 38.71 3.249445341 1.879807496
Hoxc12 homeobox protein Hox-C12 0 1.85 0 2.68 1.510961919 1.879705766
4921530L18Rik 1.99 2.59 0 2.67 0.26383836 1.875780063
Fhod3 FH1/FH2 domain-containing protein 3 1.23 10.09 7.66 30.59 2.31414375 1.867029007
Nell2 protein kinase C-binding protein NELL2 0 0 0 2.63 0 1.859969548
Tsc22d1 TSC22 domain family protein 1 isoform 3 177.46 489.86 394.68 1417.4 1.459710862 1.841858391
Krt28 keratin, type I cytoskeletal 28 2.73 3.85 8.17 31.66 0.378809117 1.832531152
BC089491 selenoprotein V 2.22 1.16 0 2.55 -0.576029376 1.827819025
Gm10451 0 1.45 0 2.55 1.292781749 1.827819025
Rapgef3 rap guanine nucleotide exchange factor 3 isoform 16.75 9.52 1.33 7.17 -0.75468432 1.810006123
Plcd4 1-phosphatidylinositol-4,5-bisphosphate 5.58 1.95 1.16 6.55 -1.157372629 1.805445332
Cxcl14 C-X-C motif chemokine 14 precursor 16599.7 33042.5 1845.22 6409.26 0.99312243 1.795808395
Pcdh20 protocadherin-20 precursor 20.9 113.02 7.95 29.84 2.380284132 1.784843178
Bex4 protein BEX4 0 0 1.11 6.19 0 1.768748772
Mfap5 microfibrillar-associated protein 5 precursor 3.67 7.18 0 2.4 0.808678293 1.765534746
Trh prothyroliberin 4.56 12.02 1.13 6.19 1.22757266 1.75513834
Xlr3c X-linked lymphocyte-regulated protein 3C 0.79 3.88 0.3 3.36 1.44692156 1.745816512
Hmga2 high mobility group protein HMGI-C 2.88 28.84 0.39 3.66 2.943118978 1.745245072
Glrb glycine receptor subunit beta precursor 25.67 155.33 9.57 34.39 2.551304931 1.743366385
Pcp4 Purkinje cell protein 4 2.06 17.68 2.62 11.06 2.609890897 1.736168305
Lmx1b LIM homeobox transcription factor 1-beta 16.3 16.5 1.64 7.73 0.016582884 1.725443724
Ptprn2 receptor-type tyrosine-protein phosphatase N2 0 0.69 0.64 4.42 0.757023247 1.724597037
Gzmc granzyme C preproprotein 2.25 4.17 0 2.3 0.669724562 1.722466024
Slc7a8 large neutral amino acids transporter small 147.69 144.26 25.08 84.52 -0.033670138 1.713317983
Rerg ras-related and estrogen-regulated growth 18.41 39.29 30.46 102.1 1.053621687 1.712453757
Tagln transgelin 24.79 52.12 18.77 63.36 1.042443374 1.702851455
Tmem200a transmembrane protein 200A 1.08 3.36 0 2.25 1.067744607 1.700439718
Sorbs2 sorbin and SH3 domain-containing protein 2 30.68 55.98 1.86 8.29 0.846883286 1.69966345
4932441J04Rik 2.67 3.3 0 2.23 0.228556597 1.691534165
AI646023 leucine-rich repeat-containing protein C22orf36 6.25 4.09 1.41 6.71 -0.510315339 1.677697714
Fgg fibrinogen gamma chain precursor 0 0 0 2.19 0 1.673556424
Pclo protein piccolo isoform 2 1.02 1.93 2.14 8.97 0.536545372 1.666828946
Chn2 beta-chimaerin isoform 1 21.1 31.9 3.13 12.11 0.574041214 1.666453999
Enox1 ecto-NOX disulfide-thiol exchanger 1 126.75 129.34 17.63 58.13 0.028956609 1.666262603
2310043J07Rik uroplakin-3b-like protein 0 0 0 2.16 0 1.659924558
Ace angiotensin-converting enzyme isoform 2 6.96 13.33 3.84 14.26 0.848198274 1.65667601
Ccdc152 coiled-coil domain-containing protein 152 1.94 1.79 0 2.15 -0.075551033 1.655351829
Mdk midkine precursor 4.13 5.17 4.82 17.3 0.266311664 1.65275259
Asphd2 aspartate beta-hydroxylase domain-containing 0 4.22 0 2.13 2.384049807 1.646162657
Dhrs9 dehydrogenase/reductase SDR family member 9 30 51.15 2.2 9 0.750399037 1.64385619
Smarca1 probable global transcription activator SNF2L1 29.63 38.96 4.21 15.24 0.383611216 1.640196355
Hoxd4 homeobox protein Hox-D4 19.15 34.33 1.8 7.66 0.81011391 1.628940198
Galnt14 polypeptide N-acetylgalactosaminyltransferase 22.72 66.18 15.33 49.23 1.501927786 1.621024484
Wnt5a protein Wnt-5a precursor 4.4 11.97 3.69 13.4 1.264147167 1.618408984
Fez1 fasciculation and elongation protein zeta-1 7.22 5.06 0 2.07 -0.4398206 1.618238656
Cd209e CD209 antigen-like protein E 2.03 3.58 0 2.05 0.596029805 1.608809243
Ly86 lymphocyte antigen 86 precursor 3.41 3.34 0 2.05 -0.023083613 1.608809243
Enho adropin precursor 14.78 8.55 9.45 30.67 -0.724524567 1.599613925
Rbpjl recombining binding protein suppressor of 1.07 6.58 0 2.03 1.872567081 1.599317794
Cpxm1 probable carboxypeptidase X1 precursor 6.26 10.21 3.75 13.38 0.626744825 1.598064257
Nrg1 pro-neuregulin-1, membrane-bound isoform 2.2 5.8 0 2.02 1.087462841 1.59454855
Timp4 metalloproteinase inhibitor 4 precursor 0 0 0 2.02 0 1.59454855
Hist2h3c2-ps histone H3.2 6.73 11.67 2.99 11.04 0.712876205 1.593374741
Cdk18 cyclin-dependent kinase 18 4.68 14.67 3.85 13.6 1.464042345 1.589911717
Eya1 eyes absent homolog 1 2.76 14.25 2.6 9.74 2.020004676 1.576925182
Pitpnm3 membrane-associated phosphatidylinositol 1.05 8.15 3.84 13.43 2.158147834 1.575992347
Stfa3 stefin-3 45.61 33.59 22.4 68.64 -0.430284499 1.573407673
Antxr1 anthrax toxin receptor 1 precursor 143.25 124.01 13.71 42.74 -0.206527813 1.572155974
Tyrp1 5,6-dihydroxyindole-2-carboxylic acid oxidase 5.47 23.58 11.16 35.15 1.925647298 1.571852418
Ctsl cathepsin L1 preproprotein 404.4 842.31 252.81 752.53 1.056716973 1.569916039
Rasd2 GTP-binding protein Rhes precursor 2 5.28 1.84 7.43 1.065802058 1.569641701
Batf basic leucine zipper transcriptional factor 0 0 0 1.96 0 1.565597176
Krt83 keratin, type II cuticular Hb3 0.44 0.43 0.7 4.03 -0.010053665 1.565023654
Slc2a13 proton myo-inositol cotransporter 2.18 2.67 1.95 7.69 0.206753298 1.558641223
Vcan versican core protein isoform 2 3.13 4.52 2.15 8.25 0.418526485 1.554101537
6330403K07Rik hypothetical protein LOC103712 3.21 7.88 5.86 19.09 1.076739443 1.550197083
Chd3 chromodomain helicase DNA binding protein 3 52.75 122.2 53.86 159.55 1.196665596 1.549196138
Fgl1 fibrinogen-like protein 1 precursor 1.94 1.5 0 1.92 -0.23388806 1.545968369
Hoxd3 homeobox protein Hox-D3 5.78 9.48 0 1.92 0.628281538 1.545968369
Hmgcs2 hydroxymethylglutaryl-CoA synthase, 320.76 156.46 378.61 1104.9 -1.030999603 1.542631034
9430007A20Rik arylacetamide deacetylase-like 4 0 0 2.94 10.44 0 1.537819517
Lgr5 leucine-rich repeat-containing G-protein coupled 636.34 361.81 109.28 319.06 -0.812848987 1.537171213
Icam2 intercellular adhesion molecule 2 precursor 0 3.73 0 1.9 2.241840184 1.5360529
Dlgap1 disks large-associated protein 1 isoform 3 8.26 10.06 2.65 9.56 0.256267287 1.532641466
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3110021A11Rik 1.89 1.96 0 1.89 0.034527683 1.531069493
Il24 interleukin-24 0 0 0 1.89 0 1.531069493
Slc10a1 sodium/bile acid cotransporter isoform 2 1.48 3.28 0 1.89 0.787270676 1.531069493
Bgn biglycan precursor 175.19 499.83 87.56 254.79 1.507188939 1.530232737
Hist1h3d histone H3.2 0 0.36 0.16 2.35 0.443606651 1.53003629
Kif26a kinesin-like protein KIF26A 4.29 3.58 0.99 4.71 -0.207920124 1.520722315
Pmel melanocyte protein PMEL precursor 11.29 31.31 14.02 41.97 1.394495835 1.516444964
Serpine1 plasminogen activator inhibitor 1 precursor 23.77 46.93 74.12 212.86 0.952335071 1.5093977
Fndc1 fibronectin type III domain-containing protein 8.64 5.15 1.73 6.77 -0.648446736 1.509013647
Stk32c serine/threonine-protein kinase 32C isoform 2 2.04 1.84 0 1.84 -0.098180394 1.50589093
Myl9 myosin regulatory light polypeptide 9 193.68 385.51 52.62 151.07 0.989401061 1.503892445
Gm6498 2.19 2.39 0 1.83 0.087728849 1.500802053
Icam4 intercellular adhesion molecule 4 precursor 2.64 2.04 0 1.83 -0.259867127 1.500802053
Kif26b kinesin-like protein KIF26B 1.7 4.45 7.48 22.95 1.013296823 1.497889486
1500015A07Rik 7.16 36.08 13.82 40.7 2.184000187 1.492501936
Wdr86 WD repeat domain 86 0 1.11 0 1.81 1.077242999 1.49057013
Gm438 hypothetical protein LOC329993 0 1.34 0 1.8 1.22650853 1.485426827
Plcl1 inactive phospholipase C-like protein 1 29.42 52 3.92 12.76 0.800972207 1.483750249
Cd3d T-cell surface glycoprotein CD3 delta chain 1.45 2.34 0 1.79 0.447066353 1.480265122
C2cd4b family with sequence similarity 148, member B 4.21 46.26 7.52 22.76 3.181264352 1.479609501
Tnfrsf11b tumor necrosis factor receptor superfamily 183.14 359.85 74.77 210.09 0.970596203 1.478159582
Creb5 cyclic AMP-responsive element-binding protein 5 100.41 215.57 34.01 96.51 1.094633487 1.477783118
Krt33a keratin, type I cuticular Ha3-I 0.52 0 1.16 5.01 -0.604071324 1.476333679
A630001G21Rik hypothetical protein LOC319997 0 1.14 1.16 5 1.097610797 1.473931188
Shisa4 protein shisa-4 precursor 2.45 3.73 0 1.77 0.455243822 1.469885976
Whrn whirlin isoform 6 20.33 44.98 8.91 26.25 1.1081225 1.459299267
Gli2 zinc finger protein GLI2 90.87 98.42 41.62 115.91 0.113942275 1.455795839
Klhl34 kelch-like protein 34 1.08 4.75 0 1.74 1.466978428 1.454175893
Nppa atrial natriuretic factor 1.73 0 0 1.73 -1.448900951 1.448900951
C2 complement C2 precursor 15.85 104.06 5.32 16.24 2.640392993 1.447763311
Prdm5 PR domain zinc finger protein 5 8.55 9.13 4.33 13.51 0.085061536 1.444840081
Ctf2 cardiotrophin-2 precursor 0 0 0 1.71 0 1.438292852
9430076C15Rik 3.77 16.76 1.69 6.28 1.89657041 1.436332278
2610203C20Rik 13.77 31.63 10.73 30.67 1.143529161 1.432913854
Samd12 sterile alpha motif domain-containing protein 50.34 32.52 13.62 38.46 -0.615061147 1.432447645
Robo1 roundabout homolog 1 precursor 5.52 8.05 16.53 46.13 0.473045828 1.426819685
Efnb3 ephrin-B3 precursor 6.2 7.37 4.41 13.54 0.217230716 1.42632677
Sema3b semaphorin-3B 9.5 20.53 2.08 7.26 1.035958992 1.423211431
Gm8773 1.12 1.49 0 1.66 0.232081478 1.411426246
Cps1 carbamoyl-phosphate synthase [ammonia], 0 0.8 0.24 2.29 0.847996907 1.407747463
Gpnmb transmembrane glycoprotein NMB precursor 55.7 243.45 16.13 44.41 2.108118765 1.406484885
Tex19.2 testis-expressed protein 19.2 0.94 1.16 0 1.65 0.15497466 1.40599236
Hist2h2bb histone H2B type 2-B 0 9.84 2.49 8.22 3.438292852 1.401539714
Phyhd1 phytanoyl-CoA dioxygenase domain-containing 7.53 13.48 3.46 10.77 0.763443956 1.399998705
Efemp2 EGF-containing fibulin-like extracellular matrix 71.92 89.22 13.11 36.23 0.307132725 1.399747628
Grb10 growth factor receptor-bound protein 10 isoform 6.3 9.53 2.67 8.67 0.528537067 1.397735827
Susd3 sushi domain-containing protein 3 2.05 1.66 0 1.63 -0.197382997 1.3950628
Upk1b uroplakin-1b 0 0 0 1.62 0 1.389566812
Kif21b kinesin-like protein KIF21B 38.35 27.06 6.26 18 -0.487848627 1.387957965
Nkd1 protein naked cuticle homolog 1 isoform 1 41.66 14.66 10.61 29.32 -1.445799753 1.384901781
1700028P14Rik hypothetical protein LOC67483 0 0 0 1.61 0 1.384049807
Thy1 thy-1 membrane glycoprotein preproprotein 84.33 301.04 27.86 74.08 1.823614669 1.37935735
Odz3 teneurin-3 isoform 1 23.88 39.14 6.51 18.53 0.690054131 1.378807136
Adamtsl1 ADAMTS-like protein 1 1.22 9.17 3.42 10.49 2.195688098 1.378260523
Fbn2 fibrillin-2 precursor 1.21 3.73 2.82 8.93 1.097793814 1.378221079
Pdlim7 PDZ and LIM domain protein 7 isoform a 95.36 97.04 39.09 103.21 0.024936091 1.378179403
Kirrel kin of IRRE-like protein 1 precursor 79.09 105.38 34.92 92.33 0.409532917 1.377553546
C2cd4a family with sequence similarity 148, member A 4.95 9.11 2.65 8.48 0.764821424 1.376990595
Gm106 RPE-spondin precursor 6.2 20.86 4.22 12.55 1.602224589 1.37617114
Ramp1 receptor activity-modifying protein 1 isoform 3 133.79 153.81 36.26 95.6 0.199785198 1.374395515
Rab6b ras-related protein Rab-6B 56.11 73.85 17.88 47.87 0.390258932 1.37209034
Mfap2 microfibrillar-associated protein 2 46.63 77.49 81.44 212.14 0.720638311 1.370384959
Gpr137c G protein-coupled receptor 137C 0 0 0 1.58 0 1.367371066
Pkd1l3 polycystic kidney disease protein 1-like 3 1.02 2.76 0.46 2.75 0.896377369 1.360922227
Ldoc1 protein LDOC1 0 0 0 1.56 0 1.35614381
Ror2 tyrosine-protein kinase transmembrane receptor 35.7 38.39 15.38 40.84 0.102049354 1.352947495
Mme neprilysin 92.61 62.2 25.63 66.82 -0.566738097 1.348658356
Xkr6 X Kell blood group precursor related family 1.91 1.57 0 1.54 -0.179250794 1.344828497
Dlg4 disks large homolog 4 isoform 1 34.03 38.64 7.61 20.83 0.178365974 1.342226988
Asb16 ankyrin repeat and SOCS box protein 16 0 0 0 1.52 0 1.333423734
Trim9 E3 ubiquitin-protein ligase TRIM9 isoform a 0.26 0.82 0 1.52 0.530514717 1.333423734
Plaur urokinase plasminogen activator surface receptor 8.75 13.42 4.39 12.53 0.564597041 1.327804661
Cyp2a5 cytochrome P450 2A5 0 0 0.59 2.99 0 1.327361981
Procr endothelial protein C receptor 9.55 20.64 6.2 17.05 1.0364575 1.325930025
4930578I06Rik hypothetical protein LOC67750 0 0 0 1.5 0 1.321928095
Haao 3-hydroxyanthranilate 3,4-dioxygenase 0 0 0 1.5 0 1.321928095
Cnksr2 connector enhancer of kinase suppressor of ras 3.05 12.51 0.45 2.62 1.738033862 1.319936797
Prune2 protein prune homolog 2 6.94 8.81 1.65 5.6 0.305114129 1.316473665
Shank1 SH3 and multiple ankyrin repeat domains 1 19.03 32.99 7.57 20.34 0.762947941 1.316193067
Nts neurotensin/neuromedin N 0 5.22 0 1.49 2.63691458 1.316145742
Ccdc60 coiled-coil domain-containing protein 60 3.56 3.66 0.9 3.73 0.03129613 1.315840765
Fhl1 four and a half LIM domains protein 1 isoform 2 134.89 156.56 34.82 88.17 0.213462028 1.31579308
Cntfr ciliary neurotrophic factor receptor subunit 7.86 12.27 43.78 110.4 0.582789767 1.314822799
Phactr1 phosphatase and actin regulator 1 isoform 3 2.75 3.13 1.81 5.98 0.139251186 1.312656906
Wif1 wnt inhibitory factor 1 precursor 136.91 502.54 154.15 384.03 1.868379315 1.311307162
Gcnt1 beta-1,3-galactosyl-O-glycosyl-glycoprotein 8.26 6.65 3.44 9.98 -0.275552446 1.306246473
Pid1 PTB-containing, cubilin and LRP1-interacting 30.94 34.98 3.25 9.51 0.171830874 1.306227923
Nckap5l nck-associated protein 5-like 5.88 11.88 8.19 21.7 0.904652123 1.304555531
Magee2 melanoma antigen, family E, 2 1.39 3.32 0 1.47 0.854020694 1.304511042
Zpbp2 zona pellucida-binding protein 2 isoform 1 2.08 1.24 0 1.47 -0.459431619 1.304511042
Sparc SPARC precursor 3462.6 1983.38 230.49 569.32 -0.803584006 1.300821753
Ano7 anoctamin-7 1.32 1.91 2.97 8.76 0.326894348 1.29774214
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Ccdc68 coiled-coil domain-containing protein 68 6.94 9.11 1.69 5.6 0.348572085 1.294859852
Acot7 cytosolic acyl coenzyme A thioester hydrolase 81.58 97.44 59.66 147.58 0.253452239 1.292422528
Heyl hairy/enhancer-of-split related with YRPW 0.61 0.63 0.62 2.96 0.017811276 1.289506617
Kcnc4 potassium voltage-gated channel subfamily C 11.82 16.27 1.77 5.77 0.429871821 1.289269858
Gda guanine deaminase 61.01 66.08 7.02 18.6 0.113381799 1.289179513
Vegfc vascular endothelial growth factor C precursor 2.15 2.91 0 1.44 0.311816779 1.286881148
Rasl11b ras-like protein family member 11B 19.23 10.82 7.37 19.42 -0.775266284 1.286683338
Acsm3 acyl-coenzyme A synthetase ACSM3, mitochondrial 1.37 4.74 3.37 9.65 1.276163678 1.285148246
Tgif2 homeobox protein TGIF2 5.84 20.16 12.98 32.98 1.629271397 1.281321492
1810024B03Rik hypothetical protein LOC329509 1.35 1.71 0 1.43 0.205632095 1.280956314
Ccdc85a coiled-coil domain-containing protein 85A 5.59 6.96 0 1.43 0.272489966 1.280956314
Dlx4 homeobox protein DLX-4 2.23 0.81 0 1.43 -0.835544468 1.280956314
Cyp21a1 steroid 21-hydroxylase 0 0.5 0.74 3.22 0.584962501 1.278155693
Mettl7a1 methyltransferase-like protein 7A 29.28 29.95 22.38 55.62 0.031574204 1.276036819
Bdh2 3-hydroxybutyrate dehydrogenase type 2 isoform 1.75 3.1 0 1.42 0.576192291 1.275007047
Lzts1 leucine zipper putative tumor suppressor 1 1.58 6.48 4.72 12.83 1.535667204 1.273714104
Rsph4a radial spoke head protein 4 homolog A 25.07 56.16 3.53 9.94 1.132615334 1.272029783
Fblim1 filamin-binding LIM protein 1 16.02 20.48 5.22 14.02 0.335762956 1.271898327
Lgals6 galectin-6 6.57 9.95 6.73 17.66 0.532565665 1.271408667
Slc20a1 sodium-dependent phosphate transporter 1 isoform 33.31 136.72 59.44 144.45 2.005037055 1.266947731
Zc3h12c probable ribonuclease ZC3H12C 17.71 32.87 24.8 61.03 0.856198428 1.265595059
Ndrg1 protein NDRG1 560.51 1094.15 172.8 415.5 0.963744865 1.260888413
Ggt1 gamma-glutamyltranspeptidase 1 precursor 0 0 0 1.39 0 1.257010618
Pcdhb9 protocadherin beta 9 2.42 4.69 0.64 2.91 0.734432327 1.253472793
Tnni1 troponin I, slow skeletal muscle 0 0 0 1.38 0 1.250961574
Tmem88b transmembrane protein 88B 1.87 6.82 1.61 5.21 1.446117871 1.250543462
Sdk1 protein sidekick-1 precursor 14.37 32.6 3.91 10.68 1.128344068 1.250245345
Psd3 PH and SEC7 domain-containing protein 3 isoform 14.56 20.39 11.21 28.03 0.459094422 1.249481372
Igfbp2 insulin-like growth factor-binding protein 2 34.8 54.85 74.9 179.27 0.641597693 1.247987537
Msi1 RNA-binding protein Musashi homolog 1 1.11 1.59 3.8 10.39 0.295709099 1.246661436
Pitpnc1 cytoplasmic phosphatidylinositol transfer 4.06 12.87 3.77 10.31 1.454758498 1.245537758
Klhl35 kelch-like protein 35 1.26 2.43 0 1.37 0.601885804 1.244887059
Mettl7a2 methyltransferase like 7A2 3.92 3.75 2.53 7.36 -0.050730802 1.243834759
Kcnn3 small conductance calcium-activated potassium 3.86 45.31 0.36 2.22 3.252295538 1.243454037
St3gal5 lactosylceramide alpha-2,3-sialyltransferase 1.76 10.68 1.63 5.21 2.081300102 1.239530469
Serpind1 heparin cofactor 2 precursor 0 0 0 1.36 0 1.23878686
Gm1987 predicted gene 1987 1.97 3.5 0.77 3.17 0.59946207 1.236298023
Hpcal4 hippocalcin-like protein 4 0 0.81 0 1.35 0.855989697 1.232660757
Gm8898 KRAB box and zinc finger C2H2 type domain 1.94 4.79 1.49 4.84 0.977747193 1.229822627
Pcdhb11 protocadherin beta 11 2.47 6.27 1.37 4.55 1.067019701 1.227600712
Hsd17b1 estradiol 17-beta-dehydrogenase 1 0 0 0 1.34 0 1.22650853
2810032G03Rik 24.46 20.34 1.99 5.98 -0.254672243 1.223081552
Adamts20 A disintegrin and metalloproteinase with 0 2.06 0.23 1.87 1.613531653 1.222392421
Bves blood vessel epicardial substance 5.42 16.23 0 1.33 1.424277499 1.220329955
Gnao1 guanine nucleotide-binding protein G(o) subunit 5.54 7.48 2.2 6.44 0.374773629 1.217230716
Pdpn podoplanin precursor 6.1 15.95 4.65 12.12 1.255394344 1.215444947
Clec3b tetranectin precursor 68.71 81.32 14.42 34.78 0.239877355 1.214350622
Hhipl1 HHIP-like protein 1 precursor 0 0 1.44 4.66 0 1.213920905
Anxa3 annexin A3 2.67 4.22 1.87 5.63 0.508269744 1.207958133
Csn3 kappa-casein precursor 0 0 0 1.31 0 1.207892852
Amt aminomethyltransferase, mitochondrial precursor 11.52 14.02 4.24 11.08 0.262650251 1.204981738
Sdk2 protein sidekick-2 precursor 86.59 47.84 15.83 37.77 -0.842702969 1.203905558
Dgat2l6 diacylglycerol O-acyltransferase 2-like protein 1.22 4.12 0 1.3 1.205584134 1.201633861
Tspan10 tetraspanin-10 0 0 0 1.3 0 1.201633861
Krt71 keratin, type II cytoskeletal 71 4.35 0.87 3.84 10.13 -1.516500621 1.20137464
Ntrk3 NT-3 growth factor receptor isoform b 0.98 1.82 0 1.29 0.510194732 1.195347598
Phxr4 0 0 0 1.29 0 1.195347598
Tbx1 T-box transcription factor TBX1 983.76 1359.55 153.15 350.89 0.466345909 1.190789627
Hs6st2 heparan-sulfate 6-O-sulfotransferase 2 isoform 1.18 5.73 4.27 11 1.62627837 1.187159539
Ddah2 N(G),N(G)-dimethylarginine 172.7 148.29 39.25 90.63 -0.218480222 1.186831236
Krt8 keratin, type II cytoskeletal 8 6.53 18.61 8.31 20.19 1.380867766 1.186530515
Mylk myosin light chain kinase, smooth muscle 20.72 47.6 5.27 13.2 1.161932211 1.179353582
Mgst2 microsomal glutathione S-transferase 2 14.85 17.19 50.76 116.11 0.198662703 1.17795475
Efhc2 EF-hand domain-containing family member C2 0 0.64 0 1.26 0.713695815 1.176322773
Gm12216 0 0 0 1.26 0 1.176322773
Gprc5d G-protein coupled receptor family C group 5 0 0 0 1.26 0 1.176322773
Pcdhb5 protocadherin beta 5 1.31 1.06 0 1.26 -0.165248514 1.176322773
Pmepa1 transmembrane prostate androgen-induced protein 12.45 22.59 25.44 58.56 0.810569246 1.171621577
Trerf1 transcriptional-regulating factor 1 isoform 1 14.41 27.96 7.46 17.96 0.910194741 1.164229396
Serpina3j serine (or cysteine) peptidase inhibitor, clade 25.58 26.31 35.57 80.94 0.039088209 1.163907266
Hlf hepatic leukemia factor 8.01 23.09 7.99 19.14 1.418835382 1.163670662
AI428936 nesprin-4 0 1.45 0 1.24 1.292781749 1.163498732
Edn2 endothelin-2 precursor 11.99 43.53 35.72 81.25 1.777376181 1.16344962
Usp11 ubiquitin carboxyl-terminal hydrolase 11 20.05 34.82 13.48 31.4 0.766945104 1.161932211
Per2 period circadian protein homolog 2 1.73 4.39 2.68 7.23 0.981384322 1.161186664
Gm14431 KRAB box and zinc finger C2H2 type domain 2.13 5 1.66 4.94 0.938799844 1.159036685
Gm889 hypothetical protein LOC380755 0 2.04 0 1.23 1.604071324 1.15704371
Sh2d4b SH2 domain-containing protein 4B 0 0 0 1.23 0 1.15704371
Dct L-dopachrome tautomerase precursor 20.76 59.2 37.62 85.03 1.46808493 1.155491673
Slc38a2 sodium-coupled neutral amino acid transporter 2 2984.97 4637.41 781.11 1739.44 0.635430678 1.154008644
Nupr1 nuclear protein 1 64.8 118.62 86.82 194.41 0.862299134 1.153882859
1700125H03Rik 0 4.16 5.12 12.61 2.367371066 1.153063509
Ccno cyclin-O 7.99 15.68 6.7 16.12 0.891726268 1.152752351
Lrrn2 leucine rich repeat protein 2, neuronal 0.34 0.65 0 1.22 0.300233024 1.150559677
Rarres2 retinoic acid receptor responder protein 2 49.98 81.15 16 36.52 0.688329202 1.142125081
Klhl13 kelch-like protein 13 7.05 11.9 1.98 5.57 0.680310377 1.14058104
Ccl11 eotaxin precursor 11.5 23.51 3.43 8.76 0.971442389 1.139574449
1700019B03Rik hypothetical protein LOC76406 0 0 0 1.2 0 1.137503524
Ttc7b tetratricopeptide repeat domain 7B 7.21 12.85 3.91 9.79 0.754431849 1.135899935
Mex3a RNA-binding protein MEX3A 5.14 6.01 12.85 29.43 0.191175789 1.135608358
Smoc1 SPARC-related modular calcium-binding protein 1 52.01 5.41 25.37 56.85 -3.047868279 1.133419388
Fxyd1 phospholemman isoform b precursor 12.39 25.64 7.53 17.71 0.992438122 1.133191912
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Tnfsf9 tumor necrosis factor ligand superfamily member 8.46 17.47 8.29 19.36 0.965271778 1.13198706
Syn2 synapsin-2 isoform IIa 0 0 1.41 4.28 0 1.131504783
Esm1 endothelial cell-specific molecule 1 precursor 0 0 0 1.19 0 1.13093087
Vamp1 vesicle-associated membrane protein 1 isoform b 3.93 7.03 7.63 17.88 0.703812341 1.1294263
Ms4a10 membrane-spanning 4-domains subfamily A member 5.09 1.77 1.21 3.83 -1.136556252 1.127976819
Srsf12 serine/arginine-rich splicing factor 12 4.85 7.59 2.64 6.95 0.554221507 1.12701641
Atp6v1b1 V-type proton ATPase subunit B, kidney isoform 26.52 20.63 85.67 188.16 -0.347446805 1.126002437
Hexa beta-hexosaminidase subunit alpha precursor 175.65 184.61 41.94 92.61 0.071380691 1.124340464
5730422E09Rik 0.68 0 0 1.18 -0.748461233 1.124328135
Egfem1 EGF-like and EMI domain-containing protein 1 0 0 0 1.18 0 1.124328135
Snord22 0 35.37 26.81 59.57 5.184677021 1.122999667
Ppp1r14a protein phosphatase 1 regulatory subunit 14A 30.18 30.34 9.66 22.19 0.007384252 1.121295382
Adamts10 12.99 19.27 6.78 15.89 0.534950126 1.118327268
Emcn endomucin isoform 1 3.21 6.05 0 1.17 0.743803024 1.117695043
Tas1r1 taste receptor type 1 member 1 precursor 1.04 0.51 0 1.17 -0.434020603 1.117695043
Rgs16 regulator of G-protein signaling 16 6.39 14.76 6.41 15.07 1.092621265 1.116824481
BC005764 28.6 27.09 19.53 43.52 -0.075540551 1.116719965
Ampd3 AMP deaminase 3 202.65 183.33 33.76 74.32 -0.143800923 1.115604918
Gm5506 hypothetical protein LOC433182 12.4 44.28 24.53 54.2 1.756640957 1.112474729
Krt33b keratin, type I cuticular Ha3-II 0 0 0 1.16 0 1.111031312
Srpx sushi-repeat-containing protein SRPX precursor 17.14 25.69 3.09 7.83 0.55712485 1.110312595
Ager advanced glycosylation end product-specific 1.28 3.65 0.83 2.94 1.028196892 1.106351981
Slc6a17 sodium-dependent neutral amino acid transporter 3.48 3.24 1.24 3.82 -0.079434467 1.105534414
Trps1 zinc finger transcription factor Trps1 34.69 72.75 26.57 58.28 1.047123148 1.10444618
Mfap4 microfibril-associated glycoprotein 4 precursor 61.8 113.39 19.28 42.53 0.865124473 1.101952368
Clip3 CAP-Gly domain-containing linker protein 3 2.87 4.58 0.72 2.69 0.527931556 1.101212251
Mtap1b microtubule-associated protein 1B 12.39 29.04 25.53 55.87 1.165728852 1.100043129
Nhs Nance-Horan syndrome protein 4.52 6.33 7.23 16.64 0.409144931 1.099886225
Inpp5j phosphatidylinositol 4,5-bisphosphate 8.92 8.13 1.19 3.69 -0.11972526 1.098657053
Fjx1 four-jointed box protein 1 precursor 57.23 105.25 28.26 61.62 0.867628317 1.097693739
1200009I06Rik exocyst complex component 3-like protein 4 2.32 4.52 3.9 9.47 0.733485025 1.095407788
Fscn1 fascin 29.84 39.34 17.95 39.45 0.387408319 1.093941854
Hectd2 probable E3 ubiquitin-protein ligase HECTD2 19.35 17.37 4.35 10.41 -0.147677168 1.092687995
Arhgef15 rho guanine nucleotide exchange factor 15 1.53 1.75 0.61 2.43 0.120294234 1.091147888
Ebf4 transcription factor COE4 17.92 10.69 1.99 5.35 -0.694637159 1.086611107
Foxi3 forkhead box protein I3 15.87 4.78 22.64 49.2 -1.545318576 1.086457329
Chst11 carbohydrate sulfotransferase 11 76.13 70.16 34.8 75 -0.1162256 1.086039831
Sdc3 syndecan-3 precursor 46.06 32.05 30.1 65.01 -0.509851049 1.085770018
Kitl kit ligand precursor 134.33 124.65 77.66 165.85 -0.107071021 1.084849595
Astn2 astrotactin-2 isoform b 0 0 0 1.12 0 1.084064265
C1qtnf2 complement C1q tumor necrosis factor-related 2.72 5.41 0 1.12 0.785021736 1.084064265
Slc7a3 cationic amino acid transporter 3 0 0.64 0 1.12 0.713695815 1.084064265
Sfxn4 sideroflexin-4 7.3 13.03 2.12 5.61 0.757331767 1.083104243
Espn espin isoform 1 10.15 7.58 5.05 11.81 -0.377994157 1.082263428
Dleu2 51.12 64.52 17.93 39.03 0.330098273 1.080407205
Tubb6 tubulin beta-6 chain 17.12 63.24 34.14 73.24 1.825888937 1.079082519
Fam110c family with sequence similarity 110, member C 23.76 19.74 14.86 32.49 -0.25559542 1.078337605
Lrat lecithin retinol acyltransferase 1.22 1.5 0.53 2.23 0.171368418 1.078002512
Kera keratocan precursor 2.49 3.24 0 1.11 0.280837228 1.077242999
Tm6sf2 transmembrane 6 superfamily member 2 0 0 0 1.11 0 1.077242999
Tmc1 transmembrane channel-like protein 1 1.22 2.35 0 1.11 0.593601419 1.077242999
Cd248 endosialin precursor 9.25 14.52 2.06 5.45 0.598504648 1.075767508
Slc39a8 zinc transporter ZIP8 197.69 189.68 82.32 174.62 -0.059365734 1.075722407
Akr1cl aldo-keto reductase family 1, member C-like 0 2.27 1.89 5.09 1.709290636 1.075372735
Tgm3 protein-glutamine gamma-glutamyltransferase E 4 11.49 1.1 3.42 1.320773477 1.073657042
Plscr1 phospholipid scramblase 1 1.97 1.95 1.89 5.08 -0.009747977 1.073001831
Tbc1d24 TBC1 domain family member 24 isoform b 9.26 15.12 3.77 9.02 0.651821013 1.070821337
Bdkrb2 B2 bradykinin receptor 0 0 0 1.1 0 1.070389328
Foxj1 forkhead box protein J1 0 1.03 0 1.1 1.021479727 1.070389328
Hist2h3b histone H3.2 4.21 4.3 1.7 4.67 0.024708987 1.070389328
S100a3 protein S100-A3 62.48 68.75 10.92 24.03 0.135891089 1.070274055
Ankrd6 ankyrin repeat domain-containing protein 6 14.05 12.97 7.04 15.87 -0.107431466 1.069192567
Slc6a6 sodium- and chloride-dependent taurine 1011.39 1103.17 128.17 269.88 0.125197147 1.068382838
G530011O06Rik 1.15 3.92 1.68 4.62 1.194321656 1.06833713
Tsga10 testis-specific gene 10 protein 5.47 5.82 1.48 4.2 0.076006027 1.068171503
Npr3 atrial natriuretic peptide receptor 3 isoform a 1.26 0.86 5.92 13.5 -0.281020151 1.067208957
Plekhg1 pleckstrin homology domain containing, family G 15.8 25.97 15.49 33.51 0.682894289 1.065423075
Ptprz1 receptor-type tyrosine-protein phosphatase zeta 1.22 2.96 7.1 15.95 0.834940754 1.06529146
Lonrf2 LON peptidase N-terminal domain and RING finger 0 0.44 0.3 1.72 0.526068812 1.065095028
Tac4 tachykinin-4 precursor 0 1.32 0 1.09 1.214124805 1.063502942
Lamb1 laminin subunit beta-1 41.04 68.74 53.21 112.17 0.730223695 1.061860656
Awat1 acyl-CoA wax alcohol acyltransferase 1 14.22 14.39 4.87 11.21 0.016024873 1.056630792
Slc45a2 membrane-associated transporter protein 0.85 0 0 1.08 -0.887525271 1.056583528
Ptpla 3-hydroxyacyl-CoA dehydratase 1 isoform 1 27.87 31.83 5.63 12.79 0.185443642 1.056541681
Serpinb6d serine (or cysteine) peptidase inhibitor, clade 10.24 5.57 4.28 9.98 -0.77467676 1.05626822
AI593442 hypothetical protein LOC330941 isoform 2 0 1.59 0.78 2.7 1.372952098 1.05564803
Mettl7b methyltransferase-like protein 7B precursor 0 1.24 10.77 23.4 1.163498732 1.051766827
Ccl20 C-C motif chemokine 20 isoform 2 0 12.8 18.46 39.31 3.786596362 1.050626073
Cyp2a4 cytochrome P450 2A4 0 0 0 1.07 0 1.049630768
Fut4 alpha-(1,3)-fucosyltransferase 0.99 1.03 0 1.07 0.028711297 1.049630768
Plekhb1 pleckstrin homology domain-containing family B 1.47 3.7 2.06 5.32 0.928149715 1.046392905
Arhgef19 rho guanine nucleotide exchange factor 19 141.71 193.56 78.73 163.56 0.447128703 1.045419125
Ddx26b protein DDX26B 83.73 141.26 48.87 101.89 0.747585294 1.044858664
Srgap3 SLIT-ROBO Rho GTPase-activating protein 3 10.99 5.85 4.17 9.66 -0.807655766 1.043971252
Hist1h2bq H2b histone family, member A 0.35 1.27 1.14 3.41 0.74973289 1.043167859
Hist1h2br histone cluster 1 H2br 0.35 1.27 1.14 3.41 0.74973289 1.043167859
Apol7a apolipoprotein L 7a 1.37 2.54 0 1.06 0.578862301 1.042644337
Tmsb15l Tmsb15b1-Tmsb15b2 readthrough transcript 22.66 20.41 9.88 21.38 -0.144165278 1.04053148
Lce1a2 small proline rich-like 2 6.48 9.51 4.81 10.95 0.490652494 1.040400549
Sox4 transcription factor SOX-4 38.03 53.51 106.78 220.68 0.481937458 1.040389124
Nrip3 nuclear receptor-interacting protein 3 104.7 84.29 33.34 69.6 -0.309526872 1.039778144
Lrp3 low density lipoprotein receptor-related protein 1.73 2.52 1.81 4.77 0.366674478 1.038001188
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Wnt9a protein Wnt-9a precursor 3.63 6.32 2.08 5.32 0.660831455 1.036994207
Basp1 brain acid soluble protein 1 12.29 16.11 40.61 84.37 0.364498655 1.036798891
Fbln2 fibulin-2 isoform b 150.07 112.24 14.59 30.98 -0.415833539 1.036549011
Mapk15 mitogen-activated protein kinase 15 4.81 5.94 2.16 5.48 0.256397499 1.036069255
Hepacam2 HEPACAM family member 2 precursor 0.81 0.7 0 1.05 -0.090454951 1.03562391
Omd osteomodulin precursor 1.33 2.12 0 1.05 0.421216074 1.03562391
2210404O07Rik transmembrane protein C19orf77 homolog 9.25 18.27 7.62 16.67 0.910732662 1.035542265
Gmpr GMP reductase 1 3.06 7.07 3.8 8.82 0.991088946 1.032688619
Gpx7 glutathione peroxidase 7 precursor 1.59 3.87 2.67 6.5 0.910969674 1.031110533
Xlr3a X-linked lymphocyte-regulated protein 3A 1.09 2.86 0.67 2.41 0.885097905 1.029923637
Ccdc3 coiled-coil domain-containing protein 3 690.23 1663.94 160.91 329.3 1.268232449 1.028584876
Sp5 transcription factor Sp5 0 0 0 1.04 0 1.028569152
Spo11 meiotic recombination protein SPO11 isoform b 0 0 2.56 6.26 0 1.028092307
2700046A07Rik 1.36 2.62 3.81 8.79 0.617202838 1.025271966
Dnajb13 dnaJ homolog subfamily B member 13 0 1.74 1.18 3.43 1.454175893 1.022978564
Lmtk3 serine/threonine-protein kinase LMTK3 precursor 1.69 2.3 0.89 2.84 0.294859852 1.022720077
Vsig8 7.32 9.01 1.53 4.14 0.266786541 1.022630974
9930012K11Rik hypothetical protein LOC268759 isoform 2 3.65 5.94 8.63 18.51 0.577704947 1.018606075
4930550C14Rik hypothetical protein LOC75311 3.31 2.54 4.81 10.75 -0.283938509 1.016050688
Mdga1 MAM domain-containing 5.49 10.3 1.81 4.68 0.800032389 1.015320799
Tcp11l1 T-complex protein 11-like protein 1 7.62 10.07 2.77 6.62 0.360895448 1.015226474
Cd69 early activation antigen CD69 1.07 2.16 0 1.02 0.610293791 1.014355293
C1ra complement C1r-A subcomponent precursor 21.62 40.71 3.72 8.53 0.882794383 1.013689355
Icam1 intercellular adhesion molecule 1 precursor 129.26 164.56 194.27 392.8 0.345960022 1.011992791
Cald1 caldesmon 1 195.2 377.77 104.65 212.05 0.948997027 1.011899284
Penk proenkephalin-A 4.69 9.82 3.32 7.7 0.927199942 1.009984089
Id2 DNA-binding protein inhibitor ID-2 2174.28 1606.45 222.14 447.97 -0.436427252 1.008669894
Pdgfd platelet-derived growth factor D 3.82 8.94 0 1.01 1.044212705 1.007195501
Tyr tyrosinase precursor 0.49 1.55 1.44 3.9 0.775184916 1.005900601
Slc1a4 neutral amino acid transporter A 18.48 20.1 9.17 19.42 0.115249322 1.005663187
Ly6c1 lymphocyte antigen 6C2 precursor 40.65 67.15 12.28 25.66 0.710397161 1.005421634
Cyp2d22 cytochrome P450, family 2, subfamily d, 62.98 44.22 7.9 16.86 -0.50066 1.004854839
A430110N23Rik soluble scavenger receptor cysteine-rich 4.38 10.51 0.68 2.37 1.097209756 1.004287358
Cd302 CD302 antigen 6.71 12.64 4.8 10.63 0.823040879 1.003726291
Plod2 procollagen-lysine,2-oxoglutarate 5-dioxygenase 3.01 3.42 3.97 8.96 0.140444133 1.002899891
Hoxd8 homeobox protein Hox-D8 117.76 118.48 17.96 36.97 0.008720144 1.001901035
Inhbb inhibin beta B chain precursor 121.35 99.19 57.34 115.83 -0.288275582 1.001853491
Sat2 diamine acetyltransferase 2 7.33 4.62 1.89 4.78 -0.567746365 1
Arid3b AT-rich interactive domain-containing protein 4.11 5.07 0.74 2.48 0.248373225 1
Cdk15 cyclin-dependent kinase 15 0 0 0 1 0 1
Pla1a phospholipase A1 member A precursor 1.21 0 0 1 -1.14404637 1
Stx1b syntaxin-1B 0 0 0 1 0 1
Wnt2 protein Wnt-2 precursor 0 0 0 1 0 1
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Bulge Down
GENE Description WT Bulge KO Bulge WT HG KO HG Log2 KO Bulge/WT Bulge Log2 KO HG/WT HG
Mir5114 70.08 0 0 79.43 -6.151371776 6.329661815
Skint4 selection and upkeep of intraepithelial T-cells 86.55 0.44 142.39 0 -5.925966462 -7.163800604
Mir568 43.3 0 0 0 -5.469234794 0
Krt13 keratin, type I cytoskeletal 13 89.24 1.22 30.2 0.85 -5.345135486 -4.075948853
Cck cholecystokinin preproprotein 207.3 4.29 3.43 3.04 -5.299251307 -0.132951406
Mir1306 36.97 0 45.16 0 -5.246788094 -5.528571319
Krt27 keratin, type I cytoskeletal 27 123.6 2.32 42.75 11.95 -5.229977017 -1.756330919
Mir5122 34.36 0 0 28.32 -5.14404637 4.873813198
St6galnac5 alpha-N-acetylgalactosaminide 69.99 1.48 2.37 1.99 -4.839203788 -0.172603107
Mir671 27.61 0 25.04 0 -4.838447593 -4.702657543
Sval2 seminal vesicle antigen-like 2 21.01 0 11.13 0 -4.46008724 -3.600507645
Gdf10 bone morphogenetic protein 3B precursor 63.64 2.64 4.1 2.73 -4.150416843 -0.451321617
Myoc myocilin precursor 586.87 35.65 33.32 3.58 -4.003612053 -2.905630049
Krt24 keratin, type I cytoskeletal 24 1264.3 83.79 5.59 4.86 -3.89944155 -0.169377801
Skint9 selection and upkeep of intraepithelial T-cells 12.04 0 46.94 0 -3.704871964 -5.583158004
Rpl34-ps1 ribosomal protein L34, pseudogene 1 14.04 0.29 13.07 23 -3.543361596 0.770412077
Slc43a1 large neutral amino acids transporter small 78.39 6.56 47.05 43.55 -3.392499157 -0.109110999
Skint3 selection and upkeep of intraepithelial T-cells 8.72 0 214.86 0 -3.280956314 -7.753952119
AA465934 8.04 0 8.1 7.15 -3.176322773 -0.159066486
Camk4 calcium/calmodulin-dependent protein kinase type 43 4.01 4.33 4.99 -3.134621015 0.16842047
Ltbp2 latent-transforming growth factor beta-binding 376.86 42.65 19.33 32.97 -3.113798245 0.740651003
Smoc1 SPARC-related modular calcium-binding protein 1 52.01 5.41 25.37 56.85 -3.047868279 1.133419388
Ccrl1 C-C chemokine receptor type 11 857.26 109.4 518.48 150.46 -2.95867459 -1.778131373
Dpysl4 dihydropyrimidinase-related protein 4 6.77 0 2.29 0 -2.957914599 -1.718087584
Lrrc18 leucine-rich repeat-containing protein 18 18.74 1.61 4.89 1.42 -2.919000278 -1.283260587
Ngef ephexin-1 isoform 1 85.59 10.71 13.49 6.07 -2.886459347 -1.035275475
BB123696 5.95 0 1.29 0 -2.797012978 -1.195347598
Scn5a sodium channel protein type 5 subunit alpha 5.85 0 1.27 0.16 -2.776103988 -0.968567492
6030419C18Rik hypothetical protein LOC319477 28.39 3.36 5.7 4.66 -2.752925319 -0.243359043
Ptchd3 patched domain-containing protein 3 5.59 0 1.37 0 -2.720278465 -1.244887059
Il3ra interleukin-3 receptor subunit alpha precursor 19.46 2.24 14.9 2.89 -2.658740427 -2.031184705
Hist1h4c histone H4 5.25 0 2.27 0.55 -2.64385619 -1.07702242
Gfra1 GDNF family receptor alpha-1 precursor 238.92 38.03 29.12 12.89 -2.619898059 -1.116675171
Adora2a adenosine receptor A2a 31.78 4.36 9.39 1.96 -2.612510949 -1.811526573
Abcb1b multidrug resistance protein 1 23.35 3.01 14.33 4.89 -2.602247631 -1.380018158
Tmem196 transmembrane protein 196 4.65 0 0 0 -2.498250868 0
Serpina9 serpin A9 precursor 4.55 0 3.79 1.49 -2.472487771 -0.943879914
Krt2 keratin, type II cytoskeletal 2 epidermal 4.54 0 1.25 0.5 -2.469885976 -0.584962501
Wdfy4 WD repeat and FYVE domain containing 4 7.74 0.62 0.55 0.2 -2.431639467 -0.36923381
1110032A04Rik small subunit of serine palmitoyltransferase B 4.17 0 5.73 6.5 -2.370164281 0.156284091
Xcl1 lymphotactin precursor 4.15 0 0 0 -2.364572432 0
1700019D03Rik hypothetical protein LOC67080 65.33 12.34 1.52 3.4 -2.313902859 0.80407979
Aass alpha-aminoadipic semialdehyde synthase, 8.15 0.85 1.24 0.44 -2.306246473 -0.637429921
Htr1b 5-hydroxytryptamine receptor 1B 3.84 0 0 0 -2.275007047 0
AI506816 3.78 0 3.26 5.75 -2.257010618 0.664034072
Trpc1 short transient receptor potential channel 1 19.48 3.3 2.77 1.98 -2.25180715 -0.339252193
Crp C-reactive protein precursor 3.72 0 0 0 -2.23878686 0
Lhb lutropin subunit beta precursor 3.71 0 0 0 -2.23572706 0
Ecm1 extracellular matrix protein 1 precursor 2342.99 500.06 379.66 164.88 -2.225911139 -1.198363026
Tll1 tolloid-like protein 1 precursor 13.34 2.07 6.03 4.59 -2.223734463 -0.330676406
Arsi arylsulfatase I precursor 14.94 2.43 3.26 4.48 -2.216371148 0.363322463
Cybrd1 cytochrome b reductase 1 21.3 3.82 4.82 2 -2.209938659 -0.956056652
Htr1d 5-hydroxytryptamine receptor 1D 11.37 1.68 7.89 3.98 -2.206540595 -0.836037677
Tspan8 tetraspanin 8 91.55 19.31 20.1 15.08 -2.18804275 -0.391975592
Pvt1 22.44 4.26 13.41 4.51 -2.155837865 -1.386946112
Chst13 carbohydrate sulfotransferase 13 22.17 4.26 3.56 2.06 -2.13912334 -0.575502171
Spink2 serine protease inhibitor Kazal-type 2 149.27 33.34 3.71 3.61 -2.129595073 -0.030960309
Tbc1d30 TBC1 domain family member 30 8.25 1.13 2.91 3.13 -2.118599935 0.078973174
Zdhhc2 palmitoyltransferase ZDHHC2 103.93 23.31 13.9 7.26 -2.109805412 -0.851098644
Anpep aminopeptidase N 88.48 20.29 243.89 109.22 -2.071389307 -1.151747831
BC028528 hypothetical protein LOC229600 precursor 3.17 0 0 0 -2.060047384 0
Upp1 uridine phosphorylase 1 22.11 4.65 7.69 2.85 -2.032194487 -1.174497731
Arrdc3 arrestin domain-containing protein 3 432.41 105.03 556.93 311.91 -2.031259924 -0.834336362
Unc79 protein unc-79 homolog 22.05 4.68 7.68 4.02 -2.020803916 -0.790007678
C1ql3 complement C1q-like protein 3 precursor 6.56 0.88 0.48 0.23 -2.007653573 -0.26693886
Abcc3 canalicular multispecific organic anion 30.21 6.81 9.63 5.52 -1.998613904 -0.705197727
Fam83a hypothetical protein LOC239463 33.26 7.63 76.28 60.95 -1.989092687 -0.318990812
Odf3l1 outer dense fiber protein 3-like protein 1 11.94 2.28 2.06 1.66 -1.980069897 -0.202105407
BC100530 stefin A-like protein 2.87 0 0 0 -1.952333566 0
Slc27a3 long-chain fatty acid transport protein 3 285.11 73.18 67.77 40.79 -1.94746775 -0.718621587
Cish cytokine-inducible SH2-containing protein 349.56 90.48 463.92 185.62 -1.938133119 -1.316878882
7420461P10Rik hypothetical protein LOC100038657 4.2 0.36 0.3 0 -1.934904972 -0.378511623
Slc7a2 low affinity cationic amino acid transporter 2 16.59 3.66 172.68 53.29 -1.916353623 -1.677673242
1700056E22Rik hypothetical protein LOC73363 2.76 0 4.01 3.36 -1.910732662 -0.200482468
Pik3r1 phosphatidylinositol 3-kinase regulatory subunit 430.77 114.64 239.99 179.09 -1.900622492 -0.420255209
Npnt nephronectin isoform b 482.66 129.76 139.8 142.86 -1.887071946 0.031018175
Cntn5 contactin-5 isoform 1 2.68 0 0.47 0 -1.879705766 -0.555816155
Dmrtc1a doublesex- and mab-3-related transcription 2.66 0 0 0 -1.871843649 0
Usp18 ubl carboxyl-terminal hydrolase 18 35.04 8.89 3.96 3.53 -1.865556585 -0.13082907
Mmp2 72 kDa type IV collagenase precursor 365.91 100.58 84.03 66.66 -1.852809846 -0.329668761
Nptx1 neuronal pentraxin-1 precursor 12.36 2.7 1.11 1.06 -1.852322832 -0.034598662
Adh7 alcohol dehydrogenase class 4 mu/sigma chain 526.18 145.22 473.24 223.87 -1.850154982 -1.076526149
Rps23 40S ribosomal protein S23 34.89 9.01 40.6 67.51 -1.842139949 0.719731057
Slc15a1 solute carrier family 15 member 1 67.44 18.2 116.55 63.9 -1.833733449 -0.856984156
Slc34a3 sodium-dependent phosphate transport protein 2C 2.56 0 0 0 -1.831877241 0
Tns1 tensin 1 448 125.41 165.48 68.25 -1.828604849 -1.265462894
Fut4-ps1 2.55 0 2.94 0 -1.827819025 -1.97819563
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Fhit bis(5'-adenosyl)-triphosphatase 52.32 14.08 20.33 30.95 -1.822040352 0.582931965
Kcnk2 potassium channel subfamily K member 2 isoform 334.81 94.09 10.47 18.04 -1.820279657 0.731168087
Gng4 guanine nucleotide-binding protein 19.89 4.94 2.93 2.88 -1.814277656 -0.01847266
Fam55d hypothetical protein LOC244853 7.22 1.34 5.66 3.72 -1.812629864 -0.496735318
Eda2r tumor necrosis factor receptor superfamily 2.51 0 22.69 5.16 -1.811471031 -1.943275943
Art5 ecto-ADP-ribosyltransferase 5 precursor 2.5 0 0.65 0 -1.807354922 -0.722466024
Ccl12 C-C motif chemokine 12 precursor 2.5 0 0 0 -1.807354922 0
Itih5 inter-alpha-trypsin inhibitor heavy chain H5 22.9 5.86 40.43 35.21 -1.800730137 -0.194287644
Adig adipogenin 2.46 0 3.63 5.45 -1.790772038 0.478286967
Mesp2 mesoderm posterior protein 2 12.07 2.8 15.3 5.79 -1.782187817 -1.263388485
Spsb4 SPRY domain-containing SOCS box protein 4 2.43 0 10.23 9.22 -1.778208576 -0.135962731
Rtn4rl1 reticulon-4 receptor-like 1 precursor 41.11 11.29 17.64 18.64 -1.77667796 0.07539307
Prickle2 prickle-like protein 2 isoform b 143.12 41.27 74.35 47.58 -1.769564539 -0.633245022
Pld1 phospholipase D1 58.33 16.43 25.39 14.98 -1.767189213 -0.723723942
Smpdl3b acid sphingomyelinase-like phosphodiesterase 3b 72.51 20.6 51.11 33.19 -1.766909209 -0.607985832
Rnf182 E3 ubiquitin-protein ligase RNF182 8.05 1.68 1.94 1.05 -1.755684792 -0.520192245
Rad54l DNA repair and recombination protein RAD54-like 12.06 2.87 27.63 19.37 -1.754749425 -0.49108169
Mfge8 lactadherin isoform 2 564.59 166.67 69.62 113.07 -1.754132032 0.691770692
Gm5084 11.47 2.71 17.1 5.88 -1.748970373 -1.395509227
Tmem171 transmembrane protein 171 2.35 0 1.53 0 -1.744161096 -1.339137385
Emilin3 EMILIN-3 22.8 6.11 3.14 1.23 -1.743040109 -0.892587058
Mmp15 matrix metalloproteinase-15 precursor 28.98 7.99 38.92 25.78 -1.737607362 -0.57595576
Gulo L-gulonolactone oxidase 47.21 13.53 7.75 7.29 -1.730297727 -0.077910915
Dclk1 serine/threonine-protein kinase DCLK1 isoform 7 30.3 8.45 50.88 16.33 -1.727776423 -1.581906825
Cstad CSA-conditional, T cell activation-dependent 2.31 0 2.01 2.33 -1.726831217 0.14575869
Ppp1r3c protein phosphatase 1 regulatory subunit 3C 34.1 9.65 1.13 1.9 -1.7206176 0.44519947
Krtap3-2 keratin-associated protein 3-2 2.26 0 2.8 0 -1.704871964 -1.925999419
Grik1 glutamate receptor, ionotropic kainate 1 isoform 24.91 6.95 2.74 0.75 -1.70448225 -1.095683348
BC048671 hypothetical protein LOC243535 2.24 0 0 0 -1.695993813 0
Slc2a3 solute carrier family 2, facilitated glucose 12.27 3.1 5.18 2.6 -1.694472556 -0.779609932
4732415M23Rik hypothetical protein LOC320869 2.23 0 0 0 -1.691534165 0
Fads6 fatty acid desaturase 6 5.97 1.17 2.87 0 -1.683463613 -1.952333566
Apobec1 C->U-editing enzyme APOBEC-1 isoform 2 11.87 3.01 28.75 12.79 -1.682337912 -1.109267212
6430531B16Rik hypothetical protein LOC381933 2.19 0 0.99 1.7 -1.673556424 0.440190977
Ccdc88c protein Daple 19.95 5.57 19.54 10.25 -1.672984968 -0.86851118
Chrm3 muscarinic acetylcholine receptor M3 2.18 0 1.74 0 -1.669026766 -1.454175893
Ednra endothelin-1 receptor precursor 105.99 32.65 26.46 20.52 -1.668797549 -0.351653548
Eng endoglin isoform 2 30.08 8.79 17.43 17.47 -1.666605739 0.003127795
Tsc22d3 TSC22 domain family protein 3 isoform 1 505.75 158.74 537.46 207.35 -1.665548565 -1.369830077
Wnt7a protein Wnt-7a precursor 2.15 0 7.41 9.22 -1.655351829 0.281217491
Maf transcription factor Maf 251.41 79.78 66.41 47.1 -1.643699017 -0.486925731
Fam159b membrane protein FAM159B 2.11 0 2.99 1.2 -1.63691458 -0.858885223
D030025P21Rik 5.46 1.09 0.3 0.64 -1.628031223 0.335184192
A330069E16Rik 2.09 0 2.22 2.21 -1.627606838 -0.004487391
Msrb2 methionine-R-sulfoxide reductase B2, 23.36 6.92 16.33 9.15 -1.620941798 -0.771791927
Chac1 cation transport regulator-like protein 1 8.84 2.2 2.59 0 -1.62058641 -1.843983844
Tspan2 tetraspanin-2 45.87 14.27 10.71 12.09 -1.617964733 0.160724021
Mettl13 methyltransferase-like protein 13 82.24 26.12 31.25 25.63 -1.617919787 -0.276246732
Zfp365 protein ZNF365 38.87 11.99 55.67 26.11 -1.617902175 -1.063760089
H60b histocompatibility 60b 2.06 0 5.75 0 -1.613531653 -2.754887502
Steap4 metalloreductase STEAP4 615.44 201.56 371.58 142.06 -1.60561117 -1.380929886
Tmem28 transmembrane protein FAM155B 2.04 0 0 0 -1.604071324 0
Ccdc113 coiled-coil domain-containing protein 113 7.83 1.91 2.49 2.26 -1.601394285 -0.098355072
Gjd3 gap junction delta-3 protein 2.03 0 2.91 0 -1.599317794 -1.967168608
1700108M19Rik hypothetical protein LOC71156 isoform 2 2.02 0 2.61 2.57 -1.59454855 -0.016074763
Tmprss7 transmembrane protease serine 7 isoform 2 4.66 0.88 9.43 5.84 -1.590069391 -0.608670928
Clec2d C-type lectin domain family 2 member D 627.29 209.41 512.72 222.92 -1.578227346 -1.197998849
Crybb3 beta-crystallin B3 1.98 0 0 0 -1.575312331 0
Itm2a integral membrane protein 2A 286.47 95.82 17.09 19.48 -1.570034407 0.179023307
Sec14l2 SEC14-like protein 2 23.54 7.27 25.07 20.01 -1.569176014 -0.311314421
Skint11 selection and upkeep of intraepithelial T-cells 5.29 1.12 4.84 0 -1.568995752 -2.545968369
Slc16a14 monocarboxylate transporter 14 19.1 5.8 49.51 21.1 -1.56358885 -1.192522672
Nlrp10 NACHT, LRR and PYD domains-containing protein 27.41 8.65 47.73 29.58 -1.557797984 -0.672221816
Rnd1 rho-related GTP-binding protein Rho6 precursor 30.6 9.74 32.79 14.04 -1.556930565 -1.167791783
Lnx1 E3 ubiquitin-protein ligase LNX isoform 1 23.97 7.49 6.7 6.16 -1.556359362 -0.104898858
Ptpru receptor-type tyrosine-protein phosphatase U 45.53 14.86 36.8 62.27 -1.552768416 0.743135361
Slc38a5 sodium-coupled neutral amino acid transporter 5 4.56 0.9 6.21 10.33 -1.549085464 0.652076697
Fbxl7 F-box/LRR-repeat protein 7 6.21 1.47 1.54 1.19 -1.545488218 -0.213897627
Foxi3 forkhead box protein I3 15.87 4.78 22.64 49.2 -1.545318576 1.086457329
Acss1 acetyl-coenzyme A synthetase 2-like, 11.6 3.32 21.72 10.34 -1.544320516 -1.002542195
Rapgef4 rap guanine nucleotide exchange factor 4 isoform 50.81 16.78 11.37 12.14 -1.542975259 0.087119775
1810062G17Rik hypothetical protein LOC72282 1.89 0 5.25 2.37 -1.531069493 -0.891107598
Hist1h4b histone H4 1.89 0 1.91 0.42 -1.531069493 -1.035128223
Gdf5 growth/differentiation factor 5 precursor 1.88 0 6.24 1.12 -1.526068812 -1.771925433
Sncg gamma-synuclein 147.54 50.62 5.65 12.08 -1.524849437 0.975936295
Cldn20 claudin-20 1.87 0 0 0 -1.521050737 0
Gm13306 chemokine (C-C motif) ligand 27b isoform 2 495.12 172.29 731.31 307.99 -1.517500714 -1.244894348
Tbc1d2 TBC1 domain family, member 2 59.72 20.21 19.16 13.93 -1.51742717 -0.433281473
Krt71 keratin, type II cytoskeletal 71 4.35 0.87 3.84 10.13 -1.516500621 1.20137464
Actr3b actin-related protein 3B 1.86 0 1.29 1.28 -1.516015147 -0.006313774
Rbm46 probable RNA-binding protein 46 1.85 0 0 0 -1.510961919 0
1700030C10Rik 5.32 1.22 8.3 1.58 -1.509364882 -1.849859651
Aqp9 aquaporin-9 8.96 2.5 14.25 6.68 -1.50879082 -0.989631027
Il10 interleukin-10 precursor 1.84 0 0 0 -1.50589093 0
Fzd9 frizzled-9 precursor 10.31 2.99 1.72 0 -1.503138278 -1.443606651
Spock2 testican-2 precursor 29.61 9.81 26.18 17.46 -1.501636522 -0.558142903
Scg3 secretogranin-3 isoform 2 precursor 1.82 0 0 0 -1.495695163 0
Fcgbp Fc fragment of IgG binding protein 1038.06 368.87 1130.6 611.4 -1.49018877 -0.885817894
Tox thymocyte selection-associated high mobility 6.33 1.63 3.94 3.55 -1.478750399 -0.118644496
Ugt1a1 UDP-glucuronosyltransferase 1-1 55.22 19.23 109.82 61.32 -1.474587134 -0.830451134
Col8a2 collagen alpha-2(VIII) chain precursor 776.45 279.02 60.27 30.7 -1.473220021 -0.950698011
Cacna2d2 voltage-dependent calcium channel subunit 11.18 3.39 7.05 2.34 -1.472221288 -1.269140681
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Fam13a family with sequence similarity 13, member A1 61.5 21.53 59.7 59.61 -1.472008876 -0.002140674
Mc5r melanocortin receptor 5 1.77 0 26.7 17.29 -1.469885976 -0.598830901
Grem1 gremlin-1 precursor 755.7 273.5 279.66 68.27 -1.462915296 -2.018520885
Cyp4b1 cytochrome P450 4B1 243.35 87.84 355.9 155.16 -1.459667807 -1.192494943
Gjb6 gap junction beta-6 protein 6.68 1.8 81.6 22.37 -1.455679484 -1.821484048
9530053A07Rik Fc fragment of IgG binding protein-like 51.01 18 55.02 28.21 -1.452789619 -0.939479625
Frmd4a FERM domain-containing protein 4A isoform 3 50.59 17.86 38.3 38.48 -1.45176177 0.006592677
Nppa atrial natriuretic factor 1.73 0 0 1.73 -1.448900951 1.448900951
Sox5 transcription factor SOX-5 isoform a 1.73 0 4.66 2.4 -1.448900951 -0.735267307
Nkd1 protein naked cuticle homolog 1 isoform 1 41.66 14.66 10.61 29.32 -1.445799753 1.384901781
LOC668917 1.72 0 0 0 -1.443606651 0
Stfa1 stefin-1 1.72 0 0 3.69 -1.443606651 2.229587923
Ctgf connective tissue growth factor precursor 9132.35 3366.87 1364.35 944.78 -1.439307669 -0.529694286
Nt5e 5'-nucleotidase precursor 883.96 326.67 352.42 133.83 -1.433368655 -1.390242149
P2ry1 P2Y purinoceptor 1 143.78 52.87 101.31 55.47 -1.426308351 -0.857390628
Zfp941 hypothetical protein LOC407812 15.74 5.25 5.44 3.67 -1.421371433 -0.463638138
Msx1 homeobox protein MSX-1 37.88 13.53 4.83 6.76 -1.419993516 0.412560769
Fgfbp1 fibroblast growth factor-binding protein 1 349.74 130.09 1887.26 622.55 -1.419844336 -1.598480273
LOC100502920 1.65 0 0 0 -1.40599236 0
B4galt1 beta-1,4-galactosyltransferase 1 277.81 104.29 163 124.83 -1.404913885 -0.382219889
Nuak1 NUAK family SNF1-like kinase 1 209.7 78.58 192.67 169.71 -1.40471251 -0.182052922
Kcnh1 potassium voltage-gated channel subfamily H 55.6 20.4 7.88 8.8 -1.403191256 0.142222073
Itpka inositol-trisphosphate 3-kinase A 7.21 2.11 5.36 3.32 -1.400467642 -0.557995453
0610010O12Rik hypothetical protein LOC66060 22.6 7.94 12.59 12.54 -1.400440123 -0.005317717
Fxyd6 FXYD domain-containing ion transport regulator 6 375.86 141.87 151.15 113.44 -1.399325666 -0.410902931
Apoo-ps 6.33 1.78 0.82 0.56 -1.398728315 -0.222392421
Me3 NADP-dependent malic enzyme, mitochondrial 14.61 4.94 0 0.59 -1.393935701 0.669026766
Cpeb1 cytoplasmic polyadenylation element-binding 20.14 7.05 11.84 4.89 -1.392914688 -1.124305663
Sesn1 sestrin-1 isoform 2 353.77 135.16 275.65 150.94 -1.381581076 -0.864560197
Kbtbd13 kelch repeat and BTB domain-containing protein 1.6 0 0.82 0.87 -1.378511623 0.03909982
Orm1 alpha-1-acid glycoprotein 1 precursor 24.42 8.79 65.81 17.61 -1.376583265 -1.843986003
Tmem56 transmembrane protein 56 16.33 5.68 33.72 16.23 -1.375351647 -1.010844246
Cyp1b1 cytochrome P450 1B1 88.63 33.55 338.56 66.29 -1.375295986 -2.335202494
BC026439 prostaglandin-specific organic anion 32.17 11.79 8.11 2.44 -1.374862748 -1.405042489
Camkv caM kinase-like vesicle-associated protein 1.59 0 3.84 2.29 -1.372952098 -0.556919464
Cldn22 claudin-22 1.59 0 0 0 -1.372952098 0
E030003E18Rik 1.59 0 15.87 2.49 -1.372952098 -2.273161032
Lmod3 leiomodin-3 1.59 0 0.58 0 -1.372952098 -0.659924558
Lgr6 leucine-rich repeat-containing G-protein coupled 143.02 55.05 338.88 106.7 -1.361482894 -1.65800722
Dusp23 dual specificity protein phosphatase 23 51.34 19.4 14.21 8.58 -1.359344772 -0.666922592
Tacr1 substance-P receptor 3.24 0.66 0.54 0.38 -1.352881023 -0.158262084
Clec4b1 C-type lectin domain family 4, member b1 isoform 1.55 0 0 0 -1.350497247 0
Rufy4 RUN and FYVE domain-containing protein 4 isoform 20.5 7.47 11.25 3.51 -1.343902785 -1.441582411
Cyr61 protein CYR61 precursor 15412.8 6087 3520.57 1876.12 -1.340182313 -0.907697879
Ttpa alpha-tocopherol transfer protein 26.45 9.85 15.03 6.06 -1.339111107 -1.183034337
Rrm2 ribonucleoside-diphosphate reductase subunit M2 171.44 67.26 81.65 67.57 -1.336982148 -0.269437297
H60c histocompatibility 60c 102.14 39.98 64.81 39.67 -1.331612061 -0.694341831
Cnih3 protein cornichon homolog 3 isoform 2 5.29 1.51 0 0 -1.325372653 0
Atp6v0d2 V-type proton ATPase subunit d 2 18.05 6.62 1.29 0.65 -1.321928095 -0.472881574
B4galnt3 N-acetyl-beta-glucosaminyl-glycoprotein 66.35 25.96 6.44 8.81 -1.320857449 0.398950515
Dpysl5 dihydropyrimidinase-related protein 5 17.46 6.39 22.31 11.57 -1.320756283 -0.890964355
Gas7 growth arrest-specific protein 7 isoform b 134.3 53.24 337.48 115.91 -1.318732756 -1.533672253
Ntrk2 BDNF/NT-3 growth factors receptor isoform b 9.81 3.34 11.43 12.76 -1.316599575 0.146654174
Odc1 ornithine decarboxylase 202.46 80.79 108.43 102.74 -1.314748821 -0.077036029
Gm12839 34.36 13.28 56.09 24.92 -1.308122295 -1.139172344
Tmem140 transmembrane protein 140 42.68 16.66 24.24 13.76 -1.306487513 -0.774019189
Calr4 calreticulin 4 1.46 0 0 0 -1.298658316 0
Nat1 arylamine N-acetyltransferase 1 1.46 0 0 0 -1.298658316 0
Kctd14 potassium channel tetramerisation domain 3.81 0.96 3.08 2.39 -1.29518324 -0.267283879
Ctnnal1 alpha-catulin 292.08 118.6 187.91 114.39 -1.293077131 -0.711180872
Hist1h2bb histone H2B type 1-B 1.45 0 0.86 2.04 -1.292781749 0.708768702
Tpbg trophoblast glycoprotein precursor 99.47 40.01 91.97 64.43 -1.292717133 -0.506812985
D18Ertd653e hypothetical protein LOC52662 29.91 11.63 15.73 26.47 -1.291219015 0.715419465
Zfp72 zinc finger protein 72 9.52 3.31 3.9 3.18 -1.28737493 -0.229278807
Wdr93 WD repeat-containing protein 93 1.44 0 2.15 1.53 -1.286881148 -0.316214444
Arhgap26 rho GTPase-activating protein 26 12.79 4.66 1.91 2.73 -1.284748499 0.358156477
Ccdc125 coiled-coil domain-containing protein 125 5.94 1.85 5.14 4.11 -1.283973744 -0.264915364
Il22ra1 interleukin-22 receptor subunit alpha-1 48.59 19.4 38.36 26.28 -1.281480073 -0.528886576
Fras1 extracellular matrix protein FRAS1 precursor 3.35 0.8 19.63 23.54 -1.273018494 0.250391428
Upb1 beta-ureidopropionase 254.13 104.7 90.79 39.22 -1.271257175 -1.190423907
D630023F18Rik hypothetical protein LOC98303 1.41 0 1.48 1.63 -1.269033146 0.084722679
Hmgcll1 probable 3-hydroxymethyl-3-methylglutaryl-CoA 2.9 0.62 3.15 0.77 -1.267480311 -1.229361976
C130079G13Rik hypothetical protein LOC229333 17.17 6.57 12.13 6.86 -1.263193214 -0.740265699
Eps8 epidermal growth factor receptor kinase 88.99 36.57 59.26 51.45 -1.260183577 -0.2002579
Igfn1 immunoglobulin-like and fibronectin type III 3.15 0.74 0.36 0 -1.25402403 -0.443606651
Prss23 serine protease 23 precursor 778.23 326.1 88.42 100.49 -1.252317462 0.182668132
Ccdc13 coiled-coil domain containing 13 1.38 0 0.36 0 -1.250961574 -0.443606651
Crisp2 cysteine-rich secretory protein 2 precursor 1.38 0 0 0 -1.250961574 0
Plekhf1 pleckstrin homology domain-containing family F 38.08 15.49 24.04 9.2 -1.244839069 -1.29566541
Plekha2 pleckstrin homology domain-containing family A 47.19 19.34 52.09 37.63 -1.244414122 -0.458718464
Grtp1 growth hormone-regulated TBC protein 1 15.76 6.08 5.55 3.73 -1.243200884 -0.469654723
Nqo1 NAD(P)H dehydrogenase [quinone] 1 160.47 67.33 175.65 78.71 -1.240675115 -1.148061116
Arhgef16 rho guanine nucleotide exchange factor 16 65.84 27.3 68.95 37.38 -1.23990968 -0.865969346
Cacnb2 voltage-dependent L-type calcium channel subunit 6.65 2.24 1.52 0.81 -1.239465935 -0.477434036
Kcnb2 potassium voltage-gated channel subfamily B 3.22 0.79 0.83 0.66 -1.237283411 -0.140660407
Bmp6 bone morphogenetic protein 6 precursor 11.94 4.49 28.74 12.12 -1.236959563 -1.180636927
Ppil6 peptidyl-prolyl cis-trans isomerase-like 6 31.39 12.76 27.22 12.1 -1.235067998 -1.107151176
Cebpd CCAAT/enhancer-binding protein delta 1129.44 479.25 356.52 357.58 -1.235026902 0.004271073
N4bp2l1 NEDD4-binding protein 2-like 1 97.86 41.04 39.63 36.06 -1.233624237 -0.132682483
Nkain1 sodium/potassium-transporting ATPase subunit 15.27 5.92 6.38 10.19 -1.233370308 0.600517315
Fam83d hypothetical protein LOC71878 258.09 109.45 151.12 52.25 -1.230059915 -1.514356414
Cmtm8 CKLF-like MARVEL transmembrane domain-containing 58.54 24.4 44.96 35.1 -1.229030725 -0.348379961
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Cdc42ep2 cdc42 effector protein 2 47.58 19.76 7.89 4 -1.226556046 -0.830255324
3110070M22Rik 1.34 0 0.69 1.51 -1.22650853 0.570664118
Zfp949 hypothetical protein LOC71640 49.88 20.8 27.33 16.1 -1.222770536 -0.728334277
Ephx2 epoxide hydrolase 2 139.9 59.4 101.87 95.15 -1.222051157 -0.097463547
Krt222 keratin-like protein KRT222 11.76 4.47 0.51 0.64 -1.222015591 0.119147265
Sh3rf2 putative E3 ubiquitin-protein ligase SH3RF2 101.21 42.94 61.87 39.36 -1.217929578 -0.639445589
Rem2 GTP-binding protein REM 2 8.63 3.14 6.99 6.49 -1.21790503 -0.093229784
6430527G18Rik interferon regulatory factor 2-binding 93.85 39.8 113.36 101.77 -1.217078621 -0.154163342
Car7 carbonic anhydrase 7 1.32 0 0 0 -1.214124805 0
Gm4832 40S ribosomal protein S24-like 1.32 0 1.02 1.43 -1.214124805 0.266601021
Ugt1a6b UDP glucuronosyltransferase 1 family, 15.72 6.21 12.58 12.2 -1.213503683 -0.04094555
Sardh sarcosine dehydrogenase, mitochondrial 179.47 76.97 37.55 28.12 -1.210767994 -0.404720505
Thg1l probable tRNA(His) guanylyltransferase 43.32 18.19 33.74 26.44 -1.20760317 -0.340317273
Fkbp11 peptidyl-prolyl cis-trans isomerase FKBP11 17.59 7.05 50.55 34.99 -1.207466082 -0.518376325
Nrg2 pro-neuregulin-2, membrane-bound isoform 5.88 1.98 0.92 2.55 -1.207096234 0.886712714
Krt14 keratin, type I cytoskeletal 14 7330.89 3177.41 10731.8 8723.41 -1.205879904 -0.298897024
Dock8 dedicator of cytokinesis protein 8 17.19 6.9 22.58 14.62 -1.203220985 -0.594169265
Ntn4 netrin-4 precursor 48.09 20.33 37.35 48.42 -1.202545201 0.365868433
1700048O20Rik 1.3 0 2.49 1.66 -1.201633861 -0.391800791
Fam180a hypothetical protein LOC208164 precursor 183.5 79.36 59.25 31.55 -1.199071347 -0.888303698
Ak1 adenylate kinase isoenzyme 1 isoform 2 161.62 69.87 15.9 25.09 -1.198257746 0.626473698
Ttyh2 protein tweety homolog 2 20.09 8.24 21.92 13.53 -1.190594338 -0.657572341
Lsm11 U7 snRNA-associated Sm-like protein LSm11 21.55 8.88 14.44 9.79 -1.190544487 -0.516977888
Ism1 isthmin-1 precursor 388.33 169.61 65.64 63.16 -1.190291306 -0.054714259
Mfsd9 major facilitator superfamily domain-containing 103.11 44.63 38.03 24.27 -1.190054091 -0.627157798
Adamtsl4 ADAMTS-like protein 4 precursor 404.65 176.82 65.17 31.3 -1.18981789 -1.034643115
Dll1 delta-like protein 1 precursor 33.58 14.16 69.97 47.48 -1.189668115 -0.549819608
Gm826 hypothetical protein LOC329554 1.28 0 2.12 2.23 -1.189033824 0.049988136
Rnase6 ribonuclease K6 precursor 1.28 0 0 0 -1.189033824 0
Zfp551 zinc finger protein 551 13.75 5.51 7.38 5.36 -1.179985506 -0.397923478
Il1rl2 interleukin-1 receptor-like 2 precursor 64.04 27.74 121.65 91.39 -1.178267196 -0.408738621
2410066E13Rik hypothetical protein LOC68235 114.53 50.06 18.67 26.93 -1.178002086 0.505818616
Nup210 nuclear pore membrane glycoprotein 210 3.25 0.88 29.82 21.97 -1.176730179 -0.424116005
Usp50 putative ubiquitin carboxyl-terminal hydrolase 1.26 0 12.11 3.01 -1.176322773 -1.708993544
Vldlr very low-density lipoprotein receptor isoform b 12.16 4.83 6.65 6.62 -1.174591701 -0.00566875
Aknad1 AKNA domain containing 1 11.02 4.33 8.87 5.88 -1.173229458 -0.52064152
Prkcq protein kinase C theta type 13.92 5.62 8.21 3.74 -1.172344413 -0.958314097
Zfp389 1.25 0 0 0 -1.169925001 0
Zkscan14 zinc finger protein 394 31.72 13.56 17.73 13.38 -1.168162393 -0.381287224
Eda ectodysplasin-A isoform 1 81.01 35.56 22.83 23.77 -1.165533767 0.055814917
AI848285 expressed sequence AI848285 1.24 0 0 0 -1.163498732 0
Igfbp5 insulin-like growth factor-binding protein 5 218.68 97.24 18.19 23.52 -1.161021065 0.353604267
Etaa1 ewing's tumor-associated antigen 1 homolog 52.11 22.8 26.11 16.35 -1.158021956 -0.64388945
Plcd4 1-phosphatidylinositol-4,5-bisphosphate 5.58 1.95 1.16 6.55 -1.157372629 1.805445332
Pfn4 profilin-4 1.23 0 0 0 -1.15704371 0
Dpy19l1 protein dpy-19 homolog 1 117.58 52.24 30.55 28.73 -1.155278225 -0.085720542
St6galnac6 alpha-N-acetylgalactosaminide 27.43 11.78 4.27 7.16 -1.153526263 0.63076619
Thbs2 thrombospondin-2 precursor 106.87 47.57 129.05 170.8 -1.151156298 0.401663637
Gca grancalcin 1.22 0 1.19 0.98 -1.150559677 -0.14543044
Atp8a2 probable phospholipid-transporting ATPase IB 42.16 18.46 8.66 9.02 -1.149183155 0.052787414
Mab21l3 protein mab-21-like 3 21.68 9.25 20.22 13.63 -1.145796731 -0.536494887
Hivep3 transcription factor HIVEP3 22.95 9.83 15.74 8.84 -1.144992413 -0.766569307
Nup62-il4i1 Nup62-Il4i1 protein 9.39 3.7 3.57 6.51 -1.144462992 0.716618742
Zfp960 zinc finger protein 960 isoform 2 33.5 14.61 26.97 14.55 -1.144125825 -0.846965673
Pla1a phospholipase A1 member A precursor 1.21 0 0 1 -1.14404637 1
Ncald neurocalcin-delta 99 44.3 19.05 15.21 -1.142417045 -0.306718146
Odz4 teneurin-4 49.31 21.8 29.22 26.14 -1.141811365 -0.15508294
Zfp97 zinc finger protein 97 31.74 13.84 24.67 14.11 -1.14156323 -0.764579635
Zfp874b regulator of sex-limitation candidate 16 45.12 19.91 25.52 17.24 -1.141199451 -0.539975046
Ear5 eosinophil cationic-type ribonuclease 5 33.11 14.47 24.25 11.08 -1.140721558 -1.063662933
Spock1 testican-1 isoform 4 precursor 2.02 0.37 0.47 0 -1.140372656 -0.555816155
Rasgef1b ras-GEF domain-containing family member 1B 175.18 78.95 191.61 281.59 -1.13988022 0.553027806
Hamp2 hepcidin-2 8.44 3.29 5.19 0 -1.137809212 -2.629939409
Krt31 keratin, type I cuticular Ha1 1.2 0 1.43 3.34 -1.137503524 0.836738729
Ms4a10 membrane-spanning 4-domains subfamily A member 5.09 1.77 1.21 3.83 -1.136556252 1.127976819
Slc26a7 anion exchange transporter 9.55 3.8 13.01 3.8 -1.136136688 -1.545350645
9430020K01Rik hypothetical protein LOC240185 27.39 11.95 31.44 12.26 -1.132430751 -1.290693044
Shisa2 protein shisa-2 homolog precursor 1288.8 587.94 285.99 227.6 -1.130954807 -0.328175064
Atp4a potassium-transporting ATPase alpha chain 1 1.19 0 0.84 0.66 -1.13093087 -0.148522525
Ang angiogenin precursor 153.81 69.69 145.85 55.53 -1.130920619 -1.377254664
Ttll7 tubulin polyglutamylase TTLL7 54.88 24.52 10.55 15.56 -1.130703692 0.519809821
Thbs1 thrombospondin-1 2119.56 968.95 2444.86 3348.76 -1.128463019 0.453715908
9930005F22Rik hypothetical protein LOC100045778 9.34 3.73 4.3 4.76 -1.128324097 0.120076452
Pcolce2 procollagen C-endopeptidase enhancer 2 57.87 25.96 7.04 9.93 -1.126712131 0.443025994
BC096441 tumor necrosis factor (ligand) superfamily, 2.36 0.54 0.09 0.03 -1.125530882 -0.081683798
Mamstr MEF2-activating motif and SAP domain-containing 16.3 6.95 2.34 2.78 -1.121745272 0.178538132
Arvcf armadillo repeat protein deleted in 226.25 103.44 66.87 53.05 -1.121605932 -0.328479395
Mlkl mixed lineage kinase domain-like protein 4.46 1.51 12.75 4.49 -1.121213587 -1.324553564
Phyhipl phytanoyl-CoA hydroxylase-interacting 46.11 20.66 2.73 6.03 -1.121000089 0.914349059
4732416N19Rik 41.54 18.58 4.36 4.75 -1.119439268 0.101328955
Crym mu-crystallin homolog 1.17 0 1.16 0 -1.117695043 -1.111031312
Igsf9b immunoglobulin superfamily, member 9B isoform 1 1.17 0 0.59 0.56 -1.117695043 -0.027480736
Tgm5 protein-glutamine gamma-glutamyltransferase 5 3055.35 1409.32 323.43 247.11 -1.115787218 -0.386927348
Etv4 ETS translocation variant 4 43.24 19.42 79.76 60.21 -1.115368519 -0.399873543
Hist1h4i histone H4 20.66 9 23.01 13.44 -1.115033243 -0.733564661
Thnsl2 threonine synthase-like 2 33.05 14.73 29.94 19.61 -1.114136127 -0.586128692
Fbxo16 F-box only protein 16 22.14 9.7 6.12 4.22 -1.112778068 -0.447827434
Krt74 1.16 0 0.6 0 -1.111031312 -0.678071905
Rasgrf1 ras-specific guanine nucleotide-releasing factor 2.67 0.7 31.23 7.6 -1.110245317 -1.905995623
Vamp4 vesicle-associated membrane protein 4 152.24 70.05 52.56 46.07 -1.108886376 -0.186348108
Nrtn neurturin precursor 418.97 193.83 228.4 117.92 -1.108070433 -0.947874023
Zfp874a zinc finger protein 874 39 17.59 22.44 14.88 -1.10547323 -0.561761657
156
Mir686 324.29 150.26 333.38 192.48 -1.104695948 -0.789304116
Tslp 4.03 1.34 4.48 0 -1.10404987 -2.454175893
Ugt1a7c UDP-glucuronosyltransferase 1-7C precursor 2.37 0.57 6.18 8.62 -1.101984032 0.42205305
Zfp119b zinc finger protein 119b 16.55 7.18 16.14 5.9 -1.101298282 -1.312698842
Fam134b family with sequence similarity 134, member B 277.11 128.73 378.28 244.97 -1.10014348 -0.624780932
Lix1 protein limb expression 1 homolog 2.75 0.75 1.28 1.09 -1.099535674 -0.125530882
Tle2 transducin-like enhancer protein 2 55.53 25.39 34.24 25.18 -1.099025346 -0.428748827
Vgll4 transcription cofactor vestigial-like protein 4 399.8 186.21 269.49 338.15 -1.098225009 0.326348234
Bmf bcl-2-modifying factor 20.94 9.27 18.36 13.03 -1.095127344 -0.464563944
Gm10416 10.68 4.48 5.37 4.56 -1.091792476 -0.19620849
Dact2 dapper homolog 2 11.52 4.88 10.95 3.66 -1.090346502 -1.358608758
9930021D14Rik hypothetical protein LOC319259 3.47 1.1 3.8 4.65 -1.089885504 0.235216462
Cspg5 chondroitin sulfate proteoglycan 5 isoform b 3.51 1.12 1.33 0.59 -1.089063169 -0.551303189
Adck3 chaperone activity of bc1 complex-like, 168.56 78.78 73.38 52.82 -1.087696843 -0.466772357
Cdc42ep3 cdc42 effector protein 3 313.49 147.07 403.64 214.93 -1.086734773 -0.906075246
Tcea3 transcription elongation factor A protein 3 47.94 22.06 13.26 12.47 -1.085621588 -0.082224131
Cyp2r1 vitamin D 25-hydroxylase 3.41 1.08 6.57 4.68 -1.084195127 -0.41440237
Csgalnact1 chondroitin sulfate 24.81 11.18 41.96 69.44 -1.083416008 0.713400916
Dsc1 desmocollin-1 23.54 10.59 172.07 97.69 -1.082254683 -0.810379857
Kcns3 potassium voltage-gated channel subfamily S 3.36 1.06 8.07 4.03 -1.081683798 -0.850544151
Dpyd dihydropyrimidine dehydrogenase [NADP+] 72.27 33.69 33.1 10.59 -1.078702775 -1.556891173
Slc6a2 sodium-dependent noradrenaline transporter 8.23 3.37 6.41 5.1 -1.078697368 -0.2806643
Gabre gamma-aminobutyric acid (GABA-A) receptor, 3.77 1.26 1.66 1.04 -1.077666494 -0.382857094
4831426I19Rik nesprin-3 isoform alpha 49.23 22.8 29.34 18.18 -1.077587701 -0.661618365
Pla2g16 group XVI phospholipase A2 21.6 9.71 26.47 12.96 -1.077364293 -0.976557969
Fbxo32 F-box only protein 32 50.79 23.55 88.83 44.96 -1.076950534 -0.966818536
Ldb2 LIM domain-binding protein 2 isoform 2 9.31 3.9 1.91 0.9 -1.073190678 -0.615019735
Acsbg1 long-chain-fatty-acid--CoA ligase ACSBG1 110.83 52.15 811.33 326.07 -1.073165667 -1.312466489
Abhd12b abhydrolase domain-containing protein 12B 84.26 39.57 53.01 34.35 -1.071455753 -0.611516333
Colec11 collectin-11 precursor 1.1 0 0 0 -1.070389328 0
Krt84 keratin, type II cuticular Hb4 1.1 0 1.91 1.84 -1.070389328 -0.035128223
Phyhip phytanoyl-CoA hydroxylase-interacting protein 606.27 288.24 398.78 198.9 -1.070071018 -0.999927827
Spns3 protein spinster homolog 3 4.03 1.4 0.84 0 -1.067523994 -0.879705766
Bnc1 zinc finger protein basonuclin-1 184.55 87.8 59.84 116.85 -1.063176419 0.9538597
Crip2 cysteine-rich protein 2 1114.88 533.19 986.76 514.04 -1.062757016 -0.939476065
Il17b interleukin-17B precursor 7.02 2.84 3.74 0 -1.062495926 -2.244887059
Slc6a9 sodium- and chloride-dependent glycine 77.91 36.84 46.89 44.65 -1.060296051 -0.069109575
Atp2a3 sarcoplasmic/endoplasmic reticulum calcium 40.66 18.99 3.01 2.77 -1.059384367 -0.089037713
Dcun1d3 DCN1-like protein 3 79.43 37.6 89.31 52.52 -1.059132873 -0.75480763
Isg20 interferon-stimulated gene 20 kDa protein 24.59 11.29 9.85 12.05 -1.058095232 0.266354764
Zfp429 zinc finger protein 429 11.78 5.15 7.75 5.93 -1.055229521 -0.336427665
Tigd2 tigger transposable element-derived protein 2 77.9 37 37.19 36.37 -1.054025882 -0.031314356
Gt(ROSA)26Sor 34.86 16.29 37.2 14.42 -1.052437619 -1.308769873
2010109K11Rik hypothetical protein LOC72123 64.8 30.73 13.49 17.52 -1.052240063 0.354026504
Celf5 CUG-BP- and ETR-3-like factor 5 2.71 0.79 0.62 0.33 -1.051459599 -0.284567567
Emb embigin precursor 862.83 416.5 580.06 344.94 -1.048971223 -0.748165306
Myom3 myomesin-3 11.31 4.95 10.74 7.45 -1.048869188 -0.474409162
Phospho1 phosphoethanolamine/phosphocholine phosphatase 427.15 206.31 180.9 151.93 -1.046326616 -0.250274098
Rhpn2 rhophilin-2 18.31 8.35 7.52 4.69 -1.046309894 -0.582424778
Krt16 keratin, type I cytoskeletal 16 557.88 269.65 889.83 740.23 -1.04611016 -0.265228871
Xk membrane transport protein XK 2.57 0.73 1.21 0.96 -1.045152036 -0.173192715
Gm6981 5 1.91 1.18 0.87 -1.043943348 -0.221289865
Mycn N-myc proto-oncogene protein 10.38 4.52 12.56 22.43 -1.043760386 0.788999776
Ascl2 achaete-scute homolog 2 5.74 2.27 1.75 3.66 -1.043457956 0.760898336
Pnp purine nucleoside phosphorylase 240.56 116.23 125.04 87.33 -1.043039765 -0.512906243
Fam131c hypothetical protein LOC277743 1.06 0 2.06 1.57 -1.042644337 -0.251763293
Gadl1 glutamate decarboxylase-like protein 1 1.06 0 1.02 0 -1.042644337 -1.014355293
Nudt17 nucleoside diphosphate-linked moiety X motif 17 28.32 13.24 67.92 54.18 -1.041935957 -0.320777245
Zfp947 zinc finger protein 947 5.54 2.18 3.2 2.37 -1.04026387 -0.317640736
Ppap2b lipid phosphate phosphohydrolase 3 289.49 140.4 169.62 123.14 -1.03870638 -0.458818718
Gpha2 glycoprotein hormone alpha-2 precursor 69.74 33.47 142.91 134.55 -1.03718492 -0.086341732
Adamts9 a disintegrin-like and metalloprotease 8.11 3.44 46.99 51.19 -1.036891377 0.121039589
Trpv4 transient receptor potential cation channel 359.81 175.04 22.32 38.54 -1.035336047 0.761745083
4931403G20Rik 9.1 3.93 2.72 6.28 -1.034695741 0.968635829
Kctd21 BTB/POZ domain-containing protein KCTD21 23.91 11.16 10.79 7.9 -1.034581793 -0.405686477
Acot1 acyl-coenzyme A thioesterase 1 338.27 164.68 253.44 173.72 -1.034034406 -0.54228073
Gm13178 hypothetical protein LOC546849 11.55 5.13 30.06 22.21 -1.033728385 -0.420311307
Fut10 alpha-(1,3)-fucosyltransferase 10 23.81 11.12 15.43 9.87 -1.033532036 -0.59598054
Gatsl3 GATS-like protein 3 292.98 142.78 68.58 90.84 -1.031855 0.400449963
Hmgcs2 hydroxymethylglutaryl-CoA synthase, 320.76 156.46 378.61 1104.9 -1.030999603 1.542631034
1700061I17Rik 2.33 0.63 3.69 1.36 -1.030650213 -0.990801063
Pycr1 pyrroline-5-carboxylate reductase 1, 4.41 1.65 2.04 3.04 -1.029636234 0.410283969
2010107G12Rik hypothetical protein LOC243753 1.04 0 0 0 -1.028569152 0
Pla2g3 phospholipase A2, group III 8.87 3.84 4.09 2.7 -1.028043037 -0.460140386
2410004N09Rik 139.65 68.08 146.65 121.47 -1.025769565 -0.269752964
Scnn1g amiloride-sensitive sodium channel subunit 40.79 19.56 25.78 19.81 -1.023317494 -0.363878996
Zfp748 zinc finger protein 748 isoform 1 39.35 18.86 20.97 20.41 -1.022703051 -0.037250074
Rnase10 ribonuclease-like protein 10 isoform 2 1.03 0 1.83 1.47 -1.021479727 -0.196291011
Il7 interleukin-7 precursor 4.55 1.74 48.1 9.75 -1.018311878 -2.191386365
Rab17 ras-related protein Rab-17 61.59 29.93 6.72 8.97 -1.016925343 0.368992657
Matn2 matrilin-2 207.42 102.01 76.67 42.83 -1.016709327 -0.825438787
Paqr8 membrane progestin receptor beta 9.9 4.39 3.64 3.39 -1.015970957 -0.079903866
Ugt1a6a UDP-glucuronosyltransferase 1-6 precursor 11.58 5.23 8.99 8.68 -1.013827854 -0.045477631
Zfp456 zinc finger protein 456 4.81 1.88 2.72 1.65 -1.012469352 -0.489310262
Noxo1 NADPH oxidase organizer 1 29.94 14.34 7.59 8.65 -1.012174714 0.167870811
Lmo1 rhombotin-1 660.08 326.84 272.55 241.5 -1.011832979 -0.173819808
Selenbp1 selenium-binding protein 1 41.93 20.29 31.79 20.02 -1.011810223 -0.641493232
Ppp1r3d protein phosphatase 1 regulatory subunit 3D 4.86 1.91 2.39 2.61 -1.009881512 0.090713564
Fam101a hypothetical protein LOC73121 11.48 5.2 12.03 16.21 -1.009277814 0.401410013
BC021891 mitogen-activated protein kinase kinase kinase 3.14 1.06 6.73 0.69 -1.00698643 -2.193445168
Gpsm1 G-protein-signaling modulator 1 isoform 2 20.31 9.61 16.78 20.13 -1.006105937 0.249037443
Adamts17 ADAM metallopeptidase with thrombospondin type 1 14.68 6.81 28.84 32.98 -1.005531106 0.187438317
157
Trim12a tripartite motif-containing protein 12 27.43 13.19 23.5 12.79 -1.00253951 -0.829159292
Tmeff2 tomoregulin-2 precursor 2.22 0.61 0.46 0 -1 -0.545968369
1110020A21Rik 10.94 4.97 4.06 5.61 -1 0.385512887
Gm5779 2.3 0.65 1.37 1.37 -1 0
Olfr856-ps1 1 0 0 0 -1 0
158
HG Down
GENE Description WT Bulge KO Bulge WT HG KO HG Log2 KO Bulge/WT Bulge Log2 KO HG/WT HG
Skint3 selection and upkeep of intraepithelial T-cells 8.72 0 214.86 0 -3.280956314 -7.753952119
Skint4 selection and upkeep of intraepithelial T-cells 86.55 0.44 142.39 0 -5.925966462 -7.163800604
Mir3074-1 80.19 93.07 51.02 0 0.21243266 -5.700994494
Skint9 selection and upkeep of intraepithelial T-cells 12.04 0 46.94 0 -3.704871964 -5.583158004
Mir1306 36.97 0 45.16 0 -5.246788094 -5.528571319
Pcp2 Purkinje cell protein 2 isoform 2 0 0 30.94 0 0 -4.997292408
Ear12 eosinophil-associated, ribonuclease A family, 0 0 28.86 0 0 -4.90014226
Mir671 27.61 0 25.04 0 -4.838447593 -4.702657543
Snora24 0 12.48 16.41 0 3.752748591 -4.121844298
Krt13 keratin, type I cytoskeletal 13 89.24 1.22 30.2 0.85 -5.345135486 -4.075948853
Snora75 0 39.71 15.14 0 5.347311316 -4.012568674
Ear10 eosinophil-associated, ribonuclease A family, 0 0 11.46 0 0 -3.639232163
Sval2 seminal vesicle antigen-like 2 21.01 0 11.13 0 -4.46008724 -3.600507645
Rptn repetin 0.35 0 32.42 1.87 -0.432959407 -3.541589091
Btg3 protein BTG3 0.12 0.11 11.11 0.04 -0.012939056 -3.541543432
Amd1 S-adenosylmethionine decarboxylase proenzyme 1 0.85 1.22 29.16 1.76 0.263034406 -3.449896256
Gjc1 gap junction gamma-1 protein 2.04 1.97 9.05 0 -0.033608393 -3.329123596
Myoc myocilin precursor 586.87 35.65 33.32 3.58 -4.003612053 -2.905630049
Grp gastrin-releasing peptide precursor 0 0 28.57 3.03 0 -2.8752825
Ear2 eosinophil cationic protein 2 precursor 0 1.73 27.83 3.09 1.448900951 -2.817398089
Hmga1-rs1 high mobility group protein HMG-I/HMG-Y isoform 10.83 15.36 20.64 2.12 0.467722675 -2.794082565
Syn1 synapsin-1 isoform b 0 0 5.93 0 0 -2.792855352
H60b histocompatibility 60b 2.06 0 5.75 0 -1.613531653 -2.754887502
Lgals2 galectin-2 2.63 2.28 5.22 0 -0.146273733 -2.63691458
Hamp2 hepcidin-2 8.44 3.29 5.19 0 -1.137809212 -2.629939409
BC090627 13.39 12.47 5.06 0 -0.095316741 -2.599317794
Klk10 kallikrein-10 6.89 10.69 201.36 32.42 0.567177725 -2.598140506
Skint11 selection and upkeep of intraepithelial T-cells 5.29 1.12 4.84 0 -1.568995752 -2.545968369
Col8a1 collagen alpha-1(VIII) chain precursor 6.4 4.1 32.21 5.02 -0.537028024 -2.463782331
Tslp 4.03 1.34 4.48 0 -1.10404987 -2.454175893
Gngt2 guanine nucleotide-binding protein 2.28 7.64 4.32 0 1.397335498 -2.411426246
Cd72 B-cell differentiation antigen CD72 isoform 4 16.28 34.26 22.16 3.44 1.028929257 -2.383003672
Il18r1 interleukin-18 receptor 1 isoform a 2.5 2.34 43.43 7.67 -0.067506819 -2.357430243
Cyp1b1 cytochrome P450 1B1 88.63 33.55 338.56 66.29 -1.375295986 -2.335202494
1700028B04Rik 0 0 3.94 0 0 -2.304511042
Acox2 peroxisomal acyl-coenzyme A oxidase 2 0.94 1.88 17.85 2.84 0.570012159 -2.295386307
Riiad1 RIIa domain-containing protein 1 3.01 4.58 3.9 0 0.476662885 -2.292781749
Dmrta1 doublesex- and mab-3-related transcription 0 0 3.88 0 0 -2.286881148
Galnt6 polypeptide N-acetylgalactosaminyltransferase 6 0.9 0.79 22.52 3.85 -0.086039831 -2.277831408
E030003E18Rik 1.59 0 15.87 2.49 -1.372952098 -2.273161032
Col6a6 collagen alpha-6(VI) chain isoform 1 0 0.16 3.77 0 0.214124805 -2.253989266
Il17b interleukin-17B precursor 7.02 2.84 3.74 0 -1.062495926 -2.244887059
Ifitm5 interferon-induced transmembrane protein 5 0 4.02 3.71 0 2.327687364 -2.23572706
Crb2 crumbs homolog 2 precursor 0.36 0 3.66 0 -0.443606651 -2.220329955
Col9a2 collagen alpha-2(IX) chain precursor 0.35 0 3.65 0 -0.432959407 -2.217230716
BC021891 mitogen-activated protein kinase kinase kinase 3.14 1.06 6.73 0.69 -1.00698643 -2.193445168
Il7 interleukin-7 precursor 4.55 1.74 48.1 9.75 -1.018311878 -2.191386365
Npbwr1 neuropeptides B/W receptor type 1 0.8 0 3.56 0 -0.847996907 -2.189033824
Mrgprb3 mas-related G-protein coupled receptor member 5.01 2.78 3.54 0 -0.668978756 -2.182692298
Tmem190 transmembrane protein 190 precursor 0 0 3.42 0 0 -2.14404637
1700016C15Rik hypothetical protein LOC69428 0 0 3.38 0 0 -2.13093087
Gm14005 0 3.25 3.2 0 2.087462841 -2.070389328
Acoxl acyl-coenzyme A oxidase-like protein 1.95 1.96 30.95 6.75 0.004882221 -2.043547716
Slc22a3 solute carrier family 22 member 3 51.5 36.19 38.12 8.55 -0.497402675 -2.034333732
Il3ra interleukin-3 receptor subunit alpha precursor 19.46 2.24 14.9 2.89 -2.658740427 -2.031184705
4930415O20Rik hypothetical protein LOC73863 2.21 3.44 3.08 0 0.467986379 -2.028569152
Grem1 gremlin-1 precursor 755.7 273.5 279.66 68.27 -1.462915296 -2.018520885
Dgkh diacylglycerol kinase eta 1.03 0.64 10.77 1.93 -0.307783913 -2.006141751
Tox2 TOX high mobility group box family member 2 0 0 2.99 0 0 -1.996388746
Fut4-ps1 2.55 0 2.94 0 -1.827819025 -1.97819563
Gjd3 gap junction delta-3 protein 2.03 0 2.91 0 -1.599317794 -1.967168608
Fads6 fatty acid desaturase 6 5.97 1.17 2.87 0 -1.683463613 -1.952333566
Cyb5r2 NADH-cytochrome b5 reductase 2 isoform 1 0.6 0.56 7.54 1.22 -0.036525876 -1.943676393
Eda2r tumor necrosis factor receptor superfamily 2.51 0 22.69 5.16 -1.811471031 -1.943275943
Gsdma2 gasdermin-A2 0.65 0.67 18.25 4.04 0.017382078 -1.933362807
Tnfrsf14 tumor necrosis factor receptor superfamily 0 0 2.81 0 0 -1.929790998
Il33 interleukin-33 precursor 18.82 11.39 157.04 40.5 -0.677780775 -1.92910651
Krtap3-2 keratin-associated protein 3-2 2.26 0 2.8 0 -1.704871964 -1.925999419
Serpina4-ps1 0 0 2.77 0 0 -1.914564523
Dbil5 diazepam-binding inhibitor-like 5 2.77 3.55 2.76 0 0.271302022 -1.910732662
C1qtnf1 complement C1q tumor necrosis factor-related 71.09 43.87 63.91 16.27 -0.684047965 -1.910172673
Rasgrf1 ras-specific guanine nucleotide-releasing factor 2.67 0.7 31.23 7.6 -1.110245317 -1.905995623
Slain1 SLAIN motif-containing protein 1 0.63 0.66 9.31 1.78 0.026311277 -1.890887545
1700030C10Rik 5.32 1.22 8.3 1.58 -1.509364882 -1.849859651
Orm1 alpha-1-acid glycoprotein 1 precursor 24.42 8.79 65.81 17.61 -1.376583265 -1.843986003
Chac1 cation transport regulator-like protein 1 8.84 2.2 2.59 0 -1.62058641 -1.843983844
Ptprcap protein tyrosine phosphatase receptor type 1.37 5.26 2.59 0 1.401275598 -1.843983844
Cdo1 cysteine dioxygenase type 1 1.31 2.35 14.06 3.2 0.536268244 -1.842260537
Pyy peptide YY precursor 0 0 2.58 0 0 -1.839959587
Rwdd2a RWD domain-containing protein 2A 4.7 2.78 2.58 0 -0.592575685 -1.839959587
Arhgap40 rho GTPase-activating protein 18-like 1.25 1.75 22.11 5.5 0.289506617 -1.830005637
Gjb6 gap junction beta-6 protein 6.68 1.8 81.6 22.37 -1.455679484 -1.821484048
Stmn1-rs1 1.9 1.93 2.53 0 0.014847764 -1.819668183
Dab1 disabled homolog 1 isoform 2 1.55 0.82 8.27 1.64 -0.486558797 -1.812031409
Cyp2b10 cytochrome P450 2B10 isoform 2 36.86 20.49 273.47 77.19 -0.817008928 -1.811592456
Adora2a adenosine receptor A2a 31.78 4.36 9.39 1.96 -2.612510949 -1.811526573
Pla2g2a phospholipase A2, membrane associated precursor 0 0 2.5 0 0 -1.807354922
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Adamts7 A disintegrin and metalloproteinase with 6.46 5.29 27.34 7.26 -0.246115613 -1.778626071
Klk12 kallikrein-12 0 0 2.43 0 0 -1.778208576
Ccrl1 C-C chemokine receptor type 11 857.26 109.4 518.48 150.46 -2.95867459 -1.778131373
Gdf5 growth/differentiation factor 5 precursor 1.88 0 6.24 1.12 -1.526068812 -1.771925433
Hist3h2bb-ps histone H2B type 3-B 0 0 2.41 0 0 -1.769771739
Timp1 metalloproteinase inhibitor 1 1.99 2.86 2.4 0 0.368455363 -1.765534746
Npy pro-neuropeptide Y precursor 0 0 2.39 0 0 -1.761285273
Pkib cAMP-dependent protein kinase inhibitor beta 4.03 3.14 54.34 15.36 -0.280927632 -1.758149896
Krt27 keratin, type I cytoskeletal 27 123.6 2.32 42.75 11.95 -5.229977017 -1.756330919
Guca1a guanylyl cyclase-activating protein 1 5.76 5.01 2.35 0 -0.169658256 -1.744161096
Gm2506 chemokine (C-C motif) ligand 27b isoform 3 4.37 3.73 8.12 1.75 -0.183081905 -1.729602206
Dpysl4 dihydropyrimidinase-related protein 4 6.77 0 2.29 0 -2.957914599 -1.718087584
Usp50 putative ubiquitin carboxyl-terminal hydrolase 1.26 0 12.11 3.01 -1.176322773 -1.708993544
Bcl2l15 bcl-2-like protein 15 isoform 2 2.93 2.48 36.1 10.35 -0.175442006 -1.708726889
Slc24a3 sodium/potassium/calcium exchanger 3 6.59 5.37 19.56 5.31 -0.252806513 -1.704128354
Bglap-rs1 osteocalcin-related protein precursor 0 0 2.25 0 0 -1.700439718
Rgn regucalcin 0 0 2.24 0 0 -1.695993813
4930538K18Rik hypothetical protein LOC75180 5.87 3.23 13.36 3.45 -0.699652436 -1.690178508
Bik bcl-2-interacting killer 1.3 2.5 2.2 0 0.605721061 -1.678071905
Slc7a2 low affinity cationic amino acid transporter 2 16.59 3.66 172.68 53.29 -1.916353623 -1.677673242
Cited4 cbp/p300-interacting transactivator 4 8.08 7.77 27.75 8.04 -0.050115455 -1.669167278
Dcdc2b doublecortin domain-containing protein 2B 1.91 3.85 2.18 0 0.736965594 -1.669026766
Lgr6 leucine-rich repeat-containing G-protein coupled 143.02 55.05 338.88 106.7 -1.361482894 -1.65800722
Enpp6 ectonucleotide pyrophosphatase/phosphodiesterase 0 0.65 2.13 0 0.722466024 -1.646162657
Fam71e1 hypothetical protein LOC75538 2.58 1.95 2.13 0 -0.279244633 -1.646162657
Gata6 transcription factor GATA-6 5.67 4.88 230.72 73.61 -0.181870606 -1.634941657
Rapsn 43 kDa receptor-associated protein of the 0 0 2.1 0 0 -1.632268215
Ch25h cholesterol 25-hydroxylase 41.85 31.13 173.03 55.2 -0.415374224 -1.63069399
Kcnj2 inward rectifier potassium channel 2 17.53 9.88 19.15 5.51 -0.768184325 -1.63005039
Fam57b hypothetical protein LOC68952 isoform 3 1.88 1.05 16.43 4.65 -0.490444902 -1.625249797
Aqp5 aquaporin-5 0.77 0 2.08 0 -0.82374936 -1.622930351
Folr2 folate receptor beta precursor 3.77 2.55 2.08 0 -0.426170242 -1.622930351
Ltbp1 latent-transforming growth factor beta-binding 121.23 82.26 144.8 46.45 -0.553902959 -1.619510727
Gm6644 8.84 7.14 6.85 1.58 -0.273629521 -1.605321588
Actn2 alpha-actinin-2 0.35 0 2.04 0 -0.432959407 -1.604071324
Fgfbp1 fibroblast growth factor-binding protein 1 349.74 130.09 1887.26 622.55 -1.419844336 -1.598480273
Slc41a2 solute carrier family 41 member 2 2.63 1.14 6.77 1.58 -0.762358752 -1.590543533
Ephx4 epoxide hydrolase 4 0 0 2.01 0 0 -1.589763487
Dclk1 serine/threonine-protein kinase DCLK1 isoform 7 30.3 8.45 50.88 16.33 -1.727776423 -1.581906825
Rnase12 ribonuclease-like protein 12 precursor 0 0 23.69 7.26 0 -1.57971315
5033406O09Rik 0.93 0 1.96 0 -0.948600847 -1.565597176
Dpyd dihydropyrimidine dehydrogenase [NADP+] 72.27 33.69 33.1 10.59 -1.078702775 -1.556891173
Aspn asporin preproprotein 176.48 184.36 313.96 106.71 0.062673491 -1.548016419
Mtag2 0 0 1.92 0 0 -1.545968369
Slc26a7 anion exchange transporter 9.55 3.8 13.01 3.8 -1.136136688 -1.545350645
Emid1 EMI domain-containing protein 1 precursor 13.79 6.77 13.92 4.12 -0.928635549 -1.54303182
Gdf15 growth/differentiation factor 15 precursor 1.68 3.08 1.91 0 0.606336152 -1.541019153
2210407C18Rik epithelial progenitor 1 0 0 1.9 0 0 -1.5360529
Prr15 proline-rich protein 15 0 0 1.9 0 0 -1.5360529
Ptk6 protein-tyrosine kinase 6 1.97 1.76 18.72 5.8 -0.105794664 -1.5360529
Sv2b synaptic vesicle glycoprotein 2B 0.44 0.41 1.9 0 -0.030373649 -1.5360529
Gas7 growth arrest-specific protein 7 isoform b 134.3 53.24 337.48 115.91 -1.318732756 -1.533672253
Lyn tyrosine-protein kinase Lyn isoform A 4.61 2.64 3.95 0.71 -0.62406232 -1.5334322
Dnm3 dynamin-3 isoform 1 2.71 0.89 7.45 1.93 -0.973032952 -1.528050677
Crispld1 cysteine-rich secretory protein LCCL 107.14 76.12 70.18 23.78 -0.487723305 -1.522295745
Rep15 rab15 effector protein 0 1.46 1.86 0 1.298658316 -1.516015147
Fam83d hypothetical protein LOC71878 258.09 109.45 151.12 52.25 -1.230059915 -1.514356414
Fmo5 dimethylaniline monooxygenase [N-oxide-forming] 53.27 27.02 110.47 38.03 -0.953697953 -1.514000121
Foxq1 forkhead box protein Q1 5.54 3.65 92.81 32.04 -0.49205992 -1.505528033
Prss22 brain-specific serine protease 4 1.35 1.64 26.84 8.82 0.167877173 -1.503364282
Slc5a11 sodium/myo-inositol cotransporter 2 0 0 9.4 2.67 0 -1.50273156
Cyp2j8 cytochrome P450, family 2, subfamily j, 1.04 1.19 1.83 0 0.102361718 -1.500802053
Ly6g5b lymphocyte antigen 6 complex locus protein G5b 0 1.94 1.83 0 1.555816155 -1.500802053
Hsd17b13 17-beta-hydroxysteroid dehydrogenase 13 isoform 0 1.06 61.86 21.22 1.042644337 -1.500283455
Otoa otoancorin precursor 0 0 1.82 0 0 -1.495695163
Sds L-serine dehydratase/L-threonine deaminase 0 0 1.82 0 0 -1.495695163
Prr5 proline-rich protein 5 1.28 0.77 1.81 0 -0.365284464 -1.49057013
Btc betacellulin preproprotein 2.58 1.11 13.54 4.2 -0.762716589 -1.483443741
Pdk4 pyruvate dehydrogenase kinase, isozyme 4 13.93 12.44 319.49 113.81 -0.151681027 -1.481031035
Cyp2b13 cytochrome P450, family 2, subfamily b, 2.63 1.43 8.67 2.47 -0.579013234 -1.478580227
BC048355 deoxyribonucleoside 5'-monophosphate 108.6 82.22 176.35 63.24 -0.397245605 -1.465055532
Cpxm2 inactive carboxypeptidase-like protein X2 8.35 8.61 25.61 8.65 0.039570066 -1.463367663
Ntf3 neurotrophin-3 isoform a 36.19 41.55 157.29 56.41 0.194244384 -1.463196155
Chrm3 muscarinic acetylcholine receptor M3 2.18 0 1.74 0 -1.669026766 -1.454175893
Sdsl serine dehydratase-like 0 0 1.74 0 0 -1.454175893
Fbln7 fibulin-7 precursor 1.97 1.34 21.88 7.37 -0.343954401 -1.450787524
Fzd9 frizzled-9 precursor 10.31 2.99 1.72 0 -1.503138278 -1.443606651
Rufy4 RUN and FYVE domain-containing protein 4 isoform 20.5 7.47 11.25 3.51 -1.343902785 -1.441582411
Hist2h2aa2 histone H2A type 2-A 7.34 6.49 7.2 2.05 -0.155081665 -1.426814667
Eml1 echinoderm microtubule-associated protein-like 1 21.66 14.2 34.84 12.35 -0.576076537 -1.424730895
Guca2a guanylin precursor 16.31 11.24 28.3 9.97 -0.500002167 -1.417337139
Hlx H2.0-like homeobox protein 1.99 3.74 1.67 0 0.664741575 -1.416839742
Faah fatty-acid amide hydrolase 1 10.17 4.81 79.58 29.24 -0.943019117 -1.413963666
Skint2 selection and upkeep of intraepithelial T-cells 2.39 4.16 49.86 18.15 0.606085792 -1.40918707
BC026439 prostaglandin-specific organic anion 32.17 11.79 8.11 2.44 -1.374862748 -1.405042489
Mogat1 2-acylglycerol O-acyltransferase 1 2.54 2.82 1.64 0 0.109823278 -1.40053793
Gm5084 11.47 2.71 17.1 5.88 -1.748970373 -1.395509227
Nt5e 5'-nucleotidase precursor 883.96 326.67 352.42 133.83 -1.433368655 -1.390242149
Fam3b cytokine-like protein 2-21 precursor 0 0 1.62 0 0 -1.389566812
Pvt1 22.44 4.26 13.41 4.51 -2.155837865 -1.386946112
Nxph1 neurexophilin-1 precursor 2.25 0.9 1.61 0 -0.7744403 -1.384049807
Steap4 metalloreductase STEAP4 615.44 201.56 371.58 142.06 -1.60561117 -1.380929886
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Sdr16c5 epidermal retinol dehydrogenase 2 44.12 21.89 347.39 132.82 -0.979049605 -1.380409465
Abcb1b multidrug resistance protein 1 23.35 3.01 14.33 4.89 -2.602247631 -1.380018158
Cxcr4 C-X-C chemokine receptor type 4 63.59 42.32 56.48 21.09 -0.576277577 -1.379666643
Ang angiogenin precursor 153.81 69.69 145.85 55.53 -1.130920619 -1.377254664
Cxcl9 C-X-C motif chemokine 9 precursor 17.14 15.62 43.3 16.08 -0.126254074 -1.374998724
Tsc22d3 TSC22 domain family protein 3 isoform 1 505.75 158.74 537.46 207.35 -1.665548565 -1.369830077
Msl3l2 male-specific lethal 3-like 2 9.16 5.19 8.12 2.53 -0.714889088 -1.369365641
Lrrn1 leucine-rich repeat neuronal protein 1 0.41 0.38 1.58 0 -0.031026896 -1.367371066
Foxc1 forkhead box protein C1 134.87 97.63 288.57 111.31 -0.462128506 -1.366425754
Elf5 ETS-related transcription factor Elf-5 0 0 15.94 5.6 0 -1.359895945
Dact2 dapper homolog 2 11.52 4.88 10.95 3.66 -1.090346502 -1.358608758
Sema3a semaphorin-3A precursor 2.18 1.32 5.43 1.51 -0.45490196 -1.357131373
Klhl8 kelch-like protein 8 41.71 24.9 159.12 61.6 -0.7216218 -1.354918959
Crip3 cysteine-rich protein 3 isoform TLP-A 17.55 10.37 18.98 6.85 -0.706186933 -1.347792024
H2-M2 histocompatibility 2, M region locus 2 8.15 12.71 15 5.29 0.583384923 -1.346939983
Myl4 myosin light chain 4 2.15 2.55 1.54 0 0.172467196 -1.344828497
Steap1 metalloreductase STEAP1 1.67 1.74 1.54 0 0.037336151 -1.344828497
Tmigd1 transmembrane and immunoglobulin 0 0 1.54 0 0 -1.344828497
Napepld N-acyl-phosphatidylethanolamine-hydrolyzing 17.88 14.5 51.83 19.84 -0.284590549 -1.342002132
Cyp27a1 sterol 26-hydroxylase, mitochondrial 22.89 12.54 257.99 101.35 -0.819179115 -1.339385292
Tmem171 transmembrane protein 171 2.35 0 1.53 0 -1.744161096 -1.339137385
Lipk lipase member K isoform 1 precursor 3.6 2.42 23.79 8.8 -0.427637536 -1.338904617
B930059L03Rik 1.62 2.22 1.52 0 0.297493877 -1.333423734
Tnfsf13b tumor necrosis factor ligand superfamily member 0.66 0 1.52 0 -0.731183242 -1.333423734
Ptn pleiotrophin 2676.71 1626.29 1360.33 540.95 -0.718528346 -1.328785172
2310042E22Rik hypothetical protein LOC66561 1.58 1.27 33.16 12.62 -0.184678768 -1.326581272
Sectm1b secreted and transmembrane protein 1b precursor 8.2 4.75 68.77 26.84 -0.678071905 -1.325447622
Mlkl mixed lineage kinase domain-like protein 4.46 1.51 12.75 4.49 -1.121213587 -1.324553564
Hist1h3a histone H3.1 1.27 0.92 2.25 0.3 -0.241585987 -1.321928095
Lipn lipase member N precursor 0 0 1.5 0 0 -1.321928095
Dach1 dachshund homolog 1 isoform 2 28.44 14.05 68.33 26.74 -0.968014184 -1.321511973
Cish cytokine-inducible SH2-containing protein 349.56 90.48 463.92 185.62 -1.938133119 -1.316878882
Spata9 spermatogenesis-associated protein 9 0 0 1.49 0 0 -1.316145742
Zdhhc12 probable palmitoyltransferase ZDHHC12 isoform b 13.56 35.39 30.89 11.81 1.321531696 -1.315833622
Zfp119b zinc finger protein 119b 16.55 7.18 16.14 5.9 -1.101298282 -1.312698842
Acsbg1 long-chain-fatty-acid--CoA ligase ACSBG1 110.83 52.15 811.33 326.07 -1.073165667 -1.312466489
Dnajb7 dnaJ homolog subfamily B member 7 0 0 1.48 0 0 -1.310340121
Olfr99 olfactory receptor 99 0 0 1.48 0 0 -1.310340121
Smcp sperm mitochondrial-associated cysteine-rich 0 0 1.48 0 0 -1.310340121
Gt(ROSA)26Sor 34.86 16.29 37.2 14.42 -1.052437619 -1.308769873
Klk6 kallikrein related-peptidase 6 precursor 0 2.17 16.83 6.2 1.66448284 -1.308237891
Clec4n C-type lectin domain family 6 member A isoform 1.92 1.37 1.47 0 -0.30108131 -1.304511042
Vpreb1 immunoglobulin iota chain precursor 1.16 2.6 1.47 0 0.736965594 -1.304511042
Nkpd1 NTPase KAP family P-loop domain-containing 0.74 0.9 6.8 2.16 0.126912112 -1.303549566
Spink5 serine protease inhibitor Kazal-type 5 33.7 24.07 227.03 91.52 -0.468973667 -1.301386469
Mecom MDS1 and EVI1 complex locus protein EVI1 isoform 0.27 0.42 1.46 0 0.161062433 -1.298658316
Zbp1 Z-DNA-binding protein 1 isoform 2 1.63 1.54 1.46 0 -0.050234303 -1.298658316
Plekhf1 pleckstrin homology domain-containing family F 38.08 15.49 24.04 9.2 -1.244839069 -1.29566541
Efhd1 EF-hand domain-containing protein D1 2.03 2.12 1.45 0 0.042228235 -1.292781749
Chrna4 neuronal acetylcholine receptor subunit alpha-4 0.47 0 3.92 1.01 -0.555816155 -1.291462814
9430020K01Rik hypothetical protein LOC240185 27.39 11.95 31.44 12.26 -1.132430751 -1.290693044
Cryab alpha-crystallin B chain 226.26 176.29 209.79 85.27 -0.358232614 -1.288875565
Liph lipase member H isoform 1 2.17 1.94 28.42 11.06 -0.108666685 -1.286567339
H2-Q7 H-2 class I histocompatibility antigen, Q7 alpha 30 30.43 333.68 136.38 0.019874057 -1.284610351
Ifi47 interferon gamma inducible protein 47 3.8 5.04 12 4.34 0.331514144 -1.283599976
Lrrc18 leucine-rich repeat-containing protein 18 18.74 1.61 4.89 1.42 -2.919000278 -1.283260587
1700001G17Rik 0 0 1.43 0 0 -1.280956314
4930505A04Rik hypothetical protein LOC75087 6.19 4.05 1.43 0 -0.509708383 -1.280956314
Chst7 carbohydrate sulfotransferase 7 1.14 0.71 1.43 0 -0.323614472 -1.280956314
Hes7 transcription factor HES-7 0 0 1.43 0 0 -1.280956314
Cdsn corneodesmosin precursor 45.76 35.39 319.77 131.11 -0.361732879 -1.279799545
H2-Q6 histocompatibility 2, Q region locus 6 109.67 90.49 556.79 229.94 -0.274578227 -1.272203993
Cacna2d2 voltage-dependent calcium channel subunit 11.18 3.39 7.05 2.34 -1.472221288 -1.269140681
Cd209f CD209f antigen 1.98 2.51 1.41 0 0.2361587 -1.269033146
Kcnj16 inward rectifier potassium channel 16 1.5 0.54 3.24 0.76 -0.698997744 -1.268488836
Cd5 T-cell surface glycoprotein CD5 precursor 2.14 2.66 9.65 3.43 0.221079089 -1.265474827
Sema3d semaphorin-3D precursor 14.03 20.14 33.33 13.28 0.492130367 -1.265473878
Tns1 tensin 1 448 125.41 165.48 68.25 -1.828604849 -1.265462894
Mesp2 mesoderm posterior protein 2 12.07 2.8 15.3 5.79 -1.782187817 -1.263388485
Dtx4 protein deltex-4 2.72 3.08 46.58 18.85 0.133266531 -1.261216264
Pglyrp3 peptidoglycan recognition protein 3 precursor 1.11 1.48 24.67 9.71 0.233097122 -1.261124816
Atp1b1 sodium/potassium-transporting ATPase subunit 22.56 27.48 31 12.39 0.273609607 -1.256915944
St8sia2 alpha-2,8-sialyltransferase 8B 2.21 2.18 5.93 1.9 -0.013546532 -1.256802452
Ccl1 C-C motif chemokine 1 precursor 3.16 3.82 20.33 7.98 0.212449618 -1.248096616
Tead4 transcriptional enhancer factor TEF-3 isoform a 28.38 13.97 20.08 7.88 -0.972760174 -1.247243285
2200002D01Rik HAI-2 related small protein 4.28 6.86 19.53 7.65 0.573991383 -1.24696159
Ccdc64b bicaudal D-related protein 2 8.07 5.55 47.17 19.32 -0.469607644 -1.245234522
Gm13306 chemokine (C-C motif) ligand 27b isoform 2 495.12 172.29 731.31 307.99 -1.517500714 -1.244894348
Ptchd3 patched domain-containing protein 3 5.59 0 1.37 0 -2.720278465 -1.244887059
Zglp1 GATA-type zinc finger protein 1 0 1.65 1.37 0 1.40599236 -1.244887059
2810403D21Rik 13.96 7.98 13.62 5.17 -0.736322825 -1.244600917
Il13ra2 interleukin-13 receptor subunit alpha-2 1.32 1.14 12.7 4.79 -0.116514009 -1.24254064
Syngr4 synaptogyrin-4 0 0 1.36 0 0 -1.23878686
Orm2 alpha-1-acid glycoprotein 2 precursor 1.81 1.44 4.87 1.49 -0.203688983 -1.237214761
Gm14047 0 0 9.23 3.34 0 -1.237039197
Iigp1 interferon-inducible GTPase 1 7.14 12.07 8.07 2.86 0.683158442 -1.232501703
Fam111a hypothetical protein LOC107373 44.13 38.85 59.67 24.86 -0.179507054 -1.230261036
Hmgcll1 probable 3-hydroxymethyl-3-methylglutaryl-CoA 2.9 0.62 3.15 0.77 -1.267480311 -1.229361976
Avpr1a vasopressin V1a receptor 4.43 3.9 115.63 48.78 -0.148170449 -1.228300796
Cd274 programmed cell death 1 ligand 1 precursor 5.8 6.01 16.11 6.32 0.043879698 -1.224924206
Tmprss11e transmembrane protease serine 11E 0 0 5.49 1.78 0 -1.223133595
Gal3st1 galactosylceramide sulfotransferase 59.06 36.97 15.15 5.92 -0.661544476 -1.222690222
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Serpinb1a leukocyte elastase inhibitor A 51.91 34.64 37.94 15.74 -0.570043081 -1.217953356
Csf1 macrophage colony-stimulating factor 1 isoform 2 19.42 14.29 31.24 12.87 -0.41739446 -1.216883956
Gm6034 H2-GS14-2 antigen 0 0 1.32 0 0 -1.214124805
Irf5 interferon regulatory factor 5 13.25 10.12 55.39 23.35 -0.357805131 -1.211517571
Tmem45a transmembrane protein 45A 305.27 201.03 1323.41 570.97 -0.600234519 -1.211338425
Gdpd1 glycerophosphodiester phosphodiesterase 3.05 1.65 44.38 18.6 -0.611929548 -1.211202955
Slc2a12 solute carrier family 2, facilitated glucose 33.92 19.08 27.58 11.35 -0.79829429 -1.210494875
Dab2 disabled homolog 2 isoform c 198.72 99.37 21.05 8.54 -0.992650691 -1.208717484
Gcnt4 glucosaminyl transferase 4, core 2 1.04 0.9 18.38 7.39 -0.102569734 -1.207825855
Sipa1l2 signal-induced proliferation-associated 1-like 21.68 15.24 88.26 37.79 -0.481869008 -1.202329031
Pik3r5 phosphoinositide 3-kinase regulatory subunit 5 0.74 1.38 2.29 0.43 0.451874267 -1.202072437
Cd209b CD209 antigen-like protein B isoform a 1.27 2.58 1.3 0 0.65726729 -1.201633861
Clec4a3 dendritic cell inhibitory receptor 3 1.43 1.11 1.3 0 -0.203713315 -1.201633861
Rgl3 ral guanine nucleotide dissociation 0.48 0.75 4.45 1.37 0.241757746 -1.201369171
Ecm1 extracellular matrix protein 1 precursor 2342.99 500.06 379.66 164.88 -2.225911139 -1.198363026
Casp12 caspase-12 precursor 2.81 5.22 15.45 6.17 0.707123583 -1.19804256
Clec2d C-type lectin domain family 2 member D 627.29 209.41 512.72 222.92 -1.578227346 -1.197998849
BB123696 5.95 0 1.29 0 -2.797012978 -1.195347598
C1ql1 C1q-related factor precursor 0 0 1.29 0 0 -1.195347598
Slc16a14 monocarboxylate transporter 14 19.1 5.8 49.51 21.1 -1.56358885 -1.192522672
Cyp4b1 cytochrome P450 4B1 243.35 87.84 355.9 155.16 -1.459667807 -1.192494943
Slc46a2 thymic stromal cotransporter protein 4.21 6.88 87.3 37.64 0.596912257 -1.192318344
Upb1 beta-ureidopropionase 254.13 104.7 90.79 39.22 -1.271257175 -1.190423907
S100b protein S100-B 1.72 1.19 1.28 0 -0.312675782 -1.189033824
Ror1 tyrosine-protein kinase transmembrane receptor 21.16 13.88 23.5 9.75 -0.574583355 -1.188445089
Loxl4 lysyl oxidase homolog 4 isoform 1 6.17 7.05 10.16 3.9 0.167015664 -1.187483373
Fam83c family with sequence similarity 83, member C 10.21 5.81 44.13 18.85 -0.719059575 -1.184947771
Cwh43 PGAP2-interacting protein 123.91 98.84 214.96 94.03 -0.323199141 -1.184309187
Ttpa alpha-tocopherol transfer protein 26.45 9.85 15.03 6.06 -1.339111107 -1.183034337
Mmp27 matrix metalloproteinase-27 5.09 4.31 1.27 0 -0.197730367 -1.182692298
Defb6 beta-defensin 6 precursor 198.48 274.88 13738.1 6057.41 0.467796764 -1.181276381
Apobec3 DNA dC->dU-editing enzyme APOBEC-3 isoform 1 2.34 2.11 7.07 2.56 -0.102933522 -1.180691432
Bmp6 bone morphogenetic protein 6 precursor 11.94 4.49 28.74 12.12 -1.236959563 -1.180636927
Krt32 keratin, type I cuticular Ha2 23.85 12.09 41.84 17.9 -0.924780755 -1.180572246
Thsd1 thrombospondin type-1 domain-containing protein 471.84 393.09 144.82 63.41 -0.262826944 -1.17883201
C630043F03Rik 24.23 30.37 91.96 40.14 0.314245323 -1.176068275
Clca2 chloride channel calcium activated 2 77.43 76.44 1652.32 731.27 -0.018326648 -1.174918388
Oip5 protein Mis18-beta 3.72 4.51 15.91 6.49 0.223265459 -1.174839036
Sphk1 sphingosine kinase 1 isoform 1 36.09 21.17 77.78 33.9 -0.742421498 -1.174602381
Upp1 uridine phosphorylase 1 22.11 4.65 7.69 2.85 -2.032194487 -1.174497731
Nexn nexilin 5.4 3.78 9.49 3.65 -0.421061287 -1.173712057
Slc46a3 solute carrier family 46 member 3 precursor 3.15 2.56 15.22 6.19 -0.221234095 -1.173710144
Vsnl1 visinin-like protein 1 79.41 59.68 137.74 60.64 -0.406153844 -1.170445023
Clca1 chloride channel calcium activated 1 15.41 16.64 344.9 152.7 0.104275322 -1.170237849
Gpr141 probable G-protein coupled receptor 141 1.94 2.88 1.25 0 0.400240497 -1.169925001
Rnd1 rho-related GTP-binding protein Rho6 precursor 30.6 9.74 32.79 14.04 -1.556930565 -1.167791783
Slco2b1 solute carrier organic anion transporter family 7.58 8.62 91.91 40.45 0.165059246 -1.164461782
1700101E01Rik hypothetical protein LOC329375 isoform 2 0 0 1.24 0 0 -1.163498732
Ces1e liver carboxylesterase 22 precursor 0 0 1.24 0 0 -1.163498732
Zbtb46 zinc finger and BTB domain-containing protein 46 0.79 0.8 1.24 0 0.008037319 -1.163498732
D0H4S114 neuronal protein 3.1 446.02 233.28 293.58 130.58 -0.932105581 -1.162719267
Fam190a hypothetical protein LOC232035 2.21 1.45 5.8 2.04 -0.389791548 -1.161463423
H2-Q8 H-2 class I histocompatibility antigen, Q8 alpha 70.77 63.23 291.09 129.69 -0.160133624 -1.160264212
Ccnd2 G1/S-specific cyclin-D2 149.3 166.86 546.85 244.13 0.159413477 -1.160233883
Gm4980 hypothetical protein LOC100503386 1.17 0.64 7.41 2.77 -0.403999228 -1.157541277
Areg amphiregulin preproprotein 23.65 22.06 295.39 132.16 -0.096195134 -1.154335997
F2r proteinase-activated receptor 1 precursor 17.62 8.38 62.76 27.65 -0.989193245 -1.15411649
X99384 paladin 14.6 12.32 40.71 17.77 -0.227951947 -1.151964662
Anpep aminopeptidase N 88.48 20.29 243.89 109.22 -2.071389307 -1.151747831
Ncapg non-SMC condensin I complex, subunit G 4.77 14.15 37.05 16.14 1.39267457 -1.150529344
Clspn claspin 0.96 4.45 16.64 6.95 1.475402576 -1.149823795
Nqo1 NAD(P)H dehydrogenase [quinone] 1 160.47 67.33 175.65 78.71 -1.240675115 -1.148061116
Kcnd3 potassium voltage-gated channel subfamily D 2.86 2.19 5.31 1.85 -0.275044424 -1.146678086
Eri2 ERI1 exoribonuclease 2 16.06 11.21 24.14 10.37 -0.482554446 -1.144752396
Noxa1 NADPH oxidase activator 1 isoform 1 0 0 1.21 0 0 -1.14404637
Itpripl1 inositol 1,4,5-triphosphate receptor-interacting 55.77 34.09 71.81 31.95 -0.694068794 -1.143858144
Gm12839 34.36 13.28 56.09 24.92 -1.308122295 -1.139172344
Cldn8 claudin-8 52.53 35.73 303.92 137.52 -0.543388757 -1.138336489
Ccl22 C-C motif chemokine 22 precursor 2.04 1.48 1.2 0 -0.293731203 -1.137503524
Mmp25 matrix metalloproteinase-25 precursor 0.46 0.64 2.21 0.46 0.167727446 -1.136604928
Psapl1 proactivator polypeptide-like 1 107.21 103.84 942.26 428.21 -0.04564457 -1.135971801
Bdnf brain-derived neurotrophic factor isoform 2 39.09 40.47 15.29 6.42 0.04882563 -1.134495512
2810417H13Rik PCNA-associated factor 4.08 17.75 71.63 32.1 1.883990193 -1.133734363
Fzd7 frizzled-7 precursor 509.44 323.81 635.37 289.45 -0.652145339 -1.131575995
Aadac arylacetamide deacetylase 22.91 18.33 764.84 349.05 -0.306772493 -1.129482008
Pcdh18 protocadherin 18 precursor 2.53 4.48 7.2 2.75 0.63450771 -1.128733314
Tnfaip8l1 tumor necrosis factor alpha-induced protein 1.35 3.25 10.93 4.46 0.854802084 -1.127621187
Arhgap44 rho GTPase-activating protein 44 isoform 1 239.22 152.37 144.03 65.41 -0.647339959 -1.126878954
Cyp3a13 cytochrome P450 3A13 1.74 2.62 10.09 4.08 0.401813804 -1.126358963
Slc39a4 zinc transporter ZIP4 precursor 1.42 0.95 4.32 1.44 -0.311532924 -1.124545098
Clca4 chloride channel calcium activated 4 1.14 1.28 31.94 14.11 0.091423028 -1.124336895
Col2a1 collagen alpha-1(II) chain isoform 2 precursor 0.34 0 1.18 0 -0.422233001 -1.124328135
Cpeb1 cytoplasmic polyadenylation element-binding 20.14 7.05 11.84 4.89 -1.392914688 -1.124305663
Kcnk5 potassium channel subfamily K member 5 0.74 1.14 7.13 2.73 0.298523491 -1.124079722
Paqr7 membrane progestin receptor alpha 105.96 77.59 190.55 87.2 -0.444653714 -1.118870465
Snx20 sorting nexin-20 1.17 2.11 1.17 0 0.519219538 -1.117695043
Rpp25 ribonuclease P protein subunit p25 0 1.38 10.91 4.49 1.250961574 -1.117295359
Gfra1 GDNF family receptor alpha-1 precursor 238.92 38.03 29.12 12.89 -2.619898059 -1.116675171
Tm4sf1 transmembrane 4 L6 family member 1 24.16 58.93 449.12 206.75 1.252146452 -1.115461192
Ces1d carboxylesterase 3 precursor 12.31 7.16 81.08 36.89 -0.705869514 -1.115213591
Ank progressive ankylosis protein 745.23 515.29 845.13 390.24 -0.531438706 -1.112825459
Crym mu-crystallin homolog 1.17 0 1.16 0 -1.117695043 -1.111031312
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Apobec1 C->U-editing enzyme APOBEC-1 isoform 2 11.87 3.01 28.75 12.79 -1.682337912 -1.109267212
Adrb3 beta-3 adrenergic receptor 2.59 1.46 11.01 4.57 -0.545325528 -1.108486918
Trim72 tripartite motif-containing protein 72 1.52 1.39 9.19 3.73 -0.076413116 -1.107241963
Ppil6 peptidyl-prolyl cis-trans isomerase-like 6 31.39 12.76 27.22 12.1 -1.235067998 -1.107151176
Rarres1 retinoic acid receptor responder (tazarotene 34.53 23.11 92.5 42.41 -0.559406038 -1.106938942
Cst6 cystatin-M 43.68 57.8 1999.6 928.46 0.396186969 -1.105968059
2310007B03Rik hypothetical protein LOC71874 1.7 1.41 30.89 13.83 -0.163926261 -1.1045855
Uchl1 ubiquitin carboxyl-terminal hydrolase isozyme 0 0 1.15 0 0 -1.10433666
Spns2 protein spinster homolog 2 4.11 5.05 22.39 9.89 0.243611851 -1.102887908
Angpt2 angiopoietin-2 precursor 0.71 2.29 4.9 1.75 0.944091259 -1.101283336
Grik1 glutamate receptor, ionotropic kainate 1 isoform 24.91 6.95 2.74 0.75 -1.70448225 -1.095683348
Irgm2 interferon inducible GTPase 2 23.59 20.03 25.48 11.42 -0.225622885 -1.092237949
Piwil2 piwi-like protein 2 26.32 13.26 34.62 15.71 -0.937983502 -1.091975783
Syt16 synaptotagmin-16 0.46 0 1.13 0 -0.545968369 -1.09085343
Tc2n tandem C2 domains nuclear protein 2.11 2.22 1.13 0 0.050146108 -1.09085343
Alpk1 alpha-protein kinase 1 1.03 1.38 6.19 2.38 0.229481846 -1.088968524
Smagp small cell adhesion glycoprotein 21.66 19.03 83.86 39.01 -0.17798544 -1.08472405
Cd163l1 CD163 molecule-like 1 1.06 0.54 1.12 0 -0.419713986 -1.084064265
Rgs18 regulator of G-protein signaling 18 1.14 1.65 1.12 0 0.308381563 -1.084064265
Hephl1 hephaestin-like protein 1 2.34 0.73 10.67 4.51 -0.949076065 -1.082680337
Rnase1 ribonuclease pancreatic precursor 5.13 5.14 24.9 11.23 0.002351582 -1.082527694
Irx3 iroquois-class homeodomain protein IRX-3 234.7 153.93 260.51 122.5 -0.60533523 -1.082355074
2210020M01Rik hypothetical protein LOC66528 26.85 19.05 56.25 26.04 -0.474075091 -1.082180542
Chrm5 muscarinic acetylcholine receptor M5 0 0.78 1.11 0 0.831877241 -1.077242999
Krtap3-3 keratin-associated protein 3-2 0 0 1.11 0 0 -1.077242999
Maob amine oxidase [flavin-containing] B 6.08 7.2 23.75 10.73 0.211874549 -1.077225512
Hist1h4c histone H4 5.25 0 2.27 0.55 -2.64385619 -1.07702242
Fam26e hypothetical protein LOC103511 68.83 78.31 83.57 39.09 0.18365581 -1.076903561
Adh7 alcohol dehydrogenase class 4 mu/sigma chain 526.18 145.22 473.24 223.87 -1.850154982 -1.076526149
1600029D21Rik placenta-expressed transcript 1 protein 160.71 130.03 1230.67 584.34 -0.303511734 -1.073268992
Card10 caspase recruitment domain-containing protein 27.4 23.45 74.38 34.87 -0.216056465 -1.07140405
Rab11fip1 rab11 family-interacting protein 1 isoform 1 12.16 7.91 28.06 12.83 -0.562662152 -1.071233546
Cldn4 claudin-4 30.62 33.37 338.44 160.62 0.120312484 -1.070550845
3930402G23Rik 0 0 1.1 0 0 -1.070389328
Tspan15 tetraspanin 15 0.99 1.34 13.61 5.96 0.233740099 -1.069796967
LOC547349 MHC class I family member 0.03 0.06 1.18 0.04 0.041419927 -1.067744607
Als2cl ALS2 C-terminal-like protein 21.06 17.77 27.27 12.49 -0.233004141 -1.067381535
Aldh3a1 aldehyde dehydrogenase, dimeric NADP-preferring 126.64 77.75 1185.89 565.54 -0.696728685 -1.066936509
Chit1 chitotriosidase-1 precursor 31.39 32.22 109.31 51.72 0.036503605 -1.065141307
Art3 ecto-ADP-ribosyltransferase 3 10.17 8.61 50.1 23.43 -0.21702085 -1.064669428
Zfp365 protein ZNF365 38.87 11.99 55.67 26.11 -1.617902175 -1.063760089
Ear5 eosinophil cationic-type ribonuclease 5 33.11 14.47 24.25 11.08 -1.140721558 -1.063662933
Mtmr7 myotubularin-related protein 7 3.96 1.64 25.38 11.63 -0.909802191 -1.062589925
Arhgap25 rho GTPase-activating protein 25 isoform a 1.3 1.6 3.49 1.15 0.176877762 -1.062378785
Dlk2 protein delta homolog 2 21.07 18.99 87.52 41.43 -0.142808158 -1.060918773
Sulf1 extracellular sulfatase Sulf-1 precursor 1.75 2.45 19.49 8.83 0.327164743 -1.059656663
Rell1 RELT-like protein 1 precursor 108.86 116.81 348.08 166.49 0.100795807 -1.05948274
Slc6a14 sodium- and chloride-dependent neutral and basic 2.76 2.04 20.69 9.41 -0.306661338 -1.059059984
Gm11202 7.86 12.61 5.04 1.9 0.619288463 -1.058495649
5730469M10Rik hypothetical protein LOC70564 precursor 300.17 179.36 650.47 312.63 -0.739698653 -1.054635179
Tmprss2 transmembrane protease serine 2 0.83 0.76 8.49 3.57 -0.05626822 -1.054213922
Gpr111 G protein-coupled receptor 111 2.34 2.5 44.2 20.82 0.067506819 -1.050671671
Amz1 archaemetzincin-1 1.03 2.23 3.93 1.38 0.670054438 -1.050626073
Pcsk9 proprotein convertase subtilisin/kexin type 9 0 0 1.07 0 0 -1.049630768
Ptpn22 tyrosine-protein phosphatase non-receptor type 0.58 2.09 1.07 0 0.96768228 -1.049630768
Ube2t ubiquitin-conjugating enzyme E2 T 12.51 18.43 47.67 22.54 0.524258226 -1.047918454
Bend4 BEN domain-containing protein 4 1.09 0.83 1.93 0.42 -0.191659294 -1.045009735
2010110P09Rik calcineurin B homologous protein 2 2.04 3.15 1.06 0 0.449040013 -1.042644337
Arhgap15 rho GTPase-activating protein 15 isoform 2 0.89 1.68 1.06 0 0.503846766 -1.042644337
Card9 caspase recruitment domain-containing protein 9 1.57 1.56 1.06 0 -0.005624549 -1.042644337
Clec4a1 C-type lectin domain family 4, member a1 2.84 2.38 1.06 0 -0.184083064 -1.042644337
Frem3 FRAS1-related extracellular matrix protein 3 0 0 1.06 0 0 -1.042644337
Ncf4 neutrophil cytosol factor 4 0 1.28 1.06 0 1.189033824 -1.042644337
Slc9a7 sodium/hydrogen exchanger 7 0 0 4.54 1.69 0 -1.042279803
Crtac1 cartilage acidic protein 1 precursor 0 0 2.17 0.54 0 -1.041552489
Podn podocan precursor 12.94 9.63 7.87 3.31 -0.391088964 -1.041246235
Tnfrsf4 tumor necrosis factor receptor superfamily 65.95 40.65 83.58 40.22 -0.68476756 -1.036972055
Orm3 alpha-1-acid glycoprotein 3 precursor 0 1.48 1.05 0 1.310340121 -1.03562391
Ngef ephexin-1 isoform 1 85.59 10.71 13.49 6.07 -2.886459347 -1.035275475
Grb7 growth factor receptor-bound protein 7 36.26 24.1 76.02 36.58 -0.56994031 -1.035268056
Hist1h4b histone H4 1.89 0 1.91 0.42 -1.531069493 -1.035128223
Adamtsl4 ADAMTS-like protein 4 precursor 404.65 176.82 65.17 31.3 -1.18981789 -1.034643115
Dusp26 dual specificity protein phosphatase 26 0.84 0 9.42 4.09 -0.879705766 -1.033617716
Sec14l4 SEC14-like protein 4 80.15 39.94 111.11 53.92 -0.987079992 -1.029511439
Ccna1 cyclin-A1 0 0 1.04 0 0 -1.028569152
Il1f9 interleukin-1 family member 9 1.18 1.93 1.04 0 0.42657253 -1.028569152
Nrgn neurogranin 0 0 1.04 0 0 -1.028569152
Panx3 pannexin-3 4.7 2.22 15.29 6.99 -0.823901231 -1.027719196
Oxtr oxytocin receptor 24.29 29.1 32.52 15.48 0.25119645 -1.024305907
Crabp2 cellular retinoic acid-binding protein 2 21.18 34.56 340.28 167 0.680995959 -1.022494638
Omp olfactory marker protein 0.74 0.71 1.03 0 -0.025090981 -1.021479727
Ociad2 OCIA domain-containing protein 2 73.63 38.62 97.14 47.41 -0.913526806 -1.019536177
Ccnf cyclin-F 5.95 8.83 22.29 10.52 0.500178439 -1.015569923
Ccl27a C-C motif chemokine 27 isoform 1 734.29 388.84 1611.94 797.21 -0.915431237 -1.014852514
Gadl1 glutamate decarboxylase-like protein 1 1.06 0 1.02 0 -1.042644337 -1.014355293
Kcne3 potassium voltage-gated channel subfamily E 0.94 0 1.02 0 -0.956056652 -1.014355293
Rasal1 rasGAP-activating-like protein 1 0.74 0.84 2.17 0.57 0.08061846 -1.013718281
Ncaph condensin complex subunit 2 7.34 16.78 53.52 26.02 1.092136035 -1.012757887
Depdc1b DEP domain-containing protein 1B 1.07 3.48 8.24 3.58 1.113867965 -1.012545253
Itga4 integrin alpha-4 4.55 4.16 7.39 3.16 -0.105116706 -1.012087282
Tmem56 transmembrane protein 56 16.33 5.68 33.72 16.23 -1.375351647 -1.010844246
Tgfb3 transforming growth factor beta-3 preproprotein 75.36 94.82 163.91 80.88 0.327509711 -1.010095878
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Krt77 keratin, type II cytoskeletal 1b 746.97 382.17 1522.06 755.47 -0.964995796 -1.009618003
BC006965 3.35 2.5 6.65 2.8 -0.313660479 -1.009460329
Tifa TRAF-interacting protein with FHA 1.86 2.68 7.43 3.19 0.363690619 -1.008582387
Mmp17 matrix metalloproteinase-17 precursor 8.11 3.86 5.92 2.44 -0.90649474 -1.008363473
Was wiskott-Aldrich syndrome protein homolog 1.05 0.76 1.01 0 -0.220048481 -1.007195501
Tec tyrosine-protein kinase Tec isoform a 34.95 29.07 63.19 30.98 -0.257666903 -1.005178622
Gm13363 2.22 8.62 29.53 14.22 1.578976206 -1.004259231
Ifngr1 interferon gamma receptor 1 precursor 79.35 61.82 184.51 91.52 -0.355074081 -1.003659787
Ptgs2 prostaglandin G/H synthase 2 167.04 223.32 131.64 65.2 0.416753564 -1.00261279
Acss1 acetyl-coenzyme A synthetase 2-like, 11.6 3.32 21.72 10.34 -1.544320516 -1.002542195
Elovl6 elongation of very long chain fatty acids 58.84 34.78 335.27 167.07 -0.741956788 -1.000557845
Arg1 arginase-1 4.89 6.18 19.5 9.25 0.28571621 -1
Arhgef26 Rho guanine nucleotide exchange factor (GEF) 26 6.1 2.94 13.02 6.01 -0.849623395 -1
BB019430 0 0 1 0 0 -1
Cftr cystic fibrosis transmembrane conductance 0 0 4.18 1.59 0 -1
Sash3 SAM and SH3 domain-containing protein 3 0.79 0 1 0 -0.839959587 -1
Uts2r urotensin-2 receptor 0 0 1 0 0 -1
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PROMOTERS(±2kb)
Transcript Name Gene name
NM_172505 A730008H23Rik Holliday junction recognition protein
NM_030210 Aacs acetoacetyl-CoA synthetase
NM_022419 Abhd8 abhydrolase domain-containing protein 8
NM_001033606 Acsl3 long-chain-fatty-acid--CoA ligase 3 isoform a
NM_027827 Afmid probable arylformamidase
NM_026375 Ahctf1 protein ELYS
NM_009667 Ampd3 AMP deaminase 3
NM_024213 Anapc4 anaphase-promoting complex subunit 4
NM_011923 Angptl2 angiopoietin-related protein 2 precursor
NR_030781 Ankrd10
NM_013473 Anxa8 annexin A8
NM_023631 Aox4 aldehyde oxidase 4
NM_001080819 Arid1a AT-rich interactive domain-containing protein
NM_001172205 Arid5a AT-rich interactive domain-containing protein 5A
NM_023066 Asph aspartyl/asparaginyl beta-hydroxylase isoform 1
NM_001039939 Asxl1 putative Polycomb group protein ASXL1
NM_007498 Atf3 cyclic AMP-dependent transcription factor ATF-3
NM_146065 Atf7 cyclic AMP-dependent transcription factor ATF-7
NM_153389 Atp10d probable phospholipid-transporting ATPase VD
NM_001081182 Atp8b2 probable phospholipid-transporting ATPase ID
NM_175183 Atxn7l2 ataxin-7-like protein 2
NM_198423 Bahcc1 BAH and coiled-coil domain-containing protein 1
NM_025833 Baiap2l1 brain-specific angiogenesis inhibitor
NM_001033284 BC026585 quinone oxidoreductase-like protein 2
NR_015528 BC029722
NM_001003910 BC030307 tetratricopeptide repeat protein GNN isoform 3
NM_172295 BC037703 hypothetical protein LOC242125
NM_016778 Bok bcl-2-related ovarian killer protein
NM_009770 Btg3 protein BTG3
NR_029450 C530005A16Rik
NM_009795 Capns1 calpain small subunit 1
NM_007616 Cav1 caveolin-1
NM_016900 Cav2 caveolin-2
NM_001033238 Cblb E3 ubiquitin-protein ligase CBL-B
NM_001037916 Ccdc17 coiled-coil domain-containing protein 17
NM_013654 Ccl7 C-C motif chemokine 7
NM_001033342 Cdc42bpg serine/threonine-protein kinase MRCK gamma
NM_007665 Cdh3 cadherin-3 isoform b
NM_007668 Cdk5 cell division protein kinase 5
NM_177270 Cdkl2 cyclin-dependent kinase-like 2 isoform 2
NM_177224 Chd9 chromodomain-helicase-DNA-binding protein 9
NM_001136240 Chdh choline dehydrogenase, mitochondrial precursor
NM_134078 Chmp7 charged multivesicular body protein 7
NM_022890 Cldn12 claudin-12
NM_007713 Clk3 dual specificity protein kinase CLK3
NM_028266 Col16a1 collagen alpha-1(XVI) chain precursor
NM_009929 Col18a1 collagen alpha-1(XVIII) chain isoform 2
NM_001161854 Csde1 cold shock domain-containing protein E1 isoform
NM_028836 Ctbs di-N-acetylchitobiase
NM_001113470 Ctdsp2 carboxy-terminal domain RNA polymerase II
NM_007795 Ctf1 cardiotrophin-1
NM_001165902 Ctnnb1 catenin beta-1
NM_001085449 Ctnnd1 catenin delta-1 isoform 3
NM_030560 Cwc22 pre-mRNA-splicing factor CWC22 homolog
NM_010010 Cyp46a1 cholesterol 24-hydroxylase
NM_010516 Cyr61 protein CYR61 precursor
NM_010015 Dad1 dolichyl-diphosphooligosaccharide--protein
NM_001037999 Dbi acyl-CoA-binding protein isoform 1
NM_010024 Dct L-dopachrome tautomerase precursor
NM_007837 Ddit3 DNA damage-inducible transcript 3 protein
NM_177564 Dhrs11 dehydrogenase/reductase SDR family member 11
NM_011303 Dhrs3 short-chain dehydrogenase/reductase 3 isoform 1
NM_027287 Dnajb4 dnaJ homolog subfamily B member 4
NM_172338 Dnajc16 dnaJ homolog subfamily C member 16 precursor
NM_007882 Dsc3 desmocollin-3
NM_001081316 Dsel dermatan-sulfate epimerase-like protein
NM_013642 Dusp1 dual specificity protein phosphatase 1
NR_029447 E130317F20Rik
NM_026598 Ebpl emopamil-binding protein-like
NM_007902 Edn2 endothelin-2 precursor
NM_010109 Efna5 ephrin-A5 isoform 2
NM_010112 Efs embryonal Fyn-associated substrate
NM_007913 Egr1 early growth response protein 1
NM_182840 Emilin3 EMILIN-3
NM_007680 Ephb6 ephrin type-B receptor 6
NM_010145 Ephx1 epoxide hydrolase 1
NM_176838 Esrp2 epithelial splicing regulatory protein 2
NM_028731 Esyt2 extended synaptotagmin-2
NM_008815 Etv4 ETS translocation variant 4
NM_145359 Fam100a hypothetical protein LOC207740
NM_153782 Fam20a family with sequence similarity 20, member A
NM_134087 Fam83h family with sequence similarity 83, member H
NM_001122603 Fcgbp Fc fragment of IgG binding protein
NM_057172 Fubp1 far upstream element-binding protein 1
NM_008059 G0s2 putative lymphocyte G0/G1 switch protein 2
NR_029457 G530011O06Rik
NM_030166 Galntl2 polypeptide
NM_001113345 Gatad2a transcriptional repressor p66 alpha isoform b
NM_028022 Gatsl3 GATS-like protein 3
NM_008112 Gdi2 rab GDP dissociation inhibitor beta
NM_145929 Gga1 ADP-ribosylation factor-binding protein GGA1
NR_002700 Gm7334
Gene Description
Table 3-2. Gene list from NFIB ChIP-seq analysis. Genes are sorted according to
NFIB bound peak distribution relative to functional structure of a gene.
165
NM_175193 Golim4 Golgi integral membrane protein 4
NM_026672 Gstm7 glutathione S-transferase Mu 7
NM_145546 Gtf2b transcription initiation factor IIB
NM_172810 Gucy1b2 guanylate cyclase soluble subunit beta-2
NM_001166633 Gyltl1b glycosyltransferase-like protein LARGE2 isoform
NM_027168 Hddc2 HD domain-containing protein 2
NM_019479 Hes6 transcription cofactor HES-6
NM_198652 Hjurp Holliday junction recognition protein
NM_021877 Hr protein hairless
NM_001130444 Hras1 GTPase HRas isoform 2
NM_011631 Hsp90b1 endoplasmin
NM_008300 Hspa4 heat shock 70 kDa protein 4
NM_030704 Hspb8 heat shock protein beta-8
NM_010499 Ier2 immediate early response gene 2 protein
NM_030694 Ifitm2 interferon-induced transmembrane protein 2
NM_019583 Il17rb interleukin-17 receptor B precursor
NM_146152 Ipo13 importin-13
NM_022655 Ireb2 iron-responsive element-binding protein 2
NM_018826 Irx5 iroquois-class homeodomain protein IRX-5
NM_027534 Kdsr 3-ketodihydrosphingosine reductase precursor
NM_001166651 Klhl33 kelch-like 33
NM_027011 Krt5 keratin, type II cytoskeletal 5
NM_028770 Krt80 keratin, type II cytoskeletal 80
NM_001113406 Krtap11-1 keratin associated protein 11-1
NM_008484 Lamb3 laminin subunit beta-3 precursor
NM_025622 Lgals2 galectin-2
NM_010710 Lhx2 LIM/homeobox protein Lhx2
NM_010720 Lipg endothelial lipase precursor
NM_001081109 Lmtk2 serine/threonine-protein kinase LMTK2 precursor
NR_028378 LOC100034739
NM_177152 Lrig3 leucine-rich repeats and immunoglobulin-like
NM_001172064 Lrrc56 leucine-rich repeat-containing protein 56
NM_001111311 Lrrfip1 leucine-rich repeat flightless-interacting
NM_010771 Matr3 matrin-3
NM_033072 Mbd6 methyl-CpG binding domain protein 6
NM_175341 Mbnl2 muscleblind-like protein 2 isoform 1
NM_008617 Mdh2 malate dehydrogenase, mitochondrial precursor
NM_008587 Mertk tyrosine-protein kinase Mer precursor
NM_001045489 Mfge8 lactadherin isoform 2




NM_027973 Mlf1ip centromere protein U
NM_008608 Mmp14 matrix metalloproteinase-14
NM_024431 Morf4l1 mortality factor 4-like protein 1 isoform b
NM_053162 Mrpl34 39S ribosomal protein L34, mitochondrial
NM_013602 Mt1 metallothionein-1
NM_181409 Mtmr11 myotubularin-related protein 11
NM_138656 Mvd diphosphomevalonate decarboxylase
NM_016662 Mxd3 max dimerization protein 3
NM_008681 Ndrg1 protein NDRG1
NR_003513 Neat1
NM_010907 Nfkbia NF-kappa-B inhibitor alpha
NM_008738 Nrtn neurturin precursor
NM_027289 Nt5dc2 5'-nucleotidase domain containing 2
NM_198190 Ntf5 neurotrophin-4 precursor
NM_175749 Nup153 nucleoporin 153
NM_010956 Ogdh 2-oxoglutarate dehydrogenase, mitochondrial
NM_153122 Oplah 5-oxoprolinase
NM_025661 Ormdl3 ORM1-like protein 3
NM_008772 P2ry1 P2Y purinoceptor 1
NM_023245 Palmd palmdelphin
NM_033581 Pcdhgc3 protocadherin gamma subfamily C, 3
NM_008808 Pdgfa platelet-derived growth factor subunit A
NM_011066 Per2 period circadian protein homolog 2
NR_028114 Pex16
NM_021453 Pga5 pepsinogen 5, group I
NR_003519 Pisd-ps2
NM_144859 Pja2 E3 ubiquitin-protein ligase Praja-2 isoform b
NM_019762 Pkp3 plakophilin-3 isoform 1
NM_016915 Pla2g6 85 kDa calcium-independent phospholipase A2
NM_024413 Plekhf1 pleckstrin homology domain-containing family F
NM_146030 Plekhh3 pleckstrin homology domain-containing family H
NM_001033225 Pnrc1 proline-rich nuclear receptor coactivator 1
NM_001081247 Polr3a DNA-directed RNA polymerase III subunit RPC1
NM_001034085 Ppp2r1b serine/threonine-protein phosphatase 2A 65 kDa
NM_008913 Ppp3ca serine/threonine-protein phosphatase 2B
NM_001161111 Pqlc3 PQ-loop repeat-containing protein 3 isoform 2
NM_011104 Prkce protein kinase C epsilon type
NM_175249 Psapl1 proactivator polypeptide-like 1
NM_008956 Ptbp1 polypyrimidine tract-binding protein 1 isoform
NM_008973 Ptn pleiotrophin
NM_009009 Rad21 double-strand-break repair protein rad21
NM_027933 Ranbp3 ran-binding protein 3
NM_001146174 Rangap1 ran GTPase-activating protein 1
NM_028712 Rap2b ras-related protein Rap-2b precursor
NM_009030 Rbbp4 histone-binding protein RBBP4
NM_001045807 Rbm15 RNA binding motif protein 15
NM_001029938 Rilp rab-interacting lysosomal protein
NM_028810 Rnd3 rho-related GTP-binding protein RhoE precursor
NM_001099632 Rnf39 ring finger protein 39
NM_031248 Robld3 mitogen-activated protein-binding
NM_001013376 Rpp38 ribonuclease P protein subunit p38
NM_026467 Rps27l 40S ribosomal protein S27-like
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NM_011305 Rxra retinoic acid receptor RXR-alpha
NM_025393 S100a14 protein S100-A14 isoform a
NM_011310 S100a3 protein S100-A3
NM_011311 S100a4 protein S100-A4
NM_138665 Sardh sarcosine dehydrogenase, mitochondrial
NM_007644 Scarb2 lysosome membrane protein 2
NM_198885 Scx basic helix-loop-helix transcription factor
NM_013657 Sema3c semaphorin-3C precursor
NM_001160307 Serpinb10 serpin B10 isoform 2
NM_009257 Serpinb5 serpin B5
NM_009825 Serpinh1 serpin H1 precursor
NM_030109 Sf3b2 splicing factor 3b, subunit 2
NM_028148 Sfrs2ip splicing factor, arginine/serine-rich 2,
NM_172276 Sfrs8 splicing factor, arginine/serine-rich 8
NM_025858 Shisa5 protein shisa-5 isoform 1
NM_029415 Slc10a6 solute carrier family 10 member 6
NM_144893 Slc35c2 solute carrier family 35 member C2
NM_153142 Slc35e4 solute carrier family 35 member E4
NM_026721 Slc39a13 zinc transporter ZIP13
NM_001081349 Slc43a1 large neutral amino acids transporter small
NM_027872 Slc46a3 solute carrier family 46 member 3 precursor
NM_009207 Slc4a2 anion exchange protein 2
NM_033314 Slco2a1 solute carrier organic anion transporter family
NM_008541 Smad5 mothers against decapentaplegic homolog 5
NM_026003 Smarca2 probable global transcription activator SNF2L2
NM_025891 Smarcd3 SWI/SNF-related matrix-associated
NM_153115 Spag11a sperm-associated antigen 11
NM_172561 Spag7 sperm-associated antigen 7 isoform 1
NM_025287 Spop speckle-type POZ protein
NM_009272 Srm spermidine synthase
NM_009179 St3gal2 CMP-N-acetylneuraminate-beta-galactosamide-
NM_011488 Stat5a signal transducer and activator of transcription
NM_013515 Stom erythrocyte band 7 integral membrane protein
NM_175162 Stox2 storkhead-box protein 2 isoform 2
NM_029659 Styxl1 serine/threonine/tyrosine-interacting-like
NM_194342 Sun2 SUN domain-containing protein 2
NM_153484 Tef thyrotroph embryonic factor isoform 2
NM_009369 Tgfbi transforming growth factor-beta-induced protein
NM_029431 Them4 thioesterase superfamily member 4
NM_025372 Tipin TIMELESS-interacting protein
NM_009387 Tk1 thymidine kinase, cytosolic
NM_026669 Tmbim6 bax inhibitor 1
NM_026734 Tmem126b transmembrane protein 126B
NM_001098271 Tmem176a transmembrane protein 176A
NM_023056 Tmem176b transmembrane protein 176B
NM_020588 Tmem183a transmembrane protein 183 isoform a
NM_178625 Tmem209 transmembrane protein 209
NM_144794 Tmem63a transmembrane protein 63A
NM_001033535 Tnfaip8l3 tumor necrosis factor alpha-induced protein
NM_013837 Tpst1 protein-tyrosine sulfotransferase 1 isoform 2
NM_001081055 Trappc10 trafficking protein particle complex subunit 10
NM_023910 Tsc22d4 TSC22 domain family protein 4
NM_146116 Tubb2c tubulin beta-2C chain
NM_019803 Ube2g2 ubiquitin-conjugating enzyme E2 G2
NM_001039157 Ube2j2 ubiquitin-conjugating enzyme E2 J2 isoform a
NM_033526 Ubqln4 ubiquilin-4
NM_001136226 Utp14b U3 small nucleolar RNA-associated protein 14
NM_175158 Utp20 small subunit processome component 20 homolog
NM_023054 Utp3 something about silencing protein 10
NM_013933 Vapa vesicle-associated membrane protein-associated
NM_147776 Vwa1 von Willebrand factor A domain-containing
NM_028875 Xrcc3 DNA repair protein XRCC3
NM_025970 Zbtb8os protein archease
NM_178404 Zc3h6 zinc finger CCCH domain-containing protein 6
NM_175160 Zdhhc1 probable palmitoyltransferase ZDHHC1
NM_001039198 Zfhx2 zinc finger homeobox protein 2
NM_013866 Zfp385a zinc finger protein 385A
NM_146183 Zfp428 zinc finger protein 428
NM_030074 Zfp687 zinc finger protein 687
NM_146202 Zfp768 zinc finger protein 768
NM_026752 Zfyve21 zinc finger FYVE domain-containing protein 21
NM_183208 Zmiz1 zinc finger MIZ domain-containing protein 1
NM_001017955 Zscan18 zinc finger and SCAN domain containing 18
NM_029821 1190003J15Rik 5-hydroxyisourate hydrolase
NM_028166 1600014C10Rik hypothetical protein LOC72244
NR_030711 2210403K04Rik
NM_026629 2410066E13Rik hypothetical protein LOC68235
NR_028428 2610005L07Rik
NR_015483 2610203C20Rik
NM_029366 2810422J05Rik hypothetical protein LOC75620
NM_001172074 3110009E18Rik hypothetical protein LOC73103 isoform 2
NM_025699 3230401D17Rik oxidative stress responsive 1
NM_001080709 4930402F06Rik hypothetical protein LOC74854
NM_177265 6330512M04Rik CD225 family protein FLJ76511 homolog
NM_175521 6430598A04Rik neuronal tyrosine phosphorylated adaptor for
NM_175398 6530418L21Rik hypothetical protein LOC109050 isoform 1
NR_030708 6820431F20Rik
NM_177205 9430015G10Rik hypothetical protein LOC230996
NM_175417 9530008L14Rik hypothetical protein LOC109254 isoform 1
NM_177003 9630033F20Rik probable fructose-2,6-bisphosphatase TIGAR
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DOWNSTREAM (±2kb)
Transcript Name Gene name
NM_016689 Aqp3 aquaporin-3
NM_025338 Aurkaip1 aurora kinase A-interacting protein
NM_146082 BC027072 hypothetical protein LOC225004
NM_153544 BC030867 hypothetical protein LOC217216
NM_001122683 Bdh1 D-beta-hydroxybutyrate dehydrogenase,
NM_178116 Camta2 calmodulin-binding transcription activator 2
NM_027112 Capns2 calpain small subunit 2
NM_001033455 Ccdc27 coiled-coil domain-containing protein 27
NM_021339 Cdon cell adhesion molecule-related/down-regulated by
NM_015734 Col5a1 collagen alpha-1(V) chain precursor
NM_019877 Copz2 coatomer subunit zeta-2
NM_001042611 Cp ceruloplasmin isoform a
NM_153679 Cpt1c carnitine O-palmitoyltransferase 1, brain
NM_153287 Csrnp1 cysteine/serine-rich nuclear protein 1
NM_153088 Ctdsp1 carboxy-terminal domain RNA polymerase II
NM_009983 Ctsd cathepsin D precursor
NM_010055 Dlx3 homeobox protein DLX-3
NM_010100 Edar tumor necrosis factor receptor superfamily
NM_153068 Ehd2 EH domain-containing protein 2
NM_010579 Eif6 eukaryotic translation initiation factor 6
NM_207706 Elmo2 engulfment and cell motility protein 2 isoform
NM_029001 Elovl7 elongation of very long chain fatty acids
NM_144866 Etf1 eukaryotic peptide chain release factor subunit
NM_194345 Fam160b2 family with sequence similarity 160, member B2
NM_015795 Fbxo16 F-box only protein 16
NM_008655 Gadd45b growth arrest and DNA damage-inducible protein
NM_010815 Grap2 GRB2-related adaptor protein 2
NM_001013385 Grm4 metabotropic glutamate receptor 4
NM_010451 Hoxa2 homeobox protein Hox-A2
NM_010458 Hoxb3 homeobox protein Hox-B3
NM_138646 Hps4 Hermansky-Pudlak syndrome 4 protein homolog
NM_019508 Il17b interleukin-17B precursor
NM_178257 Il22ra1 interleukin-22 receptor subunit alpha-1
NM_008916 Inpp5k inositol polyphosphate 5-phosphatase K
NM_001163528 Itpripl1 inositol 1,4,5-triphosphate receptor-interacting
NM_008416 Junb transcription factor jun-B
NM_021342 Kcne4 potassium voltage-gated channel subfamily E
NM_199364 Lzts1 leucine zipper putative tumor suppressor 1
NM_183195 Marveld1 putative MARVEL domain-containing protein 1
NM_010797 Mid1 midline-1
NM_010798 Mif macrophage migration inhibitory factor
NM_021462 Mknk2 MAP kinase-interacting serine/threonine-protein
NM_010808 Mmp24 matrix metalloproteinase-24
NM_010849 Myc myc proto-oncogene protein isoform a
NM_153136 Nudt18 nucleoside diphosphate-linked moiety X motif 18
NM_001025614 Otud7b zinc finger, A20 domain containing 1
NM_148917 Pabpc4 polyadenylate-binding protein 4 isoform 2
NM_027995 Paqr7 membrane progestin receptor alpha
NM_011563 Prdx2 peroxiredoxin-2
NM_138659 Prpf8 pre-mRNA-processing-splicing factor 8
NM_175022 Prr12 proline rich 12
NM_177721 Ranbp6 ran-binding protein 6
NM_177572 Rimkla ribosomal protein S6 modification-like protein
NM_030112 Rtf1 Paf1/RNA polymerase II complex component
NM_009113 S100a13 protein S100-A13
NM_009162 Scg5 neuroendocrine protein 7B2
NM_010831 Sik1 serine/threonine-protein kinase SIK1
NM_172892 Slc13a4 solute carrier family 13, member 4
NM_177243 Slc26a9 solute carrier family 26 member 9
NM_011988 Slc27a3 long-chain fatty acid transport protein 3
NM_031183 Sp6 transcription factor Sp6
NM_020564 Sult5a1 sulfotransferase family 5A, member 1
NM_008596 Sypl2 synaptophysin-like protein 2
NM_134023 Tbc1d10a TBC1 domain family member 10A
NM_198020 Trmt1 N(2),N(2)-dimethylguanosine tRNA
NM_001077591 Tsks testis-specific serine kinase substrate isoform
NM_011656 Tuft1 tuftelin
NM_019392 Tyro3 tyrosine-protein kinase receptor TYRO3
NM_198899 Uggt1 UDP-glucose:glycoprotein glucosyltransferase 1
NM_025407 Uqcrc1 cytochrome b-c1 complex subunit 1, mitochondrial
NM_011756 Zfp36 tristetraprolin
NM_028601 Zmiz2 zinc finger MIZ domain-containing protein 2
NM_026150 4921536K21Rik hypothetical protein LOC67430
NR_029475 4930581F22Rik






Transcript Name Gene name
NM_033474 Arvcf armadillo repeat protein deleted in
NM_030561 BC004004 hypothetical protein LOC80748
NM_020486 Bcam basal cell adhesion molecule
NM_010238 Brd2 bromodomain-containing protein 2 isoform a
NM_017392 Celsr2 cadherin EGF LAG seven-pass G-type receptor 2
NM_012018 Cep110 centriolin
NM_013811 Dnahc8 dynein heavy chain 8, axonemal
NM_015794 Fbxl17 F-box/LRR-repeat protein 17
NM_001033312 Fbxl18 F-box and leucine-rich repeat protein 18
NM_001085549 Gm12824 UPF0632 protein A precursor
NM_001039472 Kif21b kinesin-like protein KIF21B
NM_016693 Map3k6 mitogen-activated protein kinase kinase kinase
NM_001085373 Mcc mutated in colorectal cancers isoform 1
NM_177855 Med12l mediator of RNA polymerase II transcription
NM_011424 Ncor2 nuclear receptor corepressor 2
NM_030152 Nol3 nucleolar protein 3
NM_133947 Numa1 nuclear mitotic apparatus protein 1
NM_021512 Nup160 nuclear pore complex protein Nup160
NM_026936 Oxa1l mitochondrial inner membrane protein OXA1L
NM_144920 Plekha5 phosphoinositol 3-phosphate-binding protein-2
NM_019688 Rapgef4 rap guanine nucleotide exchange factor 4
NM_146042 Rnf144b E3 ubiquitin-protein ligase RNF144B
NM_028182 Sh2d4a SH2 domain-containing protein 4A
NM_009195 Slc12a4 solute carrier family 12 member 4
NM_152808 Slc44a2 choline transporter-like protein 2 isoform 2
NM_001004468 Tacc2 transforming acidic coiled-coil-containing
NM_011547 Tcfap2a transcription factor AP-2-alpha isoform a




Transcript Name Gene name
NR_028376 A930004D18Rik
NM_007378 Abca4 retinal-specific ATP-binding cassette
NM_008576 Abcc1 multidrug resistance-associated protein 1
NM_001103177 Ablim1 actin-binding LIM protein 1 isoform 2
NM_001164491 Ablim3 actin-binding LIM protein 3
NM_198895 Abr active breakpoint cluster region-related protein
NM_175324 Acad11 acyl-CoA dehydrogenase family member 11
NM_207668 Acpp prostatic acid phosphatase long isoform
NM_053178 Acsbg1 long-chain-fatty-acid--CoA ligase ACSBG1




NM_139153 Agap3 arf-GAP with GTPase, ANK repeat and PH
NM_146155 Ahdc1 AT-hook DNA-binding motif-containing protein 1
NM_198111 Akap6 A kinase (PRKA) anchor protein 6
NM_177859 Aknad1 AKNA domain containing 1
NM_178655 Ank2 ankyrin-2 isoform 2
NM_001081379 Ankrd11 ankyrin repeat domain 11
NM_001081139 Ankrd35 ankyrin repeat domain-containing protein 35
NM_007585 Anxa2 annexin A2
NM_001110211 Anxa6 annexin A6 isoform b
NM_175164 Arhgap26 rho GTPase-activating protein 26
NM_001130152 Arhgef1 rho guanine nucleotide exchange factor 1 isoform
NM_027871 Arhgef3 rho guanine nucleotide exchange factor 3
NM_001034858 Armc2 armadillo repeat-containing protein 2
NM_010026 Asap1 arf-GAP with SH3 domain, ANK repeat and PH
NM_025770 Atg10 ubiquitin-like-conjugating enzyme ATG10
NM_080640 Baalc brain and acute leukemia cytoplasmic protein
NM_007521 Bach2
NM_013800 Barx2 homeobox protein BarH-like 2
NM_172378 BC026439 prostaglandin-specific organic anion
NM_009954 Bcar1 breast cancer anti-estrogen resistance protein 1
NM_016707 Bcl11a B-cell lymphoma/leukemia 11A isoform 1
NM_001079883 Bcl11b B-cell lymphoma/leukemia 11B isoform a
NM_001081412 Bcr breakpoint cluster region protein
NM_001039179 Bicd2 protein bicaudal D homolog 2 isoform 1
NM_172506 Boc brother of CDO precursor
NM_028709 Btbd11 ankyrin repeat and BTB/POZ domain-containing
NM_025295 Btd biotinidase
NM_181344 C1rl complement C1r subcomponent-like protein
NM_020263 Cacna2d2 voltage-dependent calcium channel subunit
NM_001037099 Cacnb4 voltage-dependent L-type calcium channel subunit
NM_018883 Camkk1 calcium/calmodulin-dependent protein kinase
NM_007602 Capn5 calpain-5
NM_027195 Casz1 zinc finger protein castor homolog 1 isoform 2
NM_001161458 Cbfb core-binding factor subunit beta isoform 4
NM_029212 Ccdc33 coiled-coil domain-containing protein 33 isoform
NM_029586 Ccdc46 coiled-coil domain-containing protein 46 isoform
NM_025689 Ccdc51 coiled-coil domain-containing protein 51
NM_001039150 Cd44 CD44 antigen isoform b precursor
NM_183016 Cdc42bpb serine/threonine-protein kinase MRCK beta
NM_027219 Cdc42ep1 cdc42 effector protein 1
NM_009864 Cdh1 cadherin-1
NM_153599 Cdk8 cell division protein kinase 8
NM_173370 Cds1 phosphatidate cytidylyltransferase 1
NM_009886 Celsr1 cadherin EGF LAG seven-pass G-type receptor 1
NM_146019 Chd3 chromodomain helicase DNA binding protein 3
NM_027979 Chit1 chitotriosidase-1 precursor
NM_027928 Chst13 carbohydrate sulfotransferase 13
NM_019765 Clip1 CAP-Gly domain-containing linker protein 1
NM_030179 Clip4 CAP-Gly domain-containing linker protein 4
NM_029556 Clybl citrate lyase subunit beta-like protein,
NM_001160211 Cnih3 protein cornichon homolog 3 isoform 2
NM_146105 Cnst consortin
NM_139001 Cspg4 chondroitin sulfate proteoglycan 4 precursor
NM_198013 Cuedc1 CUE domain-containing protein 1 isoform 1
NM_009999 Cyp2b10 cytochrome P450 2B10 isoform 2
NM_007823 Cyp4b1 cytochrome P450 4B1
NM_001114125 Dab2ip disabled homolog 2-interacting protein isoform
NM_010019 Dapk2 death-associated protein kinase 2
NM_027030 Dcps scavenger mRNA-decapping enzyme DcpS
NM_007584 Ddr1 epithelial discoidin domain-containing receptor
NM_001159361 Dip2b disco-interacting protein 2 homolog B isoform 1
NM_027712 Dlgap1 disks large-associated protein 1 isoform 2
NM_001163537 Dnajc5b dnaJ homolog subfamily C member 5B
NM_027878 Dram1 DNA damage-regulated autophagy modulator protein
NM_023842 Dsp desmoplakin
NM_019819 Dusp14 dual specificity protein phosphatase 14
NM_199307 Ece1 endothelin-converting enzyme 1
NM_001162425 Efna1 ephrin-A1 isoform 2
NM_007912 Egfr epidermal growth factor receptor isoform 2
NM_172813 Enox1 ecto-NOX disulfide-thiol exchanger 1
NM_177304 Enpp6 ectonucleotide pyrophosphatase/phosphodiesterase
NM_007940 Ephx2 epoxide hydrolase 2
NM_001003817 Erbb2 receptor tyrosine-protein kinase erbB-2
NM_026170 Ergic1 endoplasmic reticulum-Golgi intermediate
NM_177775 Esyt3 extended synaptotagmin-3
NM_010162 Ext1 exostosin-1
NM_146119 Fam129b niban-like protein 1
NM_153574 Fam13a family with sequence similarity 13, member A1
NM_024244 Fam13c hypothetical protein LOC71721 isoform 1
Gene Description
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NM_177628 Fam167a hypothetical protein LOC219148
NM_145570 Fam176a transmembrane protein 166
NM_026062 Fam69a family with sequence similarity 69, member A
NM_025850 Fank1 fibronectin type 3 and ankyrin repeat domains 1
NM_025386 Fbxo36 F-box only protein 36
NM_010206 Fgfr1 basic fibroblast growth factor receptor 1
NM_175276 Fhod3 FH1/FH2 domain-containing protein 3
NM_030163 Filip1l
NM_021899 Foxj2 forkhead box protein J2
NM_199068 Foxk1 forkhead box protein K1
NM_019740 Foxo3 forkhead box protein O3
NM_053202 Foxp1 forkhead box protein P1 isoform 1
NM_145148 Frmd4b FERM domain-containing protein 4B
NM_172887 Fry furry homolog
NM_028194 Fryl protein furry homolog-like
NM_173739 Galntl4 putative polypeptide
NM_011820 Ggt5 gamma-glutamyltransferase 5
NM_001081125 Gli2 GLI-Kruppel family member GLI2
NM_023120 Gnb1l guanine nucleotide-binding protein subunit
NM_027694 Golga7b Golgin subfamily A member 7B
NM_001081126 Gpr161 G-protein coupled receptor 161
NM_146072 Grik1 glutamate receptor, ionotropic kainate 1 isoform
NM_001145897 Gse1 genetic suppressor element 1 isoform 3
NM_207225 Hdac4 histone deacetylase 4
NM_010412 Hdac5 histone deacetylase 5 isoform 2
NM_010657 Hivep3 transcription factor HIVEP3
NM_001024720 Hmcn1 hemicentin 1
NM_001146323 Hps3 Hermansky-Pudlak syndrome 3 protein homolog
NM_183148 Iffo2 intermediate filament family orphan 2
NM_010513 Igf1r insulin-like growth factor 1 receptor
NM_029646 Il34 interleukin-34 isoform 2
NM_001008700 Il4ra interleukin-4 receptor subunit alpha precursor
NM_198411 Inf2 inverted formin-2
NM_001134383 Iqsec1 IQ motif and SEC7 domain-containing protein 1
NM_001126490 Ism1 isthmin-1 precursor
NM_013565 Itga3 integrin alpha-3
NM_001159564 Itgb6 integrin beta-6 precursor
NM_172471 Itih5 inter-alpha-trypsin inhibitor heavy chain H5
NM_022417 Itm2c integral membrane protein 2C
NM_001081175 Itpkb inositol-trisphosphate 3-kinase B
NM_181593 Itpkc inositol-trisphosphate 3-kinase C
NM_010586 Itpr2 inositol 1,4,5-trisphosphate receptor type 2
NM_080553 Itpr3 inositol 1,4,5-trisphosphate receptor type 3
NM_021878 Jarid2 protein Jumonji
NM_010590 Jub protein ajuba
NM_010593 Jup junction plakoglobin
NM_020005 Kat2b histone acetyltransferase KAT2B isoform 1
NM_001039056 Kcnj15 ATP-sensitive inward rectifier potassium channel
NM_029911 Kcnk10 potassium channel subfamily K member 10
NM_130867 Kirrel kin of IRRE-like protein 1 precursor
NM_021366 Klf13 Krueppel-like factor 13
NM_008453 Klf3 Krueppel-like factor 3
NM_032396 Kremen1 kremen protein 1 precursor
NM_010680 Lama3 laminin subunit alpha-3
NM_008485 Lamc2 laminin subunit gamma-2
NM_173379 Leprel1 prolyl 3-hydroxylase 2 precursor
NM_008494 Lfng beta-1,3-N-acetylglucosaminyltransferase lunatic
NM_010195 Lgr5 leucine-rich repeat-containing G-protein coupled
NM_172589 Lhfpl2 lipoma HMGIC fusion partner-like 2 protein
NM_010718 Limk2 LIM domain kinase 2 isoform a
NM_001111102 Lmna prelamin-A/C isoform C
NM_022983 Lpar3 lysophosphatidic acid receptor 3
NM_001033439 Lrch1 leucine-rich repeat and calponin homology
NM_008377 Lrig1 leucine-rich repeats and immunoglobulin-like
NM_001170788 Lrrc36 leucine-rich repeat-containing protein 36
NM_175641 Ltbp4 latent-transforming growth factor beta-binding
NR_033304 Lypd6
NM_009600 Macf1 microtubule-actin cross-linking factor 1
NM_001004176 Maml3 mastermind-like 3
NM_010789 Meis1 homeobox protein Meis1 isoform A
NM_027756 Mfap3l microfibrillar-associated protein 3-like
NM_153396 Mical3 protein MICAL-3
NM_001113198 Mitf microphthalmia-associated transcription factor
NM_029797 Mnd1 meiotic nuclear division protein 1 homolog
NM_001081100 Morn1 MORN repeat-containing protein 1
NM_021509 Moxd1 DBH-like monooxygenase protein 1 precursor
NM_080456 Mrps6 28S ribosomal protein S6, mitochondrial
NM_001043355 Mtap6 microtubule-associated protein 6 isoform 3
NM_008635 Mtap7 ensconsin isoform 1
NM_001008542 Mxi1 max-interacting protein 1 isoform b
NM_028021 Myh14 myosin-14
NM_181072 Myo1e myosin IE
NM_010865 Myoc myocilin precursor
NM_001113204 Ncam1 neural cell adhesion molecule 1 isoform 3
NM_178772 Nceh1 neutral cholesterol ester hydrolase 1
NM_019681 Ncs1 neuronal calcium sensor 1
NM_001111324 Nedd9 enhancer of filamentation 1 isoform 1
NM_021605 Nek7 serine/threonine-protein kinase Nek7
NM_001081656 Neurl1B E3 ubiquitin-protein ligase NEURL1B
NM_001113210 Nfib nuclear factor 1 B-type isoform 2
NM_008688 Nfic nuclear factor 1 C-type isoform a
NM_010906 Nfix nuclear factor 1 X-type isoform 2
NM_001112698 Ngf beta-nerve growth factor isoform B
NM_001163592 Nhsl1 NHS-like protein 1 isoform 2
NM_001008421 Nol10 nucleolar protein 10
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NM_008719 Npas2 neuronal PAS domain-containing protein 2
NM_001167891 Nrg2 pro-neuregulin-2, membrane-bound isoform
NM_001004363 Nuak1 NUAK family SNF1-like kinase 1
NM_028778 Nuak2 NUAK family SNF1-like kinase 2 isoform B
NM_008750 Nxn nucleoredoxin
NM_008751 Nxph1 neurexophilin-1 precursor
NM_011856 Odz2 teneurin-2
NM_001033254 Pak6 serine/threonine-protein kinase PAK 6
NM_053117 Pard6g partitioning defective 6 homolog gamma
NM_054056 Pawr PRKC apoptosis WT1 regulator protein
NM_029357 Pcdh1 protocadherin-1
NM_001174154 Pcdha4-g protocadherin alpha 4-gamma
NM_033584 Pcdhga1 protocadherin gamma-A1
NM_033593 Pcdhga10 protocadherin gamma-A10
NM_033594 Pcdhga11 protocadherin gamma-A11
NM_033595 Pcdhga12 protocadherin gamma subfamily A, 12
NM_033585 Pcdhga2 protocadherin gamma-A2
NM_033586 Pcdhga3 protocadherin gamma-A3
NM_033587 Pcdhga4 protocadherin gamma-A4
NM_033588 Pcdhga5 protocadherin gamma-A5
NM_033589 Pcdhga6 protocadherin gamma-A6
NM_033590 Pcdhga7 protocadherin gamma subfamily A, 7
NM_033591 Pcdhga8 protocadherin gamma subfamily A, 8
NM_033592 Pcdhga9 protocadherin gamma subfamily A, 9
NM_033574 Pcdhgb1 protocadherin gamma-B1
NM_033575 Pcdhgb2 protocadherin gamma-B2
NM_033576 Pcdhgb4 protocadherin gamma-B4
NM_033577 Pcdhgb5 protocadherin gamma-B5
NM_033578 Pcdhgb6 protocadherin gamma subfamily B, 6
NM_033579 Pcdhgb7 protocadherin gamma-B7
NM_033580 Pcdhgb8 protocadherin gamma subfamily B, 8
NM_011048 Pcsk6 paired basic amino acid cleaving system 4
NM_011057 Pdgfb platelet-derived growth factor subunit B
NM_019417 Pdlim4 PDZ and LIM domain protein 4
NM_022554 Pdlim5 PDZ and LIM domain protein 5 isoform ENH3b
NM_001081064 Pdzd2 PDZ domain-containing protein 2
NM_001164594 Pdzrn4 PDZ domain containing RING finger 4 isoform 2
NM_019781 Pex14 peroxisomal membrane protein PEX14
NM_008841 Pik3r2 phosphatidylinositol 3-kinase regulatory subunit
NM_026880 Pink1 serine/threonine-protein kinase PINK1,
NM_145823 Pitpnc1 cytoplasmic phosphatidylinositol transfer




NM_001114663 Plcl1 inactive phospholipase C-like protein 1
NM_008875 Pld1 phospholipase D1
NM_013738 Plek2 pleckstrin-2
NM_031257 Plekha2 pleckstrin homology domain-containing family A
NM_001033253 Plekhg1 pleckstrin homology domain containing, family G
NM_028199 Plxdc1 plexin domain-containing protein 1 isoform 2
NM_001039509 Pnkd probable hydrolase PNKD isoform 3
NM_001034885 Pnpla1 patatin-like phospholipase domain-containing
NM_176833 Ppm1f protein phosphatase 1F
NM_001135001 Ppp2r5c serine/threonine-protein phosphatase 2A 56 kDa
NM_011155 Ppp5c serine/threonine-protein phosphatase 5
NM_001134460 Prickle2 prickle-like protein 2 isoform b
NM_011101 Prkca protein kinase C alpha type
NM_008856 Prkch protein kinase C eta type
NM_008983 Ptprk receptor-type tyrosine-protein phosphatase kappa
NM_011215 Ptprn2 receptor-type tyrosine-protein phosphatase N2
NM_011218 Ptprs receptor-type tyrosine-protein phosphatase S
NR_003368 Pvt1
NM_009014 Rad51l1 DNA repair protein RAD51 homolog 2
NM_001166408 Rai14 ankycorbin
NM_001145834 Ralgds ral guanine nucleotide dissociation stimulator
NM_001039087 Rapgef1 Rap guanine nucleotide exchange factor (GEF) 1
NM_001080925 Rapgefl1 rap guanine nucleotide exchange factor-like 1
NM_001172122 Rbms3 RNA-binding motif, single-stranded-interacting
NM_001081549 Rcan1 calcipressin-1 isoform 1
NM_007874 Reep5 receptor expression-enhancing protein 5
NM_001085492 Rere arginine-glutamic acid dipeptide repeats
NM_028713 Rftn2 raftlin-2
NM_177740 Rgma repulsive guidance molecule A precursor
NM_173402 Rgs12 regulator of G-protein signalling 12 isoform A
NM_013646 Rora nuclear receptor ROR-alpha
NM_146246 Rp1l1 retinitis pigmentosa 1-like 1 protein
NM_026830 Rreb1 ras-responsive element-binding protein 1 isoform
NM_009821 Runx1 runt-related transcription factor 1 isoform 4
NM_177225 Samd12 sterile alpha motif domain-containing protein
NM_175021 Samd4b protein Smaug homolog 2
NM_175155 Sash1 SAM and SH3 domain-containing protein 1
NM_022886 Scel sciellin
NM_013883 Scmh1 polycomb protein SCMH1 isoform 1
NM_011519 Sdc1 syndecan-1 precursor
NM_011521 Sdc4 syndecan-4 precursor
NM_172800 Sdk2 protein sidekick-2 precursor
NM_011349 Sema3f semaphorin-3F
NM_009154 Sema5a semaphorin-5A
NM_001113486 Septin9 septin-9 isoform a
NM_026535 Serpina12 serpin A12 precursor
NM_198247 Sertad4 SERTA domain-containing protein 4
NM_001162908 Sesn1 sestrin-1 isoform 1
NM_053099 Setbp1 SET-binding protein
NM_028385 Setd5 SET domain-containing protein 5
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NM_013834 Sfrp1 secreted frizzled-related protein 1 precursor
NM_133220 Sgk3 serine/threonine-protein kinase Sgk3
NM_011893 Sh3bp2 SH3 domain-binding protein 2 isoform a
NM_133816 Sh3bp4 SH3 domain-binding protein 4
NM_177364 Sh3pxd2b SH3 and PX domain-containing protein 2B
NM_001146299 Sh3rf2 putative E3 ubiquitin-protein ligase SH3RF2
NM_001113373 Shank2 SH3 and multiple ankyrin repeat domains protein
NM_011385 Ski ski oncogene
NM_207651 Slc14a2 urea transporter 2 isoform a
NM_026244 Slc39a9 zinc transporter ZIP9
NM_009209 Slc6a2 sodium-dependent noradrenaline transporter
NM_178798 Slc7a6 Y+L amino acid transporter 2
NM_008542 Smad6 mothers against decapentaplegic homolog 6
NM_022315 Smoc2 SPARC-related modular calcium-binding protein 2
NM_178362 Sorbs1 sorbin and SH3 domain-containing protein 1
NM_030889 Sorcs2 VPS10 domain-containing receptor SorCS2
NM_001025560 Sox6 transcription factor SOX-6 isoform 3
NM_001144987 Spg20 spartin isoform a
NM_001166463 Spock1 testican-1 isoform 3 precursor
NM_145134 Spsb4 SPRY domain-containing SOCS box protein 4
NM_009177 St3gal1 CMP-N-acetylneuraminate-beta-galactosamide-
NM_145465 Stk24 serine/threonine-protein kinase 24
NM_029858 Ston1 stonin-1
NM_028072 Sulf2 extracellular sulfatase Sulf-2 precursor
NM_178046 Svil
NM_018802 Syt8 synaptotagmin-8
NM_001166584 Tead1 transcriptional enhancer factor TEF-1 isoform 1
NM_011566 Tead3 transcriptional enhancer factor TEF-5 isoform 2
NM_001080979 Tead4 transcriptional enhancer factor TEF-3 isoform b
NM_001113464 Tec tyrosine-protein kinase Tec isoform a
NM_001099275 Tekt5 tektin-5
NM_031199 Tgfa protransforming growth factor alpha
NM_178060 Thra thyroid hormone receptor alpha
NM_009384 Tiam1 T-lymphoma invasion and metastasis-inducing
NM_011594 Timp2 metalloproteinase inhibitor 2 precursor
NM_027154 Tmbim1 transmembrane BAX inhibitor motif-containing
NM_178874 Tmcc2 transmembrane and coiled-coil domains protein 2
NM_019631 Tmem45a transmembrane protein 45A
NM_011609 Tnfrsf1a tumor necrosis factor receptor superfamily
NM_027884 Tns1 tensin 1
NM_001083587 Tns3 tensin-3
NM_172564 Tns4 tensin-4 precursor
NM_175165 Tprg tumor protein p63-regulated gene 1 protein
NM_013718 Trappc3 trafficking protein particle complex subunit 3
NM_023655 Trim29 tripartite motif-containing protein 29
NM_001127262 Trp63 tumor protein 63 isoform f
NM_022017 Trpv4 transient receptor potential cation channel
NM_175414 Tspan9 tetraspanin-9
NM_026132 Txndc8 thioredoxin domain-containing protein 8
NM_001160319 Ubr4 E3 ubiquitin-protein ligase UBR4
NM_016808 Usp2 ubiquitin carboxyl-terminal hydrolase 2 isoform
NM_030180 Usp54 inactive ubiquitin carboxyl-terminal hydrolase
NM_177387 Ust uronyl 2-sulfotransferase
NM_020505 Vav3 guanine nucleotide exchange factor VAV3 isoform
NM_009504 Vdr vitamin D3 receptor
NM_177683 Vgll4 transcription cofactor vestigial-like protein 4
NM_026664 Vps53 vacuolar protein sorting-associated protein 53
NM_012038 Vsnl1 visinin-like protein 1
NM_028640 Whrn whirlin isoform 1
NM_212438 Wiz protein Wiz isoform 1
NM_009523 Wnt4 protein Wnt-4 precursor
NM_019573 Wwox WW domain-containing oxidoreductase
NM_207255 Zfp532 zinc finger protein 532
NM_177086 Zmat4 zinc finger matrin-type protein 4
NM_027230 Zmynd8 protein kinase C-binding protein 1
NM_001168622 Znrf1 E3 ubiquitin-protein ligase ZNRF1 isoform b
NM_028275 1700112E06Rik leucine-rich repeat-containing protein C10orf11
NM_025599 2610528E23Rik hypothetical protein LOC66497
NM_172884 2900026A02Rik hypothetical protein LOC243219
NM_028473 3110079O15Rik hypothetical protein LOC73234 precursor
NM_028732 4632428N05Rik platelet receptor Gi24 isoform 1 precursor
NM_026359 4930578I06Rik hypothetical protein LOC67750
NM_178682 4933426M11Rik hypothetical protein LOC217684
NM_178801 6030446N20Rik transmembrane protein C18orf45 homolog
NM_145448 9030617O03Rik hypothetical protein LOC217830 precursor
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PROXIMAL (2-50kb)
Transcript Name Gene name
NM_183188 A2bp1 fox-1 homolog A isoform alpha
NM_145415 AA408296 digestive organ expansion factor homolog
NM_013454 Abca1 ATP-binding cassette sub-family A member 1
NM_172678 Acad9 acyl-CoA dehydrogenase family member 9,
NM_023735 Actr3 actin-related protein 3
NM_144899 Adamtsl4 ADAMTS-like protein 4 precursor
NM_133919 Aff1 AF4/FMR2 family member 1 isoform 2
NM_145566 Agfg2 arf-GAP domain and FG repeats-containing protein
NR_024189 AI837181
NM_172645 AI848100 AI848100
NM_172393 Aim1 absent in melanoma 1 protein
NM_029332 Akap13 A kinase (PRKA) anchor protein 13
NM_007436 Aldh3a1 aldehyde dehydrogenase, dimeric NADP-preferring
NM_009663 Alox5ap arachidonate 5-lipoxygenase-activating protein
NM_019764 Amotl2 angiomotin-like protein 2
NM_144524 Angel1 protein angel homolog 1
NM_009670 Ank3 ankyrin 3, epithelial isoform g
NM_153589 Ano2 anoctamin-2
NM_133237 Apcdd1 protein APCDD1 precursor
NM_007473 Aqp7 aquaporin-7
NM_013476 Ar androgen receptor
NM_133674 Arhgef5 Rho guanine nucleotide exchange factor (GEF) 5
NM_001085355 Arid1b AT rich interactive domain 1B (Swi1 like)
NM_007494 Ass1 argininosuccinate synthase
NM_026402 Atg3 ubiquitin-like-conjugating enzyme ATG3
NM_053069 Atg5 autophagy protein 5
NM_144900 Atp1a1 sodium/potassium-transporting ATPase subunit
NM_213616 Atp2b4 plasma membrane calcium ATPase 4 isoform x/e




NM_007520 Bach1 transcription regulator protein BACH1
NM_013863 Bag3 BAG family molecular chaperone regulator 3
NM_001044750 Banf2 barrier-to-autointegration factor-like protein
NR_027893 BB123696
NR_024085 BC006965
NM_145601 BC016201 cDNA sequence BC016201 isoform 2
NM_145972 BC027231 hypothetical protein LOC212547
NM_173022 BC048403 hypothetical protein LOC270802
NM_001164369 Bcas1 breast carcinoma-amplified sequence 1 homolog
NM_207681 Bcl2l11 bcl-2-like protein 11 isoform 2
NM_030256 Bcl9l B-cell CLL/lymphoma 9-like protein
NM_199028 Bend3 BEN domain-containing protein 3
NM_007556 Bmp6 bone morphogenetic protein 6 precursor
NM_007559 Bmp8b bone morphogenetic protein 8B precursor
NM_009758 Bmpr1a bone morphogenetic protein receptor type-1A
NM_007562 Bnc1 zinc finger protein basonuclin-1
NM_172870 Bnc2 zinc finger protein basonuclin-2
NM_027453 Btf3l4 transcription factor BTF3 homolog 4
NM_177584 Btla B- and T-lymphocyte attenuator isoform 2
NR_015546 C130026L21Rik
NM_198037 Cachd1 VWFA and cache domain-containing protein 1
NM_001008706 Calm5 calmodulin 5
NM_027416 Calml3 calmodulin-like protein 3
NM_144817 Camk1g calcium/calmodulin-dependent protein kinase type
NM_001039139 Camk2g calcium/calmodulin-dependent protein kinase type
NM_145595 Cbr4 carbonyl reductase family member 4
NM_175369 Ccdc122 coiled-coil domain-containing protein 122
NM_007631 Ccnd1 G1/S-specific cyclin-D1
NM_007635 Ccng2 cyclin-G2
NM_019937 Ccnl1 cyclin-L1
NM_007719 Ccr7 C-C chemokine receptor type 7 precursor
NM_153098 Cd109 CD109 antigen precursor
NM_010818 Cd200 OX-2 membrane glycoprotein precursor
NM_001111059 Cd34 hematopoietic progenitor cell antigen CD34
NM_001033122 Cd69 early activation antigen CD69
NM_009856 Cd83 CD83 antigen precursor
NM_007657 Cd9 CD9 antigen
NM_007658 Cdc25a M-phase inducer phosphatase 1
NM_001033373 Cdk15 cell division protein kinase 15
NM_008795 Cdk18 cell division protein kinase 18
NM_001111099 Cdkn1a cyclin-dependent kinase inhibitor 1
NM_009884 Cebpg CCAAT/enhancer-binding protein gamma
NM_145475 Cerk ceramide kinase
NM_172759 Ces5 carboxylesterase 5
NM_001081345 Chd2 chromodomain helicase DNA binding protein 2
NM_001081417 Chd7 chromodomain-helicase-DNA-binding protein 7
NM_027882 Cic protein capicua homolog isoform a
NM_010828 Cited2 cbp/p300-interacting transactivator 2
NM_175451 Ckap4 cytoskeleton-associated protein 4
NM_171826 Cldnd1 claudin domain-containing protein 1
NM_013748 Clnk cytokine-dependent hematopoietic cell linker
NM_027294 Cmtm8 CKLF-like MARVEL transmembrane domain-containing
NM_033570 Cnnm4 metal transporter CNNM4
NM_009931 Col4a1 collagen alpha-1(IV) chain precursor
NM_027904 Cpn2 carboxypeptidase N subunit 2
NM_007759 Crabp2 cellular retinoic acid-binding protein 2
NM_015800 Crim1 cysteine-rich motor neuron 1 protein precursor
NM_024223 Crip2 cysteine-rich protein 2
NM_146087 Csnk1a1 casein kinase I isoform alpha
NM_007791 Csrp1 cysteine and glycine-rich protein 1
Gene Description
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NM_133710 Ctdspl CTD small phosphatase-like protein
NM_023465 Ctnnbip1 beta-catenin-interacting protein 1
NM_019568 Cxcl14 C-X-C motif chemokine 14 precursor
NM_007722 Cxcr7 C-X-C chemokine receptor type 7
NM_025558 Cyb5b cytochrome b5 type B precursor
NM_029787 Cyb5r3 NADH-cytochrome b5 reductase 3
NM_007814 Cyp2b19 cytochrome P450 2B19
NM_001101478 D3Ertd254e hypothetical protein LOC241944
NM_026102 Daam1 disheveled-associated activator of morphogenesis
NM_029723 Dapl1 death-associated protein-like 1
NM_207533 Dbx2 developing brain homeobox 2
NM_178896 Dcun1d4 DCN1-like protein 4 isoform B
NM_026993 Ddah1 N(G),N(G)-dimethylarginine
NM_007916 Ddx19a ATP-dependent RNA helicase DDX19A
NM_007853 Degs1 sphingolipid delta(4)-desaturase DES1
NM_024440 Derl3 derlin-3
NM_015814 Dkk3 dickkopf-related protein 3 precursor
NM_007865 Dll1 delta-like protein 1 precursor
NM_001081371 Dmxl1 dmX-like protein 1
NM_018808 Dnajb1 dnaJ homolog subfamily B member 1
NM_020266 Dnajb2 dnaJ homolog subfamily B member 2 isoform 1
NM_019759 Dpt dermatopontin precursor
NM_181680 Dsg1c desmoglein-1-gamma precursor
NR_015511 E030011O05Rik
NR_015614 E230029C05Rik
NM_010332 Ednra endothelin-1 receptor precursor
NM_007910 Efna4 ephrin-A4 precursor
NM_178444 Egfl7 epidermal growth factor-like protein 7 isoform 1
NM_145139 Eif3l eukaryotic translation initiation factor 3
NM_145625 Eif4b eukaryotic translation initiation factor 4B
NM_023479 Elac2 zinc phosphodiesterase ELAC protein 2
NM_148941 Elovl4 elongation of very long chain fatty acids
NM_134255 Elovl5 elongation of very long chain fatty acids
NM_023119 Eno1 alpha-enolase
NM_019427 Epb4.1l4b band 4.1-like protein 4B
NM_010143 Ephb3 ephrin type-B receptor 3 precursor
NM_026067 Eri1 3'-5' exoribonuclease 1
NM_133753 Errfi1 ERBB receptor feedback inhibitor 1
NM_011809 Ets2 protein C-ets-2
NM_010165 Eya2 eyes absent homolog 2
NM_172647 F11r junctional adhesion molecule A precursor
NM_010171 F3 tissue factor precursor
NM_178764 Fam168a hypothetical protein LOC319604
NM_175514 Fam171b family with sequence similarity 171, member B
NM_138746 Fam50b DNA segment, human D6S2654E
NM_026143 Far1 fatty acyl-CoA reductase 1
NM_175127 Fbxo28 F-box only protein 28
NM_010193 Fem1b protein fem-1 homolog B
NM_010197 Fgf1 heparin-binding growth factor 1 precursor
NM_008010 Fgfr3 fibroblast growth factor receptor 3 isoform 1
NM_001033301 Fhdc1 FH2 domain-containing protein 1
NM_018881 Fmo2 dimethylaniline monooxygenase [N-oxide-forming]
NM_010234 Fos proto-oncogene c-Fos
NM_008037 Fosl2 fos-related antigen 2
NM_183298 Foxe1 forkhead box protein E1
NM_194060 Foxo6 forkhead box protein O6
NM_013522 Frg1 protein FRG1
NM_028127 Frmd6 FERM domain-containing protein 6
NM_016893 Fut8 alpha-(1,6)-fucosyltransferase
NM_020510 Fzd2 frizzled-2 precursor
NM_008086 Gas1 growth arrest-specific protein 1
NM_008091 Gata3 trans-acting T-cell-specific transcription
NM_153564 Gbp5 guanylate-binding protein 5
NM_010276 Gem GTP-binding protein GEM
NM_010279 Gfra1 GDNF family receptor alpha-1 precursor
NM_020014 Gfra4 GDNF family receptor alpha-4 isoform 2




NM_001127576 Gm1564 hypothetical protein LOC268491
NM_201366 Gm1631 hypothetical protein LOC381371
NM_001033403 Gm1968 hypothetical protein LOC328657
NR_028424 Gm2176
NM_001033333 Gm239 hypothetical protein LOC237558
NM_198657 Gm5148 hypothetical protein LOC381438
NM_001101609 Gm9376 hypothetical protein LOC668814
NM_001042672 Gpcpd1 putative glycerophosphocholine phosphodiesterase
NM_133776 Gpr110 G-protein coupled receptor 110 precursor
NM_001033493 Gpr111 G protein-coupled receptor 111
NM_019925 Gpr132 probable G-protein coupled receptor 132
NM_177366 Gpr157 probable G-protein coupled receptor 157
NM_181444 Gprc5a retinoic acid-induced protein 3
NM_183209 Gprin2 G protein-regulated inducer of neurite outgrowth
NM_001033498 Gramd2 GRAM domain-containing protein 2
NM_019518 Grasp general receptor for phosphoinositides
NM_001033426 Grxcr2 glutaredoxin domain-containing cysteine-rich
NM_146120 Gsn gelsolin precursor
NM_001080746 Gtf2i general transcription factor II-I isoform 1
NM_010376 H13 minor histocompatibility antigen H13 isoform 2
NM_175000 Hbq1 hemoglobin, theta T2
NM_145567 Hibadh 3-hydroxyisobutyrate dehydrogenase,
NM_010431 Hif1a hypoxia-inducible factor 1-alpha
NM_025812 Hmg20a high mobility group protein 20A
NM_010439 Hmgb1 high mobility group protein B1
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NM_053263 Hnrnpa3 heterogeneous nuclear ribonucleoprotein A3
NM_175606 Hopx homeodomain-only protein
NM_008266 Hoxb1 homeobox protein Hox-B1
NM_016677 Hpcal1 hippocalcin-like protein 1
NM_021429 Hs1bp3 HCLS1-binding protein 3
NM_010480 Hsp90aa1 heat shock protein HSP 90-alpha
NM_010479 Hspa1a heat shock 70 kDa protein 1A
NM_031166 Id4 DNA-binding protein inhibitor ID-4
NM_008329 Ifi204 interferon-activable protein 204
NM_009879 Ift81 intraflagellar transport protein 81 homolog
NM_001122737 Igf2 insulin-like growth factor II isoform 2
NM_010518 Igfbp5 insulin-like growth factor-binding protein 5
NM_010550 Il11ra2 interleukin-11 receptor subunit alpha-2
NM_001127363 Inpp5a inositol polyphosphate-5-phosphatase A isoform
NM_016721 Iqgap1 ras GTPase-activating-like protein IQGAP1
NM_001164598 Irf2bp2 interferon regulatory factor 2 binding protein
NM_015783 Isg15 ubiquitin-like protein ISG15 precursor
NM_008410 Itm2b integral membrane protein 2B
NM_001033380 Itpripl2 inositol 1,4,5-triphosphate receptor-interacting
NM_027391 Iyd iodotyrosine dehalogenase 1 precursor
NM_010592 Jund transcription factor jun-D
NM_001081140 Kcna10 potassium voltage-gated channel subfamily A
NM_025734 Kcng4 potassium voltage-gated channel subfamily G
NR_027627 Kcnk2
NM_001097621 Kif26a kinesin-like protein KIF26A
NM_178357 Klf11 Krueppel-like factor 11
NM_023184 Klf15 Krueppel-like factor 15
NM_010637 Klf4 Krueppel-like factor 4
NM_011803 Klf6 Krueppel-like factor 6
NM_010638 Klf9 Krueppel-like factor 9
NM_001039042 Klk13 kallikrein 13 precursor
NM_001159374 Krt32 keratin, type I cuticular Ha2
NM_212483 Krt42 keratin, type I cytoskeletal 42
NM_008476 Krt6a keratin, type II cytoskeletal 6A
NM_212487 Krt78 keratin Kb40
NM_031170 Krt8 keratin, type II cytoskeletal 8
NM_008477 Ktn1 kinectin
NM_008640 Laptm4a lysosomal-associated transmembrane protein 4A
NM_010691 Lbx1 transcription factor LBX1
NM_010699 Ldha L-lactate dehydrogenase A chain isoform 1
NM_001081272 Ldlrad1 low-density lipoprotein receptor class A
NM_178886 Ldlrad3 low-density lipoprotein receptor class A
NM_145554 Ldlrap1 low density lipoprotein receptor adapter protein
NM_027042 Lelp1 late cornified envelope-like proline-rich
NM_001083188 Lig1 DNA ligase 1
NM_019980 Litaf lipopolysaccharide-induced tumor necrosis
NM_001081150 Lonrf1 LON peptidase N-terminal domain and RING finger
NM_178665 Lpp lipoma-preferred partner homolog isoform 1
NM_153542 Lrrc20 leucine-rich repeat-containing protein 20
NM_026309 Lsm3 U6 snRNA-associated Sm-like protein LSm3
NM_026915 Lyzl4 lysozyme-like protein 4 precursor
NM_001013813 Maml2 mastermind like 2 isoform 1
NM_145569 Mat2a S-adenosylmethionine synthase isoform type-2
NM_001081160 Mdga1 MAM domain-containing
NM_172424 Med13l mediator of RNA polymerase II transcription
NM_026039 Med18 mediator of RNA polymerase II transcription
NM_026119 Med4 mediator of RNA polymerase II transcription







NM_008626 Mrc2 C-type mannose receptor 2 precursor
NM_025796 Mrpl33 39S ribosomal protein L33, mitochondrial
NM_025927 Mrpl45 39S ribosomal protein L45, mitochondrial
NM_023331 Mrpl46 39S ribosomal protein L46, mitochondrial
NM_001024917 N4bp2 Nedd4 binding protein 2
NM_194335 Naif1 nuclear apoptosis-inducing factor 1
NM_008675 Nbl1 neuroblastoma suppressor of tumorigenicity 1
NM_025424 Nenf neudesin precursor
NM_001047159 Net1 neuroepithelial cell-transforming gene 1 protein
NM_010903 Nfe2l3 nuclear factor erythroid 2-related factor 3
NM_017373 Nfil3 nuclear factor interleukin-3-regulated protein
NM_008689 Nfkb1 nuclear factor NF-kappa-B p105 subunit
NM_001109985 Nos1ap carboxyl-terminal PDZ ligand of neuronal nitric
NM_001163504 Nr1h4 bile acid receptor isoform 2
NM_008173 Nr3c1 glucocorticoid receptor
NM_001036293 Nrbf2 nuclear receptor-binding factor 2
NM_019761 Nxt1 NTF2-related export protein 1
NM_145153 Oas1f 2'-5'oligoadenylate synthetase 1F
NM_175360 Obfc1 CST complex subunit STN1
NM_008757 Odf1 outer dense fiber protein 1
NM_172143 Ofcc1 orofacial cleft 1 candidate gene 1 protein
NM_052976 Ophn1 oligophrenin-1
NM_007538 Opn1sw blue-sensitive opsin
NM_144500 Osbpl2 oxysterol-binding protein-related protein 2
NM_027950 Osgin1 oxidative stress-induced growth inhibitor 1
NM_001159509 Pacsin2 protein kinase C and casein kinase substrate in
NM_145962 Pank3 pantothenate kinase 3
NM_029595 Pbp2 phosphatidylethanolamine-binding protein 2
NM_018814 Pcnx pecanex-like protein 1
NM_016798 Pdlim3 PDZ and LIM domain protein 3
NM_018884 Pdzrn3 E3 ubiquitin-protein ligase PDZRN3
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NM_033602 Peli2 protein pellino homolog 2
NM_011065 Per1 period circadian protein homolog 1
NM_001042407 Pex10 peroxisome biogenesis factor 10
NM_133232 Pfkfb3 6-phosphofructo-2-kinase/fructose-2,
NM_019703 Pfkp 6-phosphofructokinase type C
NM_008831 Phb prohibitin
NM_007905 Phc1 polyhomeotic-like protein 1 isoform a
NM_013750 Phlda3 pleckstrin homology-like domain family A member
NM_133821 Phlpp1 PH domain leucine-rich repeat-containing protein
NM_026078 Pigc phosphatidylinositol
NM_013784 Pign GPI ethanolamine phosphate transferase 1
NM_029094 Pik3cb phosphatidylinositol-4,5-bisphosphate 3-kinase
NM_001146200 Pik3cg phosphatidylinositol-4,5-bisphosphate 3-kinase
NM_177905 Piwil4 piwi-like protein 4
NM_001164203 Plec plectin isoform 1hij
NM_153804 Plekhg3 pleckstrin homology domain-containing family G
NM_008882 Plxna2 plexin-A2 precursor
NM_011141 Pou3f1 POU domain, class 3, transcription factor 1
NM_008904 Ppargc1a peroxisome proliferator-activated receptor gamma
NM_008909 Ppl periplakin
NM_133485 Ppp1r14c protein phosphatase 1 regulatory subunit 14C
NM_133819 Ppp1r15b protein phosphatase 1 regulatory subunit 15B
NM_016854 Ppp1r3c protein phosphatase 1 regulatory subunit 3C
NM_001161362 Ppp2r3a protein phosphatase 2, regulatory subunit B'',
NM_011103 Prkcd protein kinase C delta type
NM_008859 Prkcq protein kinase C theta type
NM_011170 Prnp major prion protein precursor
NM_001128605 Psen2 presenilin-2
NM_011968 Psma6 proteasome subunit alpha type-6
NM_022415 Ptges prostaglandin E synthase
NM_001130409 Ptk2 focal adhesion kinase 1 isoform 2
NM_008977 Ptpn2 tyrosine-protein phosphatase non-receptor type 2
NM_001160221 Pum2 pumilio homolog 2 isoform 2
NM_001033206 Pwwp2b PWWP domain containing 2 isoform 2
NM_001033267 Qrich2 glutamine rich 2
NM_153559 Qsox2 sulfhydryl oxidase 2
NM_016676 Rab10 ras-related protein Rab-10
NM_009003 Rab4a ras-related protein Rab-4A
NM_145510 Rabif guanine nucleotide exchange factor MSS4
NM_009021 Rai1 retinoic acid-induced protein 1
NM_022327 Ralb ras-related protein Ral-B precursor
NM_011244 Rarg retinoic acid receptor gamma isoform 1
NM_138956 Rassf3 ras association domain-containing protein 3
NM_009826 Rb1cc1 RB1-inducible coiled-coil protein 1
NM_145923 Rell1 RELT-like protein 1 precursor
NM_026380 Rgs8 regulator of G-protein signaling 8
NM_139228 Rhbdl3 rhomboid-related protein 3
NM_007483 Rhob rho-related GTP-binding protein RhoB precursor
NM_026357 Ribc2 RIB43A-like with coiled-coils protein 2
NM_177158 Rinl ras and Rab interactor-like protein
NM_024242 Riok1 serine/threonine-protein kinase RIO1
NM_001162863 Rnase10 ribonuclease-like protein 10 isoform 2
NM_013846 Ror2 tyrosine-protein kinase transmembrane receptor
NM_026533 Rps13 40S ribosomal protein S13
NM_019924 Rps6ka4 ribosomal protein S6 kinase alpha-4
NM_028040 Rpusd4 RNA pseudouridylate synthase domain-containing
NM_009104 Rrm2 ribonucleoside-diphosphate reductase subunit M2
NM_019743 Rybp RING1 and YY1-binding protein
NM_016741 Scarb1 scavenger receptor class B member 1
NM_011325 Scnn1b amiloride-sensitive sodium channel subunit beta
NM_011348 Sema3e semaphorin-3E precursor
NM_023475 Serhl serine hydrolase-like protein
NM_008458 Serpina3c serine protease inhibitor A3C precursor
NM_018754 Sfn 14-3-3 protein sigma
NM_001136080 Sgca alpha-sarcoglycan isoform 1
NM_001161845 Sgk1 serine/threonine-protein kinase Sgk1 isoform a
NM_027921 Slc16a14 monocarboxylate transporter 14
NM_011395 Slc22a3 solute carrier family 22 member 3
NM_018824 Slc23a2 solute carrier family 23 member 2
NM_022880 Slc29a1 equilibrative nucleoside transporter 1 isoform
NM_011400 Slc2a1 solute carrier family 2, facilitated glucose
NM_009579 Slc30a1 zinc transporter 1
NM_028123 Slc37a3 sugar phosphate exchanger 3
NM_027052 Slc38a4 sodium-coupled neutral amino acid transporter 4
NM_009320 Slc6a6 sodium- and chloride-dependent taurine
NM_007513 Slc7a1 high affinity cationic amino acid transporter 1
NM_029949 Snapc3 snRNA-activating protein complex subunit 3
NM_175483 Snx33 sorting nexin-33
NM_007707 Socs3 suppressor of cytokine signaling 3
NM_011434 Sod1 superoxide dismutase [Cu-Zn]
NM_172752 Sorbs2 sorbin and SH3 domain-containing protein 2
NM_025312 Sostdc1 sclerostin domain-containing protein 1
NM_009242 Sparc SPARC precursor
NM_027609 Speer4f spermatogenesis associated glutamate (E)-rich
NM_001164140 Spert spermatid-associated protein isoform 4
NM_183284 Spink2 serine protease inhibitor Kazal-type 2
NM_029012 Sppl3 signal peptide peptidase-like 3
NM_001025395 Src neuronal proto-oncogene tyrosine-protein kinase
NM_012058 Srp9 signal recognition particle 9 kDa protein





NM_031394 Sytl2 synaptotagmin-like protein 2 isoform 3
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NM_001040435 Tacc3 transforming acidic coiled-coil-containing
NM_011530 Tap2 antigen peptide transporter 2
NM_001159907 Tarbp1 TAR (HIV-1) RNA binding protein 1
NM_172310 Tarsl2 probable threonyl-tRNA synthetase 2,
NM_175225 Tasp1 threonine aspartase 1 isoform a
NM_019636 Tbc1d1 TBC1 domain family member 1
NM_001163455 Tbck TBC domain-containing protein kinase-like
NM_011544 Tcf12 transcription factor 12
NM_031182 Tcfap4 transcription factor AP-4
NM_023755 Tcfcp2l1 transcription factor CP2-like protein 1
NM_172605 Tdrd3 tudor domain-containing protein 3
NM_011902 Tekt2 tektin-2
NM_009357 Tex261 protein TEX261
NM_177588 Thnsl1 threonine synthase-like 1 isoform a
NM_011597 Tjp2 tight junction protein ZO-2 isoform 2
NM_019725 Tle2 transducin-like enhancer protein 2
NM_025453 Tm4sf20 transmembrane 4 L6 family member 20
NM_172051 Tmcc3 transmembrane and coiled-coil domains protein 3
NM_028336 Tmem107 transmembrane protein 107 isoform 2
NM_018872 Tmem131 transmembrane protein 131
NM_177260 Tmem154 transmembrane protein 154 precursor
NM_001081283 Tmem28 transmembrane protein FAM155B
NM_001163172 Tmem92 transmembrane protein 92 isoform 1
NM_198967 Tmtc1 transmembrane and TPR repeat-containing protein
NM_011607 Tnc tenascin
NM_009397 Tnfaip3 tumor necrosis factor alpha-induced protein 3
NM_001159503 Tnfsf12-Tnfsf13 tumor necrosis factor (ligand) superfamily,
NM_001110147 Tnk2 activated CDC42 kinase 1 isoform 2
NM_001130180 Tnnt2 troponin T, cardiac muscle isoform e
NM_178242 Tnrc18 trinucleotide repeat-containing gene 18 protein
NM_020507 Tob2 protein Tob2
NM_011906 Tpra1 transmembrane protein adipocyte-associated 1
NM_194343 Trim45 tripartite motif-containing protein 45 isoform
NM_178110 Trim62 tripartite motif-containing protein 62
NM_001160412 Triml2 tripartite motif family-like 2
NM_001085421 Tspyl5 testis-specific Y-encoded-like protein 5
NM_027238 Ttc39b tetratricopeptide repeat protein 39B
NM_029264 Ttll10 protein polyglycylase TTLL10
NM_017379 Tuba8 tubulin alpha-8 chain
NM_019913 Txn2 thioredoxin, mitochondrial precursor
NM_010633 Uhmk1 serine/threonine-protein kinase Kist
NM_026031 Utp11l probable U3 small nucleolar RNA-associated
NM_011694 Vdac1 voltage-dependent anion-selective channel
NM_172255 Wdr11 WD repeat-containing protein 11
NM_145514 Wdr26 WD repeat-containing protein 26
NM_030215 Wrnip1 ATPase WRNIP1
NM_019653 Wsb1 WD repeat and SOCS box-containing protein 1
NM_011724 Xirp1 xin actin-binding repeat-containing protein 1
NM_001005341 Ypel2 protein yippee-like 2
NM_011740 Ywhaz 14-3-3 protein zeta/delta
NM_001122676 Zcchc2 zinc finger CCHC domain-containing protein 2
NM_001033261 Zfc3h1 proline/serine-rich coiled-coil 2
NM_199029 Zfp395 zinc finger protein 395
NM_172867 Zfp462 zinc finger protein 462
NM_201609 Zfp652 zinc finger protein 652
NM_001146000 Zfp710 zinc finger protein 710 isoform b
NM_153194 Zfp740 zinc finger protein 740
NM_172919 Zfp846 zinc finger protein 846
NM_145456 Zswim6 zinc finger SWIM domain-containing protein 6
NM_001045536 Zzef1 zinc finger ZZ-type and EF-hand
NM_025319 0610009B22Rik hypothetical protein LOC66050
NM_001164210 1110032A04Rik small subunit of serine palmitoyltransferase B
NM_001081005 1500012F01Rik hypothetical protein LOC68949
NM_024283 1500015O10Rik augurin precursor
NM_027063 1700013G24Rik hypothetical protein LOC69380
NM_027966 1700019O17Rik hypothetical protein LOC71863
NR_003953 1700022A21Rik
NM_027970 1700023E05Rik hypothetical protein LOC71868
NR_027909 1700029M20Rik
NM_028851 1700080O16Rik hypothetical protein LOC74279
NM_133998 1810008A18Rik hypothetical protein LOC108707
NM_027129 2310035K24Rik hypothetical protein LOC69596
NM_025621 2310050C09Rik hypothetical protein LOC66533




NM_172500 4831426I19Rik nesprin-3 isoform beta
NM_029440 4930434E21Rik hypothetical protein LOC381693
NR_015535 4930567H12Rik
NM_001145759 4930571K23Rik hypothetical protein LOC75861
NR_027879 4930583K01Rik
NM_001081063 4933401F05Rik serine protease 55 precursor
NM_028908 4933403G14Rik hypothetical protein LOC74393
NM_001081101 4933407H18Rik hypothetical protein LOC71101
NR_027843 4933432I09Rik
NM_176921 6030419C18Rik hypothetical protein LOC319477
NM_172859 6330439K17Rik ankyrin repeat-containing protein C20orf12
NM_026377 6330577E15Rik hypothetical protein LOC67788




Transcript Name Gene name
NM_001081067 A1bg alpha-1B-glycoprotein precursor
NM_177039 A530016L24Rik transmembrane protein C14orf180 homolog
NM_025271 Actl7b actin-like protein 7B
NM_007396 Acvr2a activin receptor type-2A precursor
NM_009623 Adcy8 adenylate cyclase type 8
NM_020332 Ank progressive ankylosis protein
NM_001080933 Ankfn1 ankyrin repeat and fibronectin type-III
NM_001167883 Ankrd50 ankyrin repeat domain 50
NM_007481 Arf6 ADP-ribosylation factor 6
NM_183019 Arhgef4 rho guanine nucleotide exchange factor 4
NM_007487 Arl4a ADP-ribosylation factor-like protein 4A
NM_001042592 Arrdc4 arrestin domain containing 4 isoform 1
NM_176999 Atp10b probable phospholipid-transporting ATPase VB
NM_007502 Atp1b3 sodium/potassium-transporting ATPase subunit
NM_175015 Atp5g3 ATP synthase lipid-binding protein,
NM_001001488 Atp8b1 probable phospholipid-transporting ATPase IC
NM_015732 Axin2 axin-2
NM_001102458 Azin1 antizyme inhibitor 1
NM_001033350 Bank1 B-cell scaffold protein with ankyrin repeats
NM_016812 Banp protein BANP isoform 2
NM_130452 Bbox1 gamma-butyrobetaine dioxygenase
NM_013867 Bcar3 breast cancer anti-estrogen resistance protein
NM_007553 Bmp2 bone morphogenetic protein 2 precursor
NM_007557 Bmp7 bone morphogenetic protein 7 precursor
NM_028472 Bmper BMP-binding endothelial regulator protein
NM_009782 Cacna1e voltage-dependent R-type calcium channel subunit
NM_018770 Cadm1 cell adhesion molecule 1 isoform c
NM_001160399 Ccdc112 coiled-coil domain-containing protein 112
NM_201362 Ccdc68 coiled-coil domain-containing protein 68
NM_009866 Cdh11 cadherin-11 preproprotein
NM_198656 Cdh26 cadherin-like protein 26 precursor
NM_009868 Cdh5 cadherin-5 precursor
NM_144536 Cdkal1 CDK5 regulatory subunit-associated protein
NM_001024624 Cdkl5 cyclin-dependent kinase-like 5
NM_029976 Cdkn2aipnl CDKN2AIP N-terminal-like protein
NM_028850 Chic2 cysteine-rich hydrophobic domain 2 protein
NM_009893 Chrd chordin precursor
NM_027998 Cldn23 claudin-23
NM_173422 Colec10 collectin-10 precursor
NM_133805 Cops8 COP9 signalosome complex subunit 8
NM_025815 Cpne8 copine-8 isoform 1
NM_001080809 Cps1 carbamoyl-phosphate synthase [ammonia],
NM_010217 Ctgf connective tissue growth factor precursor
NM_021704 Cxcl12 stromal cell-derived factor 1 isoform alpha
NM_144853 Cyyr1 cysteine and tyrosine-rich protein 1 precursor
NM_001109990 D0H4S114 neuronal protein 3.1
NM_001008702 Dab2 disabled homolog 2 isoform b
NM_029653 Dapk1 death-associated protein kinase 1
NM_019967 Dbc1 deleted in bladder cancer protein 1 homolog
NM_173419 Dleu7 leukemia-associated protein 7 homolog
NM_007862 Dlg1 disks large homolog 1
NM_029297 Dynlrb2 dynein light chain roadblock-type 2
NM_001014390 Dyrk2 dual specificity
NM_021469 Dysf dysferlin isoform 1
NM_010104 Edn1 endothelin-1 precursor
NM_001001932 Eea1 early endosome antigen 1
NM_025769 Efcab1 EF-hand calcium-binding domain-containing
NM_010111 Efnb2 ephrin-B2 precursor
NM_025829 Eif4e3 eukaryotic translation initiation factor 4E type
NM_007930 Enc1 ectoderm-neural cortex protein 1
NM_013511 Epb4.1l2 band 4.1-like protein 2
NM_007961 Etv6 transcription factor ETV6
NM_010164 Eya1 eyes absent homolog 1
NM_173426 Fam110b hypothetical protein LOC242297
NM_134096 Fam19a5 TAFA5 protein
NM_019995 Fam48a family with sequence similarity 48, member A
NM_178390 Fam53a dorsal neural-tube nuclear protein
NM_201361 Fam82a1 regulator of microtubule dynamics protein 2
NM_001045518 Fam83b hypothetical protein LOC208994
NM_001033980 Fam92b hypothetical protein LOC436062
NM_183221 Fat4 protocadherin Fat 4 precursor
NM_198029 Fermt1 fermitin family homolog 1
NM_201601 Fgfr2 fibroblast growth factor receptor 2 isoform
NM_001113412 Fggy FGGY carbohydrate kinase domain-containing
NM_201518 Flrt2 fibronectin leucine rich transmembrane protein
NM_207636 Fndc3a fibronectin type-III domain-containing protein
NM_019739 Foxo1 forkhead box protein O1
NM_008239 Foxq1 forkhead box protein Q1
NM_008057 Fzd7 frizzled-7 precursor
NM_011817 Gadd45g growth arrest and DNA damage-inducible protein
NM_008082 Galr1 galanin receptor type 1
NM_030719 Gatsl2 GATS-like protein 2
NM_010267 Gdap1 ganglioside-induced differentiation-associated
NM_008115 Gfra2 GDNF family receptor alpha-2
NM_008131 Glul glutamine synthetase
NM_001005422 Gm1574 hypothetical protein LOC380842
NM_001005420 Gm347 hypothetical protein LOC241289
NM_001033266 Gm525 hypothetical protein LOC217071 precursor
NM_001033411 Gm826 hypothetical protein LOC329554
NM_008149 Gpam glycerol-3-phosphate acyltransferase 1,
NM_001002268 Gpr126 G-protein coupled receptor 126 precursor
NM_025325 Haao 3-hydroxyanthranilate 3,4-dioxygenase
Gene Description
179
NM_008216 Has2 hyaluronan synthase 2
NM_010437 Hivep2 transcription factor HIVEP2
NM_010481 Hspa9 stress-70 protein, mitochondrial
NM_019960 Hspb3 heat shock protein beta-3
NM_008316 Hus1 checkpoint protein HUS1
NM_010496 Id2 DNA-binding protein inhibitor ID-2
NM_008343 Igfbp3 insulin-like growth factor-binding protein 3
NM_008381 Inhbb inhibin beta B chain precursor
NM_133748 Insig2 insulin-induced gene 2 protein isoform 1
NM_010573 Irx1 iroquois-class homeodomain protein IRX-1
NM_010574 Irx2 iroquois-class homeodomain protein IRX-2
NM_008393 Irx3 iroquois-class homeodomain protein IRX-3
NM_013822 Jag1 protein jagged-1 precursor
NM_001102670 Kbtbd8 kelch repeat and BTB domain-containing protein 8
NM_013692 Klf10 Krueppel-like factor 10
NM_001166659 Lekr1 leucine, glutamate and lysine rich 1 isoform 1
NM_001081298 Lphn2 latrophilin-2
NM_178725 Lrrc4c leucine-rich repeat-containing protein 4C
NM_001025577 Maf transcription factor Maf
NM_008548 Man1a mannosyl-oligosaccharide 1,2-alpha-mannosidase
NM_011945 Map3k1 mitogen-activated protein kinase kinase kinase
NM_016700 Mapk8 mitogen-activated protein kinase 8
NM_001146176 Max protein max isoform 2
NM_020007 Mbnl1 muscleblind-like protein 1
NM_008560 Mc2r adrenocorticotropic hormone receptor




NM_001113374 Mocs2 molybdopterin synthase sulfur carrier subunit
NM_010820 Mpdz multiple PDZ domain protein
NM_016804 Mtx2 metaxin-2
NM_153789 Mylip E3 ubiquitin-protein ligase MYLIP isoform 1
NM_001166030 Mylk4 myosin light chain kinase family member 4
NM_176957 Nckap5 Nck-associated protein 5 isoform 3
NM_022996 Ndfip1 NEDD4 family-interacting protein 1
NM_028757 Nebl nebulette
NM_010894 Neurod1 neurogenic differentiation factor 1
NM_153079 Nmur2 neuromedin-U receptor 2
NM_023456 Npy neuropeptide Y precursor
NM_011851 Nt5e 5'-nucleotidase precursor
NM_172290 Ntm neurotrimin precursor
NM_027722 Nudt4 diphosphoinositol polyphosphate phosphohydrolase
NM_028696 Obfc2a SOSS complex subunit B2
NM_011857 Odz3 teneurin-3 isoform 1
NM_011019 Osmr oncostatin-M-specific receptor subunit beta
NM_001081164 Otud4 OTU domain-containing protein 4
NM_011033 Pabpc2 poly A binding protein, cytoplasmic 2
NM_181402 Parp11 poly [ADP-ribose] polymerase 11
NM_008781 Pax3 paired box protein Pax-3 isoform a
NM_008783 Pbx1 pre-B-cell leukemia transcription factor 1
NM_009344 Phlda1 pleckstrin homology-like domain family A member
NM_001024955 Pik3r1 phosphatidylinositol 3-kinase regulatory subunit
NR_003202 Pinc
NM_011097 Pitx1 pituitary homeobox 1
NM_001083110 Pja1 E3 ubiquitin-protein ligase Praja-1 isoform 1
NM_153179 Pkhd1 polyductin
NM_008869 Pla2g4a cytosolic phospholipase A2
NM_018797 Plxnc1 plexin-C1 precursor
NM_080555 Ppap2b lipid phosphate phosphohydrolase 3
NM_177741 Ppp1r3b protein phosphatase 1 regulatory subunit 3B
NM_177698 Psd3 PH and SEC7 domain-containing protein 3 isoform
NM_019550 Ptbp2 polypyrimidine tract-binding protein 2
NM_008960 Pten phosphatidylinositol-3,4,5-trisphosphate
NM_008966 Ptgfr prostaglandin F2-alpha receptor
NM_011201 Ptpn1 tyrosine-protein phosphatase non-receptor type
NM_001081432 Ptprq phosphotidylinositol phosphatase PTPRQ
NM_021424 Pvrl1 poliovirus receptor-related protein 1 precursor
NM_001163303 Pxmp3 peroxisome biogenesis factor 2
NM_027455 Qpct glutaminyl-peptide cyclotransferase precursor
NM_011246 Rasgrp1 RAS guanyl-releasing protein 1
NM_001080928 Rbpj recombining binding protein suppressor of
NM_178606 Reep3 receptor expression-enhancing protein 3
NM_009061 Rgs2 regulator of G-protein signaling 2
NM_178779 Rnf152 RING finger protein 152
NM_025974 Rpl14 60S ribosomal protein L14
NM_011297 Rps24 40S ribosomal protein S24 isoform 1
NM_017475 Rragc ras-related GTP-binding protein C
NM_172769 Sc5d lathosterol oxidase
NM_030261 Sesn3 sestrin-3
NM_009144 Sfrp2 secreted frizzled-related protein 2 precursor
NM_013665 Shox2 short stature homeobox protein 2
NM_181590 Shq1 protein SHQ1 homolog
NM_015829 Slc25a13 calcium-binding mitochondrial carrier protein
NM_001033286 Slc30a10 zinc transporter 10
NM_022885 Slc30a5 zinc transporter 5
NM_175121 Slc38a2 sodium-coupled neutral amino acid transporter 2
NM_009208 Slc4a3 anion exchange protein 3
NM_011415 Snai2 zinc finger protein SNAI2
NM_028874 Snx19 sorting nexin-19
NM_025696 Sorcs3 VPS10 domain-containing receptor SorCS3
NM_011436 Sorl1 sortilin-related receptor
NM_001098425 Sp3 transcription factor Sp3 isoform 2
NR_001582 Speer5-ps1
NM_033523 Spred2 sprouty-related, EVH1 domain-containing protein
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NM_011372 St6galnac3 alpha-N-acetylgalactosaminide
NM_027399 Steap1 metalloreductase STEAP1
NM_054098 Steap4 metalloreductase STEAP4
NM_138667 Tab2 TGF-beta-activated kinase 1 and MAP3K7-binding
NM_177089 Tacc1 transforming acidic coiled-coil-containing
NM_030732 Tbl1xr1 F-box-like/WD repeat-containing protein TBL1XR1
NM_013685 Tcf4 transcription factor 4 isoform a
NM_207176 Tes testin
NM_009371 Tgfbr2 TGF-beta receptor type-2 isoform 1
NM_001164074 Tgif1 homeobox protein TGIF1 isoform c
NM_011580 Thbs1 thrombospondin-1
NM_011581 Thbs2 thrombospondin-2 precursor
NM_178413 Thnsl2 threonine synthase-like 2
NM_012033 Tinag tubulointerstitial nephritis antigen
NM_001163574 Tjp1 tight junction protein ZO-1 isoform 2
NM_001083928 Tle3 transducin-like enhancer protein 3 isoform 3
NM_178056 Tm2d3 TM2 domain-containing protein 3 isoform 2
NM_015775 Tmprss2 transmembrane protease serine 2
NM_177368 Tmtc2 transmembrane and TPR repeat-containing protein
NM_028339 Tmx1 thioredoxin-related transmembrane protein 1
NM_183391 Tnfsf18 tumor necrosis factor (ligand) superfamily,
NM_009408 Top1 DNA topoisomerase 1
NM_144549 Trib1 tribbles homolog 1
NM_030706 Trim2 tripartite motif-containing protein 2
NM_001039104 Trpm1 transient receptor potential cation channel
NM_001081300 Tshz1 teashirt homolog 1
NM_029321 Ttc32 tetratricopeptide repeat protein 32
NM_028283 Uaca uveal autoantigen with coiled-coil domains and
NM_183225 Usp24 ubiquitin carboxyl-terminal hydrolase 24
NM_144826 Utp6 U3 small nucleolar RNA-associated protein 6
NM_027614 Wdr20b WD repeat-containing protein 20
NM_080848 Wdr5 WD repeat-containing protein 5
NM_001014981 Wdr7 WD repeat-containing protein 7
NM_028599 Wdr75 WD repeat-containing protein 75
NM_026858 Xrcc6bp1 mitochondrial inner membrane protease ATP23
NM_023311 Yipf5 protein YIPF5
NM_022985 Zfand6 AN1-type zinc finger protein 6
NM_146224 Zfp280d zinc finger protein 280D
NM_001001806 Zfp36l2 zinc finger protein 36, C3H1 type-like 2
NM_183033 Zfp516 zinc finger protein 516
NM_145492 Zfp521 zinc finger protein 521
NM_175751 Zfp608 zinc finger protein 608
NM_134054 1110002B05Rik small subunit of serine palmitoyltransferase A
NM_001145198 1500009L16Rik hypothetical protein LOC69784
NM_177718 1600021P15Rik hypothetical protein LOC239796
NR_027968 1700020N01Rik
NM_026931 1810011O10Rik thyroid cancer-1






NM_027668 4933412E24Rik hypothetical protein LOC71088
NM_001081963 9430020K01Rik hypothetical protein LOC240185
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